GO.ID,Term,Annotated,Significant,Expected,classicFisher,bonferroni,bh,foldEnrichment,Ontology
GO:0006518,peptide metabolic process,749,24,4.21,3.7e-12,1.78044e-8,1.78044e-8,5.7,BP
GO:0006412,translation,572,21,3.21,7.8e-12,3.75336e-8,1.87668e-8,6.54,BP
GO:0043043,peptide biosynthetic process,595,21,3.34,1.6e-11,7.699199999999999e-8,2.5664e-8,6.29,BP
GO:0043604,amide biosynthetic process,701,21,3.94,3.3e-10,1.58796e-6,3.9699e-7,5.33,BP
GO:0071840,cellular component organization or bioge...,6181,67,34.71,5.6e-10,2.6947200000000003e-6,5.38944e-7,1.93,BP
GO:0043603,cellular amide metabolic process,970,24,5.45,7.4e-10,3.56088e-6,5.9348e-7,4.4,BP
GO:0051128,regulation of cellular component organiz...,2590,40,14.54,9.3e-10,4.47516e-6,6.393085714285715e-7,2.75,BP
GO:0048699,generation of neurons,1687,31,9.47,2.4e-09,1.15488e-5,1.4436e-6,3.27,BP
GO:0044238,primary metabolic process,9317,84,52.31,3.5e-09,1.6842e-5,1.8713333333333332e-6,1.61,BP
GO:0016043,cellular component organization,6004,64,33.71,4.5e-09,2.1654e-5,1.9248e-6,1.9,BP
GO:0009058,biosynthetic process,5115,58,28.72,4.6e-09,2.2135199999999998e-5,1.9248e-6,2.02,BP
GO:0044260,cellular macromolecule metabolic process,7120,71,39.98,4.8e-09,2.30976e-5,1.9248e-6,1.78,BP
GO:1901576,organic substance biosynthetic process,5019,57,28.18,6.8e-09,3.2721599999999995e-5,2.5170461538461535e-6,2.02,BP
GO:0022008,neurogenesis,1793,31,10.07,1.0e-08,4.812e-5,3.437142857142857e-6,3.08,BP
GO:0009059,macromolecule biosynthetic process,4105,50,23.05,1.1e-08,5.2931999999999994e-5,3.5288e-6,2.17,BP
GO:0034641,cellular nitrogen compound metabolic pro...,5536,60,31.08,1.2e-08,5.7744e-5,3.609e-6,1.93,BP
GO:0006996,organelle organization,3599,46,20.21,1.4e-08,6.7368e-5,3.9628235294117644e-06,2.28,BP
GO:0044237,cellular metabolic process,9392,83,52.73,1.7e-08,8.1804e-5,4.5446666666666665e-6,1.57,BP
GO:0044267,cellular protein metabolic process,4573,53,25.68,1.8e-08,8.6616e-5,4.558736842105263e-6,2.06,BP
GO:0048518,positive regulation of biological proces...,6114,63,34.33,2.8e-08,1.34736e-4,6.645142857142857e-6,1.84,BP
GO:0044249,cellular biosynthetic process,4923,55,27.64,2.9e-08,1.39548e-4,6.645142857142857e-6,1.99,BP
GO:0044271,cellular nitrogen compound biosynthetic ...,3970,48,22.29,3.5e-08,1.6842000000000002e-4,7.531826086956521e-6,2.15,BP
GO:0006807,nitrogen compound metabolic process,8802,79,49.42,3.6e-08,1.73232e-4,7.531826086956521e-6,1.6,BP
GO:0007399,nervous system development,2347,35,13.18,3.8e-08,1.82856e-4,7.619e-6,2.66,BP
GO:0034645,cellular macromolecule biosynthetic proc...,4006,48,22.49,4.6e-08,2.2135200000000002e-4,8.854079999999999e-6,2.13,BP
GO:0000902,cell morphogenesis,1114,23,6.25,5.2e-08,2.50224e-4,9.624e-6,3.68,BP
GO:0030182,neuron differentiation,1507,27,8.46,5.5e-08,2.6466e-4,9.802222222222224e-6,3.19,BP
GO:0043170,macromolecule metabolic process,8366,76,46.97,6.1e-08,2.93532e-4,1.0483285714285716e-5,1.62,BP
GO:0032989,cellular component morphogenesis,1225,24,6.88,6.7e-08,3.2240400000000004e-4,1.1117379310344829e-5,3.49,BP
GO:0060255,regulation of macromolecule metabolic pr...,5534,58,31.07,9.6e-08,4.61952e-4,1.53984e-5,1.87,BP
GO:0071704,organic substance metabolic process,9887,84,55.51,1.0e-07,4.812e-4,1.552258064516129e-5,1.51,BP
GO:0044085,cellular component biogenesis,3057,40,17.16,1.1e-07,5.2932e-4,1.654125e-5,2.33,BP
GO:1901564,organonitrogen compound metabolic proces...,6107,61,34.29,2.0e-07,9.624e-4,2.9163636363636362e-5,1.78,BP
GO:0008088,axo-dendritic transport,77,7,0.43,2.6e-07,0.00125112,3.679764705882353e-5,16.28,BP
GO:0010467,gene expression,4801,52,26.96,2.7e-07,0.0012992400000000001,3.712114285714286e-5,1.93,BP
GO:0007010,cytoskeleton organization,1323,24,7.43,2.8e-07,0.0013473600000000001,3.7426666666666665e-5,3.23,BP
GO:0019222,regulation of metabolic process,6009,60,33.74,2.9e-07,0.00139548,3.7715675675675675e-5,1.78,BP
GO:0048522,positive regulation of cellular process,5410,56,30.38,3.1e-07,0.00149172,3.925578947368421e-5,1.84,BP
GO:0080090,regulation of primary metabolic process,5295,55,29.73,3.9e-07,0.0018766800000000001,4.694634146341463e-5,1.85,BP
GO:0051171,regulation of nitrogen compound metaboli...,5150,54,28.92,4.0e-07,0.0019248,4.694634146341463e-5,1.87,BP
GO:0022607,cellular component assembly,2829,37,15.88,4.0e-07,0.0019248,4.694634146341463e-5,2.33,BP
GO:0031323,regulation of cellular metabolic process,5454,56,30.62,4.1e-07,0.00197292,4.6974285714285714e-5,1.83,BP
GO:0008152,metabolic process,10362,85,58.18,4.7e-07,0.00226164,5.259627906976745e-5,1.46,BP
GO:0019538,protein metabolic process,5210,54,29.25,5.9e-07,0.00283908,6.452454545454544e-5,1.85,BP
GO:0051641,cellular localization,2629,35,14.76,6.1e-07,0.00293532,6.522933333333333e-5,2.37,BP
GO:0009653,anatomical structure morphogenesis,2759,36,15.49,6.5e-07,0.0031278,6.799565217391305e-5,2.32,BP
GO:0031175,neuron projection development,1097,21,6.16,7.4e-07,0.00356088,7.576340425531915e-5,3.41,BP
GO:0048468,cell development,2424,33,13.61,8.7e-07,0.0041864400000000005,8.641959183673469e-5,2.42,BP
GO:0098930,axonal transport,58,6,0.33,8.8e-07,0.00423456,8.641959183673469e-5,18.18,BP
GO:0043933,protein-containing complex subunit organ...,1969,29,11.06,1.0e-06,0.0048119999999999994,9.623999999999999e-5,2.62,BP
GO:0042255,ribosome assembly,61,6,0.34,1.2e-06,0.0057744,1.1322352941176471e-4,17.65,BP
GO:0051246,regulation of protein metabolic process,2720,35,15.27,1.4e-06,0.006736799999999999,1.2475555555555555e-4,2.29,BP
GO:0007017,microtubule-based process,770,17,4.32,1.4e-06,0.006736799999999999,1.2475555555555555e-4,3.94,BP
GO:0042274,ribosomal small subunit biogenesis,63,6,0.35,1.4e-06,0.006736799999999999,1.2475555555555555e-4,17.14,BP
GO:0010604,positive regulation of macromolecule met...,3247,39,18.23,1.5e-06,0.0072180000000000005,1.3123636363636363e-4,2.14,BP
GO:0044087,regulation of cellular component biogene...,957,19,5.37,1.6e-06,0.0076992,1.3748571428571428e-4,3.54,BP
GO:0009893,positive regulation of metabolic process,3528,41,19.81,1.7e-06,0.0081804000000000009,1.4351578947368422e-4,2.07,BP
GO:0033043,regulation of organelle organization,1260,22,7.07,1.8e-06,0.0086616,1.4933793103448276e-4,3.11,BP
GO:0032268,regulation of cellular protein metabolic...,2529,33,14.2,2.3e-06,0.0110676,1.8758644067796613e-4,2.32,BP
GO:0009889,regulation of biosynthetic process,3570,41,20.04,2.4e-06,0.0115488,1.9248e-4,2.05,BP
GO:1904377,positive regulation of protein localizat...,69,6,0.39,2.5e-06,0.01203,1.9403225806451614e-4,15.38,BP
GO:0051493,regulation of cytoskeleton organization,548,14,3.08,2.5e-06,0.01203,1.9403225806451614e-4,4.55,BP
GO:0050790,regulation of catalytic activity,1833,27,10.29,2.6e-06,0.0125112,1.985904761904762e-4,2.62,BP
GO:0051240,positive regulation of multicellular org...,1957,28,10.99,2.9e-06,0.013954800000000002,2.1804375000000002e-4,2.55,BP
GO:0010556,regulation of macromolecule biosynthetic...,3333,39,18.71,3.0e-06,0.014436000000000001,2.220923076923077e-4,2.08,BP
GO:0010970,transport along microtubule,160,8,0.9,3.4e-06,0.016360800000000002,2.406e-4,8.89,BP
GO:0099111,microtubule-based transport,160,8,0.9,3.4e-06,0.016360800000000002,2.406e-4,8.89,BP
GO:0009890,negative regulation of biosynthetic proc...,1524,24,8.56,3.4e-06,0.016360800000000002,2.406e-4,2.8,BP
GO:0048519,negative regulation of biological proces...,5347,53,30.02,3.5e-06,0.016842,2.4408695652173914e-4,1.77,BP
GO:0009987,cellular process,15679,108,88.03,3.8e-06,0.0182856,2.6122285714285715e-4,1.23,BP
GO:0007275,multicellular organism development,5380,53,30.21,4.2e-06,0.020210399999999996,2.846535211267605e-4,1.75,BP
GO:0008090,retrograde axonal transport,20,4,0.11,4.3e-06,0.0206916,2.873833333333333e-4,36.36,BP
GO:0009892,negative regulation of metabolic process,2874,35,16.14,4.9e-06,0.023578799999999997,3.208e-4,2.17,BP
GO:0065008,regulation of biological quality,4092,44,22.98,5.0e-06,0.02406,3.208e-4,1.91,BP
GO:0048666,neuron development,1238,21,6.95,5.0e-06,0.02406,3.208e-4,3.02,BP
GO:1901566,organonitrogen compound biosynthetic pro...,1564,24,8.78,5.4e-06,0.0259848,3.4190526315789477e-4,2.73,BP
GO:0030705,cytoskeleton-dependent intracellular tra...,172,8,0.97,5.8e-06,0.027909600000000003,3.5781538461538467e-4,8.25,BP
GO:0061564,axon development,509,13,2.86,5.8e-06,0.027909600000000003,3.5781538461538467e-4,4.55,BP
GO:0071826,ribonucleoprotein complex subunit organi...,230,9,1.29,6.1e-06,0.0293532,3.7155949367088606e-4,6.98,BP
GO:0008089,anterograde axonal transport,48,5,0.27,7.2e-06,0.0346464,4.3307999999999997e-4,18.52,BP
GO:0002181,cytoplasmic translation,83,6,0.47,7.3e-06,0.0351276,4.3367407407407407e-4,12.77,BP
GO:0034613,cellular protein localization,1709,25,9.6,7.6e-06,0.0365712,4.45990243902439e-4,2.6,BP
GO:0048523,negative regulation of cellular process,4750,48,26.67,8.4e-06,0.04042079999999999,4.8119999999999993e-4,1.8,BP
GO:0070727,cellular macromolecule localization,1719,25,9.65,8.4e-06,0.04042079999999999,4.8119999999999993e-4,2.59,BP
GO:0048731,system development,4759,48,26.72,8.8e-06,0.042345600000000004,4.981835294117647e-4,1.8,BP
GO:0007044,cell-substrate junction assembly,86,6,0.48,9.0e-06,0.043308,5.035813953488372e-4,12.5,BP
GO:0048869,cellular developmental process,4475,46,25.13,9.3e-06,0.0447516,5.085409090909091e-4,1.83,BP
GO:0051093,negative regulation of developmental pro...,1082,19,6.08,9.3e-06,0.0447516,5.085409090909091e-4,3.12,BP
GO:0022603,regulation of anatomical structure morph...,1091,19,6.13,1.0e-05,0.04812,5.406741573033708e-4,3.1,BP
GO:2000112,regulation of cellular macromolecule bio...,3241,37,18.2,1.1e-05,0.052932,5.816703296703296e-4,2.03,BP
GO:0010033,response to organic substance,3108,36,17.45,1.1e-05,0.052932,5.816703296703296e-4,2.06,BP
GO:0034622,cellular protein-containing complex asse...,1000,18,5.61,1.2e-05,0.057744000000000004,6.209032258064517e-4,3.21,BP
GO:0031324,negative regulation of cellular metaboli...,2476,31,13.9,1.2e-05,0.057744000000000004,6.209032258064517e-4,2.23,BP
GO:0048856,anatomical structure development,5881,55,33.02,1.3e-05,0.062556,6.51625e-4,1.67,BP
GO:0000904,cell morphogenesis involved in different...,813,16,4.56,1.3e-05,0.062556,6.51625e-4,3.51,BP
GO:0010558,negative regulation of macromolecule bio...,1428,22,8.02,1.3e-05,0.062556,6.51625e-4,2.74,BP
GO:0032990,cell part morphogenesis,726,15,4.08,1.4e-05,0.067368,6.804848484848485e-4,3.68,BP
GO:0050793,regulation of developmental process,2753,33,15.46,1.4e-05,0.067368,6.804848484848485e-4,2.13,BP
GO:0120036,plasma membrane bounded cell projection ...,1544,23,8.67,1.4e-05,0.067368,6.804848484848485e-4,2.65,BP
GO:0007409,axonogenesis,473,12,2.66,1.5e-05,0.07218000000000001,7.218e-4,4.51,BP
GO:0065009,regulation of molecular function,2513,31,14.11,1.6e-05,0.07699199999999999,7.622970297029703e-4,2.2,BP
GO:0006928,movement of cell or subcellular componen...,2039,27,11.45,1.9e-05,0.09142800000000001,8.963529411764707e-4,2.36,BP
GO:0032502,developmental process,6278,57,35.25,2.0e-05,0.09624,9.343689320388351e-4,1.62,BP
GO:0030030,cell projection organization,1590,23,8.93,2.3e-05,0.110676,0.0010641923076923077,2.58,BP
GO:1903078,positive regulation of protein localizat...,61,5,0.34,2.4e-05,0.11548800000000001,0.0010793271028037383,14.71,BP
GO:0031326,regulation of cellular biosynthetic proc...,3496,38,19.63,2.4e-05,0.11548800000000001,0.0010793271028037383,1.94,BP
GO:1901360,organic cyclic compound metabolic proces...,5235,50,29.39,2.4e-05,0.11548800000000001,0.0010793271028037383,1.7,BP
GO:0051173,positive regulation of nitrogen compound...,3096,35,17.38,2.5e-05,0.1203,0.001113888888888889,2.01,BP
GO:0007018,microtubule-based movement,278,9,1.56,2.8e-05,0.134736,0.001213837837837838,5.77,BP
GO:0042254,ribosome biogenesis,278,9,1.56,2.8e-05,0.134736,0.001213837837837838,5.77,BP
GO:0050767,regulation of neurogenesis,967,17,5.43,2.8e-05,0.134736,0.001213837837837838,3.13,BP
GO:2000113,negative regulation of cellular macromol...,1391,21,7.81,2.9e-05,0.139548,0.001234938053097345,2.69,BP
GO:0022613,ribonucleoprotein complex biogenesis,427,11,2.4,2.9e-05,0.139548,0.001234938053097345,4.58,BP
GO:0048812,neuron projection morphogenesis,683,14,3.83,3.0e-05,0.14436000000000002,0.001255304347826087,3.66,BP
GO:0048668,collateral sprouting,32,4,0.18,3.0e-05,0.14436000000000002,0.001255304347826087,22.22,BP
GO:0071310,cellular response to organic substance,2470,30,13.87,3.1e-05,0.149172,0.001264169491525424,2.16,BP
GO:0030154,cell differentiation,4243,43,23.82,3.1e-05,0.149172,0.001264169491525424,1.81,BP
GO:0022618,ribonucleoprotein complex assembly,217,8,1.22,3.1e-05,0.149172,0.001264169491525424,6.56,BP
GO:0006139,nucleobase-containing compound metabolic...,4840,47,27.18,3.3e-05,0.15879600000000002,0.0013233000000000001,1.73,BP
GO:0051960,regulation of nervous system development,1082,18,6.08,3.3e-05,0.15879600000000002,0.0013233000000000001,2.96,BP
GO:0010605,negative regulation of macromolecule met...,2612,31,14.67,3.4e-05,0.163608,0.0013521322314049586,2.11,BP
GO:0051130,positive regulation of cellular componen...,1303,20,7.32,3.7e-05,0.17804399999999998,0.0014475121951219513,2.73,BP
GO:0050794,regulation of cellular process,10724,82,60.21,3.7e-05,0.17804399999999998,0.0014475121951219513,1.36,BP
GO:0120039,plasma membrane bounded cell projection ...,699,14,3.92,3.8e-05,0.18285600000000002,0.0014746451612903226,3.57,BP
GO:1901653,cellular response to peptide,290,9,1.63,3.9e-05,0.187668,0.0015013440000000002,5.52,BP
GO:1903827,regulation of cellular protein localizat...,526,12,2.95,4.1e-05,0.197292,0.0015534803149606297,4.07,BP
GO:0048858,cell projection morphogenesis,704,14,3.95,4.1e-05,0.197292,0.0015534803149606297,3.54,BP
GO:1901701,cellular response to oxygen-containing c...,1207,19,6.78,4.2e-05,0.20210399999999998,0.0015666976744186047,2.8,BP
GO:0006357,regulation of transcription by RNA polym...,2012,26,11.3,4.2e-05,0.20210399999999998,0.0015666976744186047,2.3,BP
GO:0040007,growth,1103,18,6.19,4.3e-05,0.20691600000000002,0.0015916615384615387,2.91,BP
GO:0009719,response to endogenous stimulus,1430,21,8.03,4.4e-05,0.211728,0.0015919398496240602,2.62,BP
GO:0022604,regulation of cell morphogenesis,530,12,2.98,4.4e-05,0.211728,0.0015919398496240602,4.03,BP
GO:0090304,nucleic acid metabolic process,4304,43,24.17,4.4e-05,0.211728,0.0015919398496240602,1.78,BP
GO:0060284,regulation of cell development,1106,18,6.21,4.5e-05,0.21654,0.0016159701492537313,2.9,BP
GO:0033554,cellular response to stress,1781,24,10,4.6e-05,0.221352,0.0016396444444444446,2.4,BP
GO:0070887,cellular response to chemical stimulus,3063,34,17.2,5.0e-05,0.2406,0.0017691176470588236,1.98,BP
GO:0042221,response to chemical,4182,42,23.48,5.1e-05,0.245412,0.0017913284671532844,1.79,BP
GO:1903829,positive regulation of cellular protein ...,302,9,1.7,5.3e-05,0.255036,0.001848086956521739,5.29,BP
GO:0010629,negative regulation of gene expression,1800,24,10.11,5.4e-05,0.25984799999999997,0.001869410071942446,2.37,BP
GO:0048667,cell morphogenesis involved in neuron di...,632,13,3.55,5.6e-05,0.269472,0.0019248000000000002,3.66,BP
GO:0051172,negative regulation of nitrogen compound...,2297,28,12.9,5.7e-05,0.27428400000000003,0.001945276595744681,2.17,BP
GO:0051649,establishment of localization in cell,1933,25,10.85,6.0e-05,0.28872000000000003,0.0020332394366197183,2.3,BP
GO:0071495,cellular response to endogenous stimulus,1241,19,6.97,6.1e-05,0.293532,0.0020526713286713287,2.73,BP
GO:1901699,cellular response to nitrogen compound,638,13,3.58,6.2e-05,0.298344,0.002071833333333333,3.63,BP
GO:0031325,positive regulation of cellular metaboli...,3240,35,18.19,6.6e-05,0.31759200000000004,0.002160489795918368,1.92,BP
GO:0046483,heterocycle metabolic process,4969,47,27.9,6.6e-05,0.31759200000000004,0.002160489795918368,1.68,BP
GO:0006366,transcription by RNA polymerase II,2067,26,11.61,6.6e-05,0.31759200000000004,0.002160489795918368,2.24,BP
GO:0019219,regulation of nucleobase-containing comp...,3382,36,18.99,6.8e-05,0.327216,0.002210918918918919,1.9,BP
GO:0007045,cell-substrate adherens junction assembl...,76,5,0.43,6.9e-05,0.332028,0.0022135199999999996,11.63,BP
GO:0048041,focal adhesion assembly,76,5,0.43,6.9e-05,0.332028,0.0022135199999999996,11.63,BP
GO:1901700,response to oxygen-containing compound,1593,22,8.94,7.0e-05,0.33684,0.002230728476821192,2.46,BP
GO:0031327,negative regulation of cellular biosynth...,1485,21,8.34,7.5e-05,0.36089999999999994,0.0023743421052631578,2.52,BP
GO:0051338,regulation of transferase activity,843,15,4.73,7.7e-05,0.370524,0.002421725490196078,3.17,BP
GO:0050789,regulation of biological process,11466,85,64.38,7.8e-05,0.375336,0.0024372467532467533,1.32,BP
GO:0065007,biological regulation,12076,88,67.8,8.9e-05,0.428268,0.00276301935483871,1.3,BP
GO:0065003,protein-containing complex assembly,1740,23,9.77,9.1e-05,0.437892,0.002807,2.35,BP
GO:0042063,gliogenesis,326,9,1.83,9.5e-05,0.45714000000000005,0.002905358490566038,4.92,BP
GO:0071417,cellular response to organonitrogen comp...,575,12,3.23,9.6e-05,0.46195200000000003,0.002905358490566038,3.72,BP
GO:0006725,cellular aromatic compound metabolic pro...,5041,47,28.3,9.6e-05,0.46195200000000003,0.002905358490566038,1.66,BP
GO:0008104,protein localization,2633,30,14.78,0.00010,0.4812,0.0029888198757763973,2.03,BP
GO:0030036,actin cytoskeleton organization,670,13,3.76,0.00010,0.4812,0.0029888198757763973,3.46,BP
GO:0060341,regulation of cellular localization,971,16,5.45,0.00011,0.52932,0.003227560975609756,2.94,BP
GO:0051272,positive regulation of cellular componen...,584,12,3.28,0.00011,0.52932,0.003227560975609756,3.66,BP
GO:0006417,regulation of translation,334,9,1.88,0.00011,0.52932,0.003227560975609756,4.79,BP
GO:0034333,adherens junction assembly,85,5,0.48,0.00012,0.5774400000000001,0.00347855421686747,10.42,BP
GO:0017148,negative regulation of translation,136,6,0.76,0.00012,0.5774400000000001,0.00347855421686747,7.89,BP
GO:0051252,regulation of RNA metabolic process,3073,33,17.25,0.00013,0.6255599999999999,0.003701538461538461,1.91,BP
GO:0008283,cell proliferation,2027,25,11.38,0.00013,0.6255599999999999,0.003701538461538461,2.2,BP
GO:0097435,supramolecular fiber organization,687,13,3.86,0.00013,0.6255599999999999,0.003701538461538461,3.37,BP
GO:1904375,regulation of protein localization to ce...,139,6,0.78,0.00014,0.67368,0.003894104046242774,7.69,BP
GO:0040017,positive regulation of locomotion,597,12,3.35,0.00014,0.67368,0.003894104046242774,3.58,BP
GO:0048589,developmental growth,790,14,4.44,0.00014,0.67368,0.003894104046242774,3.15,BP
GO:0016070,RNA metabolic process,3787,38,21.26,0.00014,0.67368,0.003894104046242774,1.79,BP
GO:0042127,regulation of cell proliferation,1676,22,9.41,0.00015,0.7217999999999999,0.004148275862068965,2.34,BP
GO:0045595,regulation of cell differentiation,1930,24,10.84,0.00016,0.76992,0.004374545454545455,2.21,BP
GO:0070507,regulation of microtubule cytoskeleton o...,205,7,1.15,0.00016,0.76992,0.004374545454545455,6.09,BP
GO:1902903,regulation of supramolecular fiber organ...,351,9,1.97,0.00017,0.8180400000000001,0.004570055865921788,4.57,BP
GO:0016049,cell growth,521,11,2.93,0.00017,0.8180400000000001,0.004570055865921788,3.75,BP
GO:0045596,negative regulation of cell differentiat...,806,14,4.53,0.00017,0.8180400000000001,0.004570055865921788,3.09,BP
GO:0030865,cortical cytoskeleton organization,50,4,0.28,0.00018,0.86616,0.004733114754098361,14.29,BP
GO:1902533,positive regulation of intracellular sig...,1016,16,5.7,0.00018,0.86616,0.004733114754098361,2.81,BP
GO:0098840,protein transport along microtubule,20,3,0.11,0.00018,0.86616,0.004733114754098361,27.27,BP
GO:0099118,microtubule-based protein transport,20,3,0.11,0.00018,0.86616,0.004733114754098361,27.27,BP
GO:0032269,negative regulation of cellular protein ...,1020,16,5.73,0.00019,0.9142800000000001,0.004889197860962567,2.79,BP
GO:0061640,cytoskeleton-dependent cytokinesis,94,5,0.53,0.00019,0.9142800000000001,0.004889197860962567,9.43,BP
GO:0030856,regulation of epithelial cell differenti...,148,6,0.83,0.00019,0.9142800000000001,0.004889197860962567,7.23,BP
GO:2000026,regulation of multicellular organismal d...,2207,26,12.39,0.00019,0.9142800000000001,0.004889197860962567,2.1,BP
GO:0051239,regulation of multicellular organismal p...,3294,34,18.5,0.00021,1,0.005346666666666666,1.84,BP
GO:0071824,protein-DNA complex subunit organization,215,7,1.21,0.00021,1,0.005346666666666666,5.79,BP
GO:0030335,positive regulation of cell migration,543,11,3.05,0.00025,1,0.006265625,3.61,BP
GO:0010468,regulation of gene expression,3892,38,21.85,0.00025,1,0.006265625,1.74,BP
GO:0034249,negative regulation of cellular amide me...,156,6,0.88,0.00025,1,0.006265625,6.82,BP
GO:0035556,intracellular signal transduction,2646,29,14.86,0.00027,1,0.006662769230769231,1.95,BP
GO:0016358,dendrite development,296,8,1.66,0.00027,1,0.006662769230769231,4.82,BP
GO:0010628,positive regulation of gene expression,2000,24,11.23,0.00027,1,0.006662769230769231,2.14,BP
GO:0051893,regulation of focal adhesion assembly,57,4,0.32,0.00030,1,0.007327918781725887,12.5,BP
GO:0090109,regulation of cell-substrate junction as...,57,4,0.32,0.00030,1,0.007327918781725887,12.5,BP
GO:0046907,intracellular transport,1523,20,8.55,0.00031,1,0.007496080402010051,2.34,BP
GO:0006355,"regulation of transcription, DNA-templat...",2805,30,15.75,0.00031,1,0.007496080402010051,1.9,BP
GO:1905477,positive regulation of protein localizat...,105,5,0.59,0.00032,1,0.00766089552238806,8.47,BP
GO:0034248,regulation of cellular amide metabolic p...,384,9,2.16,0.00032,1,0.00766089552238806,4.17,BP
GO:1903506,regulation of nucleic acid-templated tra...,2813,30,15.79,0.00033,1,0.007822463054187193,1.9,BP
GO:1903047,mitotic cell cycle process,658,12,3.69,0.00033,1,0.007822463054187193,3.25,BP
GO:0030029,actin filament-based process,758,13,4.26,0.00034,1,0.007903768115942029,3.05,BP
GO:0010948,negative regulation of cell cycle proces...,232,7,1.3,0.00034,1,0.007903768115942029,5.38,BP
GO:2000147,positive regulation of cell motility,565,11,3.17,0.00034,1,0.007903768115942029,3.47,BP
GO:2001141,regulation of RNA biosynthetic process,2822,30,15.84,0.00034,1,0.007903768115942029,1.89,BP
GO:0051129,negative regulation of cellular componen...,761,13,4.27,0.00035,1,0.008058373205741627,3.04,BP
GO:0031399,regulation of protein modification proce...,1783,22,10.01,0.00035,1,0.008058373205741627,2.2,BP
GO:1901362,organic cyclic compound biosynthetic pro...,3529,35,19.81,0.00036,1,0.008249142857142858,1.77,BP
GO:0000122,negative regulation of transcription by ...,869,14,4.88,0.00037,1,0.008398301886792452,2.87,BP
GO:1901652,response to peptide,392,9,2.2,0.00037,1,0.008398301886792452,4.09,BP
GO:0051248,negative regulation of protein metabolic...,1087,16,6.1,0.00038,1,0.008584788732394367,2.62,BP
GO:0060249,anatomical structure homeostasis,394,9,2.21,0.00039,1,0.008769532710280374,4.07,BP
GO:0032886,regulation of microtubule-based process,241,7,1.35,0.00043,1,0.009624,5.19,BP
GO:0010001,glial cell differentiation,242,7,1.36,0.00044,1,0.009712293577981652,5.15,BP
GO:0001952,regulation of cell-matrix adhesion,113,5,0.63,0.00044,1,0.009712293577981652,7.94,BP
GO:1903076,regulation of protein localization to pl...,113,5,0.63,0.00044,1,0.009712293577981652,7.94,BP
GO:0044093,positive regulation of molecular functio...,1450,19,8.14,0.00045,1,0.009887671232876712,2.33,BP
GO:0032879,regulation of localization,2869,30,16.11,0.00046,1,0.010015927601809955,1.86,BP
GO:1903391,regulation of adherens junction organiza...,64,4,0.36,0.00046,1,0.010015927601809955,11.11,BP
GO:0051336,regulation of hydrolase activity,1001,15,5.62,0.00049,1,0.010621081081081082,2.67,BP
GO:0043524,negative regulation of neuron apoptotic ...,179,6,1.01,0.00053,1,0.011436591928251121,5.94,BP
GO:0006351,"transcription, DNA-templated",2897,30,16.27,0.00054,1,0.011600357142857143,1.84,BP
GO:0010564,regulation of cell cycle process,598,11,3.36,0.00055,1,0.011762666666666668,3.27,BP
GO:0051241,negative regulation of multicellular org...,1357,18,7.62,0.00056,1,0.011822586206896551,2.36,BP
GO:0097659,nucleic acid-templated transcription,2905,30,16.31,0.00057,1,0.011822586206896551,1.84,BP
GO:0071353,cellular response to interleukin-4,29,3,0.16,0.00057,1,0.011822586206896551,18.75,BP
GO:0090169,regulation of spindle assembly,29,3,0.16,0.00057,1,0.011822586206896551,18.75,BP
GO:0070925,organelle assembly,801,13,4.5,0.00057,1,0.011822586206896551,2.89,BP
GO:0022402,cell cycle process,1128,16,6.33,0.00057,1,0.011822586206896551,2.53,BP
GO:0034654,nucleobase-containing compound biosynthe...,3328,33,18.69,0.00057,1,0.011822586206896551,1.77,BP
GO:0031109,microtubule polymerization or depolymeri...,120,5,0.67,0.00058,1,0.011978369098712447,7.46,BP
GO:0032774,RNA biosynthetic process,2918,30,16.38,0.00061,1,0.012490723404255317,1.83,BP
GO:0010608,posttranscriptional regulation of gene e...,510,10,2.86,0.00061,1,0.012490723404255317,3.5,BP
GO:0000281,mitotic cytokinesis,69,4,0.39,0.00062,1,0.012641694915254239,10.26,BP
GO:0008286,insulin receptor signaling pathway,122,5,0.69,0.00063,1,0.012791392405063292,7.25,BP
GO:0000278,mitotic cell cycle,813,13,4.56,0.00065,1,0.013142016806722688,2.85,BP
GO:0050768,negative regulation of neurogenesis,339,8,1.9,0.00066,1,0.01328836820083682,4.21,BP
GO:0008203,cholesterol metabolic process,124,5,0.7,0.00068,1,0.013634000000000002,7.14,BP
GO:0070670,response to interleukin-4,31,3,0.17,0.00069,1,0.013777095435684646,17.65,BP
GO:0023014,signal transduction by protein phosphory...,819,13,4.6,0.00070,1,0.013861728395061728,2.83,BP
GO:0045665,negative regulation of neuron differenti...,262,7,1.47,0.00070,1,0.013861728395061728,4.76,BP
GO:0048588,developmental cell growth,263,7,1.48,0.00072,1,0.014199344262295084,4.73,BP
GO:0034332,adherens junction organization,126,5,0.71,0.00073,1,0.014337795918367346,7.04,BP
GO:0035329,hippo signaling,32,3,0.18,0.00076,1,0.014746451612903225,16.67,BP
GO:0009966,regulation of signal transduction,2819,29,15.83,0.00076,1,0.014746451612903225,1.83,BP
GO:0033036,macromolecule localization,2958,30,16.61,0.00076,1,0.014746451612903225,1.81,BP
GO:0043066,negative regulation of apoptotic process,937,14,5.26,0.00078,1,0.015073734939759035,2.66,BP
GO:0051253,negative regulation of RNA metabolic pro...,1281,17,7.19,0.00080,1,0.015398400000000001,2.36,BP
GO:0018130,heterocycle biosynthetic process,3392,33,19.05,0.00081,1,0.015467142857142856,1.73,BP
GO:1902652,secondary alcohol metabolic process,129,5,0.72,0.00081,1,0.015467142857142856,6.94,BP
GO:0042592,homeostatic process,1899,22,10.66,0.00082,1,0.015596205533596837,2.06,BP
GO:0009967,positive regulation of signal transducti...,1527,19,8.57,0.00085,1,0.01604,2.22,BP
GO:0032880,regulation of protein localization,1057,15,5.93,0.00085,1,0.01604,2.53,BP
GO:0019438,aromatic compound biosynthetic process,3405,33,19.12,0.00086,1,0.0161653125,1.73,BP
GO:0045934,negative regulation of nucleobase-contai...,1410,18,7.92,0.00088,1,0.016476887159533077,2.27,BP
GO:0051783,regulation of nuclear division,198,6,1.11,0.00089,1,0.016593103448275862,5.41,BP
GO:0060560,developmental growth involved in morphog...,273,7,1.53,0.00090,1,0.016593103448275862,4.58,BP
GO:0045787,positive regulation of cell cycle,355,8,1.99,0.00090,1,0.016593103448275862,4.02,BP
GO:1990778,protein localization to cell periphery,355,8,1.99,0.00090,1,0.016593103448275862,4.02,BP
GO:0043549,regulation of kinase activity,737,12,4.14,0.00091,1,0.016713435114503815,2.9,BP
GO:0043085,positive regulation of catalytic activit...,1065,15,5.98,0.00092,1,0.016832851711026615,2.51,BP
GO:0016125,sterol metabolic process,133,5,0.75,0.00093,1,0.016951363636363636,6.67,BP
GO:0043069,negative regulation of programmed cell d...,955,14,5.36,0.00094,1,0.01706898113207547,2.61,BP
GO:0045892,"negative regulation of transcription, DN...",1189,16,6.68,0.00100,1,0.018090225563909778,2.4,BP
GO:0042981,regulation of apoptotic process,1552,19,8.71,0.00103,1,0.018493880597014928,2.18,BP
GO:0051961,negative regulation of nervous system de...,363,8,2.04,0.00103,1,0.018493880597014928,3.92,BP
GO:1903507,negative regulation of nucleic acid-temp...,1193,16,6.7,0.00104,1,0.01853511111111111,2.39,BP
GO:0007160,cell-matrix adhesion,204,6,1.15,0.00104,1,0.01853511111111111,5.22,BP
GO:1902679,negative regulation of RNA biosynthetic ...,1194,16,6.7,0.00105,1,0.018575735294117646,2.39,BP
GO:0022411,cellular component disassembly,364,8,2.04,0.00105,1,0.018575735294117646,3.92,BP
GO:0034728,nucleosome organization,137,5,0.77,0.00106,1,0.018683956043956045,6.49,BP
GO:0051094,positive regulation of developmental pro...,1560,19,8.76,0.00109,1,0.019073018181818183,2.17,BP
GO:0031032,actomyosin structure organization,206,6,1.16,0.00109,1,0.019073018181818183,5.17,BP
GO:0010557,positive regulation of macromolecule bio...,1813,21,10.18,0.00110,1,0.019178260869565218,2.06,BP
GO:0051179,localization,5896,49,33.1,0.00113,1,0.01963018050541516,1.48,BP
GO:0034329,cell junction assembly,208,6,1.17,0.00115,1,0.019834408602150536,5.13,BP
GO:1902115,regulation of organelle assembly,208,6,1.17,0.00115,1,0.019834408602150536,5.13,BP
GO:0051726,regulation of cell cycle,976,14,5.48,0.00116,1,0.019935428571428573,2.55,BP
GO:0008284,positive regulation of cell proliferatio...,979,14,5.5,0.00119,1,0.0203782206405694,2.55,BP
GO:0043067,regulation of programmed cell death,1573,19,8.83,0.00120,1,0.02047659574468085,2.15,BP
GO:1901888,regulation of cell junction assembly,83,4,0.47,0.00123,1,0.02091434628975265,8.51,BP
GO:0006338,chromatin remodeling,143,5,0.8,0.00129,1,0.02185732394366197,6.25,BP
GO:0006333,chromatin assembly or disassembly,144,5,0.81,0.00133,1,0.022299512195121954,6.17,BP
GO:0010810,regulation of cell-substrate adhesion,214,6,1.2,0.00133,1,0.022299512195121954,5,BP
GO:0016477,cell migration,1463,18,8.21,0.00133,1,0.022299512195121954,2.19,BP
GO:0045859,regulation of protein kinase activity,667,11,3.75,0.00134,1,0.022389166666666665,2.93,BP
GO:0006468,protein phosphorylation,1842,21,10.34,0.00135,1,0.022478200692041525,2.03,BP
GO:0014002,astrocyte development,39,3,0.22,0.00136,1,0.022566620689655172,13.64,BP
GO:0006464,cellular protein modification process,3496,33,19.63,0.00137,1,0.02257684931506849,1.68,BP
GO:0036211,protein modification process,3496,33,19.63,0.00137,1,0.02257684931506849,1.68,BP
GO:0032984,protein-containing complex disassembly,216,6,1.21,0.00139,1,0.022828259385665527,4.96,BP
GO:1901698,response to nitrogen compound,997,14,5.6,0.00142,1,0.02324163265306123,2.5,BP
GO:0045935,positive regulation of nucleobase-contai...,1852,21,10.4,0.00144,1,0.023489084745762716,2.02,BP
GO:0048708,astrocyte differentiation,87,4,0.49,0.00147,1,0.023897432432432433,8.16,BP
GO:0051402,neuron apoptotic process,298,7,1.67,0.00148,1,0.023978989898989896,4.19,BP
GO:0009057,macromolecule catabolic process,1235,16,6.93,0.00149,1,0.02406,2.31,BP
GO:0031110,regulation of microtubule polymerization...,88,4,0.49,0.00153,1,0.024541199999999996,8.16,BP
GO:1902531,regulation of intracellular signal trans...,1733,20,9.73,0.00153,1,0.024541199999999996,2.06,BP
GO:0045664,regulation of neuron differentiation,785,12,4.41,0.00155,1,0.02477940199335548,2.72,BP
GO:0000226,microtubule cytoskeleton organization,578,10,3.25,0.00157,1,0.025016026490066224,3.08,BP
GO:0010721,negative regulation of cell development,388,8,2.18,0.00158,1,0.02509227722772277,3.67,BP
GO:0010243,response to organonitrogen compound,898,13,5.04,0.00161,1,0.0254846052631579,2.58,BP
GO:0010646,regulation of cell communication,3387,32,19.02,0.00163,1,0.025716590163934423,1.68,BP
GO:0006886,intracellular protein transport,901,13,5.06,0.00166,1,0.02601928338762215,2.57,BP
GO:0035295,tube development,1130,15,6.34,0.00166,1,0.02601928338762215,2.37,BP
GO:0030866,cortical actin cytoskeleton organization,42,3,0.24,0.00169,1,0.026318058252427185,12.5,BP
GO:0007167,enzyme linked receptor protein signaling...,903,13,5.07,0.00169,1,0.026318058252427185,2.56,BP
GO:0003015,heart process,225,6,1.26,0.00172,1,0.02669883870967742,4.76,BP
GO:0006457,protein folding,153,5,0.86,0.00173,1,0.026767717041800643,5.81,BP
GO:0090224,regulation of spindle organization,43,3,0.24,0.00181,1,0.027802666666666667,12.5,BP
GO:0044265,cellular macromolecule catabolic process,1024,14,5.75,0.00182,1,0.027802666666666667,2.43,BP
GO:0023051,regulation of signaling,3409,32,19.14,0.00182,1,0.027802666666666667,1.67,BP
GO:0051301,cell division,590,10,3.31,0.00182,1,0.027802666666666667,3.02,BP
GO:0000165,MAPK cascade,802,12,4.5,0.00186,1,0.02832379746835443,2.67,BP
GO:0033048,negative regulation of mitotic sister ch...,44,3,0.25,0.00193,1,0.02920490566037736,12,BP
GO:0070849,response to epidermal growth factor,44,3,0.25,0.00193,1,0.02920490566037736,12,BP
GO:0000910,cytokinesis,158,5,0.89,0.00199,1,0.029981308411214956,5.62,BP
GO:0001894,tissue homeostasis,232,6,1.3,0.00200,1,0.029981308411214956,4.62,BP
GO:0003013,circulatory system process,498,9,2.8,0.00200,1,0.029981308411214956,3.21,BP
GO:0006915,apoptotic process,1905,21,10.7,0.00204,1,0.030485962732919255,1.96,BP
GO:0061061,muscle structure development,704,11,3.95,0.00206,1,0.030594814814814818,2.78,BP
GO:0043044,ATP-dependent chromatin remodeling,45,3,0.25,0.00206,1,0.030594814814814818,12,BP
GO:0044057,regulation of system process,601,10,3.37,0.00209,1,0.030944861538461536,2.97,BP
GO:0010638,positive regulation of organelle organiz...,604,10,3.39,0.00216,1,0.0317856880733945,2.95,BP
GO:0015031,protein transport,1784,20,10.02,0.00216,1,0.0317856880733945,2,BP
GO:0010942,positive regulation of cell death,710,11,3.99,0.00220,1,0.032080000000000004,2.76,BP
GO:0033046,negative regulation of sister chromatid ...,46,3,0.26,0.00220,1,0.032080000000000004,11.54,BP
GO:0007346,regulation of mitotic cell cycle,505,9,2.84,0.00220,1,0.032080000000000004,3.17,BP
GO:0007049,cell cycle,1659,19,9.31,0.00222,1,0.03212802395209581,2.04,BP
GO:0031329,regulation of cellular catabolic process,711,11,3.99,0.00222,1,0.03212802395209581,2.76,BP
GO:0031328,positive regulation of cellular biosynth...,1919,21,10.77,0.00223,1,0.03212802395209581,1.95,BP
GO:0034764,positive regulation of transmembrane tra...,237,6,1.33,0.00223,1,0.03212802395209581,4.51,BP
GO:0048584,positive regulation of response to stimu...,2187,23,12.28,0.00225,1,0.03231940298507462,1.87,BP
GO:0001667,ameboidal-type cell migration,411,8,2.31,0.00226,1,0.03236642857142857,3.46,BP
GO:0032760,positive regulation of tumor necrosis fa...,98,4,0.55,0.00227,1,0.032413175074183974,7.27,BP
GO:0032755,positive regulation of interleukin-6 pro...,99,4,0.56,0.00236,1,0.03349946902654868,7.14,BP
GO:1903557,positive regulation of tumor necrosis fa...,99,4,0.56,0.00236,1,0.03349946902654868,7.14,BP
GO:0034976,response to endoplasmic reticulum stress,240,6,1.35,0.00237,1,0.03354247058823529,4.44,BP
GO:0016310,phosphorylation,2198,23,12.34,0.00240,1,0.0338674486803519,1.86,BP
GO:0007088,regulation of mitotic nuclear division,167,5,0.94,0.00254,1,0.03573824561403509,5.32,BP
GO:0040008,regulation of growth,724,11,4.07,0.00255,1,0.035774344023323613,2.7,BP
GO:1901215,negative regulation of neuron death,245,6,1.38,0.00263,1,0.036433714285714285,4.35,BP
GO:0050772,positive regulation of axonogenesis,102,4,0.57,0.00263,1,0.036433714285714285,7.02,BP
GO:0051985,negative regulation of chromosome segreg...,49,3,0.28,0.00263,1,0.036433714285714285,10.71,BP
GO:0009894,regulation of catabolic process,837,12,4.7,0.00264,1,0.036433714285714285,2.55,BP
GO:0001932,regulation of protein phosphorylation,1431,17,8.03,0.00264,1,0.036433714285714285,2.12,BP
GO:0060548,negative regulation of cell death,1067,14,5.99,0.00265,1,0.036433714285714285,2.34,BP
GO:0012501,programmed cell death,1947,21,10.93,0.00265,1,0.036433714285714285,1.92,BP
GO:0042325,regulation of phosphorylation,1559,18,8.75,0.00268,1,0.03653303116147309,2.06,BP
GO:0043410,positive regulation of MAPK cascade,520,9,2.92,0.00268,1,0.03653303116147309,3.08,BP
GO:0071375,cellular response to peptide hormone sti...,246,6,1.38,0.00268,1,0.03653303116147309,4.35,BP
GO:0050821,protein stabilization,170,5,0.95,0.00274,1,0.03724542372881356,5.26,BP
GO:0048878,chemical homeostasis,1192,15,6.69,0.00278,1,0.03768270422535211,2.24,BP
GO:0032446,protein modification by small protein co...,627,10,3.52,0.00283,1,0.03825269662921349,2.84,BP
GO:0009891,positive regulation of biosynthetic proc...,1960,21,11.01,0.00287,1,0.03868470588235294,1.91,BP
GO:0032870,cellular response to hormone stimulus,526,9,2.95,0.00289,1,0.0388454748603352,3.05,BP
GO:0015833,peptide transport,1838,20,10.32,0.00306,1,0.04101593314763231,1.94,BP
GO:0014812,muscle cell migration,107,4,0.6,0.00313,1,0.04183766666666667,6.67,BP
GO:0043412,macromolecule modification,3676,33,20.64,0.00317,1,0.04225495844875346,1.6,BP
GO:0043408,regulation of MAPK cascade,746,11,4.19,0.00321,1,0.04255239669421488,2.63,BP
GO:0031589,cell-substrate adhesion,342,7,1.92,0.00321,1,0.04255239669421488,3.65,BP
GO:0070647,protein modification by small protein co...,748,11,4.2,0.00328,1,0.04336087912087912,2.62,BP
GO:0034330,cell junction organization,257,6,1.44,0.00333,1,0.043901260273972606,4.17,BP
GO:0010941,regulation of cell death,1723,19,9.67,0.00338,1,0.04443868852459017,1.96,BP
GO:0010769,regulation of cell morphogenesis involve...,346,7,1.94,0.00342,1,0.044842070844686645,3.61,BP
GO:0006796,phosphate-containing compound metabolic ...,2963,28,16.64,0.00344,1,0.04498173913043478,1.68,BP
GO:0045839,negative regulation of mitotic nuclear d...,54,3,0.3,0.00348,1,0.04525881081081081,10,BP
GO:0042886,amide transport,1859,20,10.44,0.00348,1,0.04525881081081081,1.92,BP
GO:0032956,regulation of actin cytoskeleton organiz...,348,7,1.95,0.00353,1,0.045785336927223724,3.59,BP
GO:0043065,positive regulation of apoptotic process,647,10,3.63,0.00354,1,0.04579161290322581,2.75,BP
GO:0001944,vasculature development,756,11,4.24,0.00355,1,0.045797855227882045,2.59,BP
GO:0045773,positive regulation of axon extension,55,3,0.31,0.00366,1,0.04709069518716578,9.68,BP
GO:0021782,glial cell development,112,4,0.63,0.00368,1,0.04722176,6.35,BP
GO:0043068,positive regulation of programmed cell d...,652,10,3.66,0.00374,1,0.04786404255319149,2.73,BP
GO:0006793,phosphorus metabolic process,2985,28,16.76,0.00382,1,0.04850089709762533,1.67,BP
GO:0048870,cell motility,1612,18,9.05,0.00382,1,0.04850089709762533,1.99,BP
GO:0051674,localization of cell,1612,18,9.05,0.00382,1,0.04850089709762533,1.99,BP
GO:0043523,regulation of neuron apoptotic process,266,6,1.49,0.00393,1,0.049766210526315795,4.03,BP
GO:0045944,positive regulation of transcription by ...,1238,15,6.95,0.00396,1,0.05000952879581151,2.16,BP
GO:0051347,positive regulation of transferase activ...,552,9,3.1,0.00397,1,0.05000952879581151,2.9,BP
GO:0010770,positive regulation of cell morphogenesi...,186,5,1.04,0.00402,1,0.050500937499999995,4.81,BP
GO:0072358,cardiovascular system development,769,11,4.32,0.00403,1,0.050500937499999995,2.55,BP
GO:0051962,positive regulation of nervous system de...,660,10,3.71,0.00407,1,0.05086971428571428,2.7,BP
GO:0010647,positive regulation of cell communicatio...,1887,20,10.6,0.00412,1,0.051361243523316065,1.89,BP
GO:0042593,glucose homeostasis,270,6,1.52,0.00423,1,0.05259627906976745,3.95,BP
GO:0023056,positive regulation of signaling,1893,20,10.63,0.00427,1,0.05295680412371134,1.88,BP
GO:0032414,positive regulation of ion transmembrane...,117,4,0.66,0.00430,1,0.05304276214833759,6.06,BP
GO:0033500,carbohydrate homeostasis,271,6,1.52,0.00431,1,0.05304276214833759,3.95,BP
GO:0007169,transmembrane receptor protein tyrosine ...,559,9,3.14,0.00431,1,0.05304276214833759,2.87,BP
GO:0045184,establishment of protein localization,1896,20,10.65,0.00435,1,0.053262595419847326,1.88,BP
GO:0043254,regulation of protein complex assembly,458,8,2.57,0.00435,1,0.053262595419847326,3.11,BP
GO:1905475,regulation of protein localization to me...,191,5,1.07,0.00450,1,0.05495939086294416,4.67,BP
GO:0048285,organelle fission,461,8,2.59,0.00452,1,0.055063898734177205,3.09,BP
GO:0044772,mitotic cell cycle phase transition,365,7,2.05,0.00458,1,0.055513753148614606,3.41,BP
GO:0045786,negative regulation of cell cycle,462,8,2.59,0.00458,1,0.055513753148614606,3.09,BP
GO:0009161,ribonucleoside monophosphate metabolic p...,275,6,1.54,0.00462,1,0.05585788944723618,3.9,BP
GO:0030334,regulation of cell migration,899,12,5.05,0.00467,1,0.0563004,2.38,BP
GO:0044380,protein localization to cytoskeleton,60,3,0.34,0.00468,1,0.0563004,8.82,BP
GO:0080135,regulation of cellular response to stres...,674,10,3.78,0.00471,1,0.05652,2.65,BP
GO:0032869,cellular response to insulin stimulus,194,5,1.09,0.00481,1,0.05757641791044776,4.59,BP
GO:0031497,chromatin assembly,121,4,0.68,0.00485,1,0.05791116625310174,5.88,BP
GO:0006749,glutathione metabolic process,61,3,0.34,0.00490,1,0.05833807407407408,8.82,BP
GO:1902905,positive regulation of supramolecular fi...,195,5,1.09,0.00491,1,0.05833807407407408,4.59,BP
GO:0051254,positive regulation of RNA metabolic pro...,1652,18,9.28,0.00493,1,0.05843142857142858,1.94,BP
GO:0040012,regulation of locomotion,1025,13,5.76,0.00500,1,0.05911547911547912,2.26,BP
GO:0014911,positive regulation of smooth muscle cel...,62,3,0.35,0.00513,1,0.0604134306569343,8.57,BP
GO:0072359,circulatory system development,1150,14,6.46,0.00514,1,0.0604134306569343,2.17,BP
GO:0051247,positive regulation of protein metabolic...,1659,18,9.31,0.00515,1,0.0604134306569343,1.93,BP
GO:0016567,protein ubiquitination,575,9,3.23,0.00516,1,0.0604134306569343,2.79,BP
GO:0032411,positive regulation of transporter activ...,124,4,0.7,0.00528,1,0.06166834951456311,5.71,BP
GO:0048583,regulation of response to stimulus,3798,33,21.32,0.00532,1,0.06198508474576271,1.55,BP
GO:0009123,nucleoside monophosphate metabolic proce...,284,6,1.59,0.00539,1,0.06264898550724637,3.77,BP
GO:0051270,regulation of cellular component movemen...,1035,13,5.81,0.00541,1,0.06272992771084338,2.24,BP
GO:0010631,epithelial cell migration,285,6,1.6,0.00549,1,0.06350451923076923,3.75,BP
GO:0071157,negative regulation of cell cycle arrest,20,2,0.11,0.00556,1,0.06400650717703349,18.18,BP
GO:0072243,metanephric nephron epithelium developme...,20,2,0.11,0.00556,1,0.06400650717703349,18.18,BP
GO:0055076,transition metal ion homeostasis,126,4,0.71,0.00559,1,0.0641982816229117,5.63,BP
GO:0046579,positive regulation of Ras protein signa...,64,3,0.36,0.00561,1,0.06427457142857143,8.33,BP
GO:0072659,protein localization to plasma membrane,287,6,1.61,0.00567,1,0.06465412322274881,3.73,BP
GO:0090132,epithelium migration,287,6,1.61,0.00567,1,0.06465412322274881,3.73,BP
GO:0061013,regulation of mRNA catabolic process,127,4,0.71,0.00575,1,0.06541134751773049,5.63,BP
GO:0051784,negative regulation of nuclear division,65,3,0.36,0.00585,1,0.06634898823529412,8.33,BP
GO:0090130,tissue migration,289,6,1.62,0.00586,1,0.06634898823529412,3.7,BP
GO:1901615,organic hydroxy compound metabolic proce...,482,8,2.71,0.00588,1,0.06641915492957746,2.95,BP
GO:0032270,positive regulation of cellular protein ...,1551,17,8.71,0.00594,1,0.06693976580796253,1.95,BP
GO:0030155,regulation of cell adhesion,698,10,3.92,0.00599,1,0.06734551401869159,2.55,BP
GO:0048871,multicellular organismal homeostasis,485,8,2.72,0.00609,1,0.06817,2.94,BP
GO:0046716,muscle cell cellular homeostasis,21,2,0.12,0.00612,1,0.06817,16.67,BP
GO:0048143,astrocyte activation,21,2,0.12,0.00612,1,0.06817,16.67,BP
GO:0072170,metanephric tubule development,21,2,0.12,0.00612,1,0.06817,16.67,BP
GO:0050770,regulation of axonogenesis,206,5,1.16,0.00617,1,0.06856822170900694,4.31,BP
GO:2000378,negative regulation of reactive oxygen s...,67,3,0.38,0.00637,1,0.07062774193548386,7.89,BP
GO:0009725,response to hormone,708,10,3.98,0.00660,1,0.07250367713004485,2.51,BP
GO:0008219,cell death,2108,21,11.84,0.00665,1,0.07250367713004485,1.77,BP
GO:0030111,regulation of Wnt signaling pathway,297,6,1.67,0.00667,1,0.07250367713004485,3.59,BP
GO:0035264,multicellular organism growth,210,5,1.18,0.00668,1,0.07250367713004485,4.24,BP
GO:0002183,cytoplasmic translational initiation,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:0031643,positive regulation of myelination,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:0046628,positive regulation of insulin receptor ...,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:0072215,regulation of metanephros development,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:1901673,regulation of mitotic spindle assembly,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:1901889,negative regulation of cell junction ass...,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:1902307,positive regulation of sodium ion transm...,22,2,0.12,0.00671,1,0.07250367713004485,16.67,BP
GO:0040011,locomotion,1837,19,10.31,0.00672,1,0.07250367713004485,1.84,BP
GO:0043087,regulation of GTPase activity,298,6,1.67,0.00678,1,0.07298738255033556,3.59,BP
GO:0048839,inner ear development,211,5,1.18,0.00681,1,0.07314669642857143,4.24,BP
GO:0033047,regulation of mitotic sister chromatid s...,69,3,0.39,0.00691,1,0.07405550111358575,7.69,BP
GO:2000145,regulation of cell motility,946,12,5.31,0.00694,1,0.07421173333333334,2.26,BP
GO:2001244,positive regulation of intrinsic apoptot...,70,3,0.39,0.00719,1,0.07671458980044346,7.69,BP
GO:0032970,regulation of actin filament-based proce...,398,7,2.23,0.00725,1,0.07718362831858407,3.14,BP
GO:0014912,negative regulation of smooth muscle cel...,23,2,0.13,0.00732,1,0.07741503296703296,15.38,BP
GO:0060390,regulation of SMAD protein signal transd...,23,2,0.13,0.00732,1,0.07741503296703296,15.38,BP
GO:0072202,cell differentiation involved in metanep...,23,2,0.13,0.00732,1,0.07741503296703296,15.38,BP
GO:0006402,mRNA catabolic process,215,5,1.21,0.00736,1,0.07766736842105264,4.13,BP
GO:0019220,regulation of phosphate metabolic proces...,1720,18,9.66,0.00742,1,0.07812919037199126,1.86,BP
GO:0051174,regulation of phosphorus metabolic proce...,1721,18,9.66,0.00747,1,0.07831294117647059,1.86,BP
GO:0051057,positive regulation of small GTPase medi...,71,3,0.4,0.00747,1,0.07831294117647059,7.5,BP
GO:0035265,organ growth,217,5,1.22,0.00765,1,0.08002565217391304,4.1,BP
GO:0044770,cell cycle phase transition,404,7,2.27,0.00785,1,0.08193969631236442,3.08,BP
GO:0043406,positive regulation of MAP kinase activi...,219,5,1.23,0.00794,1,0.08237316129032257,4.07,BP
GO:0048638,regulation of developmental growth,405,7,2.27,0.00795,1,0.08237316129032257,3.08,BP
GO:0007064,mitotic sister chromatid cohesion,24,2,0.13,0.00796,1,0.08237316129032257,15.38,BP
GO:0072207,metanephric epithelium development,24,2,0.13,0.00796,1,0.08237316129032257,15.38,BP
GO:0051168,nuclear export,140,4,0.79,0.00806,1,0.08322901287553648,5.06,BP
GO:0050921,positive regulation of chemotaxis,141,4,0.79,0.00826,1,0.08511160599571733,5.06,BP
GO:0046626,regulation of insulin receptor signaling...,74,3,0.42,0.00838,1,0.08563728813559322,7.14,BP
GO:0050766,positive regulation of phagocytosis,74,3,0.42,0.00838,1,0.08563728813559322,7.14,BP
GO:1901880,negative regulation of protein depolymer...,74,3,0.42,0.00838,1,0.08563728813559322,7.14,BP
GO:0006066,alcohol metabolic process,312,6,1.75,0.00840,1,0.08563728813559322,3.43,BP
GO:0032103,positive regulation of response to exter...,312,6,1.75,0.00840,1,0.08563728813559322,3.43,BP
GO:0070997,neuron death,411,7,2.31,0.00858,1,0.08659590814196241,3.03,BP
GO:0051050,positive regulation of transport,1096,13,6.15,0.00859,1,0.08659590814196241,2.11,BP
GO:0032515,negative regulation of phosphoprotein ph...,25,2,0.14,0.00862,1,0.08659590814196241,14.29,BP
GO:0046688,response to copper ion,25,2,0.14,0.00862,1,0.08659590814196241,14.29,BP
GO:0051894,positive regulation of focal adhesion as...,25,2,0.14,0.00862,1,0.08659590814196241,14.29,BP
GO:1904738,vascular associated smooth muscle cell m...,25,2,0.14,0.00862,1,0.08659590814196241,14.29,BP
GO:1904752,regulation of vascular associated smooth...,25,2,0.14,0.00862,1,0.08659590814196241,14.29,BP
GO:0000280,nuclear division,412,7,2.31,0.00869,1,0.08703617463617463,3.03,BP
GO:0030324,lung development,224,5,1.26,0.00870,1,0.08703617463617463,3.97,BP
GO:0010634,positive regulation of epithelial cell m...,144,4,0.81,0.00888,1,0.08865261410788383,4.94,BP
GO:0051276,chromosome organization,1105,13,6.2,0.00916,1,0.0911799587628866,2.1,BP
GO:0030323,respiratory tube development,227,5,1.27,0.00919,1,0.0911799587628866,3.94,BP
GO:0032868,response to insulin,227,5,1.27,0.00919,1,0.0911799587628866,3.94,BP
GO:0000289,nuclear-transcribed mRNA poly(A) tail sh...,26,2,0.15,0.00930,1,0.09161496932515338,13.33,BP
GO:1900078,positive regulation of cellular response...,26,2,0.15,0.00930,1,0.09161496932515338,13.33,BP
GO:1902175,regulation of oxidative stress-induced i...,26,2,0.15,0.00930,1,0.09161496932515338,13.33,BP
GO:0000070,mitotic sister chromatid segregation,146,4,0.82,0.00931,1,0.09161496932515338,4.88,BP
GO:0071705,nitrogen compound transport,2178,21,12.23,0.00953,1,0.09339788187372709,1.72,BP
GO:0034250,positive regulation of cellular amide me...,147,4,0.83,0.00953,1,0.09339788187372709,4.82,BP
GO:1901862,negative regulation of muscle tissue dev...,78,3,0.44,0.00967,1,0.09438547667342799,6.82,BP
GO:1905897,regulation of response to endoplasmic re...,78,3,0.44,0.00967,1,0.09438547667342799,6.82,BP
GO:0030855,epithelial cell differentiation,638,9,3.58,0.00990,1,0.09643481781376519,2.51,BP
GO:1902904,negative regulation of supramolecular fi...,149,4,0.84,0.00998,1,0.09701769696969696,4.76,BP
GO:1903320,regulation of protein modification by sm...,232,5,1.3,0.01003,1,0.09730717741935484,3.85,BP
GO:0048598,embryonic morphogenesis,642,9,3.6,0.01028,1,0.09953191146881288,2.5,BP
GO:0010923,negative regulation of phosphatase activ...,80,3,0.45,0.01036,1,0.0999044488977956,6.67,BP
GO:2001259,positive regulation of cation channel ac...,80,3,0.45,0.01036,1,0.0999044488977956,6.67,BP
GO:0016192,vesicle-mediated transport,1382,15,7.76,0.01056,1,0.10151211155378487,1.93,BP
GO:0009896,positive regulation of catabolic process,428,7,2.4,0.01057,1,0.10151211155378487,2.92,BP
GO:0043434,response to peptide hormone,328,6,1.84,0.01059,1,0.10151211155378487,3.26,BP
GO:0014013,regulation of gliogenesis,152,4,0.85,0.01068,1,0.10217129224652088,4.71,BP
GO:0072384,organelle transport along microtubule,81,3,0.45,0.01072,1,0.10224308910891089,6.67,BP
GO:0008544,epidermis development,329,6,1.85,0.01073,1,0.10224308910891089,3.24,BP
GO:0008360,regulation of cell shape,153,4,0.86,0.01092,1,0.1038479051383399,4.65,BP
GO:0034655,nucleobase-containing compound catabolic...,431,7,2.42,0.01095,1,0.10392781065088756,2.89,BP
GO:0044089,positive regulation of cellular componen...,538,8,3.02,0.01102,1,0.10438629921259841,2.65,BP
GO:0071900,regulation of protein serine/threonine k...,432,7,2.43,0.01108,1,0.10474844793713162,2.88,BP
GO:0051716,cellular response to stimulus,7732,56,43.41,0.01132,1,0.1068075294117647,1.29,BP
GO:0032675,regulation of interleukin-6 production,155,4,0.87,0.01141,1,0.10683011583011583,4.6,BP
GO:0033045,regulation of sister chromatid segregati...,83,3,0.47,0.01145,1,0.10683011583011583,6.38,BP
GO:0043242,negative regulation of protein complex d...,83,3,0.47,0.01145,1,0.10683011583011583,6.38,BP
GO:0061178,regulation of insulin secretion involved...,83,3,0.47,0.01145,1,0.10683011583011583,6.38,BP
GO:0000027,ribosomal large subunit assembly,29,2,0.16,0.01150,1,0.10683011583011583,12.5,BP
GO:0031116,positive regulation of microtubule polym...,29,2,0.16,0.01150,1,0.10683011583011583,12.5,BP
GO:0071480,cellular response to gamma radiation,29,2,0.16,0.01150,1,0.10683011583011583,12.5,BP
GO:1902235,regulation of endoplasmic reticulum stre...,29,2,0.16,0.01150,1,0.10683011583011583,12.5,BP
GO:0043583,ear development,241,5,1.35,0.01168,1,0.10829317919075145,3.7,BP
GO:0055072,iron ion homeostasis,84,3,0.47,0.01182,1,0.10938046153846155,6.38,BP
GO:0045860,positive regulation of protein kinase ac...,438,7,2.46,0.01188,1,0.10972468330134356,2.85,BP
GO:0050715,positive regulation of cytokine secretio...,157,4,0.88,0.01192,1,0.1098832183908046,4.55,BP
GO:0001558,regulation of cell growth,439,7,2.46,0.01202,1,0.11059319311663479,2.85,BP
GO:0006470,protein dephosphorylation,243,5,1.36,0.01207,1,0.11084129770992367,3.68,BP
GO:0034260,negative regulation of GTPase activity,30,2,0.17,0.01227,1,0.11224950570342204,11.76,BP
GO:1902003,regulation of amyloid-beta formation,30,2,0.17,0.01227,1,0.11224950570342204,11.76,BP
GO:0014910,regulation of smooth muscle cell migrati...,86,3,0.48,0.01260,1,0.11483181818181817,6.25,BP
GO:0035304,regulation of protein dephosphorylation,86,3,0.48,0.01260,1,0.11483181818181817,6.25,BP
GO:0030163,protein catabolic process,902,11,5.06,0.01266,1,0.11516052930056711,2.17,BP
GO:0042552,myelination,160,4,0.9,0.01270,1,0.11530641509433961,4.44,BP
GO:0045893,"positive regulation of transcription, DN...",1547,16,8.69,0.01280,1,0.1159954802259887,1.84,BP
GO:0009755,hormone-mediated signaling pathway,161,4,0.9,0.01297,1,0.1172755722326454,4.44,BP
GO:1901879,regulation of protein depolymerization,87,3,0.49,0.01299,1,0.1172755722326454,6.12,BP
GO:1903393,positive regulation of adherens junction...,31,2,0.17,0.01307,1,0.11755671028037383,11.76,BP
GO:2000778,positive regulation of interleukin-6 sec...,31,2,0.17,0.01307,1,0.11755671028037383,11.76,BP
GO:1903508,positive regulation of nucleic acid-temp...,1551,16,8.71,0.01310,1,0.11760671641791044,1.84,BP
GO:1902680,positive regulation of RNA biosynthetic ...,1552,16,8.71,0.01317,1,0.11788505576208179,1.84,BP
GO:0010720,positive regulation of cell development,669,9,3.76,0.01318,1,0.11788505576208179,2.39,BP
GO:0006401,RNA catabolic process,249,5,1.4,0.01330,1,0.11873766233766234,3.57,BP
GO:0035418,protein localization to synapse,88,3,0.49,0.01340,1,0.11918817005545286,6.12,BP
GO:1900076,regulation of cellular response to insul...,88,3,0.49,0.01340,1,0.11918817005545286,6.12,BP
GO:0033365,protein localization to organelle,789,10,4.43,0.01346,1,0.11950095940959408,2.26,BP
GO:0007272,ensheathment of neurons,163,4,0.92,0.01352,1,0.11959235294117648,4.35,BP
GO:0008366,axon ensheathment,163,4,0.92,0.01352,1,0.11959235294117648,4.35,BP
GO:0035239,tube morphogenesis,911,11,5.12,0.01355,1,0.1196377981651376,2.15,BP
GO:0032635,interleukin-6 production,164,4,0.92,0.01380,1,0.12162197802197802,4.35,BP
GO:0000462,maturation of SSU-rRNA from tricistronic...,32,2,0.18,0.01389,1,0.12219137111517367,11.11,BP
GO:0031330,negative regulation of cellular cataboli...,252,5,1.41,0.01394,1,0.12240744525547444,3.55,BP
GO:0032680,regulation of tumor necrosis factor prod...,166,4,0.93,0.01437,1,0.12558359346642467,4.3,BP
GO:1904064,positive regulation of cation transmembr...,166,4,0.93,0.01437,1,0.12558359346642467,4.3,BP
GO:0090068,positive regulation of cell cycle proces...,254,5,1.43,0.01438,1,0.12558359346642467,3.5,BP
GO:0060541,respiratory system development,255,5,1.43,0.01461,1,0.12679921288014312,3.5,BP
GO:0035773,insulin secretion involved in cellular r...,91,3,0.51,0.01466,1,0.12679921288014312,5.88,BP
GO:0035303,regulation of dephosphorylation,167,4,0.94,0.01466,1,0.12679921288014312,4.26,BP
GO:0007026,negative regulation of microtubule depol...,33,2,0.19,0.01473,1,0.12679921288014312,10.53,BP
GO:0031112,positive regulation of microtubule polym...,33,2,0.19,0.01473,1,0.12679921288014312,10.53,BP
GO:0035025,positive regulation of Rho protein signa...,33,2,0.19,0.01473,1,0.12679921288014312,10.53,BP
GO:1901890,positive regulation of cell junction ass...,33,2,0.19,0.01473,1,0.12679921288014312,10.53,BP
GO:1904646,cellular response to amyloid-beta,33,2,0.19,0.01473,1,0.12679921288014312,10.53,BP
GO:0006323,DNA packaging,168,4,0.94,0.01495,1,0.1282342245989305,4.26,BP
GO:1903555,regulation of tumor necrosis factor supe...,168,4,0.94,0.01495,1,0.1282342245989305,4.26,BP
GO:0001819,positive regulation of cytokine producti...,460,7,2.58,0.01519,1,0.12988141592920355,2.71,BP
GO:0007155,cell adhesion,1311,14,7.36,0.01525,1,0.12988141592920355,1.9,BP
GO:0032640,tumor necrosis factor production,169,4,0.95,0.01525,1,0.12988141592920355,4.21,BP
GO:0045931,positive regulation of mitotic cell cycl...,169,4,0.95,0.01525,1,0.12988141592920355,4.21,BP
GO:0014909,smooth muscle cell migration,93,3,0.52,0.01553,1,0.1314661996497373,5.77,BP
GO:0035305,negative regulation of dephosphorylation,93,3,0.52,0.01553,1,0.1314661996497373,5.77,BP
GO:0007051,spindle organization,170,4,0.95,0.01555,1,0.1314661996497373,4.21,BP
GO:0097242,amyloid-beta clearance,34,2,0.19,0.01560,1,0.1314661996497373,10.53,BP
GO:1905898,positive regulation of response to endop...,34,2,0.19,0.01560,1,0.1314661996497373,10.53,BP
GO:2000406,positive regulation of T cell migration,34,2,0.19,0.01560,1,0.1314661996497373,10.53,BP
GO:0033044,regulation of chromosome organization,358,6,2.01,0.01571,1,0.13212041811846692,2.99,BP
GO:0051056,regulation of small GTPase mediated sign...,260,5,1.46,0.01576,1,0.13212041811846692,3.42,BP
GO:0140014,mitotic nuclear division,260,5,1.46,0.01576,1,0.13212041811846692,3.42,BP
GO:0043086,negative regulation of catalytic activit...,690,9,3.87,0.01582,1,0.13239276521739132,2.33,BP
GO:0071706,tumor necrosis factor superfamily cytoki...,172,4,0.97,0.01617,1,0.135086875,4.12,BP
GO:0045926,negative regulation of growth,262,5,1.47,0.01624,1,0.13543653379549395,3.4,BP
GO:0031331,positive regulation of cellular cataboli...,361,6,2.03,0.01630,1,0.1357017301038062,2.96,BP
GO:0031400,negative regulation of protein modificat...,578,8,3.25,0.01634,1,0.13579979274611398,2.46,BP
GO:0022610,biological adhesion,1323,14,7.43,0.01638,1,0.1358975172413793,1.88,BP
GO:0065004,protein-DNA complex assembly,173,4,0.97,0.01648,1,0.1362573195876289,4.12,BP
GO:0035308,negative regulation of protein dephospho...,35,2,0.2,0.01648,1,0.1362573195876289,10,BP
GO:0044270,cellular nitrogen compound catabolic pro...,469,7,2.63,0.01672,1,0.13793301369863015,2.66,BP
GO:0019725,cellular homeostasis,940,11,5.28,0.01674,1,0.13793301369863015,2.08,BP
GO:2001242,regulation of intrinsic apoptotic signal...,174,4,0.98,0.01680,1,0.1381907692307692,4.08,BP
GO:0046916,cellular transition metal ion homeostasi...,96,3,0.54,0.01689,1,0.13869399317406142,5.56,BP
GO:1901575,organic substance catabolic process,1874,18,10.52,0.01692,1,0.13870364565587734,1.71,BP
GO:1901990,regulation of mitotic cell cycle phase t...,265,5,1.49,0.01697,1,0.13887693877551022,3.36,BP
GO:0007094,mitotic spindle assembly checkpoint,36,2,0.2,0.01739,1,0.14087656565656564,10,BP
GO:0031114,regulation of microtubule depolymerizati...,36,2,0.2,0.01739,1,0.14087656565656564,10,BP
GO:0033238,regulation of cellular amine metabolic p...,36,2,0.2,0.01739,1,0.14087656565656564,10,BP
GO:0034205,amyloid-beta formation,36,2,0.2,0.01739,1,0.14087656565656564,10,BP
GO:0071173,spindle assembly checkpoint,36,2,0.2,0.01739,1,0.14087656565656564,10,BP
GO:1902991,regulation of amyloid precursor protein ...,36,2,0.2,0.01739,1,0.14087656565656564,10,BP
GO:0062012,regulation of small molecule metabolic p...,367,6,2.06,0.01754,1,0.1418529075630252,2.91,BP
GO:0031346,positive regulation of cell projection o...,474,7,2.66,0.01761,1,0.14218006711409398,2.63,BP
GO:0010977,negative regulation of neuron projection...,177,4,0.99,0.01777,1,0.1430768,4.04,BP
GO:0006334,nucleosome assembly,98,3,0.55,0.01784,1,0.1430768,5.45,BP
GO:0010595,positive regulation of endothelial cell ...,98,3,0.55,0.01784,1,0.1430768,5.45,BP
GO:0070585,protein localization to mitochondrion,98,3,0.55,0.01784,1,0.1430768,5.45,BP
GO:0033674,positive regulation of kinase activity,476,7,2.67,0.01798,1,0.14372053156146178,2.62,BP
GO:0046700,heterocycle catabolic process,476,7,2.67,0.01798,1,0.14372053156146178,2.62,BP
GO:0050769,positive regulation of neurogenesis,589,8,3.31,0.01808,1,0.1442801990049751,2.42,BP
GO:0016311,dephosphorylation,370,6,2.08,0.01818,1,0.14451777049180325,2.88,BP
GO:1901214,regulation of neuron death,370,6,2.08,0.01818,1,0.14451777049180325,2.88,BP
GO:0001702,gastrulation with mouth forming second,37,2,0.21,0.01832,1,0.14451777049180325,9.52,BP
GO:0006458,'de novo' protein folding,37,2,0.21,0.01832,1,0.14451777049180325,9.52,BP
GO:0035850,epithelial cell differentiation involved...,37,2,0.21,0.01832,1,0.14451777049180325,9.52,BP
GO:0045601,regulation of endothelial cell different...,37,2,0.21,0.01832,1,0.14451777049180325,9.52,BP
GO:0048169,regulation of long-term neuronal synapti...,37,2,0.21,0.01832,1,0.14451777049180325,9.52,BP
GO:0006575,cellular modified amino acid metabolic p...,179,4,1.01,0.01844,1,0.14498901960784313,3.96,BP
GO:1901861,regulation of muscle tissue development,179,4,1.01,0.01844,1,0.14498901960784313,3.96,BP
GO:0009167,purine ribonucleoside monophosphate meta...,271,5,1.52,0.01851,1,0.14530199021207177,3.29,BP
GO:0007267,cell-cell signaling,1617,16,9.08,0.01875,1,0.14686380487804876,1.76,BP
GO:0009126,purine nucleoside monophosphate metaboli...,272,5,1.53,0.01877,1,0.14686380487804876,3.27,BP
GO:0000819,sister chromatid segregation,181,4,1.02,0.01912,1,0.14935948051948053,3.92,BP
GO:0006636,unsaturated fatty acid biosynthetic proc...,38,2,0.21,0.01926,1,0.1497239418416801,9.52,BP
GO:0071174,mitotic spindle checkpoint,38,2,0.21,0.01926,1,0.1497239418416801,9.52,BP
GO:2000403,positive regulation of lymphocyte migrat...,38,2,0.21,0.01926,1,0.1497239418416801,9.52,BP
GO:0007041,lysosomal transport,101,3,0.57,0.01931,1,0.14987051612903227,5.26,BP
GO:0031401,positive regulation of protein modificat...,1219,13,6.84,0.01936,1,0.15001661835748792,1.9,BP
GO:0034767,positive regulation of ion transmembrane...,182,4,1.02,0.01947,1,0.1506163723916533,3.92,BP
GO:1903532,positive regulation of secretion by cell,484,7,2.72,0.01950,1,0.1506163723916533,2.57,BP
GO:0007423,sensory organ development,598,8,3.36,0.01961,1,0.15122326923076923,2.38,BP
GO:0106027,neuron projection organization,102,3,0.57,0.01982,1,0.1525849840255591,5.26,BP
GO:0031647,regulation of protein stability,276,5,1.55,0.01985,1,0.1525849840255591,3.23,BP
GO:0071407,cellular response to organic cyclic comp...,487,7,2.73,0.02010,1,0.1537863507109005,2.56,BP
GO:0006950,response to stress,3538,29,19.87,0.02016,1,0.1537863507109005,1.46,BP
GO:2001252,positive regulation of chromosome organi...,184,4,1.03,0.02017,1,0.1537863507109005,3.88,BP
GO:0060236,regulation of mitotic spindle organizati...,39,2,0.22,0.02023,1,0.1537863507109005,9.09,BP
GO:0070570,regulation of neuron projection regenera...,39,2,0.22,0.02023,1,0.1537863507109005,9.09,BP
GO:1904645,response to amyloid-beta,39,2,0.22,0.02023,1,0.1537863507109005,9.09,BP
GO:2001024,negative regulation of response to drug,39,2,0.22,0.02023,1,0.1537863507109005,9.09,BP
GO:0043488,regulation of mRNA stability,103,3,0.58,0.02033,1,0.1543027760252366,5.17,BP
GO:0001568,blood vessel development,722,9,4.05,0.02058,1,0.15595426771653545,2.22,BP
GO:0006935,chemotaxis,604,8,3.39,0.02067,1,0.1561260188087774,2.36,BP
GO:0071902,positive regulation of protein serine/th...,279,5,1.57,0.02069,1,0.1561260188087774,3.18,BP
GO:0019439,aromatic compound catabolic process,490,7,2.75,0.02070,1,0.1561260188087774,2.55,BP
GO:0050764,regulation of phagocytosis,104,3,0.58,0.02085,1,0.1570112676056338,5.17,BP
GO:2001235,positive regulation of apoptotic signali...,186,4,1.04,0.02089,1,0.1570666875,3.85,BP
GO:0051223,regulation of protein transport,725,9,4.07,0.02107,1,0.15782170015455949,2.21,BP
GO:0120031,plasma membrane bounded cell projection ...,492,7,2.76,0.02111,1,0.15782170015455949,2.54,BP
GO:0042176,regulation of protein catabolic process,383,6,2.15,0.02113,1,0.15782170015455949,2.79,BP
GO:0031577,spindle checkpoint,40,2,0.22,0.02122,1,0.15782170015455949,9.09,BP
GO:0045841,negative regulation of mitotic metaphase...,40,2,0.22,0.02122,1,0.15782170015455949,9.09,BP
GO:0046825,regulation of protein export from nucleu...,40,2,0.22,0.02122,1,0.15782170015455949,9.09,BP
GO:0042330,taxis,607,8,3.41,0.02122,1,0.15782170015455949,2.35,BP
GO:0050796,regulation of insulin secretion,187,4,1.05,0.02126,1,0.15787518518518517,3.81,BP
GO:0006413,translational initiation,105,3,0.59,0.02138,1,0.1580346543778802,5.08,BP
GO:0007009,plasma membrane organization,105,3,0.59,0.02138,1,0.1580346543778802,5.08,BP
GO:0055017,cardiac muscle tissue growth,105,3,0.59,0.02138,1,0.1580346543778802,5.08,BP
GO:0051668,localization within membrane,188,4,1.06,0.02163,1,0.15963736196319017,3.77,BP
GO:0014897,striated muscle hypertrophy,106,3,0.6,0.02191,1,0.16096323664122136,5,BP
GO:0051225,spindle assembly,106,3,0.6,0.02191,1,0.16096323664122136,5,BP
GO:0051983,regulation of chromosome segregation,106,3,0.6,0.02191,1,0.16096323664122136,5,BP
GO:0014037,Schwann cell differentiation,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:0033628,regulation of cell adhesion mediated by ...,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:0035774,positive regulation of insulin secretion...,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:0046326,positive regulation of glucose import,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:0071364,cellular response to epidermal growth fa...,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:2000008,regulation of protein localization to ce...,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:2000816,negative regulation of mitotic sister ch...,41,2,0.23,0.02223,1,0.161587250755287,8.7,BP
GO:0000956,nuclear-transcribed mRNA catabolic proce...,107,3,0.6,0.02246,1,0.16301285067873303,5,BP
GO:0045597,positive regulation of cell differentiat...,1113,12,6.25,0.02256,1,0.1634920481927711,1.92,BP
GO:0006897,endocytosis,615,8,3.45,0.02273,1,0.16447633082706767,2.32,BP
GO:0006325,chromatin organization,735,9,4.13,0.02278,1,0.16459063063063065,2.18,BP
GO:0014896,muscle hypertrophy,108,3,0.61,0.02300,1,0.16593103448275862,4.92,BP
GO:0010765,positive regulation of sodium ion transp...,42,2,0.24,0.02325,1,0.16723318385650224,8.33,BP
GO:1902100,negative regulation of metaphase/anaphas...,42,2,0.24,0.02325,1,0.16723318385650224,8.33,BP
GO:0072593,reactive oxygen species metabolic proces...,288,5,1.62,0.02335,1,0.16770179104477612,3.09,BP
GO:0050708,regulation of protein secretion,503,7,2.82,0.02347,1,0.16831242921013415,2.48,BP
GO:0044257,cellular protein catabolic process,740,9,4.15,0.02367,1,0.16949410714285715,2.17,BP
GO:0030031,cell projection assembly,505,7,2.84,0.02392,1,0.17091881305637982,2.46,BP
GO:0000209,protein polyubiquitination,194,4,1.09,0.02394,1,0.17091881305637982,3.67,BP
GO:0009306,protein secretion,622,8,3.49,0.02412,1,0.17194879999999998,2.29,BP
GO:0008631,intrinsic apoptotic signaling pathway in...,43,2,0.24,0.02430,1,0.17235322533136965,8.33,BP
GO:0030490,maturation of SSU-rRNA,43,2,0.24,0.02430,1,0.17235322533136965,8.33,BP
GO:1905819,negative regulation of chromosome separa...,43,2,0.24,0.02430,1,0.17235322533136965,8.33,BP
GO:0070848,response to growth factor,623,8,3.5,0.02432,1,0.17235322533136965,2.29,BP
GO:0001934,positive regulation of protein phosphory...,996,11,5.59,0.02445,1,0.17301970588235294,1.97,BP
GO:0048514,blood vessel morphogenesis,625,8,3.51,0.02473,1,0.174744140969163,2.28,BP
GO:0007249,I-kappaB kinase/NF-kappaB signaling,197,4,1.11,0.02515,1,0.17719150805270864,3.6,BP
GO:0007266,Rho protein signal transduction,197,4,1.11,0.02515,1,0.17719150805270864,3.6,BP
GO:0043405,regulation of MAP kinase activity,294,5,1.65,0.02523,1,0.17749526315789474,3.03,BP
GO:0043487,regulation of RNA stability,112,3,0.63,0.02527,1,0.1775171386861314,4.76,BP
GO:0098657,import into cell,749,9,4.21,0.02533,1,0.17767924198250726,2.14,BP
GO:0006913,nucleocytoplasmic transport,295,5,1.66,0.02556,1,0.1787713953488372,3.01,BP
GO:0051169,nuclear transport,295,5,1.66,0.02556,1,0.1787713953488372,3.01,BP
GO:0006986,response to unfolded protein,113,3,0.63,0.02586,1,0.1800843994211288,4.76,BP
GO:0030516,regulation of axon extension,113,3,0.63,0.02586,1,0.1800843994211288,4.76,BP
GO:0043401,steroid hormone mediated signaling pathw...,113,3,0.63,0.02586,1,0.1800843994211288,4.76,BP
GO:0006979,response to oxidative stress,402,6,2.26,0.02601,1,0.18086722543352599,2.65,BP
GO:0071702,organic substance transport,2551,22,14.32,0.02621,1,0.1815654778887304,1.54,BP
GO:1901987,regulation of cell cycle phase transitio...,297,5,1.67,0.02621,1,0.1815654778887304,2.99,BP
GO:0006414,translational elongation,45,2,0.25,0.02645,1,0.1815654778887304,8,BP
GO:0006695,cholesterol biosynthetic process,45,2,0.25,0.02645,1,0.1815654778887304,8,BP
GO:0042987,amyloid precursor protein catabolic proc...,45,2,0.25,0.02645,1,0.1815654778887304,8,BP
GO:0000187,activation of MAPK activity,114,3,0.64,0.02645,1,0.1815654778887304,4.69,BP
GO:0016525,negative regulation of angiogenesis,114,3,0.64,0.02645,1,0.1815654778887304,4.69,BP
GO:0043123,positive regulation of I-kappaB kinase/N...,114,3,0.64,0.02645,1,0.1815654778887304,4.69,BP
GO:0060419,heart growth,114,3,0.64,0.02645,1,0.1815654778887304,4.69,BP
GO:0051346,negative regulation of hydrolase activit...,404,6,2.27,0.02657,1,0.1821294017094017,2.64,BP
GO:0009895,negative regulation of catabolic process,299,5,1.68,0.02688,1,0.18301934936350778,2.98,BP
GO:0071214,cellular response to abiotic stimulus,299,5,1.68,0.02688,1,0.18301934936350778,2.98,BP
GO:0104004,cellular response to environmental stimu...,299,5,1.68,0.02688,1,0.18301934936350778,2.98,BP
GO:0070201,regulation of establishment of protein l...,757,9,4.25,0.02688,1,0.18301934936350778,2.12,BP
GO:0051049,regulation of transport,1973,18,11.08,0.02689,1,0.18301934936350778,1.62,BP
GO:0042472,inner ear morphogenesis,115,3,0.65,0.02705,1,0.18384830508474576,4.62,BP
GO:0008202,steroid metabolic process,300,5,1.68,0.02722,1,0.1842347191011236,2.98,BP
GO:0031396,regulation of protein ubiquitination,202,4,1.13,0.02724,1,0.1842347191011236,3.54,BP
GO:2000377,regulation of reactive oxygen species me...,202,4,1.13,0.02724,1,0.1842347191011236,3.54,BP
GO:0032501,multicellular organismal process,8233,57,46.23,0.02726,1,0.1842347191011236,1.23,BP
GO:0010639,negative regulation of organelle organiz...,407,6,2.29,0.02741,1,0.18489623430962346,2.62,BP
GO:0031111,negative regulation of microtubule polym...,46,2,0.26,0.02755,1,0.18489623430962346,7.69,BP
GO:1902653,secondary alcohol biosynthetic process,46,2,0.26,0.02755,1,0.18489623430962346,7.69,BP
GO:1903580,positive regulation of ATP metabolic pro...,46,2,0.26,0.02755,1,0.18489623430962346,7.69,BP
GO:2000404,regulation of T cell migration,46,2,0.26,0.02755,1,0.18489623430962346,7.69,BP
GO:0051261,protein depolymerization,116,3,0.65,0.02766,1,0.18532883333333336,4.62,BP
GO:1901361,organic cyclic compound catabolic proces...,521,7,2.93,0.02772,1,0.18532883333333336,2.39,BP
GO:0007417,central nervous system development,887,10,4.98,0.02773,1,0.18532883333333336,2.01,BP
GO:0044092,negative regulation of molecular functio...,1018,11,5.72,0.02810,1,0.1872814404432133,1.92,BP
GO:0001649,osteoblast differentiation,204,4,1.15,0.02810,1,0.1872814404432133,3.48,BP
GO:0043244,regulation of protein complex disassembl...,117,3,0.66,0.02828,1,0.18822041493775934,4.55,BP
GO:0072604,interleukin-6 secretion,47,2,0.26,0.02867,1,0.1905525414364641,7.69,BP
GO:2000181,negative regulation of blood vessel morp...,118,3,0.66,0.02890,1,0.19181627586206895,4.55,BP
GO:0046677,response to antibiotic,305,5,1.71,0.02894,1,0.1918171900826446,2.92,BP
GO:0044283,small molecule biosynthetic process,646,8,3.63,0.02931,1,0.1938680769230769,2.2,BP
GO:0090087,regulation of peptide transport,769,9,4.32,0.02933,1,0.1938680769230769,2.08,BP
GO:1901565,organonitrogen compound catabolic proces...,1158,12,6.5,0.02948,1,0.19423810554803786,1.85,BP
GO:1905114,cell surface receptor signaling pathway ...,528,7,2.96,0.02951,1,0.19423810554803786,2.36,BP
GO:0016071,mRNA metabolic process,647,8,3.63,0.02954,1,0.19423810554803786,2.2,BP
GO:0050896,response to stimulus,9311,63,52.28,0.02958,1,0.19423810554803786,1.21,BP
GO:0030857,negative regulation of epithelial cell d...,48,2,0.27,0.02981,1,0.19423810554803786,7.41,BP
GO:0044786,cell cycle DNA replication,48,2,0.27,0.02981,1,0.19423810554803786,7.41,BP
GO:0045104,intermediate filament cytoskeleton organ...,48,2,0.27,0.02981,1,0.19423810554803786,7.41,BP
GO:0047496,vesicle transport along microtubule,48,2,0.27,0.02981,1,0.19423810554803786,7.41,BP
GO:0051438,regulation of ubiquitin-protein transfer...,48,2,0.27,0.02981,1,0.19423810554803786,7.41,BP
GO:0061005,cell differentiation involved in kidney ...,48,2,0.27,0.02981,1,0.19423810554803786,7.41,BP
GO:0042493,response to drug,898,10,5.04,0.02983,1,0.19423810554803786,1.98,BP
GO:0031345,negative regulation of cell projection o...,208,4,1.17,0.02988,1,0.19430075675675676,3.42,BP
GO:0071103,DNA conformation change,210,4,1.18,0.03080,1,0.19980824797843666,3.39,BP
GO:0042542,response to hydrogen peroxide,121,3,0.68,0.03081,1,0.19980824797843666,4.41,BP
GO:0045103,intermediate filament-based process,49,2,0.28,0.03097,1,0.2003059677419355,7.14,BP
GO:0050435,amyloid-beta metabolic process,49,2,0.28,0.03097,1,0.2003059677419355,7.14,BP
GO:0050714,positive regulation of protein secretion,311,5,1.75,0.03110,1,0.20087677852348992,2.86,BP
GO:0061024,membrane organization,655,8,3.68,0.03145,1,0.20286514745308312,2.17,BP
GO:0044248,cellular catabolic process,2013,18,11.3,0.03199,1,0.20538868525896414,1.59,BP
GO:0010921,regulation of phosphatase activity,123,3,0.69,0.03212,1,0.20538868525896414,4.35,BP
GO:0045727,positive regulation of translation,123,3,0.69,0.03212,1,0.20538868525896414,4.35,BP
GO:0010828,positive regulation of glucose transmemb...,50,2,0.28,0.03214,1,0.20538868525896414,7.14,BP
GO:0042491,inner ear auditory receptor cell differe...,50,2,0.28,0.03214,1,0.20538868525896414,7.14,BP
GO:0060043,regulation of cardiac muscle cell prolif...,50,2,0.28,0.03214,1,0.20538868525896414,7.14,BP
GO:0090329,regulation of DNA-dependent DNA replicat...,50,2,0.28,0.03214,1,0.20538868525896414,7.14,BP
GO:0033157,regulation of intracellular protein tran...,213,4,1.2,0.03220,1,0.2054992042440318,3.33,BP
GO:0051047,positive regulation of secretion,539,7,3.03,0.03247,1,0.20694786754966887,2.31,BP
GO:0120035,regulation of plasma membrane bounded ce...,784,9,4.4,0.03261,1,0.20756523809523808,2.05,BP
GO:0060996,dendritic spine development,124,3,0.7,0.03278,1,0.208371677675033,4.29,BP
GO:0050920,regulation of chemotaxis,215,4,1.21,0.03316,1,0.20910555410691004,3.31,BP
GO:0008038,neuron recognition,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:0010332,response to gamma radiation,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:0016126,sterol biosynthetic process,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:0032206,positive regulation of telomere maintena...,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:0046189,phenol-containing compound biosynthetic ...,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:0051353,positive regulation of oxidoreductase ac...,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:1902373,negative regulation of mRNA catabolic pr...,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:2000059,negative regulation of ubiquitin-depende...,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:2000649,regulation of sodium ion transmembrane t...,51,2,0.29,0.03333,1,0.20910555410691004,6.9,BP
GO:0032273,positive regulation of protein polymeriz...,125,3,0.7,0.03345,1,0.20958515625000002,4.29,BP
GO:0009913,epidermal cell differentiation,216,4,1.21,0.03364,1,0.21022815584415586,3.31,BP
GO:0048639,positive regulation of developmental gro...,216,4,1.21,0.03364,1,0.21022815584415586,3.31,BP
GO:0009628,response to abiotic stimulus,1048,11,5.88,0.03370,1,0.21032996108949417,1.87,BP
GO:0048562,embryonic organ morphogenesis,318,5,1.79,0.03375,1,0.21036917098445598,2.79,BP
GO:0002791,regulation of peptide secretion,544,7,3.05,0.03388,1,0.2109062871927555,2.3,BP
GO:0006810,transport,4327,33,24.3,0.03404,1,0.21145862595419848,1.36,BP
GO:0042327,positive regulation of phosphorylation,1050,11,5.9,0.03410,1,0.21145862595419848,1.86,BP
GO:0006611,protein export from nucleus,126,3,0.71,0.03413,1,0.21145862595419848,4.23,BP
GO:0055065,metal ion homeostasis,667,8,3.75,0.03446,1,0.21145862595419848,2.13,BP
GO:0000288,nuclear-transcribed mRNA catabolic proce...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0001895,retina homeostasis,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0001954,positive regulation of cell-matrix adhes...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0007019,microtubule depolymerization,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0030071,regulation of mitotic metaphase/anaphase...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0032481,positive regulation of type I interferon...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0045981,positive regulation of nucleotide metabo...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0061014,positive regulation of mRNA catabolic pr...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:1900544,positive regulation of purine nucleotide...,52,2,0.29,0.03454,1,0.21145862595419848,6.9,BP
GO:0032271,regulation of protein polymerization,218,4,1.22,0.03462,1,0.21167908513341804,3.28,BP
GO:0031344,regulation of cell projection organizati...,793,9,4.45,0.03469,1,0.2118379187817259,2.02,BP
GO:0009259,ribonucleotide metabolic process,431,6,2.42,0.03483,1,0.2124232699619772,2.48,BP
GO:0010648,negative regulation of cell communicatio...,1326,13,7.45,0.03519,1,0.2143471898734177,1.74,BP
GO:0002790,peptide secretion,671,8,3.77,0.03550,1,0.21515655,2.12,BP
GO:0010811,positive regulation of cell-substrate ad...,128,3,0.72,0.03551,1,0.21515655,4.17,BP
GO:0061387,regulation of extent of cell growth,128,3,0.72,0.03551,1,0.21515655,4.17,BP
GO:0048545,response to steroid hormone,220,4,1.24,0.03562,1,0.21515655,3.23,BP
GO:0051495,positive regulation of cytoskeleton orga...,220,4,1.24,0.03562,1,0.21515655,3.23,BP
GO:0031113,regulation of microtubule polymerization,53,2,0.3,0.03577,1,0.21515655,6.67,BP
GO:0042743,hydrogen peroxide metabolic process,53,2,0.3,0.03577,1,0.21515655,6.67,BP
GO:0043666,regulation of phosphoprotein phosphatase...,53,2,0.3,0.03577,1,0.21515655,6.67,BP
GO:0071242,cellular response to ammonium ion,53,2,0.3,0.03577,1,0.21515655,6.67,BP
GO:0099518,vesicle cytoskeletal trafficking,53,2,0.3,0.03577,1,0.21515655,6.67,BP
GO:0016055,Wnt signaling pathway,434,6,2.44,0.03584,1,0.21530846441947563,2.46,BP
GO:0023057,negative regulation of signaling,1330,13,7.47,0.03592,1,0.21552,1.74,BP
GO:0050707,regulation of cytokine secretion,221,4,1.24,0.03612,1,0.2164501120797011,3.23,BP
GO:0198738,cell-cell signaling by wnt,436,6,2.45,0.03652,1,0.2185749253731343,2.45,BP
GO:0051046,regulation of secretion,930,10,5.22,0.03658,1,0.21866206211180125,1.92,BP
GO:1901343,negative regulation of vasculature devel...,130,3,0.73,0.03692,1,0.21986681481481482,4.11,BP
GO:0010517,regulation of phospholipase activity,54,2,0.3,0.03701,1,0.21986681481481482,6.67,BP
GO:0043268,positive regulation of potassium ion tra...,54,2,0.3,0.03701,1,0.21986681481481482,6.67,BP
GO:0061900,glial cell activation,54,2,0.3,0.03701,1,0.21986681481481482,6.67,BP
GO:0072698,protein localization to microtubule cyto...,54,2,0.3,0.03701,1,0.21986681481481482,6.67,BP
GO:0072657,protein localization to membrane,555,7,3.12,0.03712,1,0.22024838471023428,2.24,BP
GO:0030073,insulin secretion,225,4,1.26,0.03818,1,0.2259573496932515,3.17,BP
GO:0007528,neuromuscular junction development,55,2,0.31,0.03827,1,0.2259573496932515,6.45,BP
GO:0035315,hair cell differentiation,55,2,0.31,0.03827,1,0.2259573496932515,6.45,BP
GO:1902099,regulation of metaphase/anaphase transit...,55,2,0.31,0.03827,1,0.2259573496932515,6.45,BP
GO:0043467,regulation of generation of precursor me...,132,3,0.74,0.03836,1,0.22621117647058825,4.05,BP
GO:0030177,positive regulation of Wnt signaling pat...,133,3,0.75,0.03909,1,0.23023388004895962,4,BP
GO:0010632,regulation of epithelial cell migration,227,4,1.27,0.03924,1,0.23083481662591687,3.15,BP
GO:0006879,cellular iron ion homeostasis,56,2,0.31,0.03954,1,0.23103432727272727,6.45,BP
GO:0007062,sister chromatid cohesion,56,2,0.31,0.03954,1,0.23103432727272727,6.45,BP
GO:0007091,metaphase/anaphase transition of mitotic...,56,2,0.31,0.03954,1,0.23103432727272727,6.45,BP
GO:0031641,regulation of myelination,56,2,0.31,0.03954,1,0.23103432727272727,6.45,BP
GO:0035019,somatic stem cell population maintenance,56,2,0.31,0.03954,1,0.23103432727272727,6.45,BP
GO:0010563,negative regulation of phosphorus metabo...,563,7,3.16,0.03961,1,0.23103432727272727,2.22,BP
GO:0045936,negative regulation of phosphate metabol...,563,7,3.16,0.03961,1,0.23103432727272727,2.22,BP
GO:0032386,regulation of intracellular transport,445,6,2.5,0.03970,1,0.23127893462469734,2.4,BP
GO:0006633,fatty acid biosynthetic process,134,3,0.75,0.03983,1,0.2317556952841596,4,BP
GO:0090066,regulation of anatomical structure size,564,7,3.17,0.03993,1,0.23205695652173913,2.21,BP
GO:0046578,regulation of Ras protein signal transdu...,229,4,1.29,0.04031,1,0.2337008674698795,3.1,BP
GO:0060828,regulation of canonical Wnt signaling pa...,229,4,1.29,0.04031,1,0.2337008674698795,3.1,BP
GO:0050801,ion homeostasis,816,9,4.58,0.04043,1,0.23411451263537905,1.97,BP
GO:0019693,ribose phosphate metabolic process,448,6,2.52,0.04080,1,0.23429106078665077,2.38,BP
GO:0051222,positive regulation of protein transport,448,6,2.52,0.04080,1,0.23429106078665077,2.38,BP
GO:0010965,regulation of mitotic sister chromatid s...,57,2,0.32,0.04083,1,0.23429106078665077,6.25,BP
GO:0046676,negative regulation of insulin secretion,57,2,0.32,0.04083,1,0.23429106078665077,6.25,BP
GO:0050879,multicellular organismal movement,57,2,0.32,0.04083,1,0.23429106078665077,6.25,BP
GO:0050881,musculoskeletal movement,57,2,0.32,0.04083,1,0.23429106078665077,6.25,BP
GO:0072678,T cell migration,57,2,0.32,0.04083,1,0.23429106078665077,6.25,BP
GO:1901617,organic hydroxy compound biosynthetic pr...,230,4,1.29,0.04085,1,0.23429106078665077,3.1,BP
GO:0007034,vacuolar transport,136,3,0.76,0.04132,1,0.23586220640569397,3.95,BP
GO:0035023,regulation of Rho protein signal transdu...,136,3,0.76,0.04132,1,0.23586220640569397,3.95,BP
GO:0035966,response to topologically incorrect prot...,136,3,0.76,0.04132,1,0.23586220640569397,3.95,BP
GO:0043624,cellular protein complex disassembly,136,3,0.76,0.04132,1,0.23586220640569397,3.95,BP
GO:0001817,regulation of cytokine production,693,8,3.89,0.04164,1,0.2374072037914692,2.06,BP
GO:0060348,bone development,232,4,1.3,0.04195,1,0.23860921985815603,3.08,BP
GO:0090276,regulation of peptide hormone secretion,232,4,1.3,0.04195,1,0.23860921985815603,3.08,BP
GO:0042471,ear morphogenesis,137,3,0.77,0.04208,1,0.23878415094339622,3.9,BP
GO:0072331,signal transduction by p53 class mediato...,137,3,0.77,0.04208,1,0.23878415094339622,3.9,BP
GO:0051603,proteolysis involved in cellular protein...,696,8,3.91,0.04253,1,0.24105342756183745,2.05,BP
GO:0048675,axon extension,138,3,0.77,0.04284,1,0.2425248,3.9,BP
GO:0042775,mitochondrial ATP synthesis coupled elec...,59,2,0.33,0.04346,1,0.24488234192037467,6.06,BP
GO:0044784,metaphase/anaphase transition of cell cy...,59,2,0.33,0.04346,1,0.24488234192037467,6.06,BP
GO:1902369,negative regulation of RNA catabolic pro...,59,2,0.33,0.04346,1,0.24488234192037467,6.06,BP
GO:2000401,regulation of lymphocyte migration,59,2,0.33,0.04346,1,0.24488234192037467,6.06,BP
GO:0008285,negative regulation of cell proliferatio...,700,8,3.93,0.04373,1,0.2461155087719298,2.04,BP
GO:0002793,positive regulation of peptide secretion,342,5,1.92,0.04386,1,0.24655878504672898,2.6,BP
GO:0006511,ubiquitin-dependent protein catabolic pr...,577,7,3.24,0.04421,1,0.24823631271878646,2.16,BP
GO:0031122,cytoplasmic microtubule organization,60,2,0.34,0.04480,1,0.25009002320185614,5.88,BP
GO:0042982,amyloid precursor protein metabolic proc...,60,2,0.34,0.04480,1,0.25009002320185614,5.88,BP
GO:0051306,mitotic sister chromatid separation,60,2,0.34,0.04480,1,0.25009002320185614,5.88,BP
GO:0090183,regulation of kidney development,60,2,0.34,0.04480,1,0.25009002320185614,5.88,BP
GO:0090307,mitotic spindle assembly,60,2,0.34,0.04480,1,0.25009002320185614,5.88,BP
GO:0045930,negative regulation of mitotic cell cycl...,238,4,1.34,0.04534,1,0.25281121668597917,2.99,BP
GO:0015850,organic hydroxy compound transport,239,4,1.34,0.04592,1,0.2557488888888889,2.99,BP
GO:0009790,embryo development,1241,12,6.97,0.04612,1,0.2558453917050691,1.72,BP
GO:0031102,neuron projection regeneration,61,2,0.34,0.04615,1,0.2558453917050691,5.88,BP
GO:0071156,regulation of cell cycle arrest,61,2,0.34,0.04615,1,0.2558453917050691,5.88,BP
GO:1902305,regulation of sodium ion transmembrane t...,61,2,0.34,0.04615,1,0.2558453917050691,5.88,BP
GO:0030278,regulation of ossification,240,4,1.35,0.04650,1,0.2574890678941312,2.96,BP
GO:0007050,cell cycle arrest,143,3,0.8,0.04677,1,0.2580931651376147,3.75,BP
GO:0106106,cold-induced thermogenesis,143,3,0.8,0.04677,1,0.2580931651376147,3.75,BP
GO:0120161,regulation of cold-induced thermogenesis,143,3,0.8,0.04677,1,0.2580931651376147,3.75,BP
GO:0048008,platelet-derived growth factor receptor ...,62,2,0.35,0.04752,1,0.2601760909090909,5.71,BP
GO:0048286,lung alveolus development,62,2,0.35,0.04752,1,0.2601760909090909,5.71,BP
GO:0048488,synaptic vesicle endocytosis,62,2,0.35,0.04752,1,0.2601760909090909,5.71,BP
GO:0060038,cardiac muscle cell proliferation,62,2,0.35,0.04752,1,0.2601760909090909,5.71,BP
GO:0140238,presynaptic endocytosis,62,2,0.35,0.04752,1,0.2601760909090909,5.71,BP
GO:0002687,positive regulation of leukocyte migrati...,144,3,0.81,0.04758,1,0.2601760909090909,3.7,BP
GO:0046330,positive regulation of JNK cascade,144,3,0.81,0.04758,1,0.2601760909090909,3.7,BP
GO:0071333,cellular response to glucose stimulus,144,3,0.81,0.04758,1,0.2601760909090909,3.7,BP
GO:1904951,positive regulation of establishment of ...,467,6,2.62,0.04820,1,0.2632671963677639,2.29,BP
GO:0043393,regulation of protein binding,243,4,1.36,0.04828,1,0.2634051700680272,2.94,BP
GO:0019941,modification-dependent protein catabolic...,589,7,3.31,0.04843,1,0.2639243035107588,2.11,BP
GO:0045666,positive regulation of neuron differenti...,468,6,2.63,0.04861,1,0.26409292929292927,2.28,BP
GO:1903362,regulation of cellular protein catabolic...,244,4,1.37,0.04888,1,0.26409292929292927,2.92,BP
GO:0030858,positive regulation of epithelial cell d...,63,2,0.35,0.04890,1,0.26409292929292927,5.71,BP
GO:0032722,positive regulation of chemokine product...,63,2,0.35,0.04890,1,0.26409292929292927,5.71,BP
GO:0042773,ATP synthesis coupled electron transport,63,2,0.35,0.04890,1,0.26409292929292927,5.71,BP
GO:0070059,intrinsic apoptotic signaling pathway in...,63,2,0.35,0.04890,1,0.26409292929292927,5.71,BP
GO:1905818,regulation of chromosome separation,63,2,0.35,0.04890,1,0.26409292929292927,5.71,BP
GO:2000242,negative regulation of reproductive proc...,63,2,0.35,0.04890,1,0.26409292929292927,5.71,BP
GO:0007613,memory,146,3,0.82,0.04921,1,0.2648753020134228,3.66,BP
GO:0031099,regeneration,146,3,0.82,0.04921,1,0.2648753020134228,3.66,BP
GO:2001251,negative regulation of chromosome organi...,146,3,0.82,0.04921,1,0.2648753020134228,3.66,BP
GO:1903530,regulation of secretion by cell,849,9,4.77,0.04975,1,0.2674826815642458,1.89,BP
GO:0045667,regulation of osteoblast differentiation,147,3,0.83,0.05004,1,0.2681124360400445,3.61,BP
GO:0071331,cellular response to hexose stimulus,147,3,0.83,0.05004,1,0.2681124360400445,3.61,BP
GO:1901991,negative regulation of mitotic cell cycl...,147,3,0.83,0.05004,1,0.2681124360400445,3.61,BP
GO:0046034,ATP metabolic process,246,4,1.38,0.05009,1,0.2681124360400445,2.9,BP
GO:0010562,positive regulation of phosphorus metabo...,1120,11,6.29,0.05028,1,0.26834101995565407,1.75,BP
GO:0045937,positive regulation of phosphate metabol...,1120,11,6.29,0.05028,1,0.26834101995565407,1.75,BP
GO:0007566,embryo implantation,64,2,0.36,0.05030,1,0.26834101995565407,5.56,BP
GO:0032147,activation of protein kinase activity,247,4,1.39,0.05070,1,0.2698765486725664,2.88,BP
GO:0099003,vesicle-mediated transport in synapse,247,4,1.39,0.05070,1,0.2698765486725664,2.88,BP
GO:0051234,establishment of localization,4469,33,25.09,0.05084,1,0.27018370860927154,1.32,BP
GO:0071326,cellular response to monosaccharide stim...,148,3,0.83,0.05087,1,0.27018370860927154,3.61,BP
GO:0009056,catabolic process,2279,19,12.8,0.05099,1,0.2705224696802646,1.48,BP
GO:0060537,muscle tissue development,474,6,2.66,0.05112,1,0.2709134801762114,2.26,BP
GO:0007411,axon guidance,248,4,1.39,0.05132,1,0.2716741914191419,2.88,BP
GO:0030330,"DNA damage response, signal transduction...",65,2,0.36,0.05171,1,0.27253945235487403,5.56,BP
GO:0033627,cell adhesion mediated by integrin,65,2,0.36,0.05171,1,0.27253945235487403,5.56,BP
GO:0071479,cellular response to ionizing radiation,65,2,0.36,0.05171,1,0.27253945235487403,5.56,BP
GO:0150076,neuroinflammatory response,65,2,0.36,0.05171,1,0.27253945235487403,5.56,BP
GO:0043632,modification-dependent macromolecule cat...,599,7,3.36,0.05213,1,0.27445247264770245,2.08,BP
GO:0097485,neuron projection guidance,250,4,1.4,0.05256,1,0.2764139016393443,2.86,BP
GO:0030968,endoplasmic reticulum unfolded protein r...,66,2,0.37,0.05313,1,0.278498431372549,5.41,BP
GO:0034394,protein localization to cell surface,66,2,0.37,0.05313,1,0.278498431372549,5.41,BP
GO:0046324,regulation of glucose import,66,2,0.37,0.05313,1,0.278498431372549,5.41,BP
GO:0030162,regulation of proteolysis,730,8,4.1,0.05348,1,0.28002803046789987,1.95,BP
GO:0051348,negative regulation of transferase activ...,252,4,1.41,0.05382,1,0.28150200000000003,2.84,BP
GO:0051656,establishment of organelle localization,481,6,2.7,0.05415,1,0.2829205211726384,2.22,BP
GO:0003143,embryonic heart tube morphogenesis,67,2,0.38,0.05457,1,0.28480568329718003,5.26,BP
GO:0050663,cytokine secretion,254,4,1.43,0.05510,1,0.28726023835319614,2.8,BP
GO:0055080,cation homeostasis,736,8,4.13,0.05559,1,0.28950116883116883,1.94,BP
GO:0032387,negative regulation of intracellular tra...,68,2,0.38,0.05602,1,0.2901703336921421,5.26,BP
GO:0042273,ribosomal large subunit biogenesis,68,2,0.38,0.05602,1,0.2901703336921421,5.26,BP
GO:0048002,antigen processing and presentation of p...,68,2,0.38,0.05602,1,0.2901703336921421,5.26,BP
GO:0048678,response to axon injury,68,2,0.38,0.05602,1,0.2901703336921421,5.26,BP
GO:0090278,negative regulation of peptide hormone s...,68,2,0.38,0.05602,1,0.2901703336921421,5.26,BP
GO:0008015,blood circulation,487,6,2.73,0.05684,1,0.29372819742489276,2.2,BP
GO:0071322,cellular response to carbohydrate stimul...,155,3,0.87,0.05689,1,0.29372819742489276,3.45,BP
GO:0071478,cellular response to radiation,155,3,0.87,0.05689,1,0.29372819742489276,3.45,BP
GO:0010975,regulation of neuron projection developm...,612,7,3.44,0.05720,1,0.29474788008565306,2.03,BP
GO:0010976,positive regulation of neuron projection...,369,5,2.07,0.05721,1,0.29474788008565306,2.42,BP
GO:0048168,regulation of neuronal synaptic plastici...,69,2,0.39,0.05749,1,0.29578442553191486,5.13,BP
GO:0032412,regulation of ion transmembrane transpor...,258,4,1.45,0.05771,1,0.29578442553191486,2.76,BP
GO:1903311,regulation of mRNA metabolic process,258,4,1.45,0.05771,1,0.29578442553191486,2.76,BP
GO:0014070,response to organic cyclic compound,742,8,4.17,0.05775,1,0.29578442553191486,1.92,BP
GO:0007264,small GTPase mediated signal transductio...,489,6,2.75,0.05775,1,0.29578442553191486,2.18,BP
GO:0030178,negative regulation of Wnt signaling pat...,156,3,0.88,0.05778,1,0.29578442553191486,3.41,BP
GO:0006605,protein targeting,260,4,1.46,0.05904,1,0.3009538983050848,2.74,BP
GO:0051403,stress-activated MAPK cascade,260,4,1.46,0.05904,1,0.3009538983050848,2.74,BP
GO:0072330,monocarboxylic acid biosynthetic process,260,4,1.46,0.05904,1,0.3009538983050848,2.74,BP
GO:0098813,nuclear chromosome segregation,260,4,1.46,0.05904,1,0.3009538983050848,2.74,BP
GO:0051494,negative regulation of cytoskeleton orga...,158,3,0.89,0.05957,1,0.302693600844773,3.37,BP
GO:0062013,positive regulation of small molecule me...,158,3,0.89,0.05957,1,0.302693600844773,3.37,BP
GO:1990845,adaptive thermogenesis,158,3,0.89,0.05957,1,0.302693600844773,3.37,BP
GO:0006974,cellular response to DNA damage stimulus,748,8,4.2,0.05996,1,0.30435392405063294,1.9,BP
GO:0015980,energy derivation by oxidation of organi...,262,4,1.47,0.06038,1,0.306162866174921,2.72,BP
GO:0010594,regulation of endothelial cell migration,159,3,0.89,0.06048,1,0.30632858044164035,3.37,BP
GO:0048568,embryonic organ development,495,6,2.78,0.06054,1,0.30632858044164035,2.16,BP
GO:0098771,inorganic ion homeostasis,750,8,4.21,0.06071,1,0.30686609243697477,1.9,BP
GO:0051650,establishment of vesicle localization,263,4,1.48,0.06106,1,0.30831135362014694,2.7,BP
GO:0071383,cellular response to steroid hormone sti...,160,3,0.9,0.06139,1,0.30965270440251574,3.33,BP
GO:0010035,response to inorganic substance,498,6,2.8,0.06196,1,0.3122005445026178,2.14,BP
GO:0022898,regulation of transmembrane transporter ...,266,4,1.49,0.06312,1,0.31760204592901875,2.68,BP
GO:0007565,female pregnancy,162,3,0.91,0.06323,1,0.31760204592901875,3.3,BP
GO:0051147,regulation of muscle cell differentiatio...,162,3,0.91,0.06323,1,0.31760204592901875,3.3,BP
GO:0007422,peripheral nervous system development,73,2,0.41,0.06349,1,0.3179124661810614,4.88,BP
GO:0051145,smooth muscle cell differentiation,73,2,0.41,0.06349,1,0.3179124661810614,4.88,BP
GO:1903051,negative regulation of proteolysis invol...,73,2,0.41,0.06349,1,0.3179124661810614,4.88,BP
GO:0034599,cellular response to oxidative stress,267,4,1.5,0.06381,1,0.31918266112266114,2.67,BP
GO:0048585,negative regulation of response to stimu...,1599,14,8.98,0.06441,1,0.3218493457943925,1.56,BP
GO:0007605,sensory perception of sound,268,4,1.5,0.06451,1,0.3220146473029046,2.67,BP
GO:0007154,cell communication,6556,45,36.81,0.06490,1,0.3228856965944272,1.22,BP
GO:0006626,protein targeting to mitochondrion,74,2,0.42,0.06502,1,0.3228856965944272,4.76,BP
GO:0036465,synaptic vesicle recycling,74,2,0.42,0.06502,1,0.3228856965944272,4.76,BP
GO:0060191,regulation of lipase activity,74,2,0.42,0.06502,1,0.3228856965944272,4.76,BP
GO:1903201,regulation of oxidative stress-induced c...,74,2,0.42,0.06502,1,0.3228856965944272,4.76,BP
GO:0001678,cellular glucose homeostasis,164,3,0.92,0.06511,1,0.3229992989690722,3.26,BP
GO:0051186,cofactor metabolic process,506,6,2.84,0.06586,1,0.3263834397528321,2.11,BP
GO:1901988,negative regulation of cell cycle phase ...,165,3,0.93,0.06605,1,0.32694894141829395,3.23,BP
GO:0006091,generation of precursor metabolites and ...,385,5,2.16,0.06611,1,0.32694894141829395,2.31,BP
GO:0014743,regulation of muscle hypertrophy,75,2,0.42,0.06656,1,0.32750108273748724,4.76,BP
GO:0045843,negative regulation of striated muscle t...,75,2,0.42,0.06656,1,0.32750108273748724,4.76,BP
GO:0046323,glucose import,75,2,0.42,0.06656,1,0.32750108273748724,4.76,BP
GO:0060563,neuroepithelial cell differentiation,75,2,0.42,0.06656,1,0.32750108273748724,4.76,BP
GO:0009205,purine ribonucleoside triphosphate metab...,271,4,1.52,0.06663,1,0.32750108273748724,2.63,BP
GO:0030336,negative regulation of cell migration,271,4,1.52,0.06663,1,0.32750108273748724,2.63,BP
GO:0034097,response to cytokine,1037,10,5.82,0.06672,1,0.3276088163265306,1.72,BP
GO:0009266,response to temperature stimulus,166,3,0.93,0.06700,1,0.32864831804281347,3.23,BP
GO:0001503,ossification,387,5,2.17,0.06727,1,0.3296367006109979,2.3,BP
GO:0046887,positive regulation of hormone secretion,167,3,0.94,0.06796,1,0.3323409756097562,3.19,BP
GO:0051017,actin filament bundle assembly,167,3,0.94,0.06796,1,0.3323409756097562,3.19,BP
GO:0051193,regulation of cofactor metabolic process,76,2,0.43,0.06812,1,0.3324477079107505,4.65,BP
GO:0044281,small molecule metabolic process,1760,15,9.88,0.06812,1,0.3324477079107505,1.52,BP
GO:0060429,epithelium development,1182,11,6.64,0.06843,1,0.3336222492401216,1.66,BP
GO:0001816,cytokine production,771,8,4.33,0.06893,1,0.3357197975708502,1.85,BP
GO:0009199,ribonucleoside triphosphate metabolic pr...,275,4,1.54,0.06951,1,0.33732410462776663,2.6,BP
GO:0060485,mesenchyme development,275,4,1.54,0.06951,1,0.33732410462776663,2.6,BP
GO:0014855,striated muscle cell proliferation,77,2,0.43,0.06968,1,0.33732410462776663,4.65,BP
GO:0048635,negative regulation of muscle organ deve...,77,2,0.43,0.06968,1,0.33732410462776663,4.65,BP
GO:0055021,regulation of cardiac muscle tissue grow...,77,2,0.43,0.06968,1,0.33732410462776663,4.65,BP
GO:1901224,positive regulation of NIK/NF-kappaB sig...,77,2,0.43,0.06968,1,0.33732410462776663,4.65,BP
GO:0019827,stem cell population maintenance,169,3,0.95,0.06989,1,0.33766132530120474,3.16,BP
GO:0043122,regulation of I-kappaB kinase/NF-kappaB ...,169,3,0.95,0.06989,1,0.33766132530120474,3.16,BP
GO:0032409,regulation of transporter activity,276,4,1.55,0.07024,1,0.3390119157472417,2.58,BP
GO:0061572,actin filament bundle organization,170,3,0.95,0.07087,1,0.3417098597194389,3.16,BP
GO:0000079,regulation of cyclin-dependent protein s...,78,2,0.44,0.07126,1,0.3422186826347306,4.55,BP
GO:0045471,response to ethanol,78,2,0.44,0.07126,1,0.3422186826347306,4.55,BP
GO:0046785,microtubule polymerization,78,2,0.44,0.07126,1,0.3422186826347306,4.55,BP
GO:0061515,myeloid cell development,78,2,0.44,0.07126,1,0.3422186826347306,4.55,BP
GO:0001525,angiogenesis,517,6,2.9,0.07144,1,0.34274105682951145,2.07,BP
GO:0009968,negative regulation of signal transducti...,1192,11,6.69,0.07171,1,0.34369374501992034,1.64,BP
GO:0045807,positive regulation of endocytosis,171,3,0.96,0.07185,1,0.3440220895522388,3.12,BP
GO:0007165,signal transduction,5929,41,33.29,0.07195,1,0.34415844930417494,1.23,BP
GO:0032101,regulation of response to external stimu...,779,8,4.37,0.07224,1,0.3452024627606753,1.83,BP
GO:0009144,purine nucleoside triphosphate metabolic...,279,4,1.57,0.07245,1,0.34537359605911333,2.55,BP
GO:0051258,protein polymerization,279,4,1.57,0.07245,1,0.34537359605911333,2.55,BP
GO:0042692,muscle cell differentiation,396,5,2.22,0.07266,1,0.34537359605911333,2.25,BP
GO:0007369,gastrulation,172,3,0.97,0.07284,1,0.34537359605911333,3.09,BP
GO:0032874,positive regulation of stress-activated ...,172,3,0.97,0.07284,1,0.34537359605911333,3.09,BP
GO:2001257,regulation of cation channel activity,172,3,0.97,0.07284,1,0.34537359605911333,3.09,BP
GO:0051881,regulation of mitochondrial membrane pot...,79,2,0.44,0.07285,1,0.34537359605911333,4.55,BP
GO:0060976,coronary vasculature development,79,2,0.44,0.07285,1,0.34537359605911333,4.55,BP
GO:0002262,myeloid cell homeostasis,173,3,0.97,0.07383,1,0.3489881728880157,3.09,BP
GO:0070304,positive regulation of stress-activated ...,173,3,0.97,0.07383,1,0.3489881728880157,3.09,BP
GO:0098727,maintenance of cell number,173,3,0.97,0.07383,1,0.3489881728880157,3.09,BP
GO:0051345,positive regulation of hydrolase activit...,522,6,2.93,0.07407,1,0.3497790382728165,2.05,BP
GO:0030500,regulation of bone mineralization,80,2,0.45,0.07446,1,0.3509319490695396,4.44,BP
GO:0051781,positive regulation of cell division,80,2,0.45,0.07446,1,0.3509319490695396,4.44,BP
GO:0030072,peptide hormone secretion,282,4,1.58,0.07470,1,0.3513747800586511,2.53,BP
GO:0051648,vesicle localization,282,4,1.58,0.07470,1,0.3513747800586511,2.53,BP
GO:0003012,muscle system process,400,5,2.25,0.07512,1,0.35266091707317077,2.22,BP
GO:0032535,regulation of cellular component size,400,5,2.25,0.07512,1,0.35266091707317077,2.22,BP
GO:0030099,myeloid cell differentiation,401,5,2.25,0.07575,1,0.35504252182347235,2.22,BP
GO:0031644,regulation of neurological system proces...,175,3,0.98,0.07584,1,0.35504252182347235,3.06,BP
GO:0002088,lens development in camera-type eye,81,2,0.45,0.07607,1,0.35504252182347235,4.44,BP
GO:0032479,regulation of type I interferon producti...,81,2,0.45,0.07607,1,0.35504252182347235,4.44,BP
GO:0033143,regulation of intracellular steroid horm...,81,2,0.45,0.07607,1,0.35504252182347235,4.44,BP
GO:0060113,inner ear receptor cell differentiation,81,2,0.45,0.07607,1,0.35504252182347235,4.44,BP
GO:0060070,canonical Wnt signaling pathway,284,4,1.59,0.07622,1,0.355053862536302,2.52,BP
GO:2000146,negative regulation of cell motility,284,4,1.59,0.07622,1,0.355053862536302,2.52,BP
GO:0051090,regulation of DNA-binding transcription ...,402,5,2.26,0.07637,1,0.3554085493230174,2.21,BP
GO:0016202,regulation of striated muscle tissue dev...,176,3,0.99,0.07685,1,0.35729681159420296,3.03,BP
GO:0031646,positive regulation of neurological syst...,82,2,0.46,0.07770,1,0.3598579403272378,4.35,BP
GO:0044106,cellular amine metabolic process,82,2,0.46,0.07770,1,0.3598579403272378,4.35,BP
GO:1903312,negative regulation of mRNA metabolic pr...,82,2,0.46,0.07770,1,0.3598579403272378,4.35,BP
GO:1904029,regulation of cyclin-dependent protein k...,82,2,0.46,0.07770,1,0.3598579403272378,4.35,BP
GO:0048513,animal organ development,3502,26,19.66,0.07780,1,0.3599746153846154,1.32,BP
GO:0007015,actin filament organization,405,5,2.27,0.07827,1,0.36180138328530265,2.2,BP
GO:0000075,cell cycle checkpoint,178,3,1,0.07890,1,0.3643635316698656,3,BP
GO:0022904,respiratory electron transport chain,83,2,0.47,0.07933,1,0.36494833652007647,4.26,BP
GO:0035050,embryonic heart tube development,83,2,0.47,0.07933,1,0.36494833652007647,4.26,BP
GO:0090630,activation of GTPase activity,83,2,0.47,0.07933,1,0.36494833652007647,4.26,BP
GO:1901992,positive regulation of mitotic cell cycl...,83,2,0.47,0.07933,1,0.36494833652007647,4.26,BP
GO:0001659,temperature homeostasis,179,3,1.01,0.07993,1,0.36735736389684814,2.97,BP
GO:0045165,cell fate commitment,289,4,1.62,0.08009,1,0.36774148854961825,2.47,BP
GO:0048634,regulation of muscle organ development,180,3,1.01,0.08096,1,0.36971134724857685,2.97,BP
GO:0032204,regulation of telomere maintenance,84,2,0.47,0.08098,1,0.36971134724857685,4.26,BP
GO:0034620,cellular response to unfolded protein,84,2,0.47,0.08098,1,0.36971134724857685,4.26,BP
GO:0045913,positive regulation of carbohydrate meta...,84,2,0.47,0.08098,1,0.36971134724857685,4.26,BP
GO:0060420,regulation of heart growth,84,2,0.47,0.08098,1,0.36971134724857685,4.26,BP
GO:1903321,negative regulation of protein modificat...,84,2,0.47,0.08098,1,0.36971134724857685,4.26,BP
GO:0023052,signaling,6490,44,36.44,0.08117,1,0.37022752606635073,1.21,BP
GO:0071345,cellular response to cytokine stimulus,938,9,5.27,0.08163,1,0.37197306818181813,1.71,BP
GO:0030100,regulation of endocytosis,292,4,1.64,0.08246,1,0.37510901886792447,2.44,BP
GO:0032606,type I interferon production,85,2,0.48,0.08263,1,0.37510901886792447,4.17,BP
GO:1900407,regulation of cellular response to oxida...,85,2,0.48,0.08263,1,0.37510901886792447,4.17,BP
GO:1903363,negative regulation of cellular protein ...,85,2,0.48,0.08263,1,0.37510901886792447,4.17,BP
GO:0006839,mitochondrial transport,182,3,1.02,0.08306,1,0.3767056738925542,2.94,BP
GO:0031098,stress-activated protein kinase signalin...,293,4,1.65,0.08325,1,0.3768570084666039,2.42,BP
GO:0043588,skin development,293,4,1.65,0.08325,1,0.3768570084666039,2.42,BP
GO:0010827,regulation of glucose transmembrane tran...,86,2,0.48,0.08430,1,0.38089352112676056,4.17,BP
GO:0051341,regulation of oxidoreductase activity,86,2,0.48,0.08430,1,0.38089352112676056,4.17,BP
GO:0009141,nucleoside triphosphate metabolic proces...,295,4,1.66,0.08486,1,0.3827050796626054,2.41,BP
GO:0009888,tissue development,1970,16,11.06,0.08486,1,0.3827050796626054,1.45,BP
GO:0050804,modulation of chemical synaptic transmis...,673,7,3.78,0.08502,1,0.38306764044943814,1.85,BP
GO:0099177,regulation of trans-synaptic signaling,674,7,3.78,0.08553,1,0.38500501403180537,1.85,BP
GO:0097193,intrinsic apoptotic signaling pathway,296,4,1.66,0.08566,1,0.3852298317757009,2.41,BP
GO:0002690,positive regulation of leukocyte chemota...,87,2,0.49,0.08598,1,0.3854076279069767,4.08,BP
GO:0022900,electron transport chain,87,2,0.49,0.08598,1,0.3854076279069767,4.08,BP
GO:0042490,mechanoreceptor differentiation,87,2,0.49,0.08598,1,0.3854076279069767,4.08,BP
GO:0007265,Ras protein signal transduction,417,5,2.34,0.08610,1,0.3854076279069767,2.14,BP
GO:0045785,positive regulation of cell adhesion,417,5,2.34,0.08610,1,0.3854076279069767,2.14,BP
GO:0009749,response to glucose,185,3,1.04,0.08623,1,0.38563081784386616,2.88,BP
GO:0033993,response to lipid,811,8,4.55,0.08643,1,0.3861663509749304,1.76,BP
GO:0032940,secretion by cell,1091,10,6.13,0.08670,1,0.38701335807050097,1.63,BP
GO:0051051,negative regulation of transport,546,6,3.07,0.08744,1,0.3899548470806303,1.95,BP
GO:0032024,positive regulation of insulin secretion,88,2,0.49,0.08767,1,0.3902572062904718,4.08,BP
GO:0040014,regulation of multicellular organism gro...,88,2,0.49,0.08767,1,0.3902572062904718,4.08,BP
GO:0050954,sensory perception of mechanical stimulu...,299,4,1.68,0.08811,1,0.3918533456561922,2.38,BP
GO:0008610,lipid biosynthetic process,548,6,3.08,0.08862,1,0.39375756232686987,1.95,BP
GO:0009150,purine ribonucleotide metabolic process,421,5,2.36,0.08880,1,0.3938300460829493,2.12,BP
GO:2001233,regulation of apoptotic signaling pathwa...,421,5,2.36,0.08880,1,0.3938300460829493,2.12,BP
GO:0001656,metanephros development,89,2,0.5,0.08937,1,0.39526511029411765,4,BP
GO:0007229,integrin-mediated signaling pathway,89,2,0.5,0.08937,1,0.39526511029411765,4,BP
GO:0033077,T cell differentiation in thymus,89,2,0.5,0.08937,1,0.39526511029411765,4,BP
GO:0006109,regulation of carbohydrate metabolic pro...,188,3,1.06,0.08947,1,0.39534402203856744,2.83,BP
GO:0055082,cellular chemical homeostasis,819,8,4.6,0.09021,1,0.3982481834862385,1.74,BP
GO:0009746,response to hexose,189,3,1.06,0.09055,1,0.3993827681026581,2.83,BP
GO:0032642,regulation of chemokine production,90,2,0.51,0.09107,1,0.4009412991765782,3.92,BP
GO:1903008,organelle disassembly,90,2,0.51,0.09107,1,0.4009412991765782,3.92,BP
GO:0051321,meiotic cell cycle,303,4,1.7,0.09142,1,0.402067383773929,2.35,BP
GO:0007517,muscle organ development,425,5,2.39,0.09155,1,0.402067383773929,2.09,BP
GO:0034284,response to monosaccharide,190,3,1.07,0.09165,1,0.402067383773929,2.8,BP
GO:0006396,RNA processing,822,8,4.62,0.09166,1,0.402067383773929,1.73,BP
GO:0046903,secretion,1250,11,7.02,0.09274,1,0.4048100453309157,1.57,BP
GO:0006364,rRNA processing,191,3,1.07,0.09275,1,0.4048100453309157,2.8,BP
GO:0046328,regulation of JNK cascade,191,3,1.07,0.09275,1,0.4048100453309157,2.8,BP
GO:0006112,energy reserve metabolic process,91,2,0.51,0.09279,1,0.4048100453309157,3.92,BP
GO:0014015,positive regulation of gliogenesis,91,2,0.51,0.09279,1,0.4048100453309157,3.92,BP
GO:0019226,transmission of nerve impulse,91,2,0.51,0.09279,1,0.4048100453309157,3.92,BP
GO:0009117,nucleotide metabolic process,556,6,3.12,0.09339,1,0.40705858695652175,1.92,BP
GO:0044706,multi-multicellular organism process,192,3,1.08,0.09385,1,0.40869339366515833,2.78,BP
GO:0001676,long-chain fatty acid metabolic process,92,2,0.52,0.09452,1,0.4093881548154816,3.85,BP
GO:0002028,regulation of sodium ion transport,92,2,0.52,0.09452,1,0.4093881548154816,3.85,BP
GO:0009308,amine metabolic process,92,2,0.52,0.09452,1,0.4093881548154816,3.85,BP
GO:0042770,signal transduction in response to DNA d...,92,2,0.52,0.09452,1,0.4093881548154816,3.85,BP
GO:0072655,establishment of protein localization to...,92,2,0.52,0.09452,1,0.4093881548154816,3.85,BP
GO:1903313,positive regulation of mRNA metabolic pr...,92,2,0.52,0.09452,1,0.4093881548154816,3.85,BP
GO:0046883,regulation of hormone secretion,307,4,1.72,0.09480,1,0.410231654676259,2.33,BP
GO:0036473,cell death in response to oxidative stre...,93,2,0.52,0.09625,1,0.41538565022421525,3.85,BP
GO:0051304,chromosome separation,93,2,0.52,0.09625,1,0.41538565022421525,3.85,BP
GO:0060395,SMAD protein signal transduction,93,2,0.52,0.09625,1,0.41538565022421525,3.85,BP
GO:0045765,regulation of angiogenesis,309,4,1.73,0.09651,1,0.41613451612903224,2.31,BP
GO:0007215,glutamate receptor signaling pathway,94,2,0.53,0.09800,1,0.42092156583629897,3.77,BP
GO:0032602,chemokine production,94,2,0.53,0.09800,1,0.42092156583629897,3.77,BP
GO:0042116,macrophage activation,94,2,0.53,0.09800,1,0.42092156583629897,3.77,BP
GO:1902882,regulation of response to oxidative stre...,94,2,0.53,0.09800,1,0.42092156583629897,3.77,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,311,4,1.75,0.09823,1,0.42092156583629897,2.29,BP
GO:0006753,nucleoside phosphate metabolic process,564,6,3.17,0.09829,1,0.42092156583629897,1.89,BP
GO:0048771,tissue remodeling,196,3,1.1,0.09832,1,0.42092156583629897,2.73,BP
GO:1990138,neuron projection extension,196,3,1.1,0.09832,1,0.42092156583629897,2.73,BP
GO:0045927,positive regulation of growth,312,4,1.75,0.09910,1,0.42330228926353153,2.29,BP
GO:0048872,homeostasis of number of cells,312,4,1.75,0.09910,1,0.42330228926353153,2.29,BP
GO:0006629,lipid metabolic process,1266,11,7.11,0.09914,1,0.42330228926353153,1.55,BP
GO:0030308,negative regulation of cell growth,197,3,1.11,0.09946,1,0.423916315323295,2.7,BP
GO:1903046,meiotic cell cycle process,197,3,1.11,0.09946,1,0.423916315323295,2.7,BP
GO:0001570,vasculogenesis,95,2,0.53,0.09975,1,0.4240256183745583,3.77,BP
GO:0072676,lymphocyte migration,95,2,0.53,0.09975,1,0.4240256183745583,3.77,BP
GO:1903578,regulation of ATP metabolic process,95,2,0.53,0.09975,1,0.4240256183745583,3.77,BP
GO:0046683,response to organophosphorus,96,2,0.54,0.10152,1,0.4304090220264317,3.7,BP
GO:0071456,cellular response to hypoxia,96,2,0.54,0.10152,1,0.4304090220264317,3.7,BP
GO:1901989,positive regulation of cell cycle phase ...,96,2,0.54,0.10152,1,0.4304090220264317,3.7,BP
GO:0030307,positive regulation of cell growth,199,3,1.12,0.10173,1,0.4305406860158311,2.68,BP
GO:1902275,regulation of chromatin organization,199,3,1.12,0.10173,1,0.4305406860158311,2.68,BP
GO:0060627,regulation of vesicle-mediated transport,570,6,3.2,0.10206,1,0.43155775043936734,1.88,BP
GO:0007173,epidermal growth factor receptor signali...,97,2,0.54,0.10329,1,0.434848188976378,3.7,BP
GO:0046888,negative regulation of hormone secretion,97,2,0.54,0.10329,1,0.434848188976378,3.7,BP
GO:0070167,regulation of biomineral tissue developm...,97,2,0.54,0.10329,1,0.434848188976378,3.7,BP
GO:0072080,nephron tubule development,97,2,0.54,0.10329,1,0.434848188976378,3.7,BP
GO:0120162,positive regulation of cold-induced ther...,97,2,0.54,0.10329,1,0.434848188976378,3.7,BP
GO:0042391,regulation of membrane potential,442,5,2.48,0.10370,1,0.4361926573426574,2.02,BP
GO:0002685,regulation of leukocyte migration,201,3,1.13,0.10403,1,0.4368170680628273,2.65,BP
GO:0048469,cell maturation,201,3,1.13,0.10403,1,0.4368170680628273,2.65,BP
GO:0043502,regulation of muscle adaptation,98,2,0.55,0.10507,1,0.4378467976088813,3.64,BP
GO:0000302,response to reactive oxygen species,202,3,1.13,0.10519,1,0.4378467976088813,2.65,BP
GO:0051271,negative regulation of cellular componen...,319,4,1.79,0.10527,1,0.4378467976088813,2.23,BP
GO:0034762,regulation of transmembrane transport,576,6,3.23,0.10591,1,0.4378467976088813,1.86,BP
GO:0009743,response to carbohydrate,203,3,1.14,0.10635,1,0.4378467976088813,2.63,BP
GO:0043542,endothelial cell migration,203,3,1.14,0.10635,1,0.4378467976088813,2.63,BP
GO:0002755,MyD88-dependent toll-like receptor signa...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0019430,removal of superoxide radicals,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0033605,positive regulation of catecholamine sec...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0035855,megakaryocyte development,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0036344,platelet morphogenesis,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0045821,positive regulation of glycolytic proces...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0045986,negative regulation of smooth muscle con...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0051383,kinetochore organization,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0051481,negative regulation of cytosolic calcium...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0060123,regulation of growth hormone secretion,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0070828,heterochromatin organization,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0072520,seminiferous tubule development,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0090502,"RNA phosphodiester bond hydrolysis, endo...",20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:1900409,positive regulation of cellular response...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:1900451,positive regulation of glutamate recepto...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:1902993,positive regulation of amyloid precursor...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:1903392,negative regulation of adherens junction...,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:1903975,regulation of glial cell migration,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:1904385,cellular response to angiotensin,20,1,0.11,0.10655,1,0.4378467976088813,9.09,BP
GO:0006163,purine nucleotide metabolic process,446,5,2.5,0.10667,1,0.43796590443686,2,BP
GO:0043473,pigmentation,99,2,0.56,0.10686,1,0.43837196930946293,3.57,BP
GO:0007059,chromosome segregation,321,4,1.8,0.10706,1,0.43881833049403746,2.22,BP
GO:0003018,vascular process in circulatory system,204,3,1.15,0.10752,1,0.440328714893617,2.61,BP
GO:0010771,negative regulation of cell morphogenesi...,100,2,0.56,0.10865,1,0.44385728925619833,3.57,BP
GO:0001666,response to hypoxia,205,3,1.15,0.10870,1,0.44385728925619833,2.61,BP
GO:0007254,JNK cascade,205,3,1.15,0.10870,1,0.44385728925619833,2.61,BP
GO:0018105,peptidyl-serine phosphorylation,323,4,1.81,0.10887,1,0.44385728925619833,2.21,BP
GO:0006909,phagocytosis,206,3,1.16,0.10987,1,0.44385728925619833,2.59,BP
GO:0014706,striated muscle tissue development,451,5,2.53,0.11044,1,0.44385728925619833,1.98,BP
GO:0006119,oxidative phosphorylation,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0033559,unsaturated fatty acid metabolic process,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0051651,maintenance of location in cell,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0055024,regulation of cardiac muscle tissue deve...,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0060359,response to ammonium ion,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0090263,positive regulation of canonical Wnt sig...,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0110020,regulation of actomyosin structure organ...,101,2,0.57,0.11046,1,0.44385728925619833,3.51,BP
GO:0000466,maturation of 5.8S rRNA from tricistroni...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0000469,cleavage involved in rRNA processing,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0002495,antigen processing and presentation of p...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0006120,"mitochondrial electron transport, NADH t...",21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0017000,antibiotic biosynthetic process,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0022010,central nervous system myelination,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0030813,positive regulation of nucleotide catabo...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0031065,positive regulation of histone deacetyla...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0032291,axon ensheathment in central nervous sys...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0036336,dendritic cell migration,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0042053,regulation of dopamine metabolic process,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0042535,positive regulation of tumor necrosis fa...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0046174,polyol catabolic process,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0051197,positive regulation of coenzyme metaboli...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0060457,negative regulation of digestive system ...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0098780,response to mitochondrial depolarisation,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0140058,neuron projection arborization,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:1900151,regulation of nuclear-transcribed mRNA c...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:1901623,regulation of lymphocyte chemotaxis,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:1904666,regulation of ubiquitin protein ligase a...,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:1990776,response to angiotensin,21,1,0.12,0.11157,1,0.44385728925619833,8.33,BP
GO:0043270,positive regulation of ion transport,326,4,1.83,0.11161,1,0.44385728925619833,2.19,BP
GO:0006875,cellular metal ion homeostasis,585,6,3.28,0.11182,1,0.4442789802631579,1.83,BP
GO:0006397,mRNA processing,453,5,2.54,0.11197,1,0.4442789802631579,1.97,BP
GO:0097305,response to alcohol,208,3,1.17,0.11224,1,0.4442789802631579,2.56,BP
GO:0003300,cardiac muscle hypertrophy,102,2,0.57,0.11227,1,0.4442789802631579,3.51,BP
GO:0008306,associative learning,102,2,0.57,0.11227,1,0.4442789802631579,3.51,BP
GO:0031123,RNA 3'-end processing,102,2,0.57,0.11227,1,0.4442789802631579,3.51,BP
GO:0048608,reproductive structure development,454,5,2.55,0.11274,1,0.44577229252259654,1.96,BP
GO:0007610,behavior,724,7,4.07,0.11334,1,0.44734653562653565,1.72,BP
GO:0008361,regulation of cell size,209,3,1.17,0.11344,1,0.44734653562653565,2.56,BP
GO:0070371,ERK1 and ERK2 cascade,328,4,1.84,0.11345,1,0.44734653562653565,2.17,BP
GO:0050808,synapse organization,455,5,2.55,0.11351,1,0.44734653562653565,1.96,BP
GO:0045778,positive regulation of ossification,103,2,0.58,0.11409,1,0.4476350518754988,3.45,BP
GO:0061326,renal tubule development,103,2,0.58,0.11409,1,0.4476350518754988,3.45,BP
GO:0017144,drug metabolic process,727,7,4.08,0.11514,1,0.4476350518754988,1.72,BP
GO:0061458,reproductive system development,458,5,2.57,0.11584,1,0.4476350518754988,1.95,BP
GO:0030038,contractile actin filament bundle assemb...,104,2,0.58,0.11592,1,0.4476350518754988,3.45,BP
GO:0043149,stress fiber assembly,104,2,0.58,0.11592,1,0.4476350518754988,3.45,BP
GO:0048704,embryonic skeletal system morphogenesis,104,2,0.58,0.11592,1,0.4476350518754988,3.45,BP
GO:1901222,regulation of NIK/NF-kappaB signaling,104,2,0.58,0.11592,1,0.4476350518754988,3.45,BP
GO:0000423,mitophagy,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0002504,antigen processing and presentation of p...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0002834,regulation of response to tumor cell,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0002837,regulation of immune response to tumor c...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0003084,positive regulation of systemic arterial...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0006837,serotonin transport,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0007063,regulation of sister chromatid cohesion,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0009110,vitamin biosynthetic process,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0032462,regulation of protein homooligomerizatio...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0032930,positive regulation of superoxide anion ...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0036314,response to sterol,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0042069,regulation of catecholamine metabolic pr...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0042438,melanin biosynthetic process,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0046823,negative regulation of nucleocytoplasmic...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0048339,paraxial mesoderm development,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0051043,regulation of membrane protein ectodomai...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0051654,establishment of mitochondrion localizat...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0060009,Sertoli cell development,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0060602,branch elongation of an epithelium,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0071450,cellular response to oxygen radical,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0071451,cellular response to superoxide,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0071870,cellular response to catecholamine stimu...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:1901626,regulation of postsynaptic membrane orga...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:2000010,positive regulation of protein localizat...,22,1,0.12,0.11656,1,0.4476350518754988,8.33,BP
GO:0045732,positive regulation of protein catabolic...,212,3,1.19,0.11704,1,0.44912,2.52,BP
GO:0010498,proteasomal protein catabolic process,460,5,2.58,0.11740,1,0.4501424701195219,1.94,BP
GO:0035967,cellular response to topologically incor...,105,2,0.59,0.11775,1,0.45112499999999994,3.39,BP
GO:1903050,regulation of proteolysis involved in ce...,213,3,1.2,0.11826,1,0.4527184725536993,2.5,BP
GO:0009408,response to heat,106,2,0.6,0.11960,1,0.4547452255054432,3.33,BP
GO:0030518,intracellular steroid hormone receptor s...,106,2,0.6,0.11960,1,0.4547452255054432,3.33,BP
GO:0120034,positive regulation of plasma membrane b...,106,2,0.6,0.11960,1,0.4547452255054432,3.33,BP
GO:0040013,negative regulation of locomotion,335,4,1.88,0.12000,1,0.4547452255054432,2.13,BP
GO:0060047,heart contraction,215,3,1.21,0.12070,1,0.4547452255054432,2.48,BP
GO:0055114,oxidation-reduction process,878,8,4.93,0.12106,1,0.4547452255054432,1.62,BP
GO:0022414,reproductive process,1467,12,8.24,0.12131,1,0.4547452255054432,1.46,BP
GO:0006275,regulation of DNA replication,107,2,0.6,0.12145,1,0.4547452255054432,3.33,BP
GO:0038127,ERBB signaling pathway,107,2,0.6,0.12145,1,0.4547452255054432,3.33,BP
GO:0043266,regulation of potassium ion transport,107,2,0.6,0.12145,1,0.4547452255054432,3.33,BP
GO:0002093,auditory receptor cell morphogenesis,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0010874,regulation of cholesterol efflux,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0022403,cell cycle phase,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0030252,growth hormone secretion,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0032727,positive regulation of interferon-alpha ...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0033145,positive regulation of intracellular ste...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0043501,skeletal muscle adaptation,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0045056,transcytosis,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0045943,positive regulation of transcription by ...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0051220,cytoplasmic sequestering of protein,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0060972,left/right pattern formation,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0071868,cellular response to monoamine stimulus,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0071869,response to catecholamine,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0098869,cellular oxidant detoxification,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:1900242,regulation of synaptic vesicle endocytos...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:1902884,positive regulation of response to oxida...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:1903055,positive regulation of extracellular mat...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:1904469,positive regulation of tumor necrosis fa...,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:2000831,regulation of steroid hormone secretion,23,1,0.13,0.12153,1,0.4547452255054432,7.69,BP
GO:0000003,reproduction,1468,12,8.24,0.12175,1,0.4552144522144522,1.46,BP
GO:0007166,cell surface receptor signaling pathway,2396,18,13.45,0.12209,1,0.45613127329192543,1.34,BP
GO:0007052,mitotic spindle organization,108,2,0.61,0.12331,1,0.4589077494199536,3.28,BP
GO:0015844,monoamine transport,108,2,0.61,0.12331,1,0.4589077494199536,3.28,BP
GO:0035725,sodium ion transmembrane transport,108,2,0.61,0.12331,1,0.4589077494199536,3.28,BP
GO:0072009,nephron epithelium development,108,2,0.61,0.12331,1,0.4589077494199536,3.28,BP
GO:1904659,glucose transmembrane transport,108,2,0.61,0.12331,1,0.4589077494199536,3.28,BP
GO:0007005,mitochondrion organization,468,5,2.63,0.12375,1,0.4601893353941267,1.9,BP
GO:0070374,positive regulation of ERK1 and ERK2 cas...,218,3,1.22,0.12439,1,0.4613901743745262,2.46,BP
GO:0042326,negative regulation of phosphorylation,469,5,2.63,0.12456,1,0.4613901743745262,1.9,BP
GO:0051640,organelle localization,604,6,3.39,0.12484,1,0.4613901743745262,1.77,BP
GO:0001942,hair follicle development,109,2,0.61,0.12517,1,0.4613901743745262,3.28,BP
GO:0008645,hexose transmembrane transport,109,2,0.61,0.12517,1,0.4613901743745262,3.28,BP
GO:0019882,antigen processing and presentation,109,2,0.61,0.12517,1,0.4613901743745262,3.28,BP
GO:0045185,maintenance of protein location,109,2,0.61,0.12517,1,0.4613901743745262,3.28,BP
GO:0048145,regulation of fibroblast proliferation,109,2,0.61,0.12517,1,0.4613901743745262,3.28,BP
GO:1900542,regulation of purine nucleotide metaboli...,109,2,0.61,0.12517,1,0.4613901743745262,3.28,BP
GO:0033673,negative regulation of kinase activity,219,3,1.23,0.12563,1,0.4613901743745262,2.44,BP
GO:0043547,positive regulation of GTPase activity,219,3,1.23,0.12563,1,0.4613901743745262,2.44,BP
GO:0099536,synaptic signaling,886,8,4.97,0.12564,1,0.4613901743745262,1.61,BP
GO:0043010,camera-type eye development,341,4,1.91,0.12575,1,0.4613901743745262,2.09,BP
GO:0002418,immune response to tumor cell,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0006582,melanin metabolic process,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0007205,protein kinase C-activating G protein-co...,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0009154,purine ribonucleotide catabolic process,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0009261,ribonucleotide catabolic process,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0030903,notochord development,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0032770,positive regulation of monooxygenase act...,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0048670,regulation of collateral sprouting,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0051602,response to electrical stimulus,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0070584,mitochondrion morphogenesis,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0071867,response to monoamine,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:1903204,negative regulation of oxidative stress-...,24,1,0.13,0.12647,1,0.4613901743745262,7.69,BP
GO:0050900,leukocyte migration,342,4,1.92,0.12672,1,0.46171939577039267,2.08,BP
GO:0071396,cellular response to lipid,607,6,3.41,0.12696,1,0.46171939577039267,1.76,BP
GO:0038061,NIK/NF-kappaB signaling,110,2,0.62,0.12704,1,0.46171939577039267,3.23,BP
GO:0042035,regulation of cytokine biosynthetic proc...,110,2,0.62,0.12704,1,0.46171939577039267,3.23,BP
GO:0045446,endothelial cell differentiation,110,2,0.62,0.12704,1,0.46171939577039267,3.23,BP
GO:1901342,regulation of vasculature development,343,4,1.93,0.12769,1,0.4637315320754717,2.07,BP
GO:0002688,regulation of leukocyte chemotaxis,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0015749,monosaccharide transmembrane transport,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0018958,phenol-containing compound metabolic pro...,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0022404,molting cycle process,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0022405,hair cycle process,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0048144,fibroblast proliferation,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0098773,skin epidermis development,111,2,0.62,0.12892,1,0.46451180014695076,3.23,BP
GO:0071363,cellular response to growth factor stimu...,610,6,3.43,0.12910,1,0.46451180014695076,1.75,BP
GO:0009636,response to toxic substance,345,4,1.94,0.12965,1,0.46451180014695076,2.06,BP
GO:0021953,central nervous system neuron differenti...,223,3,1.25,0.13063,1,0.46451180014695076,2.4,BP
GO:0032092,positive regulation of protein binding,112,2,0.63,0.13080,1,0.46451180014695076,3.17,BP
GO:0034219,carbohydrate transmembrane transport,112,2,0.63,0.13080,1,0.46451180014695076,3.17,BP
GO:0051028,mRNA transport,112,2,0.63,0.13080,1,0.46451180014695076,3.17,BP
GO:0000303,response to superoxide,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0010640,regulation of platelet-derived growth fa...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0010894,negative regulation of steroid biosynthe...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0032373,positive regulation of sterol transport,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0032376,positive regulation of cholesterol trans...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0032469,endoplasmic reticulum calcium ion homeos...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0032928,regulation of superoxide anion generatio...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0035455,response to interferon-alpha,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0043567,regulation of insulin-like growth factor...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0045939,negative regulation of steroid metabolic...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0051443,positive regulation of ubiquitin-protein...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0051580,regulation of neurotransmitter uptake,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0070050,neuron cellular homeostasis,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0071312,cellular response to alkaloid,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0085029,extracellular matrix assembly,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0095500,acetylcholine receptor signaling pathway,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0098810,neurotransmitter reuptake,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:1901032,negative regulation of response to react...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:1901798,positive regulation of signal transducti...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:1903206,negative regulation of hydrogen peroxide...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:1903747,regulation of establishment of protein l...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:1903831,signal transduction involved in cellular...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:2001039,negative regulation of cellular response...,25,1,0.14,0.13138,1,0.46451180014695076,7.14,BP
GO:0006898,receptor-mediated endocytosis,224,3,1.26,0.13189,1,0.4656307263389582,2.38,BP
GO:0099504,synaptic vesicle cycle,224,3,1.26,0.13189,1,0.4656307263389582,2.38,BP
GO:0018209,peptidyl-serine modification,348,4,1.95,0.13260,1,0.4667428947368421,2.05,BP
GO:0000086,G2/M transition of mitotic cell cycle,113,2,0.63,0.13269,1,0.4667428947368421,3.17,BP
GO:0006140,regulation of nucleotide metabolic proce...,113,2,0.63,0.13269,1,0.4667428947368421,3.17,BP
GO:0030048,actin filament-based movement,113,2,0.63,0.13269,1,0.4667428947368421,3.17,BP
GO:1905269,positive regulation of chromatin organiz...,113,2,0.63,0.13269,1,0.4667428947368421,3.17,BP
GO:0071241,cellular response to inorganic substance,226,3,1.27,0.13443,1,0.47204597667638476,2.36,BP
GO:0008637,apoptotic mitochondrial changes,114,2,0.64,0.13459,1,0.47204597667638476,3.12,BP
GO:0031398,positive regulation of protein ubiquitin...,114,2,0.64,0.13459,1,0.47204597667638476,3.12,BP
GO:0046822,regulation of nucleocytoplasmic transpor...,114,2,0.64,0.13459,1,0.47204597667638476,3.12,BP
GO:0000460,maturation of 5.8S rRNA,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0006891,intra-Golgi vesicle-mediated transport,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0007176,regulation of epidermal growth factor-ac...,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0007413,axonal fasciculation,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0009713,catechol-containing compound biosyntheti...,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0010863,positive regulation of phospholipase C a...,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0032528,microvillus organization,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0034114,regulation of heterotypic cell-cell adhe...,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0035929,steroid hormone secretion,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0042423,catecholamine biosynthetic process,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0043486,histone exchange,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0048642,negative regulation of skeletal muscle t...,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0051570,regulation of histone H3-K9 methylation,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0090140,regulation of mitochondrial fission,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0106030,neuron projection fasciculation,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:2000737,negative regulation of stem cell differe...,26,1,0.15,0.13626,1,0.4723941786743516,6.67,BP
GO:0032368,regulation of lipid transport,115,2,0.65,0.13649,1,0.47285088552915766,3.08,BP
GO:0016072,rRNA metabolic process,228,3,1.28,0.13698,1,0.4742070215827338,2.34,BP
GO:0045861,negative regulation of proteolysis,353,4,1.98,0.13759,1,0.47597633357296903,2.02,BP
GO:1903828,negative regulation of cellular protein ...,116,2,0.65,0.13840,1,0.4780910265613783,3.08,BP
GO:2001023,regulation of response to drug,116,2,0.65,0.13840,1,0.4780910265613783,3.08,BP
GO:1904062,regulation of cation transmembrane trans...,354,4,1.99,0.13859,1,0.478403931133429,2.01,BP
GO:0006508,proteolysis,1661,13,9.33,0.13972,1,0.4816095319148936,1.39,BP
GO:0030282,bone mineralization,117,2,0.66,0.14032,1,0.4816095319148936,3.03,BP
GO:0080134,regulation of response to stress,1357,11,7.62,0.14048,1,0.4816095319148936,1.44,BP
GO:0036293,response to decreased oxygen levels,231,3,1.3,0.14085,1,0.4816095319148936,2.31,BP
GO:0000305,response to oxygen radical,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0002347,response to tumor cell,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0010971,positive regulation of G2/M transition o...,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0021697,cerebellar cortex formation,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0045736,negative regulation of cyclin-dependent ...,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0050901,leukocyte tethering or rolling,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0060008,Sertoli cell differentiation,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0060045,positive regulation of cardiac muscle ce...,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:1900273,positive regulation of long-term synapti...,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:1904353,regulation of telomere capping,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:1905144,response to acetylcholine,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:1905145,cellular response to acetylcholine,27,1,0.15,0.14112,1,0.4816095319148936,6.67,BP
GO:0046394,carboxylic acid biosynthetic process,359,4,2.02,0.14367,1,0.4892367432150313,1.98,BP
GO:0055074,calcium ion homeostasis,492,5,2.76,0.14374,1,0.4892367432150313,1.81,BP
GO:0072521,purine-containing compound metabolic pro...,492,5,2.76,0.14374,1,0.4892367432150313,1.81,BP
GO:0007498,mesoderm development,119,2,0.67,0.14417,1,0.4892367432150313,2.99,BP
GO:0055086,nucleobase-containing small molecule met...,631,6,3.54,0.14456,1,0.4892367432150313,1.69,BP
GO:0016053,organic acid biosynthetic process,360,4,2.02,0.14469,1,0.4892367432150313,1.98,BP
GO:0007420,brain development,632,6,3.55,0.14532,1,0.4892367432150313,1.69,BP
GO:0006195,purine nucleotide catabolic process,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0021952,central nervous system projection neuron...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0031063,regulation of histone deacetylation,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0032369,negative regulation of lipid transport,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0032647,regulation of interferon-alpha productio...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0035335,peptidyl-tyrosine dephosphorylation,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0044342,type B pancreatic cell proliferation,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0044550,secondary metabolite biosynthetic proces...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0045408,regulation of interleukin-6 biosynthetic...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0045724,positive regulation of cilium assembly,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0048596,embryonic camera-type eye morphogenesis,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0051194,positive regulation of cofactor metaboli...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0070198,"protein localization to chromosome, telo...",28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0090103,cochlea morphogenesis,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0090200,positive regulation of release of cytoch...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0090312,positive regulation of protein deacetyla...,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:2000310,regulation of NMDA receptor activity,28,1,0.16,0.14594,1,0.4892367432150313,6.25,BP
GO:0032872,regulation of stress-activated MAPK casc...,235,3,1.32,0.14605,1,0.4892367432150313,2.27,BP
GO:0090092,regulation of transmembrane receptor pro...,235,3,1.32,0.14605,1,0.4892367432150313,2.27,BP
GO:2000045,regulation of G1/S transition of mitotic...,120,2,0.67,0.14610,1,0.4892367432150313,2.99,BP
GO:0050806,positive regulation of synaptic transmis...,362,4,2.03,0.14675,1,0.4910313273106324,1.97,BP
GO:0007507,heart development,634,6,3.56,0.14684,1,0.4910313273106324,1.69,BP
GO:0036294,cellular response to decreased oxygen le...,121,2,0.68,0.14804,1,0.4940142024965326,2.94,BP
GO:0046620,regulation of organ growth,121,2,0.68,0.14804,1,0.4940142024965326,2.94,BP
GO:1903409,reactive oxygen species biosynthetic pro...,121,2,0.68,0.14804,1,0.4940142024965326,2.94,BP
GO:0033002,muscle cell proliferation,237,3,1.33,0.14868,1,0.4951597269624573,2.26,BP
GO:0070302,regulation of stress-activated protein k...,237,3,1.33,0.14868,1,0.4951597269624573,2.26,BP
GO:0001101,response to acid chemical,364,4,2.04,0.14882,1,0.4951597269624573,1.96,BP
GO:0007178,transmembrane receptor protein serine/th...,364,4,2.04,0.14882,1,0.4951597269624573,1.96,BP
GO:0010508,positive regulation of autophagy,122,2,0.69,0.14998,1,0.4951597269624573,2.9,BP
GO:0010906,regulation of glucose metabolic process,122,2,0.69,0.14998,1,0.4951597269624573,2.9,BP
GO:0042089,cytokine biosynthetic process,122,2,0.69,0.14998,1,0.4951597269624573,2.9,BP
GO:0090277,positive regulation of peptide hormone s...,122,2,0.69,0.14998,1,0.4951597269624573,2.9,BP
GO:0005979,regulation of glycogen biosynthetic proc...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0006376,mRNA splice site selection,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0007007,inner mitochondrial membrane organizatio...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0010800,positive regulation of peptidyl-threonin...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0010962,regulation of glucan biosynthetic proces...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0030318,melanocyte differentiation,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0034508,centromere complex assembly,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0042026,protein refolding,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0042226,interleukin-6 biosynthetic process,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0043032,positive regulation of macrophage activa...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0051589,negative regulation of neurotransmitter ...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0060117,auditory receptor cell development,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0071880,adenylate cyclase-activating adrenergic ...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0090181,regulation of cholesterol metabolic proc...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:1904030,negative regulation of cyclin-dependent ...,29,1,0.16,0.15075,1,0.4951597269624573,6.25,BP
GO:0008380,RNA splicing,366,4,2.06,0.15090,1,0.49531432469304226,1.94,BP
GO:0003158,endothelium development,123,2,0.69,0.15193,1,0.4983552556237219,2.9,BP
GO:0090257,regulation of muscle system process,240,3,1.35,0.15265,1,0.5003758855585831,2.22,BP
GO:0043500,muscle adaptation,124,2,0.7,0.15388,1,0.5015832707774799,2.86,BP
GO:0051153,regulation of striated muscle cell diffe...,124,2,0.7,0.15388,1,0.5015832707774799,2.86,BP
GO:0090090,negative regulation of canonical Wnt sig...,124,2,0.7,0.15388,1,0.5015832707774799,2.86,BP
GO:0046879,hormone secretion,369,4,2.07,0.15404,1,0.5015832707774799,1.93,BP
GO:0048167,regulation of synaptic plasticity,369,4,2.07,0.15404,1,0.5015832707774799,1.93,BP
GO:0030003,cellular cation homeostasis,645,6,3.62,0.15532,1,0.5015832707774799,1.66,BP
GO:0006336,DNA replication-independent nucleosome a...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0006536,glutamate metabolic process,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0009303,rRNA transcription,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0016242,negative regulation of macroautophagy,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0022011,myelination in peripheral nervous system,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0031297,replication fork processing,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0032292,peripheral nervous system axon ensheathm...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0032607,interferon-alpha production,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0042481,regulation of odontogenesis,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0042533,tumor necrosis factor biosynthetic proce...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0042534,regulation of tumor necrosis factor bios...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0043951,negative regulation of cAMP-mediated sig...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0048384,retinoic acid receptor signaling pathway,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0055022,negative regulation of cardiac muscle ti...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0061117,negative regulation of heart growth,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0070306,lens fiber cell differentiation,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:1900274,regulation of phospholipase C activity,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:1902751,positive regulation of cell cycle G2/M p...,30,1,0.17,0.15552,1,0.5015832707774799,5.88,BP
GO:0033138,positive regulation of peptidyl-serine p...,125,2,0.7,0.15584,1,0.5022786872069659,2.86,BP
GO:0000723,telomere maintenance,126,2,0.71,0.15780,1,0.5079154515050167,2.82,BP
GO:0018107,peptidyl-threonine phosphorylation,126,2,0.71,0.15780,1,0.5079154515050167,2.82,BP
GO:0046777,protein autophosphorylation,245,3,1.38,0.15934,1,0.5104032031767042,2.17,BP
GO:0010212,response to ionizing radiation,127,2,0.71,0.15977,1,0.5104032031767042,2.82,BP
GO:0006767,water-soluble vitamin metabolic process,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0022617,extracellular matrix disassembly,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0033081,regulation of T cell differentiation in ...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0034724,DNA replication-independent nucleosome o...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0045932,negative regulation of muscle contractio...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0050999,regulation of nitric-oxide synthase acti...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0051085,chaperone cofactor-dependent protein ref...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0071875,adrenergic receptor signaling pathway,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0090075,relaxation of muscle,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0098884,postsynaptic neurotransmitter receptor i...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0140239,postsynaptic endocytosis,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:1903421,regulation of synaptic vesicle recycling,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:2000781,positive regulation of double-strand bre...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:2001014,regulation of skeletal muscle cell diffe...,31,1,0.17,0.16027,1,0.5104032031767042,5.88,BP
GO:0006631,fatty acid metabolic process,375,4,2.11,0.16039,1,0.5104475396825396,1.9,BP
GO:0051091,positive regulation of DNA-binding trans...,246,3,1.38,0.16069,1,0.5110642961004627,2.17,BP
GO:0010565,regulation of cellular ketone metabolic ...,128,2,0.72,0.16174,1,0.5123718762343648,2.78,BP
GO:0030218,erythrocyte differentiation,128,2,0.72,0.16174,1,0.5123718762343648,2.78,BP
GO:0032200,telomere organization,128,2,0.72,0.16174,1,0.5123718762343648,2.78,BP
GO:0042107,cytokine metabolic process,128,2,0.72,0.16174,1,0.5123718762343648,2.78,BP
GO:0042303,molting cycle,128,2,0.72,0.16174,1,0.5123718762343648,2.78,BP
GO:0042633,hair cycle,128,2,0.72,0.16174,1,0.5123718762343648,2.78,BP
GO:0009914,hormone transport,377,4,2.12,0.16253,1,0.5145357631578948,1.89,BP
GO:0008277,regulation of G protein-coupled receptor...,129,2,0.72,0.16372,1,0.5162105851755526,2.78,BP
GO:0031334,positive regulation of protein complex a...,249,3,1.4,0.16476,1,0.5162105851755526,2.14,BP
GO:0051054,positive regulation of DNA metabolic pro...,249,3,1.4,0.16476,1,0.5162105851755526,2.14,BP
GO:0051188,cofactor biosynthetic process,249,3,1.4,0.16476,1,0.5162105851755526,2.14,BP
GO:0008608,attachment of spindle microtubules to ki...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0031069,hair follicle morphogenesis,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0032212,positive regulation of telomere maintena...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0032728,positive regulation of interferon-beta p...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0036475,neuron death in response to oxidative st...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0043457,regulation of cellular respiration,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0045616,regulation of keratinocyte differentiati...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0048011,neurotrophin TRK receptor signaling path...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0048048,embryonic eye morphogenesis,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0051150,regulation of smooth muscle cell differe...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0051642,centrosome localization,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0060561,apoptotic process involved in morphogene...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0090504,epiboly,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:1903203,regulation of oxidative stress-induced n...,32,1,0.18,0.16499,1,0.5162105851755526,5.56,BP
GO:0007093,mitotic cell cycle checkpoint,130,2,0.73,0.16570,1,0.5174227125243348,2.74,BP
GO:0016999,antibiotic metabolic process,130,2,0.73,0.16570,1,0.5174227125243348,2.74,BP
GO:0044839,cell cycle G2/M phase transition,130,2,0.73,0.16570,1,0.5174227125243348,2.74,BP
GO:0007626,locomotory behavior,250,3,1.4,0.16612,1,0.5183978210116731,2.14,BP
GO:0006873,cellular ion homeostasis,659,6,3.7,0.16643,1,0.5190286195722618,1.62,BP
GO:0002064,epithelial cell development,251,3,1.41,0.16748,1,0.521605869424693,2.13,BP
GO:0015696,ammonium transport,131,2,0.74,0.16769,1,0.521605869424693,2.7,BP
GO:0042177,negative regulation of protein catabolic...,131,2,0.74,0.16769,1,0.521605869424693,2.7,BP
GO:0045995,regulation of embryonic development,131,2,0.74,0.16769,1,0.521605869424693,2.7,BP
GO:0007568,aging,252,3,1.41,0.16885,1,0.5220896930946293,2.13,BP
GO:0035690,cellular response to drug,383,4,2.15,0.16902,1,0.5220896930946293,1.86,BP
GO:0009166,nucleotide catabolic process,132,2,0.74,0.16968,1,0.5220896930946293,2.7,BP
GO:0014044,Schwann cell development,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0021591,ventricular system development,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0032743,positive regulation of interleukin-2 pro...,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0045879,negative regulation of smoothened signal...,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0048013,ephrin receptor signaling pathway,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0048841,regulation of axon extension involved in...,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0061157,mRNA destabilization,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0061842,microtubule organizing center localizati...,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0071709,membrane assembly,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:1901976,regulation of cell cycle checkpoint,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:1903146,regulation of autophagy of mitochondrion,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:1903205,regulation of hydrogen peroxide-induced ...,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:1905606,regulation of presynapse assembly,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:2001171,positive regulation of ATP biosynthetic ...,33,1,0.19,0.16969,1,0.5220896930946293,5.26,BP
GO:0019637,organophosphate metabolic process,957,8,5.37,0.17006,1,0.522893750798722,1.49,BP
GO:0030900,forebrain development,385,4,2.16,0.17120,1,0.5260628352490422,1.85,BP
GO:0031503,protein-containing complex localization,254,3,1.43,0.17160,1,0.5264984321223709,2.1,BP
GO:0008037,cell recognition,133,2,0.75,0.17167,1,0.5264984321223709,2.67,BP
GO:1902850,microtubule cytoskeleton organization in...,133,2,0.75,0.17167,1,0.5264984321223709,2.67,BP
GO:0072507,divalent inorganic cation homeostasis,525,5,2.95,0.17334,1,0.5286832514177694,1.69,BP
GO:0010256,endomembrane system organization,387,4,2.17,0.17339,1,0.5286832514177694,1.84,BP
GO:0010469,regulation of signaling receptor activit...,134,2,0.75,0.17367,1,0.5286832514177694,2.67,BP
GO:0018210,peptidyl-threonine modification,134,2,0.75,0.17367,1,0.5286832514177694,2.67,BP
GO:0090316,positive regulation of intracellular pro...,134,2,0.75,0.17367,1,0.5286832514177694,2.67,BP
GO:0006356,regulation of transcription by RNA polym...,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0006984,ER-nucleus signaling pathway,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0007617,mating behavior,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0010837,regulation of keratinocyte proliferation,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0014047,glutamate secretion,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0014741,negative regulation of muscle hypertroph...,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0015804,neutral amino acid transport,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0045070,positive regulation of viral genome repl...,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0060487,lung epithelial cell differentiation,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0071539,protein localization to centrosome,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:1904467,regulation of tumor necrosis factor secr...,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:1990748,cellular detoxification,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:2000785,regulation of autophagosome assembly,34,1,0.19,0.17436,1,0.5286832514177694,5.26,BP
GO:0001654,eye development,389,4,2.18,0.17559,1,0.5313161785040854,1.83,BP
GO:0006261,DNA-dependent DNA replication,135,2,0.76,0.17567,1,0.5313161785040854,2.63,BP
GO:0071453,cellular response to oxygen levels,135,2,0.76,0.17567,1,0.5313161785040854,2.63,BP
GO:1902806,regulation of cell cycle G1/S phase tran...,135,2,0.76,0.17567,1,0.5313161785040854,2.63,BP
GO:0001501,skeletal system development,528,5,2.96,0.17614,1,0.5324030653266332,1.69,BP
GO:0110053,regulation of actin filament organizatio...,258,3,1.45,0.17714,1,0.5333424148606811,2.07,BP
GO:1903322,positive regulation of protein modificat...,136,2,0.76,0.17767,1,0.5333424148606811,2.63,BP
GO:0150063,visual system development,392,4,2.2,0.17891,1,0.5333424148606811,1.82,BP
GO:0023061,signal release,531,5,2.98,0.17896,1,0.5333424148606811,1.68,BP
GO:0002082,regulation of oxidative phosphorylation,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0007143,female meiotic nuclear division,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0008045,motor neuron axon guidance,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0008156,negative regulation of DNA replication,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0009954,proximal/distal pattern formation,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0031338,regulation of vesicle fusion,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0032228,"regulation of synaptic transmission, GAB...",35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0032435,negative regulation of proteasomal ubiqu...,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0035909,aorta morphogenesis,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0048679,regulation of axon regeneration,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0050779,RNA destabilization,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0051567,histone H3-K9 methylation,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0060479,lung cell differentiation,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0090322,regulation of superoxide metabolic proce...,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:1902116,negative regulation of organelle assembl...,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:1904707,positive regulation of vascular smooth m...,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:1905508,protein localization to microtubule orga...,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:2000036,regulation of stem cell population maint...,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:2001038,regulation of cellular response to drug,35,1,0.2,0.17900,1,0.5333424148606811,5,BP
GO:0009791,post-embryonic development,137,2,0.77,0.17968,1,0.5350372277227723,2.6,BP
GO:0043161,proteasome-mediated ubiquitin-dependent ...,393,4,2.21,0.18002,1,0.5357181447124304,1.81,BP
GO:0048738,cardiac muscle tissue development,261,3,1.47,0.18132,1,0.5390320243902439,2.04,BP
GO:0048880,sensory system development,395,4,2.22,0.18225,1,0.5390320243902439,1.8,BP
GO:0000184,nuclear-transcribed mRNA catabolic proce...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0001963,"synaptic transmission, dopaminergic",36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0003401,axis elongation,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0021846,cell proliferation in forebrain,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0032735,positive regulation of interleukin-12 pr...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0035886,vascular smooth muscle cell differentiat...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0040020,regulation of meiotic nuclear division,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0042311,vasodilation,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0043114,regulation of vascular permeability,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0048009,insulin-like growth factor receptor sign...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0051084,'de novo' posttranslational protein fold...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0051973,positive regulation of telomerase activi...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0060441,epithelial tube branching involved in lu...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0070873,regulation of glycogen metabolic process,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0072583,clathrin-dependent endocytosis,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:1903427,negative regulation of reactive oxygen s...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:1904037,positive regulation of epithelial cell a...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:1904358,positive regulation of telomere maintena...,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:1990774,tumor necrosis factor secretion,36,1,0.2,0.18362,1,0.5390320243902439,5,BP
GO:0034101,erythrocyte homeostasis,139,2,0.78,0.18371,1,0.5390320243902439,2.56,BP
GO:0048706,embryonic skeletal system development,139,2,0.78,0.18371,1,0.5390320243902439,2.56,BP
GO:0046165,alcohol biosynthetic process,141,2,0.79,0.18775,1,0.545911103074141,2.53,BP
GO:0014003,oligodendrocyte development,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0032733,positive regulation of interleukin-10 pr...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0033144,negative regulation of intracellular ste...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0033146,regulation of intracellular estrogen rec...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0033260,nuclear DNA replication,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0036474,cell death in response to hydrogen perox...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0043628,ncRNA 3'-end processing,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0048147,negative regulation of fibroblast prolif...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0048730,epidermis morphogenesis,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0048846,axon extension involved in axon guidance,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0051482,positive regulation of cytosolic calcium...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0051693,actin filament capping,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0061756,leukocyte adhesion to vascular endotheli...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0072348,sulfur compound transport,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0098751,bone cell development,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0099174,regulation of presynapse organization,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:1901385,regulation of voltage-gated calcium chan...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:1902284,neuron projection extension involved in ...,37,1,0.21,0.18821,1,0.545911103074141,4.76,BP
GO:0048193,Golgi vesicle transport,266,3,1.49,0.18836,1,0.5460170602409639,2.01,BP
GO:0060322,head development,686,6,3.85,0.18878,1,0.5469050933172788,1.56,BP
GO:0009314,response to radiation,401,4,2.25,0.18899,1,0.5471840433212996,1.78,BP
GO:0051048,negative regulation of secretion,267,3,1.5,0.18977,1,0.5481520768307323,2,BP
GO:0007292,female gamete generation,142,2,0.8,0.18978,1,0.5481520768307323,2.5,BP
GO:0030216,keratinocyte differentiation,142,2,0.8,0.18978,1,0.5481520768307323,2.5,BP
GO:0072073,kidney epithelium development,142,2,0.8,0.18978,1,0.5481520768307323,2.5,BP
GO:0002376,immune system process,2407,17,13.51,0.19073,1,0.5505655428914218,1.26,BP
GO:0050807,regulation of synapse organization,268,3,1.5,0.19119,1,0.5515625179856115,2,BP
GO:0035637,multicellular organismal signaling,143,2,0.8,0.19181,1,0.5518198929208804,2.5,BP
GO:1901292,nucleoside phosphate catabolic process,143,2,0.8,0.19181,1,0.5518198929208804,2.5,BP
GO:0001953,negative regulation of cell-matrix adhes...,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0006284,base-excision repair,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0010762,regulation of fibroblast migration,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0032506,cytokinetic process,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0032885,regulation of polysaccharide biosyntheti...,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0040019,positive regulation of embryonic develop...,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0042554,superoxide anion generation,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0045005,DNA-dependent DNA replication maintenanc...,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0071158,positive regulation of cell cycle arrest,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0071320,cellular response to cAMP,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:2001025,positive regulation of response to drug,38,1,0.21,0.19277,1,0.5518198929208804,4.76,BP
GO:0031333,negative regulation of protein complex a...,144,2,0.81,0.19384,1,0.5545529607609989,2.47,BP
GO:0051098,regulation of binding,407,4,2.29,0.19582,1,0.5591612014134276,1.75,BP
GO:0048609,multicellular organismal reproductive pr...,843,7,4.73,0.19585,1,0.5591612014134276,1.48,BP
GO:0030198,extracellular matrix organization,272,3,1.53,0.19689,1,0.5591612014134276,1.96,BP
GO:0006826,iron ion transport,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0010613,positive regulation of cardiac muscle hy...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0016233,telomere capping,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0030810,positive regulation of nucleotide biosyn...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0031076,embryonic camera-type eye development,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0044088,regulation of vacuole organization,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0050931,pigment cell differentiation,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0060251,regulation of glial cell proliferation,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0072595,maintenance of protein localization in o...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:1900026,positive regulation of substrate adhesio...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:1900087,positive regulation of G1/S transition o...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:1900373,positive regulation of purine nucleotide...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:1901021,positive regulation of calcium ion trans...,39,1,0.22,0.19731,1,0.5591612014134276,4.55,BP
GO:0002065,columnar/cuboidal epithelial cell differ...,146,2,0.82,0.19791,1,0.5595434312573443,2.44,BP
GO:0050680,negative regulation of epithelial cell p...,146,2,0.82,0.19791,1,0.5595434312573443,2.44,BP
GO:0072006,nephron development,146,2,0.82,0.19791,1,0.5595434312573443,2.44,BP
GO:1905952,regulation of lipid localization,146,2,0.82,0.19791,1,0.5595434312573443,2.44,BP
GO:0010038,response to metal ion,274,3,1.54,0.19975,1,0.5643163636363636,1.95,BP
GO:0006954,inflammatory response,699,6,3.92,0.19994,1,0.5643163636363636,1.53,BP
GO:0098693,regulation of synaptic vesicle cycle,147,2,0.83,0.19995,1,0.5643163636363636,2.41,BP
GO:0003009,skeletal muscle contraction,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0014742,positive regulation of muscle hypertroph...,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0021696,cerebellar cortex morphogenesis,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0030225,macrophage differentiation,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0032594,protein transport within lipid bilayer,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0035307,positive regulation of protein dephospho...,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0044091,membrane biogenesis,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0046627,negative regulation of insulin receptor ...,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0060325,face morphogenesis,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0072523,purine-containing compound catabolic pro...,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0099590,neurotransmitter receptor internalizatio...,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0110111,negative regulation of animal organ morp...,40,1,0.22,0.20183,1,0.5656412114152592,4.55,BP
GO:0008643,carbohydrate transport,148,2,0.83,0.20199,1,0.5657601164144354,2.41,BP
GO:1901135,carbohydrate derivative metabolic proces...,1003,8,5.63,0.20223,1,0.5661028272251308,1.42,BP
GO:0002263,cell activation involved in immune respo...,276,3,1.55,0.20263,1,0.5665633701336432,1.94,BP
GO:0006790,sulfur compound metabolic process,276,3,1.55,0.20263,1,0.5665633701336432,1.94,BP
GO:0034614,cellular response to reactive oxygen spe...,149,2,0.84,0.20403,1,0.5682952718946767,2.38,BP
GO:0032504,multicellular organism reproduction,854,7,4.8,0.20449,1,0.5682952718946767,1.46,BP
GO:0050803,regulation of synapse structure or activ...,278,3,1.56,0.20551,1,0.5682952718946767,1.92,BP
GO:0002227,innate immune response in mucosa,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0003298,physiological muscle hypertrophy,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0003301,physiological cardiac muscle hypertrophy,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0006509,membrane protein ectodomain proteolysis,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0009409,response to cold,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0010470,regulation of gastrulation,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0021522,spinal cord motor neuron differentiation,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0021955,central nervous system neuron axonogenes...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0030501,positive regulation of bone mineralizati...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0033344,cholesterol efflux,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0034105,positive regulation of tissue remodeling,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0038179,neurotrophin signaling pathway,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0043001,Golgi to plasma membrane protein transpo...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0045494,photoreceptor cell maintenance,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0046164,alcohol catabolic process,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0048873,homeostasis of number of cells within a ...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0051154,negative regulation of striated muscle c...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0055026,negative regulation of cardiac muscle ti...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0061049,cell growth involved in cardiac muscle c...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:1903053,regulation of extracellular matrix organ...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:1903672,positive regulation of sprouting angioge...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:1905953,negative regulation of lipid localizatio...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:2000273,positive regulation of signaling recepto...,41,1,0.23,0.20632,1,0.5682952718946767,4.35,BP
GO:0006865,amino acid transport,151,2,0.85,0.20813,1,0.5726252487135506,2.35,BP
GO:2000058,regulation of ubiquitin-dependent protei...,151,2,0.85,0.20813,1,0.5726252487135506,2.35,BP
GO:0001822,kidney development,280,3,1.57,0.20841,1,0.5730679542857143,1.91,BP
GO:0048646,anatomical structure formation involved ...,1168,9,6.56,0.20985,1,0.5756375482406356,1.37,BP
GO:0000266,mitochondrial fission,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0030835,negative regulation of actin filament de...,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0032459,regulation of protein oligomerization,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0032768,regulation of monooxygenase activity,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0033059,cellular pigmentation,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0042417,dopamine metabolic process,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0045740,positive regulation of DNA replication,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0055023,positive regulation of cardiac muscle ti...,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0060122,inner ear receptor cell stereocilium org...,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0097178,ruffle assembly,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:1902742,apoptotic process involved in developmen...,42,1,0.24,0.21078,1,0.5756375482406356,4.17,BP
GO:0044703,multi-organism reproductive process,1015,8,5.7,0.21101,1,0.5757214285714286,1.4,BP
GO:0032787,monocarboxylic acid metabolic process,564,5,3.17,0.21105,1,0.5757214285714286,1.58,BP
GO:0070482,response to oxygen levels,282,3,1.58,0.21131,1,0.5757778708946772,1.9,BP
GO:0071229,cellular response to acid chemical,282,3,1.58,0.21131,1,0.5757778708946772,1.9,BP
GO:0001933,negative regulation of protein phosphory...,421,4,2.36,0.21203,1,0.5770050169491526,1.69,BP
GO:0052547,regulation of peptidase activity,421,4,2.36,0.21203,1,0.5770050169491526,1.69,BP
GO:0050657,nucleic acid transport,153,2,0.86,0.21224,1,0.5770050169491526,2.33,BP
GO:0050658,RNA transport,153,2,0.86,0.21224,1,0.5770050169491526,2.33,BP
GO:0010675,regulation of cellular carbohydrate meta...,154,2,0.86,0.21429,1,0.5808405159842961,2.33,BP
GO:0031056,regulation of histone modification,154,2,0.86,0.21429,1,0.5808405159842961,2.33,BP
GO:0001937,negative regulation of endothelial cell ...,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0003416,endochondral bone growth,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0010518,positive regulation of phospholipase act...,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0010907,positive regulation of glucose metabolic...,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0032371,regulation of sterol transport,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0032374,regulation of cholesterol transport,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0044743,protein transmembrane import into intrac...,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0046621,negative regulation of organ growth,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0048255,mRNA stabilization,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0051293,establishment of spindle localization,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:1901031,regulation of response to reactive oxyge...,43,1,0.24,0.21522,1,0.5808405159842961,4.17,BP
GO:0007268,chemical synaptic transmission,868,7,4.87,0.21570,1,0.5814836974789916,1.44,BP
GO:0098916,anterograde trans-synaptic signaling,868,7,4.87,0.21570,1,0.5814836974789916,1.44,BP
GO:0050709,negative regulation of protein secretion,155,2,0.87,0.21635,1,0.5829094064949607,2.3,BP
GO:0006694,steroid biosynthetic process,156,2,0.88,0.21841,1,0.5874728451648965,2.27,BP
GO:0051236,establishment of RNA localization,156,2,0.88,0.21841,1,0.5874728451648965,2.27,BP
GO:0071248,cellular response to metal ion,156,2,0.88,0.21841,1,0.5874728451648965,2.27,BP
GO:0018023,peptidyl-lysine trimethylation,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:0032924,activin receptor signaling pathway,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:0043277,apoptotic cell clearance,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:0050918,positive chemotaxis,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:0070830,bicellular tight junction assembly,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:0098781,ncRNA transcription,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:1900077,negative regulation of cellular response...,44,1,0.25,0.21964,1,0.5884786636971047,4,BP
GO:0009156,ribonucleoside monophosphate biosyntheti...,158,2,0.89,0.22253,1,0.5939572231404958,2.25,BP
GO:0033135,regulation of peptidyl-serine phosphoryl...,158,2,0.89,0.22253,1,0.5939572231404958,2.25,BP
GO:0007548,sex differentiation,290,3,1.63,0.22302,1,0.5939572231404958,1.84,BP
GO:0099537,trans-synaptic signaling,877,7,4.92,0.22303,1,0.5939572231404958,1.42,BP
GO:0050673,epithelial cell proliferation,431,4,2.42,0.22384,1,0.5939572231404958,1.65,BP
GO:0005978,glycogen biosynthetic process,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0009250,glucan biosynthetic process,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0010464,regulation of mesenchymal cell prolifera...,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0014046,dopamine secretion,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0014059,regulation of dopamine secretion,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0019228,neuronal action potential,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0032881,regulation of polysaccharide metabolic p...,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0035136,forelimb morphogenesis,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0043616,keratinocyte proliferation,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0051646,mitochondrion localization,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0060421,positive regulation of heart growth,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0061647,histone H3-K9 modification,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0120192,tight junction assembly,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:1901381,positive regulation of potassium ion tra...,45,1,0.25,0.22403,1,0.5939572231404958,4,BP
GO:0007162,negative regulation of cell adhesion,291,3,1.63,0.22449,1,0.5944858085808581,1.84,BP
GO:0007569,cell aging,159,2,0.89,0.22460,1,0.5944858085808581,2.25,BP
GO:0051302,regulation of cell division,159,2,0.89,0.22460,1,0.5944858085808581,2.25,BP
GO:0019932,second-messenger-mediated signaling,432,4,2.43,0.22503,1,0.5952965145684442,1.65,BP
GO:0007611,learning or memory,293,3,1.65,0.22744,1,0.5999240174672489,1.82,BP
GO:0001774,microglial cell activation,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0002269,leukocyte activation involved in inflamm...,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0006378,mRNA polyadenylation,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0010799,regulation of peptidyl-threonine phospho...,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0016574,histone ubiquitination,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0042307,positive regulation of protein import in...,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0045010,actin nucleation,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0060323,head morphogenesis,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0071385,cellular response to glucocorticoid stim...,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0098754,detoxification,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0098868,bone growth,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:1902667,regulation of axon guidance,46,1,0.26,0.22840,1,0.5999240174672489,3.85,BP
GO:0031214,biomineral tissue development,161,2,0.9,0.22873,1,0.6004630441898526,2.22,BP
GO:0030833,regulation of actin filament polymerizat...,162,2,0.91,0.23080,1,0.6055668484187569,2.2,BP
GO:0001941,postsynaptic membrane organization,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0006110,regulation of glycolytic process,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0019098,reproductive behavior,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0030811,regulation of nucleotide catabolic proce...,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0061028,establishment of endothelial barrier,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0071300,cellular response to retinoic acid,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0120163,negative regulation of cold-induced ther...,47,1,0.26,0.23274,1,0.6083350787615427,3.85,BP
GO:0009124,nucleoside monophosphate biosynthetic pr...,164,2,0.92,0.23494,1,0.6134190341833966,2.17,BP
GO:0043433,negative regulation of DNA-binding trans...,164,2,0.92,0.23494,1,0.6134190341833966,2.17,BP
GO:0002792,negative regulation of peptide secretion,165,2,0.93,0.23701,1,0.6146189224137931,2.15,BP
GO:0000245,spliceosomal complex assembly,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0001504,neurotransmitter uptake,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0002474,antigen processing and presentation of p...,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0003382,epithelial cell morphogenesis,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0010107,potassium ion import,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0010718,positive regulation of epithelial to mes...,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0043631,RNA polyadenylation,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0044848,biological phase,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0051653,spindle localization,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0071384,cellular response to corticosteroid stim...,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0090311,regulation of protein deacetylation,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:1902808,positive regulation of cell cycle G1/S p...,48,1,0.27,0.23706,1,0.6146189224137931,3.7,BP
GO:0060326,cell chemotaxis,301,3,1.69,0.23932,1,0.6197876707907477,1.78,BP
GO:0072001,renal system development,301,3,1.69,0.23932,1,0.6197876707907477,1.78,BP
GO:0051052,regulation of DNA metabolic process,444,4,2.49,0.23944,1,0.6197876707907477,1.61,BP
GO:0090596,sensory organ morphogenesis,302,3,1.7,0.24081,1,0.6213890850722311,1.76,BP
GO:0034404,nucleobase-containing small molecule bio...,167,2,0.94,0.24116,1,0.6213890850722311,2.13,BP
GO:0014888,striated muscle adaptation,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0030520,intracellular estrogen receptor signalin...,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0043489,RNA stabilization,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0061912,selective autophagy,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0070169,positive regulation of biomineral tissue...,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0090102,cochlea development,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0090199,regulation of release of cytochrome c fr...,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0099054,presynapse assembly,49,1,0.28,0.24135,1,0.6213890850722311,3.57,BP
GO:0045333,cellular respiration,168,2,0.94,0.24324,1,0.625920256684492,2.13,BP
GO:0071216,cellular response to biotic stimulus,304,3,1.71,0.24380,1,0.627025975414217,1.75,BP
GO:0097237,cellular response to toxic substance,169,2,0.95,0.24531,1,0.6293522044728435,2.11,BP
GO:0006360,transcription by RNA polymerase I,50,1,0.28,0.24562,1,0.6293522044728435,3.57,BP
GO:0010761,fibroblast migration,50,1,0.28,0.24562,1,0.6293522044728435,3.57,BP
GO:0032941,secretion by tissue,50,1,0.28,0.24562,1,0.6293522044728435,3.57,BP
GO:0051055,negative regulation of lipid biosyntheti...,50,1,0.28,0.24562,1,0.6293522044728435,3.57,BP
GO:0120193,tight junction organization,50,1,0.28,0.24562,1,0.6293522044728435,3.57,BP
GO:1902930,regulation of alcohol biosynthetic proce...,50,1,0.28,0.24562,1,0.6293522044728435,3.57,BP
GO:2000241,regulation of reproductive process,170,2,0.95,0.24739,1,0.6335501224055349,2.11,BP
GO:0007612,learning,171,2,0.96,0.24947,1,0.6351433280507132,2.08,BP
GO:0046890,regulation of lipid biosynthetic process,171,2,0.96,0.24947,1,0.6351433280507132,2.08,BP
GO:0001974,blood vessel remodeling,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0021587,cerebellum morphogenesis,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0030834,regulation of actin filament depolymeriz...,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-depe...,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0032648,regulation of interferon-beta production,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0033619,membrane protein proteolysis,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0043618,regulation of transcription from RNA pol...,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0048247,lymphocyte chemotaxis,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0048806,genitalia development,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0051954,positive regulation of amine transport,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0051972,regulation of telomerase activity,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:1904591,positive regulation of protein import,51,1,0.29,0.24986,1,0.6351433280507132,3.45,BP
GO:0043271,negative regulation of ion transport,172,2,0.97,0.25154,1,0.639076282998944,2.06,BP
GO:0035296,regulation of tube diameter,173,2,0.97,0.25362,1,0.6411542108023073,2.06,BP
GO:0050880,regulation of blood vessel size,173,2,0.97,0.25362,1,0.6411542108023073,2.06,BP
GO:0097746,regulation of blood vessel diameter,173,2,0.97,0.25362,1,0.6411542108023073,2.06,BP
GO:0001662,behavioral fear response,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0006406,mRNA export from nucleus,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0017145,stem cell division,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0031103,axon regeneration,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0044058,regulation of digestive system process,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0048066,developmental pigmentation,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0060428,lung epithelium development,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0070542,response to fatty acid,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0071427,mRNA-containing ribonucleoprotein comple...,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:1903202,negative regulation of oxidative stress-...,52,1,0.29,0.25409,1,0.6411542108023073,3.45,BP
GO:0035107,appendage morphogenesis,174,2,0.98,0.25570,1,0.6442033507853403,2.04,BP
GO:0035108,limb morphogenesis,174,2,0.98,0.25570,1,0.6442033507853403,2.04,BP
GO:0035150,regulation of tube size,174,2,0.98,0.25570,1,0.6442033507853403,2.04,BP
GO:0002209,behavioral defense response,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0014014,negative regulation of gliogenesis,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0030219,megakaryocyte differentiation,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0030850,prostate gland development,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0031529,ruffle organization,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0032608,interferon-beta production,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0045214,sarcomere organization,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0045777,positive regulation of blood pressure,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0046148,pigment biosynthetic process,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0051932,"synaptic transmission, GABAergic",53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0061077,chaperone-mediated protein folding,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:1900408,negative regulation of cellular response...,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:1904705,regulation of vascular smooth muscle cel...,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:1990874,vascular smooth muscle cell proliferatio...,53,1,0.3,0.25829,1,0.6459934927234927,3.33,BP
GO:0097190,apoptotic signaling pathway,612,5,3.44,0.26069,1,0.6506736321483771,1.45,BP
GO:0043062,extracellular structure organization,316,3,1.77,0.26186,1,0.6506736321483771,1.69,BP
GO:0006403,RNA localization,177,2,0.99,0.26194,1,0.6506736321483771,2.02,BP
GO:0008016,regulation of heart contraction,177,2,0.99,0.26194,1,0.6506736321483771,2.02,BP
GO:0043409,negative regulation of MAPK cascade,177,2,0.99,0.26194,1,0.6506736321483771,2.02,BP
GO:0002385,mucosal immune response,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0007618,mating,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0030199,collagen fibril organization,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0032731,positive regulation of interleukin-1 bet...,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0034113,heterotypic cell-cell adhesion,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0043297,apical junction assembly,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0045604,regulation of epidermal cell differentia...,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0051496,positive regulation of stress fiber asse...,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0055025,positive regulation of cardiac muscle ti...,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0098815,modulation of excitatory postsynaptic po...,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:1900271,regulation of long-term synaptic potenti...,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:1903533,regulation of protein targeting,54,1,0.3,0.26246,1,0.6506736321483771,3.33,BP
GO:0051146,striated muscle cell differentiation,317,3,1.78,0.26337,1,0.6525934294541709,1.69,BP
GO:0030041,actin filament polymerization,178,2,1,0.26402,1,0.6528593216855086,2,BP
GO:0048489,synaptic vesicle transport,178,2,1,0.26402,1,0.6528593216855086,2,BP
GO:0048813,dendrite morphogenesis,178,2,1,0.26402,1,0.6528593216855086,2,BP
GO:0097480,establishment of synaptic vesicle locali...,178,2,1,0.26402,1,0.6528593216855086,2,BP
GO:0006281,DNA repair,465,4,2.61,0.26516,1,0.653221649694501,1.53,BP
GO:0008064,regulation of actin polymerization or de...,179,2,1.01,0.26610,1,0.653221649694501,1.98,BP
GO:0140013,meiotic nuclear division,179,2,1.01,0.26610,1,0.653221649694501,1.98,BP
GO:0014009,glial cell proliferation,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0019369,arachidonic acid metabolic process,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0021575,hindbrain morphogenesis,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0030042,actin filament depolymerization,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0032210,regulation of telomere maintenance via t...,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0032655,regulation of interleukin-12 production,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0035306,positive regulation of dephosphorylation,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0043030,regulation of macrophage activation,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0044060,regulation of endocrine process,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0045599,negative regulation of fat cell differen...,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0045687,positive regulation of glial cell differ...,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0048662,negative regulation of smooth muscle cel...,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0060193,positive regulation of lipase activity,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:1900024,regulation of substrate adhesion-depende...,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:1901799,negative regulation of proteasomal prote...,55,1,0.31,0.26661,1,0.653221649694501,3.23,BP
GO:0000082,G1/S transition of mitotic cell cycle,180,2,1.01,0.26818,1,0.6563998779247202,1.98,BP
GO:0007416,synapse assembly,180,2,1.01,0.26818,1,0.6563998779247202,1.98,BP
GO:0009887,animal organ morphogenesis,1090,8,6.12,0.26901,1,0.6576480969207471,1.31,BP
GO:0021700,developmental maturation,321,3,1.8,0.26943,1,0.6576480969207471,1.67,BP
GO:0009605,response to external stimulus,2399,16,13.47,0.26990,1,0.6576480969207471,1.19,BP
GO:0019933,cAMP-mediated signaling,181,2,1.02,0.27026,1,0.6576480969207471,1.96,BP
GO:0002204,somatic recombination of immunoglobulin ...,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0002208,somatic diversification of immunoglobuli...,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0002251,organ or tissue specific immune response,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0002833,positive regulation of response to bioti...,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0019731,antibacterial humoral response,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0042596,fear response,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0043620,regulation of DNA-templated transcriptio...,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0045190,isotype switching,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0048538,thymus development,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0099172,presynapse organization,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:1902883,negative regulation of response to oxida...,56,1,0.31,0.27074,1,0.6576480969207471,3.23,BP
GO:0018108,peptidyl-tyrosine phosphorylation,322,3,1.81,0.27095,1,0.6578261352169527,1.66,BP
GO:0007389,pattern specification process,470,4,2.64,0.27136,1,0.6584893192133132,1.52,BP
GO:0030832,regulation of actin filament length,182,2,1.02,0.27234,1,0.6598691238670695,1.96,BP
GO:0061136,regulation of proteasomal protein catabo...,182,2,1.02,0.27234,1,0.6598691238670695,1.96,BP
GO:0120032,regulation of plasma membrane bounded ce...,182,2,1.02,0.27234,1,0.6598691238670695,1.96,BP
GO:0044255,cellular lipid metabolic process,936,7,5.26,0.27307,1,0.6609586206896552,1.33,BP
GO:0006584,catecholamine metabolic process,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0009712,catechol-containing compound metabolic p...,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0010463,mesenchymal cell proliferation,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0010823,negative regulation of mitochondrion org...,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0019080,viral gene expression,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0021517,ventral spinal cord development,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0032653,regulation of interleukin-10 production,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0042551,neuron maturation,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0043470,regulation of carbohydrate catabolic pro...,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0043536,positive regulation of blood vessel endo...,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0046622,positive regulation of organ growth,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0051196,regulation of coenzyme metabolic process,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0051445,regulation of meiotic cell cycle,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0072347,response to anesthetic,57,1,0.32,0.27485,1,0.6609586206896552,3.12,BP
GO:0018212,peptidyl-tyrosine modification,325,3,1.82,0.27551,1,0.6622148451548451,1.65,BP
GO:0060491,regulation of cell projection assembly,184,2,1.03,0.27650,1,0.6642626060908637,1.94,BP
GO:0007159,leukocyte cell-cell adhesion,326,3,1.83,0.27704,1,0.664896,1.64,BP
GO:0051235,maintenance of location,326,3,1.83,0.27704,1,0.664896,1.64,BP
GO:0003006,developmental process involved in reprod...,784,6,4.4,0.27818,1,0.6664404965243297,1.36,BP
GO:0050890,cognition,327,3,1.84,0.27856,1,0.6664404965243297,1.63,BP
GO:0051588,regulation of neurotransmitter transport,185,2,1.04,0.27858,1,0.6664404965243297,1.92,BP
GO:0006874,cellular calcium ion homeostasis,476,4,2.67,0.27883,1,0.6664404965243297,1.5,BP
GO:0008333,endosome to lysosome transport,58,1,0.33,0.27893,1,0.6664404965243297,3.03,BP
GO:0032615,interleukin-12 production,58,1,0.33,0.27893,1,0.6664404965243297,3.03,BP
GO:0060443,mammary gland morphogenesis,58,1,0.33,0.27893,1,0.6664404965243297,3.03,BP
GO:0065002,intracellular protein transmembrane tran...,58,1,0.33,0.27893,1,0.6664404965243297,3.03,BP
GO:1900449,regulation of glutamate receptor signali...,58,1,0.33,0.27893,1,0.6664404965243297,3.03,BP
GO:0015931,nucleobase-containing compound transport,187,2,1.05,0.28274,1,0.672136169792695,1.9,BP
GO:0001755,neural crest cell migration,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0002011,morphogenesis of an epithelial sheet,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0007029,endoplasmic reticulum organization,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0015872,dopamine transport,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0032663,regulation of interleukin-2 production,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0032835,glomerulus development,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0051148,negative regulation of muscle cell diffe...,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0070936,protein K48-linked ubiquitination,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0071806,protein transmembrane transport,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:1901616,organic hydroxy compound catabolic proce...,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:1903902,positive regulation of viral life cycle,59,1,0.33,0.28299,1,0.672136169792695,3.03,BP
GO:0061351,neural precursor cell proliferation,188,2,1.06,0.28481,1,0.6761251702022694,1.89,BP
GO:0097479,synaptic vesicle localization,189,2,1.06,0.28689,1,0.6780502503681886,1.89,BP
GO:0008347,glial cell migration,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0021515,cell differentiation in spinal cord,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0031124,mRNA 3'-end processing,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0046847,filopodium assembly,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0060119,inner ear receptor cell development,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0060324,face development,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0060986,endocrine hormone secretion,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0070098,chemokine-mediated signaling pathway,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:1902017,regulation of cilium assembly,60,1,0.34,0.28703,1,0.6780502503681886,2.94,BP
GO:0034765,regulation of ion transmembrane transpor...,485,4,2.72,0.29011,1,0.6848334865525673,1.47,BP
GO:0006446,regulation of translational initiation,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0006493,protein O-linked glycosylation,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0016447,somatic recombination of immunoglobulin ...,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0021695,cerebellar cortex development,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0030837,negative regulation of actin filament po...,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0032613,interleukin-10 production,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0042058,regulation of epidermal growth factor re...,61,1,0.34,0.29104,1,0.6848334865525673,2.94,BP
GO:0034470,ncRNA processing,336,3,1.89,0.29230,1,0.6874621700879766,1.59,BP
GO:0009108,coenzyme biosynthetic process,192,2,1.08,0.29312,1,0.689053952125061,1.85,BP
GO:0001836,release of cytochrome c from mitochondri...,62,1,0.35,0.29503,1,0.6918539766081871,2.86,BP
GO:0010171,body morphogenesis,62,1,0.35,0.29503,1,0.6918539766081871,2.86,BP
GO:0010812,negative regulation of cell-substrate ad...,62,1,0.35,0.29503,1,0.6918539766081871,2.86,BP
GO:0032732,positive regulation of interleukin-1 pro...,62,1,0.35,0.29503,1,0.6918539766081871,2.86,BP
GO:0090501,RNA phosphodiester bond hydrolysis,62,1,0.35,0.29503,1,0.6918539766081871,2.86,BP
GO:0009611,response to wounding,491,4,2.76,0.29767,1,0.6977048416950804,1.45,BP
GO:0015800,acidic amino acid transport,63,1,0.35,0.29900,1,0.6997996108949417,2.86,BP
GO:0042246,tissue regeneration,63,1,0.35,0.29900,1,0.6997996108949417,2.86,BP
GO:0043949,regulation of cAMP-mediated signaling,63,1,0.35,0.29900,1,0.6997996108949417,2.86,BP
GO:0044843,cell cycle G1/S phase transition,195,2,1.09,0.29934,1,0.7002547788040836,1.83,BP
GO:0006006,glucose metabolic process,196,2,1.1,0.30142,1,0.7039388646288209,1.82,BP
GO:0042180,cellular ketone metabolic process,196,2,1.1,0.30142,1,0.7039388646288209,1.82,BP
GO:0099173,postsynapse organization,196,2,1.1,0.30142,1,0.7039388646288209,1.82,BP
GO:0019216,regulation of lipid metabolic process,342,3,1.92,0.30150,1,0.7039388646288209,1.56,BP
GO:0010676,positive regulation of cellular carbohyd...,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:0032233,positive regulation of actin filament bu...,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:0035904,aorta development,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:0060999,positive regulation of dendritic spine d...,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:0061951,establishment of protein localization to...,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:0090398,cellular senescence,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:1904356,regulation of telomere maintenance via t...,64,1,0.36,0.30295,1,0.7049300773694391,2.78,BP
GO:0006469,negative regulation of protein kinase ac...,198,2,1.11,0.30556,1,0.7099550769230769,1.8,BP
GO:0007519,skeletal muscle tissue development,198,2,1.11,0.30556,1,0.7099550769230769,1.8,BP
GO:0008217,regulation of blood pressure,198,2,1.11,0.30556,1,0.7099550769230769,1.8,BP
GO:0001655,urogenital system development,345,3,1.94,0.30610,1,0.7099550769230769,1.55,BP
GO:0006278,RNA-dependent DNA biosynthetic process,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:0007004,telomere maintenance via telomerase,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:0045668,negative regulation of osteoblast differ...,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:0099024,plasma membrane invagination,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:0099601,regulation of neurotransmitter receptor ...,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:2000134,negative regulation of G1/S transition o...,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:2000736,regulation of stem cell differentiation,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:2001169,regulation of ATP biosynthetic process,65,1,0.36,0.30688,1,0.7099550769230769,2.78,BP
GO:0048736,appendage development,199,2,1.12,0.30763,1,0.7106651752280366,1.79,BP
GO:0060173,limb development,199,2,1.12,0.30763,1,0.7106651752280366,1.79,BP
GO:0071236,cellular response to antibiotic,199,2,1.12,0.30763,1,0.7106651752280366,1.79,BP
GO:0052548,regulation of endopeptidase activity,347,3,1.95,0.30917,1,0.7124694425917104,1.54,BP
GO:0072503,cellular divalent inorganic cation homeo...,501,4,2.81,0.31031,1,0.7124694425917104,1.42,BP
GO:0000422,autophagy of mitochondrion,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0009064,glutamine family amino acid metabolic pr...,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0019748,secondary metabolic process,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0034605,cellular response to heat,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0042306,regulation of protein import into nucleu...,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0042440,pigment metabolic process,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0043647,inositol phosphate metabolic process,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0045123,cellular extravasation,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0051591,response to cAMP,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0060425,lung morphogenesis,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0061726,mitochondrion disassembly,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0071260,cellular response to mechanical stimulus,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:1901184,regulation of ERBB signaling pathway,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:1904888,cranial skeletal system development,66,1,0.37,0.31078,1,0.7124694425917104,2.7,BP
GO:0044403,symbiont process,349,3,1.96,0.31224,1,0.7154756571428572,1.53,BP
GO:0030522,intracellular receptor signaling pathway,202,2,1.13,0.31383,1,0.7176037535545023,1.77,BP
GO:0002381,immunoglobulin production involved in im...,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0006801,superoxide metabolic process,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0006940,regulation of smooth muscle contraction,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0016445,somatic diversification of immunoglobuli...,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0032623,interleukin-2 production,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0045739,positive regulation of DNA repair,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0046824,positive regulation of nucleocytoplasmic...,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0061371,determination of heart left/right asymme...,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:2000179,positive regulation of neural precursor ...,67,1,0.38,0.31466,1,0.7176037535545023,2.63,BP
GO:0018193,peptidyl-amino acid modification,1147,8,6.44,0.31592,1,0.720135973472288,1.24,BP
GO:0002711,positive regulation of T cell mediated i...,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0006893,Golgi to plasma membrane transport,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0008542,visual learning,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0032922,circadian regulation of gene expression,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0043113,receptor clustering,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0050771,negative regulation of axonogenesis,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0071426,ribonucleoprotein complex export from nu...,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:1905515,non-motile cilium assembly,68,1,0.38,0.31852,1,0.7233214912694668,2.63,BP
GO:0006952,defense response,1481,10,8.32,0.31964,1,0.7250170621468927,1.2,BP
GO:0007188,adenylate cyclase-modulating G protein-c...,205,2,1.15,0.32002,1,0.7250170621468927,1.74,BP
GO:0008154,actin polymerization or depolymerization,205,2,1.15,0.32002,1,0.7250170621468927,1.74,BP
GO:0032388,positive regulation of intracellular tra...,205,2,1.15,0.32002,1,0.7250170621468927,1.74,BP
GO:0046434,organophosphate catabolic process,205,2,1.15,0.32002,1,0.7250170621468927,1.74,BP
GO:0001541,ovarian follicle development,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0006766,vitamin metabolic process,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0016239,positive regulation of macroautophagy,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0021536,diencephalon development,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0032370,positive regulation of lipid transport,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0033692,cellular polysaccharide biosynthetic pro...,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0048146,positive regulation of fibroblast prolif...,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0050885,neuromuscular process controlling balanc...,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0060997,dendritic spine morphogenesis,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0071166,ribonucleoprotein complex localization,69,1,0.39,0.32236,1,0.7268961199625117,2.56,BP
GO:0050727,regulation of inflammatory response,356,3,2,0.32299,1,0.7279755878220141,1.5,BP
GO:0051224,negative regulation of protein transport,207,2,1.16,0.32414,1,0.7298124976613657,1.72,BP
GO:0060538,skeletal muscle organ development,207,2,1.16,0.32414,1,0.7298124976613657,1.72,BP
GO:0043009,chordate embryonic development,831,6,4.67,0.32426,1,0.7298124976613657,1.28,BP
GO:0001885,endothelial cell development,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:0002562,somatic diversification of immune recept...,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:0016444,somatic cell DNA recombination,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:0048641,regulation of skeletal muscle tissue dev...,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:1902807,negative regulation of cell cycle G1/S p...,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:1903670,regulation of sprouting angiogenesis,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:1990868,response to chemokine,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:1990869,cellular response to chemokine,70,1,0.39,0.32618,1,0.7310788448998603,2.56,BP
GO:0051099,positive regulation of binding,208,2,1.17,0.32619,1,0.7310788448998603,1.71,BP
GO:0015893,drug transport,209,2,1.17,0.32825,1,0.7353533519553072,1.71,BP
GO:0006513,protein monoubiquitination,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:0007632,visual behavior,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:0016575,histone deacetylation,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:0045669,positive regulation of osteoblast differ...,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:0050433,regulation of catecholamine secretion,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:0070192,chromosome organization involved in meio...,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:1901796,regulation of signal transduction by p53...,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:1904589,regulation of protein import,71,1,0.4,0.32997,1,0.7364636549165121,2.5,BP
GO:0043281,regulation of cysteine-type endopeptidas...,210,2,1.18,0.33030,1,0.7365169601482855,1.69,BP
GO:0071559,response to transforming growth factor b...,210,2,1.18,0.33030,1,0.7365169601482855,1.69,BP
GO:0019722,calcium-mediated signaling,211,2,1.18,0.33236,1,0.7407671699861046,1.69,BP
GO:0010324,membrane invagination,72,1,0.4,0.33375,1,0.7418036951501156,2.5,BP
GO:0010611,regulation of cardiac muscle hypertrophy,72,1,0.4,0.33375,1,0.7418036951501156,2.5,BP
GO:0030239,myofibril assembly,72,1,0.4,0.33375,1,0.7418036951501156,2.5,BP
GO:0097755,positive regulation of blood vessel diam...,72,1,0.4,0.33375,1,0.7418036951501156,2.5,BP
GO:2000779,regulation of double-strand break repair,72,1,0.4,0.33375,1,0.7418036951501156,2.5,BP
GO:0050678,regulation of epithelial cell proliferat...,363,3,2.04,0.33375,1,0.7418036951501156,1.47,BP
GO:0006814,sodium ion transport,212,2,1.19,0.33441,1,0.7422421217712176,1.68,BP
GO:0030595,leukocyte chemotaxis,212,2,1.19,0.33441,1,0.7422421217712176,1.68,BP
GO:1904950,negative regulation of establishment of ...,212,2,1.19,0.33441,1,0.7422421217712176,1.68,BP
GO:0019935,cyclic-nucleotide-mediated signaling,213,2,1.2,0.33646,1,0.7464479114799447,1.67,BP
GO:0021766,hippocampus development,73,1,0.41,0.33750,1,0.7477209944751382,2.44,BP
GO:0097120,receptor localization to synapse,73,1,0.41,0.33750,1,0.7477209944751382,2.44,BP
GO:1990542,mitochondrial transmembrane transport,73,1,0.41,0.33750,1,0.7477209944751382,2.44,BP
GO:0017038,protein import,214,2,1.2,0.33850,1,0.7495913483663139,1.67,BP
GO:0002274,myeloid leukocyte activation,215,2,1.21,0.34055,1,0.751830934065934,1.65,BP
GO:0009792,embryo development ending in birth or eg...,848,6,4.76,0.34122,1,0.751830934065934,1.26,BP
GO:0002066,columnar/cuboidal epithelial cell develo...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0007193,adenylate cyclase-inhibiting G protein-c...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0031060,regulation of histone methylation,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0031397,negative regulation of protein ubiquitin...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0042108,positive regulation of cytokine biosynth...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0050432,catecholamine secretion,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0050810,regulation of steroid biosynthetic proce...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:1903036,positive regulation of response to wound...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:2000573,positive regulation of DNA biosynthetic ...,74,1,0.42,0.34123,1,0.751830934065934,2.38,BP
GO:0008406,gonad development,216,2,1.21,0.34259,1,0.7544819588100686,1.65,BP
GO:0007163,establishment or maintenance of cell pol...,217,2,1.22,0.34463,1,0.7575989958922866,1.64,BP
GO:0010507,negative regulation of autophagy,75,1,0.42,0.34495,1,0.7575989958922866,2.38,BP
GO:0030433,ubiquitin-dependent ERAD pathway,75,1,0.42,0.34495,1,0.7575989958922866,2.38,BP
GO:0045670,regulation of osteoclast differentiation,75,1,0.42,0.34495,1,0.7575989958922866,2.38,BP
GO:0051705,multi-organism behavior,75,1,0.42,0.34495,1,0.7575989958922866,2.38,BP
GO:0061097,regulation of protein tyrosine kinase ac...,75,1,0.42,0.34495,1,0.7575989958922866,2.38,BP
GO:0009060,aerobic respiration,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0010822,positive regulation of mitochondrion org...,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0021879,forebrain neuron differentiation,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0032272,negative regulation of protein polymeriz...,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0032507,maintenance of protein location in cell,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0048844,artery morphogenesis,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0051865,protein autoubiquitination,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0097327,response to antineoplastic agent,76,1,0.43,0.34864,1,0.7623773375738301,2.33,BP
GO:0002573,myeloid leukocyte differentiation,219,2,1.23,0.34871,1,0.7623773375738301,1.63,BP
GO:0048762,mesenchymal cell differentiation,219,2,1.23,0.34871,1,0.7623773375738301,1.63,BP
GO:0045137,development of primary sexual characteri...,220,2,1.24,0.35074,1,0.7664672479564033,1.61,BP
GO:0000271,polysaccharide biosynthetic process,77,1,0.43,0.35231,1,0.7681539284096058,2.33,BP
GO:0001756,somitogenesis,77,1,0.43,0.35231,1,0.7681539284096058,2.33,BP
GO:0002200,somatic diversification of immune recept...,77,1,0.43,0.35231,1,0.7681539284096058,2.33,BP
GO:0015918,sterol transport,77,1,0.43,0.35231,1,0.7681539284096058,2.33,BP
GO:0030301,cholesterol transport,77,1,0.43,0.35231,1,0.7681539284096058,2.33,BP
GO:0003002,regionalization,376,3,2.11,0.35372,1,0.7708789130434782,1.42,BP
GO:0006405,RNA export from nucleus,78,1,0.44,0.35596,1,0.7740079168549481,2.27,BP
GO:0032729,positive regulation of interferon-gamma ...,78,1,0.44,0.35596,1,0.7740079168549481,2.27,BP
GO:0034644,cellular response to UV,78,1,0.44,0.35596,1,0.7740079168549481,2.27,BP
GO:0043507,positive regulation of JUN kinase activi...,78,1,0.44,0.35596,1,0.7740079168549481,2.27,BP
GO:1900182,positive regulation of protein localizat...,78,1,0.44,0.35596,1,0.7740079168549481,2.27,BP
GO:1902532,negative regulation of intracellular sig...,537,4,3.02,0.35619,1,0.7741582113821138,1.32,BP
GO:0002520,immune system development,1030,7,5.78,0.35789,1,0.7775018871331828,1.21,BP
GO:0006835,dicarboxylic acid transport,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0010389,regulation of G2/M transition of mitotic...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0010833,telomere maintenance via telomere length...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0030808,regulation of nucleotide biosynthetic pr...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0032088,negative regulation of NF-kappaB transcr...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0048663,neuron fate commitment,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0061844,antimicrobial humoral immune response me...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0070373,negative regulation of ERK1 and ERK2 cas...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0071277,cellular response to calcium ion,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:1900371,regulation of purine nucleotide biosynth...,79,1,0.44,0.35959,1,0.7776840808988764,2.27,BP
GO:0019318,hexose metabolic process,225,2,1.26,0.36089,1,0.7801449595687332,1.59,BP
GO:0019953,sexual reproduction,868,6,4.87,0.36130,1,0.7805029443447038,1.23,BP
GO:0060562,epithelial tube morphogenesis,381,3,2.14,0.36138,1,0.7805029443447038,1.4,BP
GO:0007276,gamete generation,704,5,3.95,0.36172,1,0.7808867833109018,1.27,BP
GO:0090150,establishment of protein localization to...,226,2,1.27,0.36291,1,0.7812777827447475,1.57,BP
GO:0006919,activation of cysteine-type endopeptidas...,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:0034637,cellular carbohydrate biosynthetic proce...,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:0043154,negative regulation of cysteine-type end...,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:0043525,positive regulation of neuron apoptotic ...,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:0045682,regulation of epidermis development,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:1902117,positive regulation of organelle assembl...,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:1904427,positive regulation of calcium ion trans...,80,1,0.45,0.36320,1,0.7812777827447475,2.22,BP
GO:0072594,establishment of protein localization to...,383,3,2.15,0.36444,1,0.7835948525469169,1.4,BP
GO:0005977,glycogen metabolic process,81,1,0.45,0.36679,1,0.7868820855614974,2.22,BP
GO:0006073,cellular glucan metabolic process,81,1,0.45,0.36679,1,0.7868820855614974,2.22,BP
GO:0043279,response to alkaloid,81,1,0.45,0.36679,1,0.7868820855614974,2.22,BP
GO:0044042,glucan metabolic process,81,1,0.45,0.36679,1,0.7868820855614974,2.22,BP
GO:0051702,interaction with symbiont,81,1,0.45,0.36679,1,0.7868820855614974,2.22,BP
GO:0009260,ribonucleotide biosynthetic process,228,2,1.28,0.36695,1,0.7868820855614974,1.56,BP
GO:0051260,protein homooligomerization,385,3,2.16,0.36750,1,0.7877104677060134,1.39,BP
GO:0022406,membrane docking,82,1,0.46,0.37035,1,0.7931126835781042,2.17,BP
GO:0032651,regulation of interleukin-1 beta product...,82,1,0.46,0.37035,1,0.7931126835781042,2.17,BP
GO:0048863,stem cell differentiation,230,2,1.29,0.37097,1,0.794087028469751,1.55,BP
GO:0002312,B cell activation involved in immune res...,83,1,0.47,0.37390,1,0.7996474666666666,2.13,BP
GO:1901019,regulation of calcium ion transmembrane ...,83,1,0.47,0.37390,1,0.7996474666666666,2.13,BP
GO:0009952,anterior/posterior pattern specification,232,2,1.3,0.37499,1,0.801622336739227,1.54,BP
GO:0045844,positive regulation of striated muscle t...,84,1,0.47,0.37743,1,0.8061221304926764,2.13,BP
GO:0048636,positive regulation of muscle organ deve...,84,1,0.47,0.37743,1,0.8061221304926764,2.13,BP
GO:0007187,G protein-coupled receptor signaling pat...,234,2,1.31,0.37900,1,0.8087574279379157,1.53,BP
GO:2001234,negative regulation of apoptotic signali...,234,2,1.31,0.37900,1,0.8087574279379157,1.53,BP
GO:0002009,morphogenesis of an epithelium,555,4,3.12,0.37918,1,0.8087828723404256,1.28,BP
GO:0051704,multi-organism process,2245,14,12.61,0.38088,1,0.8090785525154457,1.11,BP
GO:0008589,regulation of smoothened signaling pathw...,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:0014032,neural crest cell development,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:0032526,response to retinoic acid,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:0034502,protein localization to chromosome,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:0048524,positive regulation of viral process,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:0097581,lamellipodium organization,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:1901863,positive regulation of muscle tissue dev...,85,1,0.48,0.38094,1,0.8090785525154457,2.08,BP
GO:0046390,ribose phosphate biosynthetic process,235,2,1.32,0.38100,1,0.8090785525154457,1.52,BP
GO:2000116,regulation of cysteine-type endopeptidas...,235,2,1.32,0.38100,1,0.8090785525154457,1.52,BP
GO:0006096,glycolytic process,86,1,0.48,0.38443,1,0.8149238590308371,2.08,BP
GO:0034103,regulation of tissue remodeling,86,1,0.48,0.38443,1,0.8149238590308371,2.08,BP
GO:0042632,cholesterol homeostasis,86,1,0.48,0.38443,1,0.8149238590308371,2.08,BP
GO:1901379,regulation of potassium ion transmembran...,86,1,0.48,0.38443,1,0.8149238590308371,2.08,BP
GO:0006813,potassium ion transport,237,2,1.33,0.38499,1,0.8153925528169014,1.5,BP
GO:1903531,negative regulation of secretion by cell,237,2,1.33,0.38499,1,0.8153925528169014,1.5,BP
GO:0006757,ATP generation from ADP,87,1,0.49,0.38790,1,0.819391922739245,2.04,BP
GO:0043648,dicarboxylic acid metabolic process,87,1,0.49,0.38790,1,0.819391922739245,2.04,BP
GO:0051384,response to glucocorticoid,87,1,0.49,0.38790,1,0.819391922739245,2.04,BP
GO:0055092,sterol homeostasis,87,1,0.49,0.38790,1,0.819391922739245,2.04,BP
GO:0060079,excitatory postsynaptic potential,87,1,0.49,0.38790,1,0.819391922739245,2.04,BP
GO:2000117,negative regulation of cysteine-type end...,87,1,0.49,0.38790,1,0.819391922739245,2.04,BP
GO:0010817,regulation of hormone levels,562,4,3.16,0.38810,1,0.8194546731022377,1.27,BP
GO:0044419,interspecies interaction between organis...,399,3,2.24,0.38885,1,0.820571521262604,1.34,BP
GO:1903522,regulation of blood circulation,239,2,1.34,0.38897,1,0.820571521262604,1.49,BP
GO:0010717,regulation of epithelial to mesenchymal ...,88,1,0.49,0.39135,1,0.8248691195795006,2.04,BP
GO:0019217,regulation of fatty acid metabolic proce...,88,1,0.49,0.39135,1,0.8248691195795006,2.04,BP
GO:0019752,carboxylic acid metabolic process,901,6,5.06,0.39459,1,0.8295551790393013,1.19,BP
GO:0021872,forebrain generation of neurons,89,1,0.5,0.39478,1,0.8295551790393013,2,BP
GO:0035914,skeletal muscle cell differentiation,89,1,0.5,0.39478,1,0.8295551790393013,2,BP
GO:0051492,regulation of stress fiber assembly,89,1,0.5,0.39478,1,0.8295551790393013,2,BP
GO:0051937,catecholamine transport,89,1,0.5,0.39478,1,0.8295551790393013,2,BP
GO:0070301,cellular response to hydrogen peroxide,89,1,0.5,0.39478,1,0.8295551790393013,2,BP
GO:1904035,regulation of epithelial cell apoptotic ...,89,1,0.5,0.39478,1,0.8295551790393013,2,BP
GO:0006260,DNA replication,243,2,1.36,0.39689,1,0.8332612041884818,1.47,BP
GO:0010466,negative regulation of peptidase activit...,243,2,1.36,0.39689,1,0.8332612041884818,1.47,BP
GO:0014031,mesenchymal cell development,90,1,0.51,0.39820,1,0.8341917283413147,1.96,BP
GO:0042866,pyruvate biosynthetic process,90,1,0.51,0.39820,1,0.8341917283413147,1.96,BP
GO:0045833,negative regulation of lipid metabolic p...,90,1,0.51,0.39820,1,0.8341917283413147,1.96,BP
GO:0072091,regulation of stem cell proliferation,90,1,0.51,0.39820,1,0.8341917283413147,1.96,BP
GO:1905954,positive regulation of lipid localizatio...,90,1,0.51,0.39820,1,0.8341917283413147,1.96,BP
GO:0000041,transition metal ion transport,91,1,0.51,0.40159,1,0.8391016413373861,1.96,BP
GO:0002709,regulation of T cell mediated immunity,91,1,0.51,0.40159,1,0.8391016413373861,1.96,BP
GO:0006476,protein deacetylation,91,1,0.51,0.40159,1,0.8391016413373861,1.96,BP
GO:0021954,central nervous system neuron developmen...,91,1,0.51,0.40159,1,0.8391016413373861,1.96,BP
GO:0031960,response to corticosteroid,91,1,0.51,0.40159,1,0.8391016413373861,1.96,BP
GO:0048864,stem cell development,91,1,0.51,0.40159,1,0.8391016413373861,1.96,BP
GO:0043269,regulation of ion transport,741,5,4.16,0.40311,1,0.84191203125,1.2,BP
GO:0009798,axis specification,92,1,0.52,0.40497,1,0.8435998441558442,1.92,BP
GO:0014033,neural crest cell differentiation,92,1,0.52,0.40497,1,0.8435998441558442,1.92,BP
GO:0030838,positive regulation of actin filament po...,92,1,0.52,0.40497,1,0.8435998441558442,1.92,BP
GO:0043535,regulation of blood vessel endothelial c...,92,1,0.52,0.40497,1,0.8435998441558442,1.92,BP
GO:0045685,regulation of glial cell differentiation,92,1,0.52,0.40497,1,0.8435998441558442,1.92,BP
GO:0070252,actin-mediated cell contraction,92,1,0.52,0.40497,1,0.8435998441558442,1.92,BP
GO:0002027,regulation of heart rate,93,1,0.52,0.40832,1,0.8491079688850476,1.92,BP
GO:0045445,myoblast differentiation,93,1,0.52,0.40832,1,0.8491079688850476,1.92,BP
GO:0046889,positive regulation of lipid biosyntheti...,93,1,0.52,0.40832,1,0.8491079688850476,1.92,BP
GO:0060998,regulation of dendritic spine developmen...,93,1,0.52,0.40832,1,0.8491079688850476,1.92,BP
GO:0032611,interleukin-1 beta production,94,1,0.53,0.41166,1,0.8538396206896552,1.89,BP
GO:0043506,regulation of JUN kinase activity,94,1,0.53,0.41166,1,0.8538396206896552,1.89,BP
GO:0046031,ADP metabolic process,94,1,0.53,0.41166,1,0.8538396206896552,1.89,BP
GO:0048477,oogenesis,94,1,0.53,0.41166,1,0.8538396206896552,1.89,BP
GO:0070555,response to interleukin-1,94,1,0.53,0.41166,1,0.8538396206896552,1.89,BP
GO:0097061,dendritic spine organization,94,1,0.53,0.41166,1,0.8538396206896552,1.89,BP
GO:0006259,DNA metabolic process,920,6,5.17,0.41376,1,0.8578255579491598,1.16,BP
GO:0010506,regulation of autophagy,252,2,1.41,0.41455,1,0.8585054858125538,1.42,BP
GO:0006906,vesicle fusion,95,1,0.53,0.41498,1,0.8585054858125538,1.89,BP
GO:0045069,regulation of viral genome replication,95,1,0.53,0.41498,1,0.8585054858125538,1.89,BP
GO:0060021,roof of mouth development,95,1,0.53,0.41498,1,0.8585054858125538,1.89,BP
GO:1902749,regulation of cell cycle G2/M phase tran...,95,1,0.53,0.41498,1,0.8585054858125538,1.89,BP
GO:0030097,hemopoiesis,922,6,5.18,0.41577,1,0.859770193382037,1.16,BP
GO:0000045,autophagosome assembly,96,1,0.54,0.41828,1,0.8641980257510729,1.85,BP
GO:0061053,somite development,96,1,0.54,0.41828,1,0.8641980257510729,1.85,BP
GO:0005996,monosaccharide metabolic process,254,2,1.43,0.41845,1,0.8641980257510729,1.4,BP
GO:0007200,phospholipase C-activating G protein-cou...,97,1,0.54,0.42156,1,0.868756625267666,1.85,BP
GO:0021761,limbic system development,97,1,0.54,0.42156,1,0.868756625267666,1.85,BP
GO:0036503,ERAD pathway,97,1,0.54,0.42156,1,0.868756625267666,1.85,BP
GO:0071482,cellular response to light stimulus,97,1,0.54,0.42156,1,0.868756625267666,1.85,BP
GO:0099565,"chemical synaptic transmission, postsyna...",97,1,0.54,0.42156,1,0.868756625267666,1.85,BP
GO:0000375,"RNA splicing, via transesterification re...",257,2,1.44,0.42426,1,0.8728581725021348,1.39,BP
GO:0000377,"RNA splicing, via transesterification re...",257,2,1.44,0.42426,1,0.8728581725021348,1.39,BP
GO:0000398,"mRNA splicing, via spliceosome",257,2,1.44,0.42426,1,0.8728581725021348,1.39,BP
GO:0019730,antimicrobial humoral response,98,1,0.55,0.42482,1,0.8728581725021348,1.82,BP
GO:0031058,positive regulation of histone modificat...,98,1,0.55,0.42482,1,0.8728581725021348,1.82,BP
GO:0060993,kidney morphogenesis,98,1,0.55,0.42482,1,0.8728581725021348,1.82,BP
GO:2001237,negative regulation of extrinsic apoptot...,98,1,0.55,0.42482,1,0.8728581725021348,1.82,BP
GO:0010959,regulation of metal ion transport,425,3,2.39,0.42800,1,0.8762506678009357,1.26,BP
GO:0006165,nucleoside diphosphate phosphorylation,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:0006641,triglyceride metabolic process,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:0009135,purine nucleoside diphosphate metabolic ...,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:0009179,purine ribonucleoside diphosphate metabo...,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:0030279,negative regulation of ossification,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:0099072,regulation of postsynaptic membrane neur...,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:2001243,negative regulation of intrinsic apoptot...,99,1,0.56,0.42806,1,0.8762506678009357,1.79,BP
GO:0048705,skeletal system morphogenesis,259,2,1.45,0.42811,1,0.8762506678009357,1.38,BP
GO:0016570,histone modification,427,3,2.4,0.43098,1,0.881260076433121,1.25,BP
GO:0007006,mitochondrial membrane organization,100,1,0.56,0.43129,1,0.881260076433121,1.79,BP
GO:0032652,regulation of interleukin-1 production,100,1,0.56,0.43129,1,0.881260076433121,1.79,BP
GO:1905037,autophagosome organization,100,1,0.56,0.43129,1,0.881260076433121,1.79,BP
GO:0016050,vesicle organization,261,2,1.47,0.43196,1,0.8820230632159525,1.36,BP
GO:0006812,cation transport,1110,7,6.23,0.43203,1,0.8820230632159525,1.12,BP
GO:0043436,oxoacid metabolic process,940,6,5.28,0.43388,1,0.8851879762912784,1.14,BP
GO:0001578,microtubule bundle formation,101,1,0.57,0.43450,1,0.8851879762912784,1.75,BP
GO:0046939,nucleotide phosphorylation,101,1,0.57,0.43450,1,0.8851879762912784,1.75,BP
GO:0055013,cardiac muscle cell development,101,1,0.57,0.43450,1,0.8851879762912784,1.75,BP
GO:0090174,organelle membrane fusion,101,1,0.57,0.43450,1,0.8851879762912784,1.75,BP
GO:0000077,DNA damage checkpoint,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0006892,post-Golgi vesicle-mediated transport,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0021510,spinal cord development,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0021549,cerebellum development,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0033555,multicellular organismal response to str...,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0035601,protein deacylation,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0050886,endocrine process,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0062014,negative regulation of small molecule me...,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0098732,macromolecule deacylation,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0098876,vesicle-mediated transport to the plasma...,102,1,0.57,0.43769,1,0.8879276053962901,1.75,BP
GO:0050730,regulation of peptidyl-tyrosine phosphor...,265,2,1.49,0.43961,1,0.890977874842503,1.34,BP
GO:0001708,cell fate specification,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0009185,ribonucleoside diphosphate metabolic pro...,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0019218,regulation of steroid metabolic process,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0019359,nicotinamide nucleotide biosynthetic pro...,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0034446,substrate adhesion-dependent cell spread...,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0048709,oligodendrocyte differentiation,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0051897,positive regulation of protein kinase B ...,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:1903426,regulation of reactive oxygen species bi...,103,1,0.58,0.44086,1,0.890977874842503,1.72,BP
GO:0002367,cytokine production involved in immune r...,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:0009953,dorsal/ventral pattern formation,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:0017015,regulation of transforming growth factor...,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:0032231,regulation of actin filament bundle asse...,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:0043255,regulation of carbohydrate biosynthetic ...,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:2000300,regulation of synaptic vesicle exocytosi...,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:2001022,positive regulation of response to DNA d...,104,1,0.58,0.44402,1,0.8947337688442213,1.72,BP
GO:0002224,toll-like receptor signaling pathway,105,1,0.59,0.44715,1,0.9003876150627615,1.69,BP
GO:0030217,T cell differentiation,269,2,1.51,0.44720,1,0.9003876150627615,1.32,BP
GO:0019363,pyridine nucleotide biosynthetic process,106,1,0.6,0.45027,1,0.9050539849624061,1.67,BP
GO:0032091,negative regulation of protein binding,106,1,0.6,0.45027,1,0.9050539849624061,1.67,BP
GO:0035282,segmentation,106,1,0.6,0.45027,1,0.9050539849624061,1.67,BP
GO:1903844,regulation of cellular response to trans...,106,1,0.6,0.45027,1,0.9050539849624061,1.67,BP
GO:0016241,regulation of macroautophagy,107,1,0.6,0.45337,1,0.909385760733639,1.67,BP
GO:0044264,cellular polysaccharide metabolic proces...,107,1,0.6,0.45337,1,0.909385760733639,1.67,BP
GO:0048661,positive regulation of smooth muscle cel...,107,1,0.6,0.45337,1,0.909385760733639,1.67,BP
GO:0055006,cardiac cell development,107,1,0.6,0.45337,1,0.909385760733639,1.67,BP
GO:0060840,artery development,107,1,0.6,0.45337,1,0.909385760733639,1.67,BP
GO:0016569,covalent chromatin modification,444,3,2.49,0.45607,1,0.9144203499999999,1.2,BP
GO:0022600,digestive system process,108,1,0.61,0.45646,1,0.9148211245314453,1.64,BP
GO:0006690,icosanoid metabolic process,109,1,0.61,0.45953,1,0.9186781719983381,1.64,BP
GO:0007043,cell-cell junction assembly,109,1,0.61,0.45953,1,0.9186781719983381,1.64,BP
GO:0008344,adult locomotory behavior,109,1,0.61,0.45953,1,0.9186781719983381,1.64,BP
GO:0034968,histone lysine methylation,109,1,0.61,0.45953,1,0.9186781719983381,1.64,BP
GO:1900006,positive regulation of dendrite developm...,109,1,0.61,0.45953,1,0.9186781719983381,1.64,BP
GO:1902803,regulation of synaptic vesicle transport,109,1,0.61,0.45953,1,0.9186781719983381,1.64,BP
GO:0034504,protein localization to nucleus,276,2,1.55,0.46035,1,0.9199352990033222,1.29,BP
GO:0051259,protein complex oligomerization,620,4,3.48,0.46112,1,0.9210915068493151,1.15,BP
GO:0006082,organic acid metabolic process,968,6,5.44,0.46187,1,0.9220940182270091,1.1,BP
GO:0030316,osteoclast differentiation,110,1,0.62,0.46258,1,0.9220940182270091,1.61,BP
GO:0032649,regulation of interferon-gamma productio...,110,1,0.62,0.46258,1,0.9220940182270091,1.61,BP
GO:0072525,pyridine-containing compound biosyntheti...,110,1,0.62,0.46258,1,0.9220940182270091,1.61,BP
GO:2000379,positive regulation of reactive oxygen s...,110,1,0.62,0.46258,1,0.9220940182270091,1.61,BP
GO:0001843,neural tube closure,111,1,0.62,0.46561,1,0.9273656125827815,1.61,BP
GO:0014074,response to purine-containing compound,111,1,0.62,0.46561,1,0.9273656125827815,1.61,BP
GO:0048534,hematopoietic or lymphoid organ developm...,972,6,5.46,0.46584,1,0.9274398345055854,1.1,BP
GO:0003007,heart morphogenesis,280,2,1.57,0.46778,1,0.9306840940982254,1.27,BP
GO:0006939,smooth muscle contraction,112,1,0.63,0.46863,1,0.9306840940982254,1.59,BP
GO:0019079,viral genome replication,112,1,0.63,0.46863,1,0.9306840940982254,1.59,BP
GO:0031570,DNA integrity checkpoint,112,1,0.63,0.46863,1,0.9306840940982254,1.59,BP
GO:0042100,B cell proliferation,112,1,0.63,0.46863,1,0.9306840940982254,1.59,BP
GO:0060606,tube closure,112,1,0.63,0.46863,1,0.9306840940982254,1.59,BP
GO:0007589,body fluid secretion,113,1,0.63,0.47163,1,0.9343283491148621,1.59,BP
GO:0008585,female gonad development,113,1,0.63,0.47163,1,0.9343283491148621,1.59,BP
GO:0032612,interleukin-1 production,113,1,0.63,0.47163,1,0.9343283491148621,1.59,BP
GO:0050830,defense response to Gram-positive bacter...,113,1,0.63,0.47163,1,0.9343283491148621,1.59,BP
GO:0060078,regulation of postsynaptic membrane pote...,113,1,0.63,0.47163,1,0.9343283491148621,1.59,BP
GO:2000177,regulation of neural precursor cell prol...,113,1,0.63,0.47163,1,0.9343283491148621,1.59,BP
GO:0001892,embryonic placenta development,114,1,0.64,0.47461,1,0.9386861159062885,1.56,BP
GO:0006090,pyruvate metabolic process,114,1,0.64,0.47461,1,0.9386861159062885,1.56,BP
GO:0022037,metencephalon development,114,1,0.64,0.47461,1,0.9386861159062885,1.56,BP
GO:1904019,epithelial cell apoptotic process,114,1,0.64,0.47461,1,0.9386861159062885,1.56,BP
GO:0009165,nucleotide biosynthetic process,284,2,1.59,0.47516,1,0.9393878060805259,1.26,BP
GO:0016032,viral process,285,2,1.6,0.47699,1,0.942618431211499,1.25,BP
GO:0071901,negative regulation of protein serine/th...,115,1,0.65,0.47758,1,0.9433969458128079,1.54,BP
GO:0010927,cellular component assembly involved in ...,116,1,0.65,0.48052,1,0.9484258572600492,1.54,BP
GO:0046545,development of primary female sexual cha...,116,1,0.65,0.48052,1,0.9484258572600492,1.54,BP
GO:0044262,cellular carbohydrate metabolic process,288,2,1.62,0.48247,1,0.951496736196319,1.23,BP
GO:0003073,regulation of systemic arterial blood pr...,117,1,0.66,0.48346,1,0.951496736196319,1.52,BP
GO:0006282,regulation of DNA repair,117,1,0.66,0.48346,1,0.951496736196319,1.52,BP
GO:0009132,nucleoside diphosphate metabolic process,117,1,0.66,0.48346,1,0.951496736196319,1.52,BP
GO:0043534,blood vessel endothelial cell migration,117,1,0.66,0.48346,1,0.951496736196319,1.52,BP
GO:0060349,bone morphogenesis,117,1,0.66,0.48346,1,0.951496736196319,1.52,BP
GO:0090305,nucleic acid phosphodiester bond hydroly...,117,1,0.66,0.48346,1,0.951496736196319,1.52,BP
GO:0071496,cellular response to external stimulus,290,2,1.63,0.48610,1,0.9537917359413204,1.23,BP
GO:1901293,nucleoside phosphate biosynthetic proces...,290,2,1.63,0.48610,1,0.9537917359413204,1.23,BP
GO:0003008,system process,2937,17,16.49,0.48627,1,0.9537917359413204,1.03,BP
GO:0002040,sprouting angiogenesis,118,1,0.66,0.48637,1,0.9537917359413204,1.52,BP
GO:0005976,polysaccharide metabolic process,118,1,0.66,0.48637,1,0.9537917359413204,1.52,BP
GO:0014020,primary neural tube formation,118,1,0.66,0.48637,1,0.9537917359413204,1.52,BP
GO:0019751,polyol metabolic process,118,1,0.66,0.48637,1,0.9537917359413204,1.52,BP
GO:0042476,odontogenesis,118,1,0.66,0.48637,1,0.9537917359413204,1.52,BP
GO:0034660,ncRNA metabolic process,465,3,2.61,0.48641,1,0.9537917359413204,1.15,BP
GO:0051952,regulation of amine transport,119,1,0.67,0.48927,1,0.9582284249084249,1.49,BP
GO:0051963,regulation of synapse assembly,119,1,0.67,0.48927,1,0.9582284249084249,1.49,BP
GO:0071346,cellular response to interferon-gamma,119,1,0.67,0.48927,1,0.9582284249084249,1.49,BP
GO:0006936,muscle contraction,292,2,1.64,0.48972,1,0.958719544344996,1.22,BP
GO:0009416,response to light stimulus,293,2,1.65,0.49152,1,0.961852069947133,1.21,BP
GO:1901136,carbohydrate derivative catabolic proces...,120,1,0.67,0.49216,1,0.9627129756097561,1.49,BP
GO:1903037,regulation of leukocyte cell-cell adhesi...,294,2,1.65,0.49332,1,0.9645899390491669,1.21,BP
GO:0018022,peptidyl-lysine methylation,121,1,0.68,0.49503,1,0.967147527405603,1.47,BP
GO:1901216,positive regulation of neuron death,121,1,0.68,0.49503,1,0.967147527405603,1.47,BP
GO:0006888,ER to Golgi vesicle-mediated transport,122,1,0.69,0.49788,1,0.9707449594813614,1.45,BP
GO:0008584,male gonad development,122,1,0.69,0.49788,1,0.9707449594813614,1.45,BP
GO:0046717,acid secretion,122,1,0.69,0.49788,1,0.9707449594813614,1.45,BP
GO:0048565,digestive tract development,122,1,0.69,0.49788,1,0.9707449594813614,1.45,BP
GO:2000278,regulation of DNA biosynthetic process,122,1,0.69,0.49788,1,0.9707449594813614,1.45,BP
GO:1902105,regulation of leukocyte differentiation,298,2,1.67,0.50047,1,0.9723230508474576,1.2,BP
GO:0002377,immunoglobulin production,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0006639,acylglycerol metabolic process,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0006997,nucleus organization,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0007368,determination of left/right symmetry,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0015837,amine transport,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0032609,interferon-gamma production,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0046546,development of primary male sexual chara...,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0048284,organelle fusion,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:1900180,regulation of protein localization to nu...,123,1,0.69,0.50071,1,0.9723230508474576,1.45,BP
GO:0007586,digestion,124,1,0.7,0.50353,1,0.9770106290322582,1.43,BP
GO:0032434,regulation of proteasomal ubiquitin-depe...,124,1,0.7,0.50353,1,0.9770106290322582,1.43,BP
GO:0006638,neutral lipid metabolic process,125,1,0.7,0.50634,1,0.9816712651087832,1.43,BP
GO:0006665,sphingolipid metabolic process,125,1,0.7,0.50634,1,0.9816712651087832,1.43,BP
GO:0007631,feeding behavior,126,1,0.71,0.50912,1,0.9854828950542822,1.41,BP
GO:0016064,immunoglobulin mediated immune response,126,1,0.71,0.50912,1,0.9854828950542822,1.41,BP
GO:0006836,neurotransmitter transport,303,2,1.7,0.50933,1,0.9854828950542822,1.18,BP
GO:0046942,carboxylic acid transport,303,2,1.7,0.50933,1,0.9854828950542822,1.18,BP
GO:0060271,cilium assembly,303,2,1.7,0.50933,1,0.9854828950542822,1.18,BP
GO:0015849,organic acid transport,304,2,1.71,0.51108,1,0.9884714469453376,1.17,BP
GO:0002761,regulation of myeloid leukocyte differen...,127,1,0.71,0.51190,1,0.9888650341228423,1.41,BP
GO:0043280,positive regulation of cysteine-type end...,127,1,0.71,0.51190,1,0.9888650341228423,1.41,BP
GO:0099175,regulation of postsynapse organization,127,1,0.71,0.51190,1,0.9888650341228423,1.41,BP
GO:0031623,receptor internalization,128,1,0.72,0.51465,1,0.993379783393502,1.39,BP
GO:0050852,T cell receptor signaling pathway,128,1,0.72,0.51465,1,0.993379783393502,1.39,BP
GO:0003279,cardiac septum development,129,1,0.72,0.51740,1,0.9970880256307568,1.39,BP
GO:0048640,negative regulation of developmental gro...,129,1,0.72,0.51740,1,0.9970880256307568,1.39,BP
GO:0051092,positive regulation of NF-kappaB transcr...,129,1,0.72,0.51740,1,0.9970880256307568,1.39,BP
GO:0051592,response to calcium ion,129,1,0.72,0.51740,1,0.9970880256307568,1.39,BP
GO:0050863,regulation of T cell activation,309,2,1.73,0.51981,1,1,1.16,BP
GO:0019724,B cell mediated immunity,130,1,0.73,0.52012,1,1,1.37,BP
GO:0006955,immune response,1387,8,7.79,0.52116,1,1,1.03,BP
GO:0007189,adenylate cyclase-activating G protein-c...,131,1,0.74,0.52283,1,1,1.35,BP
GO:0001508,action potential,132,1,0.74,0.52553,1,1,1.35,BP
GO:0001936,regulation of endothelial cell prolifera...,132,1,0.74,0.52553,1,1,1.35,BP
GO:0009855,determination of bilateral symmetry,132,1,0.74,0.52553,1,1,1.35,BP
GO:1901568,fatty acid derivative metabolic process,132,1,0.74,0.52553,1,1,1.35,BP
GO:0001841,neural tube formation,133,1,0.75,0.52821,1,1,1.33,BP
GO:0002456,T cell mediated immunity,133,1,0.75,0.52821,1,1,1.33,BP
GO:0006754,ATP biosynthetic process,133,1,0.75,0.52821,1,1,1.33,BP
GO:0009799,specification of symmetry,133,1,0.75,0.52821,1,1,1.33,BP
GO:0042110,T cell activation,496,3,2.78,0.52969,1,1,1.08,BP
GO:0051928,positive regulation of calcium ion trans...,134,1,0.75,0.53088,1,1,1.33,BP
GO:0061025,membrane fusion,134,1,0.75,0.53088,1,1,1.33,BP
GO:0048729,tissue morphogenesis,679,4,3.81,0.53222,1,1,1.05,BP
GO:0001837,epithelial to mesenchymal transition,135,1,0.76,0.53353,1,1,1.32,BP
GO:0050905,neuromuscular process,135,1,0.76,0.53353,1,1,1.32,BP
GO:0055123,digestive system development,135,1,0.76,0.53353,1,1,1.32,BP
GO:0070646,protein modification by small protein re...,135,1,0.76,0.53353,1,1,1.32,BP
GO:0097306,cellular response to alcohol,135,1,0.76,0.53353,1,1,1.32,BP
GO:0002708,positive regulation of lymphocyte mediat...,136,1,0.76,0.53616,1,1,1.32,BP
GO:0002824,positive regulation of adaptive immune r...,136,1,0.76,0.53616,1,1,1.32,BP
GO:1903038,negative regulation of leukocyte cell-ce...,136,1,0.76,0.53616,1,1,1.32,BP
GO:0045598,regulation of fat cell differentiation,137,1,0.77,0.53878,1,1,1.3,BP
GO:0046928,regulation of neurotransmitter secretion,137,1,0.77,0.53878,1,1,1.3,BP
GO:0048593,camera-type eye morphogenesis,137,1,0.77,0.53878,1,1,1.3,BP
GO:1903364,positive regulation of cellular protein ...,137,1,0.77,0.53878,1,1,1.3,BP
GO:0002757,immune response-activating signal transd...,321,2,1.8,0.54035,1,1,1.11,BP
GO:0009411,response to UV,138,1,0.77,0.54139,1,1,1.3,BP
GO:0016571,histone methylation,138,1,0.77,0.54139,1,1,1.3,BP
GO:0030010,establishment of cell polarity,138,1,0.77,0.54139,1,1,1.3,BP
GO:0017158,regulation of calcium ion-dependent exoc...,139,1,0.78,0.54398,1,1,1.28,BP
GO:0002221,pattern recognition receptor signaling p...,140,1,0.79,0.54656,1,1,1.27,BP
GO:0016079,synaptic vesicle exocytosis,140,1,0.79,0.54656,1,1,1.27,BP
GO:0010821,regulation of mitochondrion organization,141,1,0.79,0.54912,1,1,1.27,BP
GO:0016052,carbohydrate catabolic process,141,1,0.79,0.54912,1,1,1.27,BP
GO:0034341,response to interferon-gamma,141,1,0.79,0.54912,1,1,1.27,BP
GO:0050729,positive regulation of inflammatory resp...,141,1,0.79,0.54912,1,1,1.27,BP
GO:0002758,innate immune response-activating signal...,142,1,0.8,0.55167,1,1,1.25,BP
GO:0055088,lipid homeostasis,142,1,0.8,0.55167,1,1,1.25,BP
GO:0007204,positive regulation of cytosolic calcium...,328,2,1.84,0.55204,1,1,1.09,BP
GO:0098655,cation transmembrane transport,698,4,3.92,0.55415,1,1,1.02,BP
GO:0002821,positive regulation of adaptive immune r...,143,1,0.8,0.55420,1,1,1.25,BP
GO:0009206,purine ribonucleoside triphosphate biosy...,143,1,0.8,0.55420,1,1,1.25,BP
GO:0072089,stem cell proliferation,143,1,0.8,0.55420,1,1,1.25,BP
GO:0006732,coenzyme metabolic process,330,2,1.85,0.55535,1,1,1.08,BP
GO:0046486,glycerolipid metabolic process,330,2,1.85,0.55535,1,1,1.08,BP
GO:0009145,purine nucleoside triphosphate biosynthe...,144,1,0.81,0.55672,1,1,1.23,BP
GO:0009267,cellular response to starvation,144,1,0.81,0.55672,1,1,1.23,BP
GO:0055007,cardiac muscle cell differentiation,144,1,0.81,0.55672,1,1,1.23,BP
GO:2001056,positive regulation of cysteine-type end...,144,1,0.81,0.55672,1,1,1.23,BP
GO:0044782,cilium organization,331,2,1.86,0.55699,1,1,1.08,BP
GO:0006869,lipid transport,332,2,1.86,0.55863,1,1,1.08,BP
GO:0030326,embryonic limb morphogenesis,145,1,0.81,0.55923,1,1,1.23,BP
GO:0035113,embryonic appendage morphogenesis,145,1,0.81,0.55923,1,1,1.23,BP
GO:0001935,endothelial cell proliferation,146,1,0.82,0.56172,1,1,1.22,BP
GO:0007224,smoothened signaling pathway,146,1,0.82,0.56172,1,1,1.22,BP
GO:0009201,ribonucleoside triphosphate biosynthetic...,146,1,0.82,0.56172,1,1,1.22,BP
GO:1903900,regulation of viral life cycle,146,1,0.82,0.56172,1,1,1.22,BP
GO:0002764,immune response-regulating signaling pat...,334,2,1.88,0.56190,1,1,1.06,BP
GO:0016482,cytosolic transport,147,1,0.83,0.56420,1,1,1.2,BP
GO:0045216,cell-cell junction organization,147,1,0.83,0.56420,1,1,1.2,BP
GO:0046660,female sex differentiation,147,1,0.83,0.56420,1,1,1.2,BP
GO:0009607,response to biotic stimulus,1076,6,6.04,0.56576,1,1,0.99,BP
GO:0045087,innate immune response,710,4,3.99,0.56772,1,1,1,BP
GO:0045862,positive regulation of proteolysis,339,2,1.9,0.57000,1,1,1.05,BP
GO:0002831,regulation of response to biotic stimulu...,150,1,0.84,0.57155,1,1,1.19,BP
GO:0022612,gland morphogenesis,151,1,0.85,0.57397,1,1,1.18,BP
GO:0045580,regulation of T cell differentiation,151,1,0.85,0.57397,1,1,1.18,BP
GO:0050728,negative regulation of inflammatory resp...,152,1,0.85,0.57638,1,1,1.18,BP
GO:0006606,protein import into nucleus,153,1,0.86,0.57878,1,1,1.16,BP
GO:0018205,peptidyl-lysine modification,345,2,1.94,0.57958,1,1,1.03,BP
GO:0006937,regulation of muscle contraction,154,1,0.86,0.58116,1,1,1.16,BP
GO:0009127,purine nucleoside monophosphate biosynth...,154,1,0.86,0.58116,1,1,1.16,BP
GO:0009168,purine ribonucleoside monophosphate bios...,154,1,0.86,0.58116,1,1,1.16,BP
GO:0046661,male sex differentiation,154,1,0.86,0.58116,1,1,1.16,BP
GO:0001838,embryonic epithelial tube formation,155,1,0.87,0.58353,1,1,1.15,BP
GO:0051053,negative regulation of DNA metabolic pro...,155,1,0.87,0.58353,1,1,1.15,BP
GO:0055085,transmembrane transport,1281,7,7.19,0.58444,1,1,0.97,BP
GO:0009142,nucleoside triphosphate biosynthetic pro...,156,1,0.88,0.58589,1,1,1.14,BP
GO:0046496,nicotinamide nucleotide metabolic proces...,156,1,0.88,0.58589,1,1,1.14,BP
GO:0021543,pallium development,157,1,0.88,0.58823,1,1,1.14,BP
GO:0045834,positive regulation of lipid metabolic p...,157,1,0.88,0.58823,1,1,1.14,BP
GO:0051170,import into nucleus,157,1,0.88,0.58823,1,1,1.14,BP
GO:0051896,regulation of protein kinase B signaling,157,1,0.88,0.58823,1,1,1.14,BP
GO:0001701,in utero embryonic development,542,3,3.04,0.59005,1,1,0.99,BP
GO:0019362,pyridine nucleotide metabolic process,158,1,0.89,0.59056,1,1,1.12,BP
GO:0098609,cell-cell adhesion,731,4,4.1,0.59093,1,1,0.98,BP
GO:0005975,carbohydrate metabolic process,545,3,3.06,0.59381,1,1,0.98,BP
GO:1903169,regulation of calcium ion transmembrane ...,160,1,0.9,0.59518,1,1,1.11,BP
GO:0006941,striated muscle contraction,161,1,0.9,0.59747,1,1,1.11,BP
GO:0010950,positive regulation of endopeptidase act...,161,1,0.9,0.59747,1,1,1.11,BP
GO:0071466,cellular response to xenobiotic stimulus,161,1,0.9,0.59747,1,1,1.11,BP
GO:0072175,epithelial tube formation,161,1,0.9,0.59747,1,1,1.11,BP
GO:0007283,spermatogenesis,549,3,3.08,0.59879,1,1,0.97,BP
GO:0007601,visual perception,162,1,0.91,0.59974,1,1,1.1,BP
GO:0051291,protein heterooligomerization,162,1,0.91,0.59974,1,1,1.1,BP
GO:2001236,regulation of extrinsic apoptotic signal...,162,1,0.91,0.59974,1,1,1.1,BP
GO:0030879,mammary gland development,163,1,0.92,0.60201,1,1,1.09,BP
GO:0030902,hindbrain development,163,1,0.92,0.60201,1,1,1.09,BP
GO:0031047,gene silencing by RNA,163,1,0.92,0.60201,1,1,1.09,BP
GO:0043901,negative regulation of multi-organism pr...,163,1,0.92,0.60201,1,1,1.09,BP
GO:0050851,antigen receptor-mediated signaling path...,163,1,0.92,0.60201,1,1,1.09,BP
GO:0072524,pyridine-containing compound metabolic p...,163,1,0.92,0.60201,1,1,1.09,BP
GO:0060041,retina development in camera-type eye,165,1,0.93,0.60650,1,1,1.08,BP
GO:0006643,membrane lipid metabolic process,166,1,0.93,0.60873,1,1,1.08,BP
GO:0007033,vacuole organization,166,1,0.93,0.60873,1,1,1.08,BP
GO:0007179,transforming growth factor beta receptor...,166,1,0.93,0.60873,1,1,1.08,BP
GO:0048660,regulation of smooth muscle cell prolife...,166,1,0.93,0.60873,1,1,1.08,BP
GO:0050953,sensory perception of light stimulus,166,1,0.93,0.60873,1,1,1.08,BP
GO:0042060,wound healing,365,2,2.05,0.61038,1,1,0.98,BP
GO:0002218,activation of innate immune response,167,1,0.94,0.61094,1,1,1.06,BP
GO:0042594,response to starvation,168,1,0.94,0.61314,1,1,1.06,BP
GO:0002252,immune effector process,752,4,4.22,0.61341,1,1,0.95,BP
GO:0002705,positive regulation of leukocyte mediate...,169,1,0.95,0.61533,1,1,1.05,BP
GO:0071897,DNA biosynthetic process,169,1,0.95,0.61533,1,1,1.05,BP
GO:0010952,positive regulation of peptidase activit...,170,1,0.95,0.61751,1,1,1.05,BP
GO:0030509,BMP signaling pathway,170,1,0.95,0.61751,1,1,1.05,BP
GO:0097164,ammonium ion metabolic process,170,1,0.95,0.61751,1,1,1.05,BP
GO:0048659,smooth muscle cell proliferation,171,1,0.96,0.61968,1,1,1.04,BP
GO:0010876,lipid localization,373,2,2.09,0.62222,1,1,0.96,BP
GO:0048232,male gamete generation,569,3,3.19,0.62311,1,1,0.94,BP
GO:0001890,placenta development,173,1,0.97,0.62397,1,1,1.03,BP
GO:0002521,leukocyte differentiation,570,3,3.2,0.62430,1,1,0.94,BP
GO:0031667,response to nutrient levels,375,2,2.11,0.62513,1,1,0.95,BP
GO:0051480,regulation of cytosolic calcium ion conc...,375,2,2.11,0.62513,1,1,0.95,BP
GO:0051100,negative regulation of binding,174,1,0.98,0.62610,1,1,1.02,BP
GO:1901654,response to ketone,174,1,0.98,0.62610,1,1,1.02,BP
GO:0006733,oxidoreduction coenzyme metabolic proces...,175,1,0.98,0.62821,1,1,1.02,BP
GO:0071230,cellular response to amino acid stimulus,175,1,0.98,0.62821,1,1,1.02,BP
GO:0001505,regulation of neurotransmitter levels,378,2,2.12,0.62947,1,1,0.94,BP
GO:0035148,tube formation,176,1,0.99,0.63032,1,1,1.01,BP
GO:0048592,eye morphogenesis,176,1,0.99,0.63032,1,1,1.01,BP
GO:0006479,protein methylation,177,1,0.99,0.63241,1,1,1.01,BP
GO:0008213,protein alkylation,177,1,0.99,0.63241,1,1,1.01,BP
GO:0043902,positive regulation of multi-organism pr...,177,1,0.99,0.63241,1,1,1.01,BP
GO:0017156,calcium ion regulated exocytosis,178,1,1,0.63449,1,1,1,BP
GO:0007219,Notch signaling pathway,179,1,1.01,0.63656,1,1,0.99,BP
GO:0010951,negative regulation of endopeptidase act...,179,1,1.01,0.63656,1,1,0.99,BP
GO:0071772,response to BMP,181,1,1.02,0.64067,1,1,0.98,BP
GO:0071773,cellular response to BMP stimulus,181,1,1.02,0.64067,1,1,0.98,BP
GO:1903034,regulation of response to wounding,182,1,1.02,0.64270,1,1,0.98,BP
GO:0001775,cell activation,973,5,5.46,0.64278,1,1,0.92,BP
GO:0009612,response to mechanical stimulus,183,1,1.03,0.64473,1,1,0.97,BP
GO:0035051,cardiocyte differentiation,183,1,1.03,0.64473,1,1,0.97,BP
GO:0016331,morphogenesis of embryonic epithelium,184,1,1.03,0.64674,1,1,0.97,BP
GO:0045619,regulation of lymphocyte differentiation,184,1,1.03,0.64674,1,1,0.97,BP
GO:0050792,regulation of viral process,184,1,1.03,0.64674,1,1,0.97,BP
GO:0002822,regulation of adaptive immune response b...,185,1,1.04,0.64874,1,1,0.96,BP
GO:0045766,positive regulation of angiogenesis,185,1,1.04,0.64874,1,1,0.96,BP
GO:0043900,regulation of multi-organism process,393,2,2.21,0.65060,1,1,0.9,BP
GO:0048754,branching morphogenesis of an epithelial...,186,1,1.04,0.65073,1,1,0.96,BP
GO:0002706,regulation of lymphocyte mediated immuni...,187,1,1.05,0.65271,1,1,0.95,BP
GO:0006914,autophagy,395,2,2.22,0.65334,1,1,0.9,BP
GO:0061919,process utilizing autophagic mechanism,395,2,2.22,0.65334,1,1,0.9,BP
GO:0030534,adult behavior,188,1,1.06,0.65467,1,1,0.94,BP
GO:0043200,response to amino acid,188,1,1.06,0.65467,1,1,0.94,BP
GO:0002253,activation of immune response,396,2,2.22,0.65471,1,1,0.9,BP
GO:0030098,lymphocyte differentiation,396,2,2.22,0.65471,1,1,0.9,BP
GO:0007269,neurotransmitter secretion,189,1,1.06,0.65663,1,1,0.94,BP
GO:0050870,positive regulation of T cell activation,189,1,1.06,0.65663,1,1,0.94,BP
GO:1903305,regulation of regulated secretory pathwa...,189,1,1.06,0.65663,1,1,0.94,BP
GO:0043491,protein kinase B signaling,190,1,1.07,0.65858,1,1,0.93,BP
GO:0099643,signal release from synapse,190,1,1.07,0.65858,1,1,0.93,BP
GO:1901137,carbohydrate derivative biosynthetic pro...,600,3,3.37,0.65881,1,1,0.89,BP
GO:0050773,regulation of dendrite development,192,1,1.08,0.66243,1,1,0.93,BP
GO:0071695,anatomical structure maturation,192,1,1.08,0.66243,1,1,0.93,BP
GO:0021915,neural tube development,193,1,1.08,0.66435,1,1,0.93,BP
GO:0022408,negative regulation of cell-cell adhesio...,193,1,1.08,0.66435,1,1,0.93,BP
GO:0055002,striated muscle cell development,193,1,1.08,0.66435,1,1,0.93,BP
GO:0002429,immune response-activating cell surface ...,194,1,1.09,0.66625,1,1,0.92,BP
GO:0071804,cellular potassium ion transport,194,1,1.09,0.66625,1,1,0.92,BP
GO:0071805,potassium ion transmembrane transport,194,1,1.09,0.66625,1,1,0.92,BP
GO:0009991,response to extracellular stimulus,405,2,2.27,0.66681,1,1,0.88,BP
GO:0022407,regulation of cell-cell adhesion,405,2,2.27,0.66681,1,1,0.88,BP
GO:0002285,lymphocyte activation involved in immune...,195,1,1.09,0.66814,1,1,0.92,BP
GO:0031669,cellular response to nutrient levels,195,1,1.09,0.66814,1,1,0.92,BP
GO:0003205,cardiac chamber development,196,1,1.1,0.67002,1,1,0.91,BP
GO:0016051,carbohydrate biosynthetic process,196,1,1.1,0.67002,1,1,0.91,BP
GO:0050731,positive regulation of peptidyl-tyrosine...,196,1,1.1,0.67002,1,1,0.91,BP
GO:0006811,ion transport,1581,8,8.88,0.67093,1,1,0.9,BP
GO:1903706,regulation of hemopoiesis,410,2,2.3,0.67339,1,1,0.87,BP
GO:1901605,alpha-amino acid metabolic process,198,1,1.11,0.67375,1,1,0.9,BP
GO:0006486,protein glycosylation,199,1,1.12,0.67560,1,1,0.89,BP
GO:0016236,macroautophagy,199,1,1.12,0.67560,1,1,0.89,BP
GO:0043413,macromolecule glycosylation,199,1,1.12,0.67560,1,1,0.89,BP
GO:0043903,"regulation of symbiosis, encompassing mu...",199,1,1.12,0.67560,1,1,0.89,BP
GO:0044242,cellular lipid catabolic process,199,1,1.12,0.67560,1,1,0.89,BP
GO:0002819,regulation of adaptive immune response,201,1,1.13,0.67927,1,1,0.88,BP
GO:0019058,viral life cycle,201,1,1.13,0.67927,1,1,0.88,BP
GO:0098662,inorganic cation transmembrane transport,621,3,3.49,0.68159,1,1,0.86,BP
GO:0006959,humoral immune response,204,1,1.15,0.68469,1,1,0.87,BP
GO:1904018,positive regulation of vasculature devel...,204,1,1.15,0.68469,1,1,0.87,BP
GO:0015711,organic anion transport,420,2,2.36,0.68623,1,1,0.85,BP
GO:0098742,cell-cell adhesion via plasma-membrane a...,205,1,1.15,0.68648,1,1,0.87,BP
GO:1903039,positive regulation of leukocyte cell-ce...,205,1,1.15,0.68648,1,1,0.87,BP
GO:0002768,immune response-regulating cell surface ...,206,1,1.16,0.68825,1,1,0.86,BP
GO:0071560,cellular response to transforming growth...,206,1,1.16,0.68825,1,1,0.86,BP
GO:0022412,cellular process involved in reproductio...,423,2,2.38,0.69000,1,1,0.84,BP
GO:0043112,receptor metabolic process,207,1,1.16,0.69002,1,1,0.86,BP
GO:0055001,muscle cell development,207,1,1.16,0.69002,1,1,0.86,BP
GO:0051216,cartilage development,210,1,1.18,0.69527,1,1,0.85,BP
GO:0007623,circadian rhythm,211,1,1.18,0.69699,1,1,0.85,BP
GO:0051249,regulation of lymphocyte activation,430,2,2.41,0.69865,1,1,0.83,BP
GO:2000027,regulation of animal organ morphogenesis,212,1,1.19,0.69871,1,1,0.84,BP
GO:2001020,regulation of response to DNA damage sti...,212,1,1.19,0.69871,1,1,0.84,BP
GO:0070085,glycosylation,213,1,1.2,0.70042,1,1,0.83,BP
GO:0045637,regulation of myeloid cell differentiati...,216,1,1.21,0.70549,1,1,0.83,BP
GO:0030001,metal ion transport,848,4,4.76,0.70615,1,1,0.84,BP
GO:0002440,production of molecular mediator of immu...,218,1,1.22,0.70882,1,1,0.82,BP
GO:0006302,double-strand break repair,218,1,1.22,0.70882,1,1,0.82,BP
GO:0002250,adaptive immune response,439,2,2.46,0.70949,1,1,0.81,BP
GO:0009152,purine ribonucleotide biosynthetic proce...,219,1,1.23,0.71047,1,1,0.81,BP
GO:0042445,hormone metabolic process,219,1,1.23,0.71047,1,1,0.81,BP
GO:0031347,regulation of defense response,650,3,3.65,0.71118,1,1,0.82,BP
GO:0031348,negative regulation of defense response,223,1,1.25,0.71699,1,1,0.8,BP
GO:0061138,morphogenesis of a branching epithelium,223,1,1.25,0.71699,1,1,0.8,BP
GO:0031668,cellular response to extracellular stimu...,224,1,1.26,0.71859,1,1,0.79,BP
GO:0045321,leukocyte activation,866,4,4.86,0.72165,1,1,0.82,BP
GO:0098660,inorganic ion transmembrane transport,664,3,3.73,0.72471,1,1,0.8,BP
GO:0006650,glycerophospholipid metabolic process,229,1,1.29,0.72649,1,1,0.78,BP
GO:0097191,extrinsic apoptotic signaling pathway,231,1,1.3,0.72959,1,1,0.77,BP
GO:0015672,monovalent inorganic cation transport,459,2,2.58,0.73242,1,1,0.78,BP
GO:0045089,positive regulation of innate immune res...,235,1,1.32,0.73567,1,1,0.76,BP
GO:0009410,response to xenobiotic stimulus,236,1,1.33,0.73718,1,1,0.75,BP
GO:0051607,defense response to virus,236,1,1.33,0.73718,1,1,0.75,BP
GO:0034220,ion transmembrane transport,887,4,4.98,0.73896,1,1,0.8,BP
GO:0006164,purine nucleotide biosynthetic process,238,1,1.34,0.74015,1,1,0.75,BP
GO:0048732,gland development,467,2,2.62,0.74115,1,1,0.76,BP
GO:0045444,fat cell differentiation,241,1,1.35,0.74455,1,1,0.74,BP
GO:0001763,morphogenesis of a branching structure,242,1,1.36,0.74600,1,1,0.74,BP
GO:0002703,regulation of leukocyte mediated immunit...,243,1,1.36,0.74745,1,1,0.74,BP
GO:0072522,purine-containing compound biosynthetic ...,243,1,1.36,0.74745,1,1,0.74,BP
GO:0022409,positive regulation of cell-cell adhesio...,246,1,1.38,0.75173,1,1,0.72,BP
GO:0017157,regulation of exocytosis,247,1,1.39,0.75314,1,1,0.72,BP
GO:0021537,telencephalon development,249,1,1.4,0.75593,1,1,0.71,BP
GO:0002699,positive regulation of immune effector p...,253,1,1.42,0.76143,1,1,0.7,BP
GO:0060291,long-term synaptic potentiation,253,1,1.42,0.76143,1,1,0.7,BP
GO:0045055,regulated exocytosis,258,1,1.45,0.76814,1,1,0.69,BP
GO:0046649,lymphocyte activation,714,3,4.01,0.76903,1,1,0.75,BP
GO:0016458,gene silencing,261,1,1.47,0.77207,1,1,0.68,BP
GO:0051251,positive regulation of lymphocyte activa...,265,1,1.49,0.77721,1,1,0.67,BP
GO:0002682,regulation of immune system process,1351,6,7.59,0.77758,1,1,0.79,BP
GO:0006520,cellular amino acid metabolic process,266,1,1.49,0.77847,1,1,0.67,BP
GO:0090407,organophosphate biosynthetic process,505,2,2.84,0.77942,1,1,0.7,BP
GO:0002684,positive regulation of immune system pro...,942,4,5.29,0.78049,1,1,0.76,BP
GO:0002366,leukocyte activation involved in immune ...,272,1,1.53,0.78593,1,1,0.65,BP
GO:0051924,regulation of calcium ion transport,273,1,1.53,0.78714,1,1,0.65,BP
GO:0071222,cellular response to lipopolysaccharide,273,1,1.53,0.78714,1,1,0.65,BP
GO:0090287,regulation of cellular response to growt...,274,1,1.54,0.78835,1,1,0.65,BP
GO:0009615,response to virus,278,1,1.56,0.79313,1,1,0.64,BP
GO:0042113,B cell activation,278,1,1.56,0.79313,1,1,0.64,BP
GO:0009101,glycoprotein biosynthetic process,281,1,1.58,0.79664,1,1,0.63,BP
GO:0042742,defense response to bacterium,281,1,1.58,0.79664,1,1,0.63,BP
GO:0071219,cellular response to molecule of bacteri...,281,1,1.58,0.79664,1,1,0.63,BP
GO:0006310,DNA recombination,282,1,1.58,0.79780,1,1,0.63,BP
GO:0070588,calcium ion transmembrane transport,283,1,1.59,0.79895,1,1,0.63,BP
GO:0061448,connective tissue development,284,1,1.59,0.80009,1,1,0.63,BP
GO:0002694,regulation of leukocyte activation,528,2,2.96,0.80012,1,1,0.68,BP
GO:0098542,defense response to other organism,529,2,2.97,0.80098,1,1,0.67,BP
GO:0043414,macromolecule methylation,285,1,1.6,0.80123,1,1,0.62,BP
GO:0002449,lymphocyte mediated immunity,287,1,1.61,0.80349,1,1,0.62,BP
GO:0048511,rhythmic process,296,1,1.66,0.81333,1,1,0.6,BP
GO:0045088,regulation of innate immune response,297,1,1.67,0.81439,1,1,0.6,BP
GO:0006820,anion transport,555,2,3.12,0.82222,1,1,0.64,BP
GO:0002460,adaptive immune response based on somati...,305,1,1.71,0.82268,1,1,0.58,BP
GO:0016042,lipid catabolic process,307,1,1.72,0.82470,1,1,0.58,BP
GO:0046651,lymphocyte proliferation,313,1,1.76,0.83061,1,1,0.57,BP
GO:0044282,small molecule catabolic process,314,1,1.76,0.83157,1,1,0.57,BP
GO:0032943,mononuclear cell proliferation,315,1,1.77,0.83253,1,1,0.56,BP
GO:0050865,regulation of cell activation,570,2,3.2,0.83354,1,1,0.62,BP
GO:0002696,positive regulation of leukocyte activat...,318,1,1.79,0.83538,1,1,0.56,BP
GO:0007281,germ cell development,326,1,1.83,0.84274,1,1,0.55,BP
GO:1990823,response to leukemia inhibitory factor,328,1,1.84,0.84453,1,1,0.54,BP
GO:1990830,cellular response to leukemia inhibitory...,328,1,1.84,0.84453,1,1,0.54,BP
GO:0050867,positive regulation of cell activation,334,1,1.88,0.84977,1,1,0.53,BP
GO:0032259,methylation,339,1,1.9,0.85401,1,1,0.53,BP
GO:0070661,leukocyte proliferation,339,1,1.9,0.85401,1,1,0.53,BP
GO:0009100,glycoprotein metabolic process,341,1,1.91,0.85567,1,1,0.52,BP
GO:0032102,negative regulation of response to exter...,341,1,1.91,0.85567,1,1,0.52,BP
GO:0019221,cytokine-mediated signaling pathway,342,1,1.92,0.85649,1,1,0.52,BP
GO:0050878,regulation of body fluid levels,345,1,1.94,0.85894,1,1,0.52,BP
GO:0032496,response to lipopolysaccharide,349,1,1.96,0.86213,1,1,0.51,BP
GO:0006644,phospholipid metabolic process,352,1,1.98,0.86448,1,1,0.51,BP
GO:0050778,positive regulation of immune response,617,2,3.46,0.86495,1,1,0.58,BP
GO:0002237,response to molecule of bacterial origin,367,1,2.06,0.87564,1,1,0.49,BP
GO:0002443,leukocyte mediated immunity,372,1,2.09,0.87915,1,1,0.48,BP
GO:0031349,positive regulation of defense response,372,1,2.09,0.87915,1,1,0.48,BP
GO:0006887,exocytosis,377,1,2.12,0.88256,1,1,0.47,BP
GO:0002697,regulation of immune effector process,414,1,2.32,0.90503,1,1,0.43,BP
GO:0006816,calcium ion transport,427,1,2.4,0.91186,1,1,0.42,BP
GO:0009617,response to bacterium,769,2,4.32,0.93311,1,1,0.46,BP
GO:0070838,divalent metal ion transport,477,1,2.68,0.93390,1,1,0.37,BP
GO:0072511,divalent inorganic cation transport,480,1,2.7,0.93503,1,1,0.37,BP
GO:0050776,regulation of immune response,777,2,4.36,0.93560,1,1,0.46,BP
GO:0051707,response to other organism,1040,3,5.84,0.93567,1,1,0.51,BP
GO:0043207,response to external biotic stimulus,1042,3,5.85,0.93621,1,1,0.51,BP
GO:0050877,nervous system process,2290,8,12.86,0.95181,1,1,0.62,BP
GO:0007186,G protein-coupled receptor signaling pat...,1902,6,10.68,0.96176,1,1,0.56,BP
GO:0007600,sensory perception,1781,5,10,0.97571,1,1,0.5,BP
GO:0008150,biological_process,21194,119,119,1.00000,1,1,1,BP
GO:0000002,mitochondrial genome maintenance,34,0,0.19,1.00000,1,1,0,BP
GO:0000018,regulation of DNA recombination,105,0,0.59,1.00000,1,1,0,BP
GO:0000038,very long-chain fatty acid metabolic pro...,30,0,0.17,1.00000,1,1,0,BP
GO:0000096,sulfur amino acid metabolic process,38,0,0.21,1.00000,1,1,0,BP
GO:0000132,establishment of mitotic spindle orienta...,30,0,0.17,1.00000,1,1,0,BP
GO:0000154,rRNA modification,25,0,0.14,1.00000,1,1,0,BP
GO:0000186,activation of MAPKK activity,34,0,0.19,1.00000,1,1,0,BP
GO:0000272,polysaccharide catabolic process,25,0,0.14,1.00000,1,1,0,BP
GO:0000380,"alternative mRNA splicing, via spliceoso...",77,0,0.43,1.00000,1,1,0,BP
GO:0000381,"regulation of alternative mRNA splicing,...",65,0,0.36,1.00000,1,1,0,BP
GO:0000387,spliceosomal snRNP assembly,31,0,0.17,1.00000,1,1,0,BP
GO:0000413,protein peptidyl-prolyl isomerization,21,0,0.12,1.00000,1,1,0,BP
GO:0000470,maturation of LSU-rRNA,22,0,0.12,1.00000,1,1,0,BP
GO:0000578,embryonic axis specification,38,0,0.21,1.00000,1,1,0,BP
GO:0000724,double-strand break repair via homologou...,126,0,0.71,1.00000,1,1,0,BP
GO:0000725,recombinational repair,126,0,0.71,1.00000,1,1,0,BP
GO:0000726,non-recombinational repair,57,0,0.32,1.00000,1,1,0,BP
GO:0000731,DNA synthesis involved in DNA repair,28,0,0.16,1.00000,1,1,0,BP
GO:0000737,"DNA catabolic process, endonucleolytic",26,0,0.15,1.00000,1,1,0,BP
GO:0000768,syncytium formation by plasma membrane f...,69,0,0.39,1.00000,1,1,0,BP
GO:0000959,mitochondrial RNA metabolic process,42,0,0.24,1.00000,1,1,0,BP
GO:0001510,RNA methylation,64,0,0.36,1.00000,1,1,0,BP
GO:0001516,prostaglandin biosynthetic process,25,0,0.14,1.00000,1,1,0,BP
GO:0001523,retinoid metabolic process,55,0,0.31,1.00000,1,1,0,BP
GO:0001539,cilium or flagellum-dependent cell motil...,35,0,0.2,1.00000,1,1,0,BP
GO:0001556,oocyte maturation,30,0,0.17,1.00000,1,1,0,BP
GO:0001562,response to protozoan,37,0,0.21,1.00000,1,1,0,BP
GO:0001569,branching involved in blood vessel morph...,44,0,0.25,1.00000,1,1,0,BP
GO:0001573,ganglioside metabolic process,20,0,0.11,1.00000,1,1,0,BP
GO:0001580,detection of chemical stimulus involved ...,48,0,0.27,1.00000,1,1,0,BP
GO:0001657,ureteric bud development,104,0,0.58,1.00000,1,1,0,BP
GO:0001658,branching involved in ureteric bud morph...,64,0,0.36,1.00000,1,1,0,BP
GO:0001696,gastric acid secretion,20,0,0.11,1.00000,1,1,0,BP
GO:0001704,formation of primary germ layer,95,0,0.53,1.00000,1,1,0,BP
GO:0001706,endoderm formation,33,0,0.19,1.00000,1,1,0,BP
GO:0001707,mesoderm formation,65,0,0.36,1.00000,1,1,0,BP
GO:0001709,cell fate determination,42,0,0.24,1.00000,1,1,0,BP
GO:0001736,establishment of planar polarity,61,0,0.34,1.00000,1,1,0,BP
GO:0001738,morphogenesis of a polarized epithelium,82,0,0.46,1.00000,1,1,0,BP
GO:0001754,eye photoreceptor cell differentiation,58,0,0.33,1.00000,1,1,0,BP
GO:0001759,organ induction,28,0,0.16,1.00000,1,1,0,BP
GO:0001764,neuron migration,187,0,1.05,1.00000,1,1,0,BP
GO:0001773,myeloid dendritic cell activation,33,0,0.19,1.00000,1,1,0,BP
GO:0001776,leukocyte homeostasis,110,0,0.62,1.00000,1,1,0,BP
GO:0001779,natural killer cell differentiation,31,0,0.17,1.00000,1,1,0,BP
GO:0001780,neutrophil homeostasis,22,0,0.12,1.00000,1,1,0,BP
GO:0001782,B cell homeostasis,37,0,0.21,1.00000,1,1,0,BP
GO:0001783,B cell apoptotic process,41,0,0.23,1.00000,1,1,0,BP
GO:0001818,negative regulation of cytokine producti...,263,0,1.48,1.00000,1,1,0,BP
GO:0001823,mesonephros development,107,0,0.6,1.00000,1,1,0,BP
GO:0001824,blastocyst development,153,0,0.86,1.00000,1,1,0,BP
GO:0001825,blastocyst formation,60,0,0.34,1.00000,1,1,0,BP
GO:0001829,trophectodermal cell differentiation,25,0,0.14,1.00000,1,1,0,BP
GO:0001832,blastocyst growth,31,0,0.17,1.00000,1,1,0,BP
GO:0001835,blastocyst hatching,40,0,0.22,1.00000,1,1,0,BP
GO:0001881,receptor recycling,40,0,0.22,1.00000,1,1,0,BP
GO:0001889,liver development,122,0,0.69,1.00000,1,1,0,BP
GO:0001893,maternal placenta development,32,0,0.18,1.00000,1,1,0,BP
GO:0001906,cell killing,172,0,0.97,1.00000,1,1,0,BP
GO:0001909,leukocyte mediated cytotoxicity,135,0,0.76,1.00000,1,1,0,BP
GO:0001910,regulation of leukocyte mediated cytotox...,103,0,0.58,1.00000,1,1,0,BP
GO:0001911,negative regulation of leukocyte mediate...,23,0,0.13,1.00000,1,1,0,BP
GO:0001912,positive regulation of leukocyte mediate...,80,0,0.45,1.00000,1,1,0,BP
GO:0001913,T cell mediated cytotoxicity,71,0,0.4,1.00000,1,1,0,BP
GO:0001914,regulation of T cell mediated cytotoxici...,51,0,0.29,1.00000,1,1,0,BP
GO:0001916,positive regulation of T cell mediated c...,46,0,0.26,1.00000,1,1,0,BP
GO:0001919,regulation of receptor recycling,29,0,0.16,1.00000,1,1,0,BP
GO:0001938,positive regulation of endothelial cell ...,92,0,0.52,1.00000,1,1,0,BP
GO:0001945,lymph vessel development,29,0,0.16,1.00000,1,1,0,BP
GO:0001946,lymphangiogenesis,21,0,0.12,1.00000,1,1,0,BP
GO:0001947,heart looping,60,0,0.34,1.00000,1,1,0,BP
GO:0001956,positive regulation of neurotransmitter ...,26,0,0.15,1.00000,1,1,0,BP
GO:0001958,endochondral ossification,30,0,0.17,1.00000,1,1,0,BP
GO:0001959,regulation of cytokine-mediated signalin...,112,0,0.63,1.00000,1,1,0,BP
GO:0001960,negative regulation of cytokine-mediated...,52,0,0.29,1.00000,1,1,0,BP
GO:0001961,positive regulation of cytokine-mediated...,49,0,0.28,1.00000,1,1,0,BP
GO:0001964,startle response,32,0,0.18,1.00000,1,1,0,BP
GO:0001976,neurological system process involved in ...,21,0,0.12,1.00000,1,1,0,BP
GO:0001990,regulation of systemic arterial blood pr...,46,0,0.26,1.00000,1,1,0,BP
GO:0002021,response to dietary excess,34,0,0.19,1.00000,1,1,0,BP
GO:0002026,regulation of the force of heart contrac...,31,0,0.17,1.00000,1,1,0,BP
GO:0002029,desensitization of G protein-coupled rec...,28,0,0.16,1.00000,1,1,0,BP
GO:0002042,cell migration involved in sprouting ang...,57,0,0.32,1.00000,1,1,0,BP
GO:0002052,positive regulation of neuroblast prolif...,27,0,0.15,1.00000,1,1,0,BP
GO:0002053,positive regulation of mesenchymal cell ...,37,0,0.21,1.00000,1,1,0,BP
GO:0002062,chondrocyte differentiation,119,0,0.67,1.00000,1,1,0,BP
GO:0002063,chondrocyte development,45,0,0.25,1.00000,1,1,0,BP
GO:0002067,glandular epithelial cell differentiatio...,59,0,0.33,1.00000,1,1,0,BP
GO:0002068,glandular epithelial cell development,28,0,0.16,1.00000,1,1,0,BP
GO:0002076,osteoblast development,20,0,0.11,1.00000,1,1,0,BP
GO:0002089,lens morphogenesis in camera-type eye,28,0,0.16,1.00000,1,1,0,BP
GO:0002090,regulation of receptor internalization,70,0,0.39,1.00000,1,1,0,BP
GO:0002092,positive regulation of receptor internal...,29,0,0.16,1.00000,1,1,0,BP
GO:0002097,tRNA wobble base modification,21,0,0.12,1.00000,1,1,0,BP
GO:0002115,store-operated calcium entry,22,0,0.12,1.00000,1,1,0,BP
GO:0002228,natural killer cell mediated immunity,63,0,0.35,1.00000,1,1,0,BP
GO:0002230,positive regulation of defense response ...,31,0,0.17,1.00000,1,1,0,BP
GO:0002244,hematopoietic progenitor cell differenti...,158,0,0.89,1.00000,1,1,0,BP
GO:0002260,lymphocyte homeostasis,78,0,0.44,1.00000,1,1,0,BP
GO:0002275,myeloid cell activation involved in immu...,86,0,0.48,1.00000,1,1,0,BP
GO:0002279,mast cell activation involved in immune ...,49,0,0.28,1.00000,1,1,0,BP
GO:0002286,T cell activation involved in immune res...,113,0,0.63,1.00000,1,1,0,BP
GO:0002287,alpha-beta T cell activation involved in...,66,0,0.37,1.00000,1,1,0,BP
GO:0002292,T cell differentiation involved in immun...,71,0,0.4,1.00000,1,1,0,BP
GO:0002293,alpha-beta T cell differentiation involv...,65,0,0.36,1.00000,1,1,0,BP
GO:0002294,"CD4-positive, alpha-beta T cell differen...",64,0,0.36,1.00000,1,1,0,BP
GO:0002313,mature B cell differentiation involved i...,20,0,0.11,1.00000,1,1,0,BP
GO:0002320,lymphoid progenitor cell differentiation,23,0,0.13,1.00000,1,1,0,BP
GO:0002323,natural killer cell activation involved ...,39,0,0.22,1.00000,1,1,0,BP
GO:0002335,mature B cell differentiation,27,0,0.15,1.00000,1,1,0,BP
GO:0002360,T cell lineage commitment,28,0,0.16,1.00000,1,1,0,BP
GO:0002369,T cell cytokine production,40,0,0.22,1.00000,1,1,0,BP
GO:0002374,cytokine secretion involved in immune re...,24,0,0.13,1.00000,1,1,0,BP
GO:0002428,antigen processing and presentation of p...,31,0,0.17,1.00000,1,1,0,BP
GO:0002437,inflammatory response to antigenic stimu...,58,0,0.33,1.00000,1,1,0,BP
GO:0002438,acute inflammatory response to antigenic...,25,0,0.14,1.00000,1,1,0,BP
GO:0002444,myeloid leukocyte mediated immunity,95,0,0.53,1.00000,1,1,0,BP
GO:0002446,neutrophil mediated immunity,34,0,0.19,1.00000,1,1,0,BP
GO:0002448,mast cell mediated immunity,49,0,0.28,1.00000,1,1,0,BP
GO:0002455,humoral immune response mediated by circ...,44,0,0.25,1.00000,1,1,0,BP
GO:0002475,antigen processing and presentation via ...,35,0,0.2,1.00000,1,1,0,BP
GO:0002476,antigen processing and presentation of e...,30,0,0.17,1.00000,1,1,0,BP
GO:0002478,antigen processing and presentation of e...,26,0,0.15,1.00000,1,1,0,BP
GO:0002483,antigen processing and presentation of e...,37,0,0.21,1.00000,1,1,0,BP
GO:0002484,antigen processing and presentation of e...,30,0,0.17,1.00000,1,1,0,BP
GO:0002486,antigen processing and presentation of e...,29,0,0.16,1.00000,1,1,0,BP
GO:0002507,tolerance induction,28,0,0.16,1.00000,1,1,0,BP
GO:0002523,leukocyte migration involved in inflamma...,20,0,0.11,1.00000,1,1,0,BP
GO:0002526,acute inflammatory response,119,0,0.67,1.00000,1,1,0,BP
GO:0002532,production of molecular mediator involve...,74,0,0.42,1.00000,1,1,0,BP
GO:0002534,cytokine production involved in inflamma...,45,0,0.25,1.00000,1,1,0,BP
GO:0002548,monocyte chemotaxis,54,0,0.3,1.00000,1,1,0,BP
GO:0002577,regulation of antigen processing and pre...,21,0,0.12,1.00000,1,1,0,BP
GO:0002637,regulation of immunoglobulin production,75,0,0.42,1.00000,1,1,0,BP
GO:0002639,positive regulation of immunoglobulin pr...,50,0,0.28,1.00000,1,1,0,BP
GO:0002673,regulation of acute inflammatory respons...,63,0,0.35,1.00000,1,1,0,BP
GO:0002675,positive regulation of acute inflammator...,32,0,0.18,1.00000,1,1,0,BP
GO:0002683,negative regulation of immune system pro...,478,0,2.68,1.00000,1,1,0,BP
GO:0002686,negative regulation of leukocyte migrati...,40,0,0.22,1.00000,1,1,0,BP
GO:0002691,regulation of cellular extravasation,32,0,0.18,1.00000,1,1,0,BP
GO:0002693,positive regulation of cellular extravas...,23,0,0.13,1.00000,1,1,0,BP
GO:0002695,negative regulation of leukocyte activat...,187,0,1.05,1.00000,1,1,0,BP
GO:0002698,negative regulation of immune effector p...,134,0,0.75,1.00000,1,1,0,BP
GO:0002700,regulation of production of molecular me...,150,0,0.84,1.00000,1,1,0,BP
GO:0002701,negative regulation of production of mol...,35,0,0.2,1.00000,1,1,0,BP
GO:0002702,positive regulation of production of mol...,103,0,0.58,1.00000,1,1,0,BP
GO:0002704,negative regulation of leukocyte mediate...,56,0,0.31,1.00000,1,1,0,BP
GO:0002707,negative regulation of lymphocyte mediat...,46,0,0.26,1.00000,1,1,0,BP
GO:0002712,regulation of B cell mediated immunity,61,0,0.34,1.00000,1,1,0,BP
GO:0002714,positive regulation of B cell mediated i...,46,0,0.26,1.00000,1,1,0,BP
GO:0002715,regulation of natural killer cell mediat...,51,0,0.29,1.00000,1,1,0,BP
GO:0002716,negative regulation of natural killer ce...,20,0,0.11,1.00000,1,1,0,BP
GO:0002717,positive regulation of natural killer ce...,34,0,0.19,1.00000,1,1,0,BP
GO:0002718,regulation of cytokine production involv...,82,0,0.46,1.00000,1,1,0,BP
GO:0002719,negative regulation of cytokine producti...,23,0,0.13,1.00000,1,1,0,BP
GO:0002720,positive regulation of cytokine producti...,53,0,0.3,1.00000,1,1,0,BP
GO:0002724,regulation of T cell cytokine production,30,0,0.17,1.00000,1,1,0,BP
GO:0002753,cytoplasmic pattern recognition receptor...,38,0,0.21,1.00000,1,1,0,BP
GO:0002762,negative regulation of myeloid leukocyte...,48,0,0.27,1.00000,1,1,0,BP
GO:0002763,positive regulation of myeloid leukocyte...,65,0,0.36,1.00000,1,1,0,BP
GO:0002820,negative regulation of adaptive immune r...,47,0,0.26,1.00000,1,1,0,BP
GO:0002823,negative regulation of adaptive immune r...,42,0,0.24,1.00000,1,1,0,BP
GO:0002825,regulation of T-helper 1 type immune res...,31,0,0.17,1.00000,1,1,0,BP
GO:0002827,positive regulation of T-helper 1 type i...,24,0,0.13,1.00000,1,1,0,BP
GO:0002828,regulation of type 2 immune response,32,0,0.18,1.00000,1,1,0,BP
GO:0002832,negative regulation of response to bioti...,41,0,0.23,1.00000,1,1,0,BP
GO:0002861,regulation of inflammatory response to a...,32,0,0.18,1.00000,1,1,0,BP
GO:0002886,regulation of myeloid leukocyte mediated...,61,0,0.34,1.00000,1,1,0,BP
GO:0002888,positive regulation of myeloid leukocyte...,41,0,0.23,1.00000,1,1,0,BP
GO:0002889,regulation of immunoglobulin mediated im...,61,0,0.34,1.00000,1,1,0,BP
GO:0002891,positive regulation of immunoglobulin me...,46,0,0.26,1.00000,1,1,0,BP
GO:0002902,regulation of B cell apoptotic process,30,0,0.17,1.00000,1,1,0,BP
GO:0002903,negative regulation of B cell apoptotic ...,23,0,0.13,1.00000,1,1,0,BP
GO:0002920,regulation of humoral immune response,36,0,0.2,1.00000,1,1,0,BP
GO:0002931,response to ischemia,35,0,0.2,1.00000,1,1,0,BP
GO:0003014,renal system process,108,0,0.61,1.00000,1,1,0,BP
GO:0003016,respiratory system process,33,0,0.19,1.00000,1,1,0,BP
GO:0003044,regulation of systemic arterial blood pr...,54,0,0.3,1.00000,1,1,0,BP
GO:0003071,renal system process involved in regulat...,27,0,0.15,1.00000,1,1,0,BP
GO:0003081,regulation of systemic arterial blood pr...,32,0,0.18,1.00000,1,1,0,BP
GO:0003085,negative regulation of systemic arterial...,27,0,0.15,1.00000,1,1,0,BP
GO:0003094,glomerular filtration,22,0,0.12,1.00000,1,1,0,BP
GO:0003148,outflow tract septum morphogenesis,29,0,0.16,1.00000,1,1,0,BP
GO:0003151,outflow tract morphogenesis,84,0,0.47,1.00000,1,1,0,BP
GO:0003156,regulation of animal organ formation,44,0,0.25,1.00000,1,1,0,BP
GO:0003170,heart valve development,58,0,0.33,1.00000,1,1,0,BP
GO:0003171,atrioventricular valve development,27,0,0.15,1.00000,1,1,0,BP
GO:0003176,aortic valve development,23,0,0.13,1.00000,1,1,0,BP
GO:0003177,pulmonary valve development,21,0,0.12,1.00000,1,1,0,BP
GO:0003179,heart valve morphogenesis,47,0,0.26,1.00000,1,1,0,BP
GO:0003181,atrioventricular valve morphogenesis,24,0,0.13,1.00000,1,1,0,BP
GO:0003197,endocardial cushion development,47,0,0.26,1.00000,1,1,0,BP
GO:0003203,endocardial cushion morphogenesis,34,0,0.19,1.00000,1,1,0,BP
GO:0003206,cardiac chamber morphogenesis,148,0,0.83,1.00000,1,1,0,BP
GO:0003208,cardiac ventricle morphogenesis,79,0,0.44,1.00000,1,1,0,BP
GO:0003209,cardiac atrium morphogenesis,34,0,0.19,1.00000,1,1,0,BP
GO:0003229,ventricular cardiac muscle tissue develo...,62,0,0.35,1.00000,1,1,0,BP
GO:0003230,cardiac atrium development,38,0,0.21,1.00000,1,1,0,BP
GO:0003231,cardiac ventricle development,149,0,0.84,1.00000,1,1,0,BP
GO:0003254,regulation of membrane depolarization,45,0,0.25,1.00000,1,1,0,BP
GO:0003272,endocardial cushion formation,24,0,0.13,1.00000,1,1,0,BP
GO:0003281,ventricular septum development,87,0,0.49,1.00000,1,1,0,BP
GO:0003283,atrial septum development,21,0,0.12,1.00000,1,1,0,BP
GO:0003299,muscle hypertrophy in response to stress,26,0,0.15,1.00000,1,1,0,BP
GO:0003309,type B pancreatic cell differentiation,31,0,0.17,1.00000,1,1,0,BP
GO:0003323,type B pancreatic cell development,22,0,0.12,1.00000,1,1,0,BP
GO:0003333,amino acid transmembrane transport,75,0,0.42,1.00000,1,1,0,BP
GO:0003338,metanephros morphogenesis,27,0,0.15,1.00000,1,1,0,BP
GO:0003341,cilium movement,70,0,0.39,1.00000,1,1,0,BP
GO:0003351,epithelial cilium movement,25,0,0.14,1.00000,1,1,0,BP
GO:0003407,neural retina development,66,0,0.37,1.00000,1,1,0,BP
GO:0003413,chondrocyte differentiation involved in ...,29,0,0.16,1.00000,1,1,0,BP
GO:0003417,growth plate cartilage development,36,0,0.2,1.00000,1,1,0,BP
GO:0003418,growth plate cartilage chondrocyte diffe...,22,0,0.12,1.00000,1,1,0,BP
GO:0003433,chondrocyte development involved in endo...,22,0,0.12,1.00000,1,1,0,BP
GO:0005980,glycogen catabolic process,20,0,0.11,1.00000,1,1,0,BP
GO:0006022,aminoglycan metabolic process,101,0,0.57,1.00000,1,1,0,BP
GO:0006023,aminoglycan biosynthetic process,53,0,0.3,1.00000,1,1,0,BP
GO:0006024,glycosaminoglycan biosynthetic process,43,0,0.24,1.00000,1,1,0,BP
GO:0006026,aminoglycan catabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0006029,proteoglycan metabolic process,79,0,0.44,1.00000,1,1,0,BP
GO:0006040,amino sugar metabolic process,43,0,0.24,1.00000,1,1,0,BP
GO:0006081,cellular aldehyde metabolic process,70,0,0.39,1.00000,1,1,0,BP
GO:0006084,acetyl-CoA metabolic process,33,0,0.19,1.00000,1,1,0,BP
GO:0006089,lactate metabolic process,21,0,0.12,1.00000,1,1,0,BP
GO:0006094,gluconeogenesis,73,0,0.41,1.00000,1,1,0,BP
GO:0006099,tricarboxylic acid cycle,31,0,0.17,1.00000,1,1,0,BP
GO:0006101,citrate metabolic process,32,0,0.18,1.00000,1,1,0,BP
GO:0006111,regulation of gluconeogenesis,51,0,0.29,1.00000,1,1,0,BP
GO:0006144,purine nucleobase metabolic process,23,0,0.13,1.00000,1,1,0,BP
GO:0006213,pyrimidine nucleoside metabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0006220,pyrimidine nucleotide metabolic process,32,0,0.18,1.00000,1,1,0,BP
GO:0006221,pyrimidine nucleotide biosynthetic proce...,24,0,0.13,1.00000,1,1,0,BP
GO:0006270,DNA replication initiation,29,0,0.16,1.00000,1,1,0,BP
GO:0006289,nucleotide-excision repair,54,0,0.3,1.00000,1,1,0,BP
GO:0006298,mismatch repair,26,0,0.15,1.00000,1,1,0,BP
GO:0006301,postreplication repair,23,0,0.13,1.00000,1,1,0,BP
GO:0006303,double-strand break repair via nonhomolo...,50,0,0.28,1.00000,1,1,0,BP
GO:0006304,DNA modification,97,0,0.54,1.00000,1,1,0,BP
GO:0006305,DNA alkylation,68,0,0.38,1.00000,1,1,0,BP
GO:0006306,DNA methylation,68,0,0.38,1.00000,1,1,0,BP
GO:0006308,DNA catabolic process,33,0,0.19,1.00000,1,1,0,BP
GO:0006312,mitotic recombination,24,0,0.13,1.00000,1,1,0,BP
GO:0006335,DNA replication-dependent nucleosome ass...,31,0,0.17,1.00000,1,1,0,BP
GO:0006342,chromatin silencing,84,0,0.47,1.00000,1,1,0,BP
GO:0006346,methylation-dependent chromatin silencin...,23,0,0.13,1.00000,1,1,0,BP
GO:0006349,regulation of gene expression by genetic...,21,0,0.12,1.00000,1,1,0,BP
GO:0006352,"DNA-templated transcription, initiation",96,0,0.54,1.00000,1,1,0,BP
GO:0006353,"DNA-templated transcription, termination",22,0,0.12,1.00000,1,1,0,BP
GO:0006354,"DNA-templated transcription, elongation",65,0,0.36,1.00000,1,1,0,BP
GO:0006367,transcription initiation from RNA polyme...,62,0,0.35,1.00000,1,1,0,BP
GO:0006368,transcription elongation from RNA polyme...,48,0,0.27,1.00000,1,1,0,BP
GO:0006379,mRNA cleavage,20,0,0.11,1.00000,1,1,0,BP
GO:0006383,transcription by RNA polymerase III,36,0,0.2,1.00000,1,1,0,BP
GO:0006399,tRNA metabolic process,169,0,0.95,1.00000,1,1,0,BP
GO:0006400,tRNA modification,72,0,0.4,1.00000,1,1,0,BP
GO:0006418,tRNA aminoacylation for protein translat...,41,0,0.23,1.00000,1,1,0,BP
GO:0006471,protein ADP-ribosylation,36,0,0.2,1.00000,1,1,0,BP
GO:0006473,protein acetylation,188,0,1.06,1.00000,1,1,0,BP
GO:0006475,internal protein amino acid acetylation,148,0,0.83,1.00000,1,1,0,BP
GO:0006482,protein demethylation,31,0,0.17,1.00000,1,1,0,BP
GO:0006487,protein N-linked glycosylation,67,0,0.38,1.00000,1,1,0,BP
GO:0006497,protein lipidation,91,0,0.51,1.00000,1,1,0,BP
GO:0006505,GPI anchor metabolic process,32,0,0.18,1.00000,1,1,0,BP
GO:0006506,GPI anchor biosynthetic process,31,0,0.17,1.00000,1,1,0,BP
GO:0006515,protein quality control for misfolded or...,27,0,0.15,1.00000,1,1,0,BP
GO:0006516,glycoprotein catabolic process,21,0,0.12,1.00000,1,1,0,BP
GO:0006525,arginine metabolic process,20,0,0.11,1.00000,1,1,0,BP
GO:0006541,glutamine metabolic process,21,0,0.12,1.00000,1,1,0,BP
GO:0006576,cellular biogenic amine metabolic proces...,46,0,0.26,1.00000,1,1,0,BP
GO:0006612,protein targeting to membrane,108,0,0.61,1.00000,1,1,0,BP
GO:0006623,protein targeting to vacuole,33,0,0.19,1.00000,1,1,0,BP
GO:0006625,protein targeting to peroxisome,20,0,0.11,1.00000,1,1,0,BP
GO:0006635,fatty acid beta-oxidation,67,0,0.38,1.00000,1,1,0,BP
GO:0006637,acyl-CoA metabolic process,82,0,0.46,1.00000,1,1,0,BP
GO:0006661,phosphatidylinositol biosynthetic proces...,59,0,0.33,1.00000,1,1,0,BP
GO:0006664,glycolipid metabolic process,81,0,0.45,1.00000,1,1,0,BP
GO:0006672,ceramide metabolic process,84,0,0.47,1.00000,1,1,0,BP
GO:0006687,glycosphingolipid metabolic process,42,0,0.24,1.00000,1,1,0,BP
GO:0006688,glycosphingolipid biosynthetic process,20,0,0.11,1.00000,1,1,0,BP
GO:0006692,prostanoid metabolic process,41,0,0.23,1.00000,1,1,0,BP
GO:0006693,prostaglandin metabolic process,41,0,0.23,1.00000,1,1,0,BP
GO:0006699,bile acid biosynthetic process,20,0,0.11,1.00000,1,1,0,BP
GO:0006706,steroid catabolic process,24,0,0.13,1.00000,1,1,0,BP
GO:0006720,isoprenoid metabolic process,81,0,0.45,1.00000,1,1,0,BP
GO:0006721,terpenoid metabolic process,62,0,0.35,1.00000,1,1,0,BP
GO:0006730,one-carbon metabolic process,27,0,0.15,1.00000,1,1,0,BP
GO:0006734,NADH metabolic process,29,0,0.16,1.00000,1,1,0,BP
GO:0006739,NADP metabolic process,36,0,0.2,1.00000,1,1,0,BP
GO:0006760,folic acid-containing compound metabolic...,25,0,0.14,1.00000,1,1,0,BP
GO:0006775,fat-soluble vitamin metabolic process,33,0,0.19,1.00000,1,1,0,BP
GO:0006778,porphyrin-containing compound metabolic ...,38,0,0.21,1.00000,1,1,0,BP
GO:0006779,porphyrin-containing compound biosynthet...,26,0,0.15,1.00000,1,1,0,BP
GO:0006783,heme biosynthetic process,21,0,0.12,1.00000,1,1,0,BP
GO:0006805,xenobiotic metabolic process,113,0,0.63,1.00000,1,1,0,BP
GO:0006809,nitric oxide biosynthetic process,76,0,0.43,1.00000,1,1,0,BP
GO:0006817,phosphate ion transport,26,0,0.15,1.00000,1,1,0,BP
GO:0006821,chloride transport,100,0,0.56,1.00000,1,1,0,BP
GO:0006829,zinc ion transport,32,0,0.18,1.00000,1,1,0,BP
GO:0006855,drug transmembrane transport,70,0,0.39,1.00000,1,1,0,BP
GO:0006882,cellular zinc ion homeostasis,26,0,0.15,1.00000,1,1,0,BP
GO:0006884,cell volume homeostasis,31,0,0.17,1.00000,1,1,0,BP
GO:0006885,regulation of pH,93,0,0.52,1.00000,1,1,0,BP
GO:0006890,"retrograde vesicle-mediated transport, G...",44,0,0.25,1.00000,1,1,0,BP
GO:0006900,vesicle budding from membrane,55,0,0.31,1.00000,1,1,0,BP
GO:0006903,vesicle targeting,38,0,0.21,1.00000,1,1,0,BP
GO:0006904,vesicle docking involved in exocytosis,46,0,0.26,1.00000,1,1,0,BP
GO:0006907,pinocytosis,21,0,0.12,1.00000,1,1,0,BP
GO:0006911,"phagocytosis, engulfment",56,0,0.31,1.00000,1,1,0,BP
GO:0006921,cellular component disassembly involved ...,30,0,0.17,1.00000,1,1,0,BP
GO:0006925,inflammatory cell apoptotic process,25,0,0.14,1.00000,1,1,0,BP
GO:0006929,substrate-dependent cell migration,28,0,0.16,1.00000,1,1,0,BP
GO:0006942,regulation of striated muscle contractio...,83,0,0.47,1.00000,1,1,0,BP
GO:0006949,syncytium formation,71,0,0.4,1.00000,1,1,0,BP
GO:0006953,acute-phase response,41,0,0.23,1.00000,1,1,0,BP
GO:0006956,complement activation,52,0,0.29,1.00000,1,1,0,BP
GO:0006958,"complement activation, classical pathway",30,0,0.17,1.00000,1,1,0,BP
GO:0006970,response to osmotic stress,86,0,0.48,1.00000,1,1,0,BP
GO:0006972,hyperosmotic response,36,0,0.2,1.00000,1,1,0,BP
GO:0006998,nuclear envelope organization,39,0,0.22,1.00000,1,1,0,BP
GO:0007020,microtubule nucleation,23,0,0.13,1.00000,1,1,0,BP
GO:0007030,Golgi organization,123,0,0.69,1.00000,1,1,0,BP
GO:0007031,peroxisome organization,35,0,0.2,1.00000,1,1,0,BP
GO:0007032,endosome organization,51,0,0.29,1.00000,1,1,0,BP
GO:0007035,vacuolar acidification,20,0,0.11,1.00000,1,1,0,BP
GO:0007040,lysosome organization,62,0,0.35,1.00000,1,1,0,BP
GO:0007080,mitotic metaphase plate congression,43,0,0.24,1.00000,1,1,0,BP
GO:0007095,mitotic G2 DNA damage checkpoint,21,0,0.12,1.00000,1,1,0,BP
GO:0007097,nuclear migration,33,0,0.19,1.00000,1,1,0,BP
GO:0007098,centrosome cycle,128,0,0.72,1.00000,1,1,0,BP
GO:0007099,centriole replication,40,0,0.22,1.00000,1,1,0,BP
GO:0007127,meiosis I,112,0,0.63,1.00000,1,1,0,BP
GO:0007129,synapsis,51,0,0.29,1.00000,1,1,0,BP
GO:0007130,synaptonemal complex assembly,22,0,0.12,1.00000,1,1,0,BP
GO:0007131,reciprocal meiotic recombination,48,0,0.27,1.00000,1,1,0,BP
GO:0007140,male meiotic nuclear division,51,0,0.29,1.00000,1,1,0,BP
GO:0007141,male meiosis I,22,0,0.12,1.00000,1,1,0,BP
GO:0007156,homophilic cell adhesion via plasma memb...,111,0,0.62,1.00000,1,1,0,BP
GO:0007157,heterophilic cell-cell adhesion via plas...,48,0,0.27,1.00000,1,1,0,BP
GO:0007164,establishment of tissue polarity,62,0,0.35,1.00000,1,1,0,BP
GO:0007190,activation of adenylate cyclase activity,21,0,0.12,1.00000,1,1,0,BP
GO:0007212,dopamine receptor signaling pathway,43,0,0.24,1.00000,1,1,0,BP
GO:0007214,gamma-aminobutyric acid signaling pathwa...,27,0,0.15,1.00000,1,1,0,BP
GO:0007218,neuropeptide signaling pathway,81,0,0.45,1.00000,1,1,0,BP
GO:0007257,activation of JUN kinase activity,39,0,0.22,1.00000,1,1,0,BP
GO:0007259,JAK-STAT cascade,190,0,1.07,1.00000,1,1,0,BP
GO:0007260,tyrosine phosphorylation of STAT protein,76,0,0.43,1.00000,1,1,0,BP
GO:0007263,nitric oxide mediated signal transductio...,27,0,0.15,1.00000,1,1,0,BP
GO:0007271,"synaptic transmission, cholinergic",34,0,0.19,1.00000,1,1,0,BP
GO:0007274,neuromuscular synaptic transmission,34,0,0.19,1.00000,1,1,0,BP
GO:0007286,spermatid development,206,0,1.16,1.00000,1,1,0,BP
GO:0007289,spermatid nucleus differentiation,26,0,0.15,1.00000,1,1,0,BP
GO:0007338,single fertilization,141,0,0.79,1.00000,1,1,0,BP
GO:0007339,binding of sperm to zona pellucida,40,0,0.22,1.00000,1,1,0,BP
GO:0007340,acrosome reaction,39,0,0.22,1.00000,1,1,0,BP
GO:0007405,neuroblast proliferation,69,0,0.39,1.00000,1,1,0,BP
GO:0007431,salivary gland development,42,0,0.24,1.00000,1,1,0,BP
GO:0007435,salivary gland morphogenesis,38,0,0.21,1.00000,1,1,0,BP
GO:0007492,endoderm development,71,0,0.4,1.00000,1,1,0,BP
GO:0007520,myoblast fusion,49,0,0.28,1.00000,1,1,0,BP
GO:0007530,sex determination,29,0,0.16,1.00000,1,1,0,BP
GO:0007549,dosage compensation,27,0,0.15,1.00000,1,1,0,BP
GO:0007584,response to nutrient,101,0,0.57,1.00000,1,1,0,BP
GO:0007585,respiratory gaseous exchange,56,0,0.31,1.00000,1,1,0,BP
GO:0007588,excretion,57,0,0.32,1.00000,1,1,0,BP
GO:0007595,lactation,60,0,0.34,1.00000,1,1,0,BP
GO:0007596,blood coagulation,158,0,0.89,1.00000,1,1,0,BP
GO:0007599,hemostasis,160,0,0.9,1.00000,1,1,0,BP
GO:0007602,phototransduction,31,0,0.17,1.00000,1,1,0,BP
GO:0007606,sensory perception of chemical stimulus,1218,0,6.84,1.00000,1,1,0,BP
GO:0007608,sensory perception of smell,1120,0,6.29,1.00000,1,1,0,BP
GO:0007616,long-term memory,39,0,0.22,1.00000,1,1,0,BP
GO:0007620,copulation,26,0,0.15,1.00000,1,1,0,BP
GO:0007622,rhythmic behavior,64,0,0.36,1.00000,1,1,0,BP
GO:0007625,grooming behavior,21,0,0.12,1.00000,1,1,0,BP
GO:0007628,adult walking behavior,45,0,0.25,1.00000,1,1,0,BP
GO:0007635,chemosensory behavior,22,0,0.12,1.00000,1,1,0,BP
GO:0008033,tRNA processing,115,0,0.65,1.00000,1,1,0,BP
GO:0008053,mitochondrial fusion,21,0,0.12,1.00000,1,1,0,BP
GO:0008206,bile acid metabolic process,29,0,0.16,1.00000,1,1,0,BP
GO:0008207,C21-steroid hormone metabolic process,39,0,0.22,1.00000,1,1,0,BP
GO:0008210,estrogen metabolic process,21,0,0.12,1.00000,1,1,0,BP
GO:0008211,glucocorticoid metabolic process,23,0,0.13,1.00000,1,1,0,BP
GO:0008214,protein dealkylation,31,0,0.17,1.00000,1,1,0,BP
GO:0008299,isoprenoid biosynthetic process,30,0,0.17,1.00000,1,1,0,BP
GO:0008340,determination of adult lifespan,28,0,0.16,1.00000,1,1,0,BP
GO:0008356,asymmetric cell division,21,0,0.12,1.00000,1,1,0,BP
GO:0008535,respiratory chain complex IV assembly,23,0,0.13,1.00000,1,1,0,BP
GO:0008543,fibroblast growth factor receptor signal...,74,0,0.42,1.00000,1,1,0,BP
GO:0008593,regulation of Notch signaling pathway,87,0,0.49,1.00000,1,1,0,BP
GO:0008625,extrinsic apoptotic signaling pathway vi...,75,0,0.42,1.00000,1,1,0,BP
GO:0008630,intrinsic apoptotic signaling pathway in...,114,0,0.64,1.00000,1,1,0,BP
GO:0008652,cellular amino acid biosynthetic process,64,0,0.36,1.00000,1,1,0,BP
GO:0008654,phospholipid biosynthetic process,160,0,0.9,1.00000,1,1,0,BP
GO:0009048,dosage compensation by inactivation of X...,25,0,0.14,1.00000,1,1,0,BP
GO:0009062,fatty acid catabolic process,93,0,0.52,1.00000,1,1,0,BP
GO:0009063,cellular amino acid catabolic process,92,0,0.52,1.00000,1,1,0,BP
GO:0009065,glutamine family amino acid catabolic pr...,25,0,0.14,1.00000,1,1,0,BP
GO:0009066,aspartate family amino acid metabolic pr...,42,0,0.24,1.00000,1,1,0,BP
GO:0009067,aspartate family amino acid biosynthetic...,22,0,0.12,1.00000,1,1,0,BP
GO:0009069,serine family amino acid metabolic proce...,40,0,0.22,1.00000,1,1,0,BP
GO:0009072,aromatic amino acid family metabolic pro...,34,0,0.19,1.00000,1,1,0,BP
GO:0009112,nucleobase metabolic process,36,0,0.2,1.00000,1,1,0,BP
GO:0009116,nucleoside metabolic process,90,0,0.51,1.00000,1,1,0,BP
GO:0009119,ribonucleoside metabolic process,71,0,0.4,1.00000,1,1,0,BP
GO:0009163,nucleoside biosynthetic process,27,0,0.15,1.00000,1,1,0,BP
GO:0009187,cyclic nucleotide metabolic process,35,0,0.2,1.00000,1,1,0,BP
GO:0009190,cyclic nucleotide biosynthetic process,24,0,0.13,1.00000,1,1,0,BP
GO:0009225,nucleotide-sugar metabolic process,31,0,0.17,1.00000,1,1,0,BP
GO:0009247,glycolipid biosynthetic process,57,0,0.32,1.00000,1,1,0,BP
GO:0009251,glucan catabolic process,20,0,0.11,1.00000,1,1,0,BP
GO:0009262,deoxyribonucleotide metabolic process,31,0,0.17,1.00000,1,1,0,BP
GO:0009268,response to pH,40,0,0.22,1.00000,1,1,0,BP
GO:0009299,mRNA transcription,26,0,0.15,1.00000,1,1,0,BP
GO:0009311,oligosaccharide metabolic process,35,0,0.2,1.00000,1,1,0,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0009395,phospholipid catabolic process,43,0,0.24,1.00000,1,1,0,BP
GO:0009404,toxin metabolic process,22,0,0.12,1.00000,1,1,0,BP
GO:0009451,RNA modification,138,0,0.77,1.00000,1,1,0,BP
GO:0009566,fertilization,186,0,1.04,1.00000,1,1,0,BP
GO:0009581,detection of external stimulus,129,0,0.72,1.00000,1,1,0,BP
GO:0009582,detection of abiotic stimulus,128,0,0.72,1.00000,1,1,0,BP
GO:0009583,detection of light stimulus,53,0,0.3,1.00000,1,1,0,BP
GO:0009584,detection of visible light,31,0,0.17,1.00000,1,1,0,BP
GO:0009593,detection of chemical stimulus,87,0,0.49,1.00000,1,1,0,BP
GO:0009595,detection of biotic stimulus,26,0,0.15,1.00000,1,1,0,BP
GO:0009620,response to fungus,39,0,0.22,1.00000,1,1,0,BP
GO:0009648,photoperiodism,24,0,0.13,1.00000,1,1,0,BP
GO:0009649,entrainment of circadian clock,26,0,0.15,1.00000,1,1,0,BP
GO:0009651,response to salt stress,41,0,0.23,1.00000,1,1,0,BP
GO:0009880,embryonic pattern specification,64,0,0.36,1.00000,1,1,0,BP
GO:0009948,anterior/posterior axis specification,54,0,0.3,1.00000,1,1,0,BP
GO:0009988,cell-cell recognition,64,0,0.36,1.00000,1,1,0,BP
GO:0009994,oocyte differentiation,52,0,0.29,1.00000,1,1,0,BP
GO:0010039,response to iron ion,20,0,0.11,1.00000,1,1,0,BP
GO:0010043,response to zinc ion,31,0,0.17,1.00000,1,1,0,BP
GO:0010092,specification of animal organ identity,40,0,0.22,1.00000,1,1,0,BP
GO:0010155,regulation of proton transport,26,0,0.15,1.00000,1,1,0,BP
GO:0010165,response to X-ray,25,0,0.14,1.00000,1,1,0,BP
GO:0010257,NADH dehydrogenase complex assembly,45,0,0.25,1.00000,1,1,0,BP
GO:0010259,multicellular organism aging,46,0,0.26,1.00000,1,1,0,BP
GO:0010390,histone monoubiquitination,30,0,0.17,1.00000,1,1,0,BP
GO:0010453,regulation of cell fate commitment,32,0,0.18,1.00000,1,1,0,BP
GO:0010458,exit from mitosis,28,0,0.16,1.00000,1,1,0,BP
GO:0010460,positive regulation of heart rate,27,0,0.15,1.00000,1,1,0,BP
GO:0010499,proteasomal ubiquitin-independent protei...,23,0,0.13,1.00000,1,1,0,BP
GO:0010522,regulation of calcium ion transport into...,102,0,0.57,1.00000,1,1,0,BP
GO:0010524,positive regulation of calcium ion trans...,59,0,0.33,1.00000,1,1,0,BP
GO:0010543,regulation of platelet activation,34,0,0.19,1.00000,1,1,0,BP
GO:0010559,regulation of glycoprotein biosynthetic ...,42,0,0.24,1.00000,1,1,0,BP
GO:0010560,positive regulation of glycoprotein bios...,21,0,0.12,1.00000,1,1,0,BP
GO:0010569,regulation of double-strand break repair...,43,0,0.24,1.00000,1,1,0,BP
GO:0010573,vascular endothelial growth factor produ...,34,0,0.19,1.00000,1,1,0,BP
GO:0010574,regulation of vascular endothelial growt...,32,0,0.18,1.00000,1,1,0,BP
GO:0010575,positive regulation of vascular endothel...,25,0,0.14,1.00000,1,1,0,BP
GO:0010586,miRNA metabolic process,29,0,0.16,1.00000,1,1,0,BP
GO:0010591,regulation of lamellipodium assembly,32,0,0.18,1.00000,1,1,0,BP
GO:0010592,positive regulation of lamellipodium ass...,23,0,0.13,1.00000,1,1,0,BP
GO:0010596,negative regulation of endothelial cell ...,51,0,0.29,1.00000,1,1,0,BP
GO:0010614,negative regulation of cardiac muscle hy...,32,0,0.18,1.00000,1,1,0,BP
GO:0010623,programmed cell death involved in cell d...,20,0,0.11,1.00000,1,1,0,BP
GO:0010633,negative regulation of epithelial cell m...,70,0,0.39,1.00000,1,1,0,BP
GO:0010656,negative regulation of muscle cell apopt...,59,0,0.33,1.00000,1,1,0,BP
GO:0010657,muscle cell apoptotic process,105,0,0.59,1.00000,1,1,0,BP
GO:0010658,striated muscle cell apoptotic process,64,0,0.36,1.00000,1,1,0,BP
GO:0010659,cardiac muscle cell apoptotic process,61,0,0.34,1.00000,1,1,0,BP
GO:0010660,regulation of muscle cell apoptotic proc...,100,0,0.56,1.00000,1,1,0,BP
GO:0010661,positive regulation of muscle cell apopt...,40,0,0.22,1.00000,1,1,0,BP
GO:0010662,regulation of striated muscle cell apopt...,60,0,0.34,1.00000,1,1,0,BP
GO:0010663,positive regulation of striated muscle c...,24,0,0.13,1.00000,1,1,0,BP
GO:0010664,negative regulation of striated muscle c...,37,0,0.21,1.00000,1,1,0,BP
GO:0010665,regulation of cardiac muscle cell apopto...,57,0,0.32,1.00000,1,1,0,BP
GO:0010666,positive regulation of cardiac muscle ce...,23,0,0.13,1.00000,1,1,0,BP
GO:0010667,negative regulation of cardiac muscle ce...,34,0,0.19,1.00000,1,1,0,BP
GO:0010669,epithelial structure maintenance,25,0,0.14,1.00000,1,1,0,BP
GO:0010677,negative regulation of cellular carbohyd...,47,0,0.26,1.00000,1,1,0,BP
GO:0010712,regulation of collagen metabolic process,52,0,0.29,1.00000,1,1,0,BP
GO:0010714,positive regulation of collagen metaboli...,34,0,0.19,1.00000,1,1,0,BP
GO:0010719,negative regulation of epithelial to mes...,28,0,0.16,1.00000,1,1,0,BP
GO:0010737,protein kinase A signaling,35,0,0.2,1.00000,1,1,0,BP
GO:0010738,regulation of protein kinase A signaling,24,0,0.13,1.00000,1,1,0,BP
GO:0010742,macrophage derived foam cell differentia...,25,0,0.14,1.00000,1,1,0,BP
GO:0010743,regulation of macrophage derived foam ce...,21,0,0.12,1.00000,1,1,0,BP
GO:0010758,regulation of macrophage chemotaxis,31,0,0.17,1.00000,1,1,0,BP
GO:0010759,positive regulation of macrophage chemot...,21,0,0.12,1.00000,1,1,0,BP
GO:0010803,regulation of tumor necrosis factor-medi...,30,0,0.17,1.00000,1,1,0,BP
GO:0010824,regulation of centrosome duplication,44,0,0.25,1.00000,1,1,0,BP
GO:0010829,negative regulation of glucose transmemb...,26,0,0.15,1.00000,1,1,0,BP
GO:0010830,regulation of myotube differentiation,64,0,0.36,1.00000,1,1,0,BP
GO:0010831,positive regulation of myotube different...,39,0,0.22,1.00000,1,1,0,BP
GO:0010842,retina layer formation,20,0,0.11,1.00000,1,1,0,BP
GO:0010862,positive regulation of pathway-restricte...,49,0,0.28,1.00000,1,1,0,BP
GO:0010866,regulation of triglyceride biosynthetic ...,21,0,0.12,1.00000,1,1,0,BP
GO:0010869,regulation of receptor biosynthetic proc...,20,0,0.11,1.00000,1,1,0,BP
GO:0010883,regulation of lipid storage,43,0,0.24,1.00000,1,1,0,BP
GO:0010884,positive regulation of lipid storage,23,0,0.13,1.00000,1,1,0,BP
GO:0010893,positive regulation of steroid biosynthe...,27,0,0.15,1.00000,1,1,0,BP
GO:0010922,positive regulation of phosphatase activ...,30,0,0.17,1.00000,1,1,0,BP
GO:0010939,regulation of necrotic cell death,28,0,0.16,1.00000,1,1,0,BP
GO:0010954,positive regulation of protein processin...,28,0,0.16,1.00000,1,1,0,BP
GO:0010955,negative regulation of protein processin...,37,0,0.21,1.00000,1,1,0,BP
GO:0010972,negative regulation of G2/M transition o...,41,0,0.23,1.00000,1,1,0,BP
GO:0010996,response to auditory stimulus,23,0,0.13,1.00000,1,1,0,BP
GO:0014048,regulation of glutamate secretion,25,0,0.14,1.00000,1,1,0,BP
GO:0014065,phosphatidylinositol 3-kinase signaling,129,0,0.72,1.00000,1,1,0,BP
GO:0014066,regulation of phosphatidylinositol 3-kin...,97,0,0.54,1.00000,1,1,0,BP
GO:0014068,positive regulation of phosphatidylinosi...,72,0,0.4,1.00000,1,1,0,BP
GO:0014075,response to amine,20,0,0.11,1.00000,1,1,0,BP
GO:0014808,release of sequestered calcium ion into ...,21,0,0.12,1.00000,1,1,0,BP
GO:0014821,phasic smooth muscle contraction,25,0,0.14,1.00000,1,1,0,BP
GO:0014823,response to activity,34,0,0.19,1.00000,1,1,0,BP
GO:0014829,vascular smooth muscle contraction,27,0,0.15,1.00000,1,1,0,BP
GO:0014850,response to muscle activity,21,0,0.12,1.00000,1,1,0,BP
GO:0014887,cardiac muscle adaptation,27,0,0.15,1.00000,1,1,0,BP
GO:0014898,cardiac muscle hypertrophy in response t...,26,0,0.15,1.00000,1,1,0,BP
GO:0014902,myotube differentiation,124,0,0.7,1.00000,1,1,0,BP
GO:0014904,myotube cell development,43,0,0.24,1.00000,1,1,0,BP
GO:0015012,heparan sulfate proteoglycan biosyntheti...,30,0,0.17,1.00000,1,1,0,BP
GO:0015695,organic cation transport,37,0,0.21,1.00000,1,1,0,BP
GO:0015698,inorganic anion transport,141,0,0.79,1.00000,1,1,0,BP
GO:0015718,monocarboxylic acid transport,151,0,0.85,1.00000,1,1,0,BP
GO:0015721,bile acid and bile salt transport,23,0,0.13,1.00000,1,1,0,BP
GO:0015732,prostaglandin transport,21,0,0.12,1.00000,1,1,0,BP
GO:0015748,organophosphate ester transport,85,0,0.48,1.00000,1,1,0,BP
GO:0015807,L-amino acid transport,60,0,0.34,1.00000,1,1,0,BP
GO:0015813,L-glutamate transmembrane transport,22,0,0.12,1.00000,1,1,0,BP
GO:0015874,norepinephrine transport,22,0,0.12,1.00000,1,1,0,BP
GO:0015908,fatty acid transport,86,0,0.48,1.00000,1,1,0,BP
GO:0015909,long-chain fatty acid transport,58,0,0.33,1.00000,1,1,0,BP
GO:0015914,phospholipid transport,65,0,0.36,1.00000,1,1,0,BP
GO:0015985,"energy coupled proton transport, down el...",22,0,0.12,1.00000,1,1,0,BP
GO:0015986,ATP synthesis coupled proton transport,22,0,0.12,1.00000,1,1,0,BP
GO:0016048,detection of temperature stimulus,22,0,0.12,1.00000,1,1,0,BP
GO:0016054,organic acid catabolic process,215,0,1.21,1.00000,1,1,0,BP
GO:0016073,snRNA metabolic process,42,0,0.24,1.00000,1,1,0,BP
GO:0016075,rRNA catabolic process,24,0,0.13,1.00000,1,1,0,BP
GO:0016082,synaptic vesicle priming,28,0,0.16,1.00000,1,1,0,BP
GO:0016101,diterpenoid metabolic process,57,0,0.32,1.00000,1,1,0,BP
GO:0016180,snRNA processing,25,0,0.14,1.00000,1,1,0,BP
GO:0016197,endosomal transport,208,0,1.17,1.00000,1,1,0,BP
GO:0016339,calcium-dependent cell-cell adhesion via...,39,0,0.22,1.00000,1,1,0,BP
GO:0016441,posttranscriptional gene silencing,138,0,0.77,1.00000,1,1,0,BP
GO:0016485,protein processing,238,0,1.34,1.00000,1,1,0,BP
GO:0016556,mRNA modification,27,0,0.15,1.00000,1,1,0,BP
GO:0016572,histone phosphorylation,35,0,0.2,1.00000,1,1,0,BP
GO:0016573,histone acetylation,140,0,0.79,1.00000,1,1,0,BP
GO:0016577,histone demethylation,28,0,0.16,1.00000,1,1,0,BP
GO:0016578,histone deubiquitination,24,0,0.13,1.00000,1,1,0,BP
GO:0016579,protein deubiquitination,117,0,0.66,1.00000,1,1,0,BP
GO:0016601,Rac protein signal transduction,38,0,0.21,1.00000,1,1,0,BP
GO:0016925,protein sumoylation,44,0,0.25,1.00000,1,1,0,BP
GO:0016973,poly(A)+ mRNA export from nucleus,20,0,0.11,1.00000,1,1,0,BP
GO:0017001,antibiotic catabolic process,46,0,0.26,1.00000,1,1,0,BP
GO:0017004,cytochrome complex assembly,33,0,0.19,1.00000,1,1,0,BP
GO:0018126,protein hydroxylation,25,0,0.14,1.00000,1,1,0,BP
GO:0018149,peptide cross-linking,62,0,0.35,1.00000,1,1,0,BP
GO:0018195,peptidyl-arginine modification,27,0,0.15,1.00000,1,1,0,BP
GO:0018196,peptidyl-asparagine modification,21,0,0.12,1.00000,1,1,0,BP
GO:0018198,peptidyl-cysteine modification,46,0,0.26,1.00000,1,1,0,BP
GO:0018200,peptidyl-glutamic acid modification,26,0,0.15,1.00000,1,1,0,BP
GO:0018208,peptidyl-proline modification,34,0,0.19,1.00000,1,1,0,BP
GO:0018230,peptidyl-L-cysteine S-palmitoylation,22,0,0.12,1.00000,1,1,0,BP
GO:0018231,peptidyl-S-diacylglycerol-L-cysteine bio...,22,0,0.12,1.00000,1,1,0,BP
GO:0018279,protein N-linked glycosylation via aspar...,20,0,0.11,1.00000,1,1,0,BP
GO:0018345,protein palmitoylation,35,0,0.2,1.00000,1,1,0,BP
GO:0018393,internal peptidyl-lysine acetylation,145,0,0.81,1.00000,1,1,0,BP
GO:0018394,peptidyl-lysine acetylation,156,0,0.88,1.00000,1,1,0,BP
GO:0019048,modulation by virus of host morphology o...,24,0,0.13,1.00000,1,1,0,BP
GO:0019068,virion assembly,24,0,0.13,1.00000,1,1,0,BP
GO:0019076,viral release from host cell,34,0,0.19,1.00000,1,1,0,BP
GO:0019083,viral transcription,44,0,0.25,1.00000,1,1,0,BP
GO:0019229,regulation of vasoconstriction,76,0,0.43,1.00000,1,1,0,BP
GO:0019233,sensory perception of pain,144,0,0.81,1.00000,1,1,0,BP
GO:0019236,response to pheromone,105,0,0.59,1.00000,1,1,0,BP
GO:0019319,hexose biosynthetic process,76,0,0.43,1.00000,1,1,0,BP
GO:0019320,hexose catabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0019373,epoxygenase P450 pathway,31,0,0.17,1.00000,1,1,0,BP
GO:0019395,fatty acid oxidation,97,0,0.54,1.00000,1,1,0,BP
GO:0019400,alditol metabolic process,22,0,0.12,1.00000,1,1,0,BP
GO:0019432,triglyceride biosynthetic process,35,0,0.2,1.00000,1,1,0,BP
GO:0019433,triglyceride catabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0019674,NAD metabolic process,47,0,0.26,1.00000,1,1,0,BP
GO:0019692,deoxyribose phosphate metabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0019835,cytolysis,35,0,0.2,1.00000,1,1,0,BP
GO:0019883,antigen processing and presentation of e...,40,0,0.22,1.00000,1,1,0,BP
GO:0019884,antigen processing and presentation of e...,32,0,0.18,1.00000,1,1,0,BP
GO:0019885,antigen processing and presentation of e...,37,0,0.21,1.00000,1,1,0,BP
GO:0019915,lipid storage,71,0,0.4,1.00000,1,1,0,BP
GO:0019934,cGMP-mediated signaling,39,0,0.22,1.00000,1,1,0,BP
GO:0021511,spinal cord patterning,28,0,0.16,1.00000,1,1,0,BP
GO:0021513,spinal cord dorsal/ventral patterning,26,0,0.15,1.00000,1,1,0,BP
GO:0021516,dorsal spinal cord development,22,0,0.12,1.00000,1,1,0,BP
GO:0021532,neural tube patterning,47,0,0.26,1.00000,1,1,0,BP
GO:0021533,cell differentiation in hindbrain,26,0,0.15,1.00000,1,1,0,BP
GO:0021544,subpallium development,24,0,0.13,1.00000,1,1,0,BP
GO:0021545,cranial nerve development,50,0,0.28,1.00000,1,1,0,BP
GO:0021602,cranial nerve morphogenesis,31,0,0.17,1.00000,1,1,0,BP
GO:0021675,nerve development,82,0,0.46,1.00000,1,1,0,BP
GO:0021680,cerebellar Purkinje cell layer developme...,32,0,0.18,1.00000,1,1,0,BP
GO:0021772,olfactory bulb development,46,0,0.26,1.00000,1,1,0,BP
GO:0021795,cerebral cortex cell migration,55,0,0.31,1.00000,1,1,0,BP
GO:0021799,cerebral cortex radially oriented cell m...,37,0,0.21,1.00000,1,1,0,BP
GO:0021801,cerebral cortex radial glia guided migra...,25,0,0.14,1.00000,1,1,0,BP
GO:0021871,forebrain regionalization,27,0,0.15,1.00000,1,1,0,BP
GO:0021884,forebrain neuron development,37,0,0.21,1.00000,1,1,0,BP
GO:0021885,forebrain cell migration,73,0,0.41,1.00000,1,1,0,BP
GO:0021889,olfactory bulb interneuron differentiati...,24,0,0.13,1.00000,1,1,0,BP
GO:0021895,cerebral cortex neuron differentiation,25,0,0.14,1.00000,1,1,0,BP
GO:0021904,dorsal/ventral neural tube patterning,30,0,0.17,1.00000,1,1,0,BP
GO:0021983,pituitary gland development,39,0,0.22,1.00000,1,1,0,BP
GO:0021987,cerebral cortex development,109,0,0.61,1.00000,1,1,0,BP
GO:0021988,olfactory lobe development,48,0,0.27,1.00000,1,1,0,BP
GO:0022029,telencephalon cell migration,70,0,0.39,1.00000,1,1,0,BP
GO:0022030,telencephalon glial cell migration,25,0,0.14,1.00000,1,1,0,BP
GO:0022401,negative adaptation of signaling pathway,28,0,0.16,1.00000,1,1,0,BP
GO:0022410,circadian sleep/wake cycle process,32,0,0.18,1.00000,1,1,0,BP
GO:0022602,ovulation cycle process,48,0,0.27,1.00000,1,1,0,BP
GO:0022616,DNA strand elongation,22,0,0.12,1.00000,1,1,0,BP
GO:0023019,signal transduction involved in regulati...,23,0,0.13,1.00000,1,1,0,BP
GO:0023058,adaptation of signaling pathway,30,0,0.17,1.00000,1,1,0,BP
GO:0030004,cellular monovalent inorganic cation hom...,97,0,0.54,1.00000,1,1,0,BP
GO:0030032,lamellipodium assembly,65,0,0.36,1.00000,1,1,0,BP
GO:0030101,natural killer cell activation,100,0,0.56,1.00000,1,1,0,BP
GO:0030104,water homeostasis,56,0,0.31,1.00000,1,1,0,BP
GO:0030148,sphingolipid biosynthetic process,78,0,0.44,1.00000,1,1,0,BP
GO:0030149,sphingolipid catabolic process,29,0,0.16,1.00000,1,1,0,BP
GO:0030166,proteoglycan biosynthetic process,55,0,0.31,1.00000,1,1,0,BP
GO:0030168,platelet activation,79,0,0.44,1.00000,1,1,0,BP
GO:0030183,B cell differentiation,150,0,0.84,1.00000,1,1,0,BP
GO:0030193,regulation of blood coagulation,78,0,0.44,1.00000,1,1,0,BP
GO:0030194,positive regulation of blood coagulation,26,0,0.15,1.00000,1,1,0,BP
GO:0030195,negative regulation of blood coagulation,49,0,0.28,1.00000,1,1,0,BP
GO:0030201,heparan sulfate proteoglycan metabolic p...,35,0,0.2,1.00000,1,1,0,BP
GO:0030203,glycosaminoglycan metabolic process,83,0,0.47,1.00000,1,1,0,BP
GO:0030204,chondroitin sulfate metabolic process,22,0,0.12,1.00000,1,1,0,BP
GO:0030212,hyaluronan metabolic process,27,0,0.15,1.00000,1,1,0,BP
GO:0030224,monocyte differentiation,29,0,0.16,1.00000,1,1,0,BP
GO:0030258,lipid modification,221,0,1.24,1.00000,1,1,0,BP
GO:0030260,entry into host cell,59,0,0.33,1.00000,1,1,0,BP
GO:0030261,chromosome condensation,45,0,0.25,1.00000,1,1,0,BP
GO:0030262,apoptotic nuclear changes,29,0,0.16,1.00000,1,1,0,BP
GO:0030317,flagellated sperm motility,104,0,0.58,1.00000,1,1,0,BP
GO:0030325,adrenal gland development,24,0,0.13,1.00000,1,1,0,BP
GO:0030431,sleep,39,0,0.22,1.00000,1,1,0,BP
GO:0030488,tRNA methylation,29,0,0.16,1.00000,1,1,0,BP
GO:0030510,regulation of BMP signaling pathway,97,0,0.54,1.00000,1,1,0,BP
GO:0030511,positive regulation of transforming grow...,29,0,0.16,1.00000,1,1,0,BP
GO:0030512,negative regulation of transforming grow...,64,0,0.36,1.00000,1,1,0,BP
GO:0030513,positive regulation of BMP signaling pat...,38,0,0.21,1.00000,1,1,0,BP
GO:0030514,negative regulation of BMP signaling pat...,53,0,0.3,1.00000,1,1,0,BP
GO:0030517,negative regulation of axon extension,47,0,0.26,1.00000,1,1,0,BP
GO:0030521,androgen receptor signaling pathway,39,0,0.22,1.00000,1,1,0,BP
GO:0030539,male genitalia development,23,0,0.13,1.00000,1,1,0,BP
GO:0030574,collagen catabolic process,36,0,0.2,1.00000,1,1,0,BP
GO:0030593,neutrophil chemotaxis,101,0,0.57,1.00000,1,1,0,BP
GO:0030641,regulation of cellular pH,76,0,0.43,1.00000,1,1,0,BP
GO:0030728,ovulation,23,0,0.13,1.00000,1,1,0,BP
GO:0030851,granulocyte differentiation,38,0,0.21,1.00000,1,1,0,BP
GO:0030878,thyroid gland development,28,0,0.16,1.00000,1,1,0,BP
GO:0030888,regulation of B cell proliferation,69,0,0.39,1.00000,1,1,0,BP
GO:0030889,negative regulation of B cell proliferat...,20,0,0.11,1.00000,1,1,0,BP
GO:0030890,positive regulation of B cell proliferat...,44,0,0.25,1.00000,1,1,0,BP
GO:0030901,midbrain development,52,0,0.29,1.00000,1,1,0,BP
GO:0030947,regulation of vascular endothelial growt...,33,0,0.19,1.00000,1,1,0,BP
GO:0030970,"retrograde protein transport, ER to cyto...",27,0,0.15,1.00000,1,1,0,BP
GO:0031016,pancreas development,90,0,0.51,1.00000,1,1,0,BP
GO:0031018,endocrine pancreas development,52,0,0.29,1.00000,1,1,0,BP
GO:0031023,microtubule organizing center organizati...,137,0,0.77,1.00000,1,1,0,BP
GO:0031050,dsRNA processing,49,0,0.28,1.00000,1,1,0,BP
GO:0031057,negative regulation of histone modificat...,43,0,0.24,1.00000,1,1,0,BP
GO:0031061,negative regulation of histone methylati...,24,0,0.13,1.00000,1,1,0,BP
GO:0031062,positive regulation of histone methylati...,41,0,0.23,1.00000,1,1,0,BP
GO:0031100,animal organ regeneration,25,0,0.14,1.00000,1,1,0,BP
GO:0031128,developmental induction,43,0,0.24,1.00000,1,1,0,BP
GO:0031279,regulation of cyclase activity,37,0,0.21,1.00000,1,1,0,BP
GO:0031290,retinal ganglion cell axon guidance,21,0,0.12,1.00000,1,1,0,BP
GO:0031294,lymphocyte costimulation,32,0,0.18,1.00000,1,1,0,BP
GO:0031295,T cell costimulation,30,0,0.17,1.00000,1,1,0,BP
GO:0031341,regulation of cell killing,125,0,0.7,1.00000,1,1,0,BP
GO:0031342,negative regulation of cell killing,27,0,0.15,1.00000,1,1,0,BP
GO:0031343,positive regulation of cell killing,94,0,0.53,1.00000,1,1,0,BP
GO:0031365,N-terminal protein amino acid modificati...,27,0,0.15,1.00000,1,1,0,BP
GO:0031424,keratinization,35,0,0.2,1.00000,1,1,0,BP
GO:0031440,regulation of mRNA 3'-end processing,28,0,0.16,1.00000,1,1,0,BP
GO:0031532,actin cytoskeleton reorganization,102,0,0.57,1.00000,1,1,0,BP
GO:0031572,G2 DNA damage checkpoint,32,0,0.18,1.00000,1,1,0,BP
GO:0031579,membrane raft organization,22,0,0.12,1.00000,1,1,0,BP
GO:0031629,synaptic vesicle fusion to presynaptic a...,25,0,0.14,1.00000,1,1,0,BP
GO:0031638,zymogen activation,64,0,0.36,1.00000,1,1,0,BP
GO:0031639,plasminogen activation,25,0,0.14,1.00000,1,1,0,BP
GO:0031640,killing of cells of other organism,40,0,0.22,1.00000,1,1,0,BP
GO:0031645,negative regulation of neurological syst...,30,0,0.17,1.00000,1,1,0,BP
GO:0031648,protein destabilization,48,0,0.27,1.00000,1,1,0,BP
GO:0031649,heat generation,22,0,0.12,1.00000,1,1,0,BP
GO:0031663,lipopolysaccharide-mediated signaling pa...,51,0,0.29,1.00000,1,1,0,BP
GO:0031670,cellular response to nutrient,43,0,0.24,1.00000,1,1,0,BP
GO:0031929,TOR signaling,121,0,0.68,1.00000,1,1,0,BP
GO:0031935,regulation of chromatin silencing,38,0,0.21,1.00000,1,1,0,BP
GO:0031952,regulation of protein autophosphorylatio...,48,0,0.27,1.00000,1,1,0,BP
GO:0031954,positive regulation of protein autophosp...,24,0,0.13,1.00000,1,1,0,BP
GO:0032006,regulation of TOR signaling,101,0,0.57,1.00000,1,1,0,BP
GO:0032007,negative regulation of TOR signaling,46,0,0.26,1.00000,1,1,0,BP
GO:0032008,positive regulation of TOR signaling,40,0,0.22,1.00000,1,1,0,BP
GO:0032042,mitochondrial DNA metabolic process,22,0,0.12,1.00000,1,1,0,BP
GO:0032069,regulation of nuclease activity,27,0,0.15,1.00000,1,1,0,BP
GO:0032094,response to food,35,0,0.2,1.00000,1,1,0,BP
GO:0032095,regulation of response to food,20,0,0.11,1.00000,1,1,0,BP
GO:0032098,regulation of appetite,22,0,0.12,1.00000,1,1,0,BP
GO:0032104,regulation of response to extracellular ...,26,0,0.15,1.00000,1,1,0,BP
GO:0032107,regulation of response to nutrient level...,26,0,0.15,1.00000,1,1,0,BP
GO:0032148,activation of protein kinase B activity,20,0,0.11,1.00000,1,1,0,BP
GO:0032196,transposition,22,0,0.12,1.00000,1,1,0,BP
GO:0032205,negative regulation of telomere maintena...,36,0,0.2,1.00000,1,1,0,BP
GO:0032211,negative regulation of telomere maintena...,20,0,0.11,1.00000,1,1,0,BP
GO:0032232,negative regulation of actin filament bu...,31,0,0.17,1.00000,1,1,0,BP
GO:0032288,myelin assembly,20,0,0.11,1.00000,1,1,0,BP
GO:0032303,regulation of icosanoid secretion,22,0,0.12,1.00000,1,1,0,BP
GO:0032309,icosanoid secretion,47,0,0.26,1.00000,1,1,0,BP
GO:0032330,regulation of chondrocyte differentiatio...,50,0,0.28,1.00000,1,1,0,BP
GO:0032331,negative regulation of chondrocyte diffe...,22,0,0.12,1.00000,1,1,0,BP
GO:0032332,positive regulation of chondrocyte diffe...,21,0,0.12,1.00000,1,1,0,BP
GO:0032350,regulation of hormone metabolic process,54,0,0.3,1.00000,1,1,0,BP
GO:0032352,positive regulation of hormone metabolic...,24,0,0.13,1.00000,1,1,0,BP
GO:0032355,response to estradiol,51,0,0.29,1.00000,1,1,0,BP
GO:0032365,intracellular lipid transport,27,0,0.15,1.00000,1,1,0,BP
GO:0032366,intracellular sterol transport,22,0,0.12,1.00000,1,1,0,BP
GO:0032367,intracellular cholesterol transport,22,0,0.12,1.00000,1,1,0,BP
GO:0032392,DNA geometric change,38,0,0.21,1.00000,1,1,0,BP
GO:0032400,melanosome localization,22,0,0.12,1.00000,1,1,0,BP
GO:0032410,negative regulation of transporter activ...,80,0,0.45,1.00000,1,1,0,BP
GO:0032413,negative regulation of ion transmembrane...,71,0,0.4,1.00000,1,1,0,BP
GO:0032418,lysosome localization,76,0,0.43,1.00000,1,1,0,BP
GO:0032436,positive regulation of proteasomal ubiqu...,83,0,0.47,1.00000,1,1,0,BP
GO:0032456,endocytic recycling,48,0,0.27,1.00000,1,1,0,BP
GO:0032461,positive regulation of protein oligomeri...,24,0,0.13,1.00000,1,1,0,BP
GO:0032465,regulation of cytokinesis,79,0,0.44,1.00000,1,1,0,BP
GO:0032467,positive regulation of cytokinesis,33,0,0.19,1.00000,1,1,0,BP
GO:0032480,negative regulation of type I interferon...,25,0,0.14,1.00000,1,1,0,BP
GO:0032482,Rab protein signal transduction,69,0,0.39,1.00000,1,1,0,BP
GO:0032495,response to muramyl dipeptide,23,0,0.13,1.00000,1,1,0,BP
GO:0032508,DNA duplex unwinding,32,0,0.18,1.00000,1,1,0,BP
GO:0032509,endosome transport via multivesicular bo...,27,0,0.15,1.00000,1,1,0,BP
GO:0032527,protein exit from endoplasmic reticulum,44,0,0.25,1.00000,1,1,0,BP
GO:0032543,mitochondrial translation,76,0,0.43,1.00000,1,1,0,BP
GO:0032616,interleukin-13 production,22,0,0.12,1.00000,1,1,0,BP
GO:0032620,interleukin-17 production,40,0,0.22,1.00000,1,1,0,BP
GO:0032633,interleukin-4 production,38,0,0.21,1.00000,1,1,0,BP
GO:0032637,interleukin-8 production,69,0,0.39,1.00000,1,1,0,BP
GO:0032660,regulation of interleukin-17 production,33,0,0.19,1.00000,1,1,0,BP
GO:0032673,regulation of interleukin-4 production,31,0,0.17,1.00000,1,1,0,BP
GO:0032677,regulation of interleukin-8 production,63,0,0.35,1.00000,1,1,0,BP
GO:0032682,negative regulation of chemokine product...,22,0,0.12,1.00000,1,1,0,BP
GO:0032689,negative regulation of interferon-gamma ...,32,0,0.18,1.00000,1,1,0,BP
GO:0032691,negative regulation of interleukin-1 bet...,24,0,0.13,1.00000,1,1,0,BP
GO:0032692,negative regulation of interleukin-1 pro...,33,0,0.19,1.00000,1,1,0,BP
GO:0032693,negative regulation of interleukin-10 pr...,21,0,0.12,1.00000,1,1,0,BP
GO:0032703,negative regulation of interleukin-2 pro...,25,0,0.14,1.00000,1,1,0,BP
GO:0032715,negative regulation of interleukin-6 pro...,51,0,0.29,1.00000,1,1,0,BP
GO:0032720,negative regulation of tumor necrosis fa...,64,0,0.36,1.00000,1,1,0,BP
GO:0032753,positive regulation of interleukin-4 pro...,25,0,0.14,1.00000,1,1,0,BP
GO:0032757,positive regulation of interleukin-8 pro...,46,0,0.26,1.00000,1,1,0,BP
GO:0032780,negative regulation of ATPase activity,22,0,0.12,1.00000,1,1,0,BP
GO:0032781,positive regulation of ATPase activity,39,0,0.22,1.00000,1,1,0,BP
GO:0032784,regulation of DNA-templated transcriptio...,51,0,0.29,1.00000,1,1,0,BP
GO:0032786,positive regulation of DNA-templated tra...,34,0,0.19,1.00000,1,1,0,BP
GO:0032800,receptor biosynthetic process,25,0,0.14,1.00000,1,1,0,BP
GO:0032801,receptor catabolic process,27,0,0.15,1.00000,1,1,0,BP
GO:0032814,regulation of natural killer cell activa...,44,0,0.25,1.00000,1,1,0,BP
GO:0032816,positive regulation of natural killer ce...,31,0,0.17,1.00000,1,1,0,BP
GO:0032873,negative regulation of stress-activated ...,46,0,0.26,1.00000,1,1,0,BP
GO:0032878,regulation of establishment or maintenan...,24,0,0.13,1.00000,1,1,0,BP
GO:0032890,regulation of organic acid transport,80,0,0.45,1.00000,1,1,0,BP
GO:0032891,negative regulation of organic acid tran...,28,0,0.16,1.00000,1,1,0,BP
GO:0032892,positive regulation of organic acid tran...,48,0,0.27,1.00000,1,1,0,BP
GO:0032897,negative regulation of viral transcripti...,22,0,0.12,1.00000,1,1,0,BP
GO:0032925,regulation of activin receptor signaling...,28,0,0.16,1.00000,1,1,0,BP
GO:0032944,regulation of mononuclear cell prolifera...,232,0,1.3,1.00000,1,1,0,BP
GO:0032945,negative regulation of mononuclear cell ...,88,0,0.49,1.00000,1,1,0,BP
GO:0032946,positive regulation of mononuclear cell ...,139,0,0.78,1.00000,1,1,0,BP
GO:0032957,inositol trisphosphate metabolic process,27,0,0.15,1.00000,1,1,0,BP
GO:0032958,inositol phosphate biosynthetic process,43,0,0.24,1.00000,1,1,0,BP
GO:0032959,inositol trisphosphate biosynthetic proc...,23,0,0.13,1.00000,1,1,0,BP
GO:0032963,collagen metabolic process,109,0,0.61,1.00000,1,1,0,BP
GO:0032964,collagen biosynthetic process,54,0,0.3,1.00000,1,1,0,BP
GO:0032965,regulation of collagen biosynthetic proc...,45,0,0.25,1.00000,1,1,0,BP
GO:0032967,positive regulation of collagen biosynth...,31,0,0.17,1.00000,1,1,0,BP
GO:0032968,positive regulation of transcription elo...,23,0,0.13,1.00000,1,1,0,BP
GO:0032981,mitochondrial respiratory chain complex ...,45,0,0.25,1.00000,1,1,0,BP
GO:0033003,regulation of mast cell activation,50,0,0.28,1.00000,1,1,0,BP
GO:0033005,positive regulation of mast cell activat...,30,0,0.17,1.00000,1,1,0,BP
GO:0033006,regulation of mast cell activation invol...,36,0,0.2,1.00000,1,1,0,BP
GO:0033008,positive regulation of mast cell activat...,22,0,0.12,1.00000,1,1,0,BP
GO:0033013,tetrapyrrole metabolic process,46,0,0.26,1.00000,1,1,0,BP
GO:0033014,tetrapyrrole biosynthetic process,27,0,0.15,1.00000,1,1,0,BP
GO:0033028,myeloid cell apoptotic process,37,0,0.21,1.00000,1,1,0,BP
GO:0033032,regulation of myeloid cell apoptotic pro...,34,0,0.19,1.00000,1,1,0,BP
GO:0033033,negative regulation of myeloid cell apop...,20,0,0.11,1.00000,1,1,0,BP
GO:0033108,mitochondrial respiratory chain complex ...,78,0,0.44,1.00000,1,1,0,BP
GO:0033119,negative regulation of RNA splicing,29,0,0.16,1.00000,1,1,0,BP
GO:0033120,positive regulation of RNA splicing,47,0,0.26,1.00000,1,1,0,BP
GO:0033137,negative regulation of peptidyl-serine p...,29,0,0.16,1.00000,1,1,0,BP
GO:0033139,regulation of peptidyl-serine phosphoryl...,31,0,0.17,1.00000,1,1,0,BP
GO:0033141,positive regulation of peptidyl-serine p...,29,0,0.16,1.00000,1,1,0,BP
GO:0033173,calcineurin-NFAT signaling cascade,50,0,0.28,1.00000,1,1,0,BP
GO:0033198,response to ATP,28,0,0.16,1.00000,1,1,0,BP
GO:0033209,tumor necrosis factor-mediated signaling...,60,0,0.34,1.00000,1,1,0,BP
GO:0033233,regulation of protein sumoylation,24,0,0.13,1.00000,1,1,0,BP
GO:0033273,response to vitamin,29,0,0.16,1.00000,1,1,0,BP
GO:0033363,secretory granule organization,36,0,0.2,1.00000,1,1,0,BP
GO:0033522,histone H2A ubiquitination,25,0,0.14,1.00000,1,1,0,BP
GO:0033561,regulation of water loss via skin,31,0,0.17,1.00000,1,1,0,BP
GO:0033598,mammary gland epithelial cell proliferat...,33,0,0.19,1.00000,1,1,0,BP
GO:0033599,regulation of mammary gland epithelial c...,20,0,0.11,1.00000,1,1,0,BP
GO:0033617,mitochondrial respiratory chain complex ...,20,0,0.11,1.00000,1,1,0,BP
GO:0033622,integrin activation,24,0,0.13,1.00000,1,1,0,BP
GO:0033630,positive regulation of cell adhesion med...,20,0,0.11,1.00000,1,1,0,BP
GO:0033687,osteoblast proliferation,30,0,0.17,1.00000,1,1,0,BP
GO:0033688,regulation of osteoblast proliferation,27,0,0.15,1.00000,1,1,0,BP
GO:0033865,nucleoside bisphosphate metabolic proces...,99,0,0.56,1.00000,1,1,0,BP
GO:0033866,nucleoside bisphosphate biosynthetic pro...,35,0,0.2,1.00000,1,1,0,BP
GO:0033875,ribonucleoside bisphosphate metabolic pr...,99,0,0.56,1.00000,1,1,0,BP
GO:0033962,cytoplasmic mRNA processing body assembl...,20,0,0.11,1.00000,1,1,0,BP
GO:0034030,ribonucleoside bisphosphate biosynthetic...,35,0,0.2,1.00000,1,1,0,BP
GO:0034032,purine nucleoside bisphosphate metabolic...,99,0,0.56,1.00000,1,1,0,BP
GO:0034033,purine nucleoside bisphosphate biosynthe...,35,0,0.2,1.00000,1,1,0,BP
GO:0034067,protein localization to Golgi apparatus,27,0,0.15,1.00000,1,1,0,BP
GO:0034104,negative regulation of tissue remodeling,24,0,0.13,1.00000,1,1,0,BP
GO:0034109,homotypic cell-cell adhesion,68,0,0.38,1.00000,1,1,0,BP
GO:0034110,regulation of homotypic cell-cell adhesi...,31,0,0.17,1.00000,1,1,0,BP
GO:0034121,regulation of toll-like receptor signali...,64,0,0.36,1.00000,1,1,0,BP
GO:0034122,negative regulation of toll-like recepto...,35,0,0.2,1.00000,1,1,0,BP
GO:0034123,positive regulation of toll-like recepto...,26,0,0.15,1.00000,1,1,0,BP
GO:0034142,toll-like receptor 4 signaling pathway,33,0,0.19,1.00000,1,1,0,BP
GO:0034143,regulation of toll-like receptor 4 signa...,20,0,0.11,1.00000,1,1,0,BP
GO:0034198,cellular response to amino acid starvati...,42,0,0.24,1.00000,1,1,0,BP
GO:0034204,lipid translocation,29,0,0.16,1.00000,1,1,0,BP
GO:0034243,regulation of transcription elongation f...,37,0,0.21,1.00000,1,1,0,BP
GO:0034308,primary alcohol metabolic process,62,0,0.35,1.00000,1,1,0,BP
GO:0034311,diol metabolic process,23,0,0.13,1.00000,1,1,0,BP
GO:0034314,Arp2/3 complex-mediated actin nucleation,33,0,0.19,1.00000,1,1,0,BP
GO:0034340,response to type I interferon,44,0,0.25,1.00000,1,1,0,BP
GO:0034367,protein-containing complex remodeling,21,0,0.12,1.00000,1,1,0,BP
GO:0034368,protein-lipid complex remodeling,20,0,0.11,1.00000,1,1,0,BP
GO:0034369,plasma lipoprotein particle remodeling,20,0,0.11,1.00000,1,1,0,BP
GO:0034377,plasma lipoprotein particle assembly,20,0,0.11,1.00000,1,1,0,BP
GO:0034381,plasma lipoprotein particle clearance,36,0,0.2,1.00000,1,1,0,BP
GO:0034383,low-density lipoprotein particle clearan...,24,0,0.13,1.00000,1,1,0,BP
GO:0034390,smooth muscle cell apoptotic process,29,0,0.16,1.00000,1,1,0,BP
GO:0034391,regulation of smooth muscle cell apoptot...,29,0,0.16,1.00000,1,1,0,BP
GO:0034405,response to fluid shear stress,22,0,0.12,1.00000,1,1,0,BP
GO:0034440,lipid oxidation,99,0,0.56,1.00000,1,1,0,BP
GO:0034453,microtubule anchoring,27,0,0.15,1.00000,1,1,0,BP
GO:0034505,tooth mineralization,24,0,0.13,1.00000,1,1,0,BP
GO:0034612,response to tumor necrosis factor,178,0,1,1.00000,1,1,0,BP
GO:0034629,cellular protein-containing complex loca...,29,0,0.16,1.00000,1,1,0,BP
GO:0034661,ncRNA catabolic process,37,0,0.21,1.00000,1,1,0,BP
GO:0034694,response to prostaglandin,21,0,0.12,1.00000,1,1,0,BP
GO:0034723,DNA replication-dependent nucleosome org...,31,0,0.17,1.00000,1,1,0,BP
GO:0034754,cellular hormone metabolic process,106,0,0.6,1.00000,1,1,0,BP
GO:0034763,negative regulation of transmembrane tra...,134,0,0.75,1.00000,1,1,0,BP
GO:0034766,negative regulation of ion transmembrane...,106,0,0.6,1.00000,1,1,0,BP
GO:0035024,negative regulation of Rho protein signa...,25,0,0.14,1.00000,1,1,0,BP
GO:0035036,sperm-egg recognition,46,0,0.26,1.00000,1,1,0,BP
GO:0035065,regulation of histone acetylation,54,0,0.3,1.00000,1,1,0,BP
GO:0035066,positive regulation of histone acetylati...,30,0,0.17,1.00000,1,1,0,BP
GO:0035082,axoneme assembly,68,0,0.38,1.00000,1,1,0,BP
GO:0035088,establishment or maintenance of apical/b...,50,0,0.28,1.00000,1,1,0,BP
GO:0035094,response to nicotine,33,0,0.19,1.00000,1,1,0,BP
GO:0035115,embryonic forelimb morphogenesis,36,0,0.2,1.00000,1,1,0,BP
GO:0035116,embryonic hindlimb morphogenesis,34,0,0.19,1.00000,1,1,0,BP
GO:0035137,hindlimb morphogenesis,47,0,0.26,1.00000,1,1,0,BP
GO:0035162,embryonic hemopoiesis,28,0,0.16,1.00000,1,1,0,BP
GO:0035176,social behavior,53,0,0.3,1.00000,1,1,0,BP
GO:0035188,hatching,40,0,0.22,1.00000,1,1,0,BP
GO:0035194,posttranscriptional gene silencing by RN...,135,0,0.76,1.00000,1,1,0,BP
GO:0035195,gene silencing by miRNA,129,0,0.72,1.00000,1,1,0,BP
GO:0035196,production of miRNAs involved in gene si...,47,0,0.26,1.00000,1,1,0,BP
GO:0035249,"synaptic transmission, glutamatergic",106,0,0.6,1.00000,1,1,0,BP
GO:0035268,protein mannosylation,22,0,0.12,1.00000,1,1,0,BP
GO:0035270,endocrine system development,137,0,0.77,1.00000,1,1,0,BP
GO:0035272,exocrine system development,55,0,0.31,1.00000,1,1,0,BP
GO:0035357,peroxisome proliferator activated recept...,21,0,0.12,1.00000,1,1,0,BP
GO:0035383,thioester metabolic process,82,0,0.46,1.00000,1,1,0,BP
GO:0035384,thioester biosynthetic process,25,0,0.14,1.00000,1,1,0,BP
GO:0035456,response to interferon-beta,66,0,0.37,1.00000,1,1,0,BP
GO:0035458,cellular response to interferon-beta,56,0,0.31,1.00000,1,1,0,BP
GO:0035493,SNARE complex assembly,23,0,0.13,1.00000,1,1,0,BP
GO:0035510,DNA dealkylation,23,0,0.13,1.00000,1,1,0,BP
GO:0035561,regulation of chromatin binding,24,0,0.13,1.00000,1,1,0,BP
GO:0035567,non-canonical Wnt signaling pathway,59,0,0.33,1.00000,1,1,0,BP
GO:0035584,calcium-mediated signaling using intrace...,20,0,0.11,1.00000,1,1,0,BP
GO:0035634,response to stilbenoid,22,0,0.12,1.00000,1,1,0,BP
GO:0035640,exploration behavior,30,0,0.17,1.00000,1,1,0,BP
GO:0035710,"CD4-positive, alpha-beta T cell activati...",100,0,0.56,1.00000,1,1,0,BP
GO:0035743,"CD4-positive, alpha-beta T cell cytokine...",23,0,0.13,1.00000,1,1,0,BP
GO:0035767,endothelial cell chemotaxis,31,0,0.17,1.00000,1,1,0,BP
GO:0035794,positive regulation of mitochondrial mem...,37,0,0.21,1.00000,1,1,0,BP
GO:0035809,regulation of urine volume,26,0,0.15,1.00000,1,1,0,BP
GO:0035812,renal sodium excretion,27,0,0.15,1.00000,1,1,0,BP
GO:0035813,regulation of renal sodium excretion,25,0,0.14,1.00000,1,1,0,BP
GO:0035821,modification of morphology or physiology...,147,0,0.83,1.00000,1,1,0,BP
GO:0035825,homologous recombination,49,0,0.28,1.00000,1,1,0,BP
GO:0035883,enteroendocrine cell differentiation,34,0,0.19,1.00000,1,1,0,BP
GO:0035890,exit from host,34,0,0.19,1.00000,1,1,0,BP
GO:0035891,exit from host cell,34,0,0.19,1.00000,1,1,0,BP
GO:0035924,cellular response to vascular endothelia...,52,0,0.29,1.00000,1,1,0,BP
GO:0035987,endodermal cell differentiation,27,0,0.15,1.00000,1,1,0,BP
GO:0036003,positive regulation of transcription fro...,27,0,0.15,1.00000,1,1,0,BP
GO:0036010,protein localization to endosome,23,0,0.13,1.00000,1,1,0,BP
GO:0036037,"CD8-positive, alpha-beta T cell activati...",27,0,0.15,1.00000,1,1,0,BP
GO:0036075,replacement ossification,30,0,0.17,1.00000,1,1,0,BP
GO:0036230,granulocyte activation,35,0,0.2,1.00000,1,1,0,BP
GO:0036297,interstrand cross-link repair,28,0,0.16,1.00000,1,1,0,BP
GO:0036303,lymph vessel morphogenesis,22,0,0.12,1.00000,1,1,0,BP
GO:0036342,post-anal tail morphogenesis,26,0,0.15,1.00000,1,1,0,BP
GO:0038034,signal transduction in absence of ligand,81,0,0.45,1.00000,1,1,0,BP
GO:0038066,p38MAPK cascade,48,0,0.27,1.00000,1,1,0,BP
GO:0038083,peptidyl-tyrosine autophosphorylation,42,0,0.24,1.00000,1,1,0,BP
GO:0038084,vascular endothelial growth factor signa...,35,0,0.2,1.00000,1,1,0,BP
GO:0038202,TORC1 signaling,43,0,0.24,1.00000,1,1,0,BP
GO:0039528,cytoplasmic pattern recognition receptor...,24,0,0.13,1.00000,1,1,0,BP
GO:0039694,viral RNA genome replication,27,0,0.15,1.00000,1,1,0,BP
GO:0040001,establishment of mitotic spindle localiz...,33,0,0.19,1.00000,1,1,0,BP
GO:0040018,positive regulation of multicellular org...,43,0,0.24,1.00000,1,1,0,BP
GO:0040029,"regulation of gene expression, epigeneti...",288,0,1.62,1.00000,1,1,0,BP
GO:0040036,regulation of fibroblast growth factor r...,32,0,0.18,1.00000,1,1,0,BP
GO:0042036,negative regulation of cytokine biosynth...,32,0,0.18,1.00000,1,1,0,BP
GO:0042044,fluid transport,26,0,0.15,1.00000,1,1,0,BP
GO:0042059,negative regulation of epidermal growth ...,25,0,0.14,1.00000,1,1,0,BP
GO:0042073,intraciliary transport,46,0,0.26,1.00000,1,1,0,BP
GO:0042088,T-helper 1 type immune response,49,0,0.28,1.00000,1,1,0,BP
GO:0042092,type 2 immune response,38,0,0.21,1.00000,1,1,0,BP
GO:0042093,T-helper cell differentiation,63,0,0.35,1.00000,1,1,0,BP
GO:0042094,interleukin-2 biosynthetic process,22,0,0.12,1.00000,1,1,0,BP
GO:0042098,T cell proliferation,211,0,1.18,1.00000,1,1,0,BP
GO:0042102,positive regulation of T cell proliferat...,100,0,0.56,1.00000,1,1,0,BP
GO:0042104,positive regulation of activated T cell ...,27,0,0.15,1.00000,1,1,0,BP
GO:0042119,neutrophil activation,29,0,0.16,1.00000,1,1,0,BP
GO:0042129,regulation of T cell proliferation,176,0,0.99,1.00000,1,1,0,BP
GO:0042130,negative regulation of T cell proliferat...,74,0,0.42,1.00000,1,1,0,BP
GO:0042133,neurotransmitter metabolic process,148,0,0.83,1.00000,1,1,0,BP
GO:0042136,neurotransmitter biosynthetic process,104,0,0.58,1.00000,1,1,0,BP
GO:0042147,"retrograde transport, endosome to Golgi",81,0,0.45,1.00000,1,1,0,BP
GO:0042149,cellular response to glucose starvation,38,0,0.21,1.00000,1,1,0,BP
GO:0042157,lipoprotein metabolic process,124,0,0.7,1.00000,1,1,0,BP
GO:0042158,lipoprotein biosynthetic process,96,0,0.54,1.00000,1,1,0,BP
GO:0042168,heme metabolic process,30,0,0.17,1.00000,1,1,0,BP
GO:0042178,xenobiotic catabolic process,22,0,0.12,1.00000,1,1,0,BP
GO:0042181,ketone biosynthetic process,44,0,0.25,1.00000,1,1,0,BP
GO:0042220,response to cocaine,42,0,0.24,1.00000,1,1,0,BP
GO:0042267,natural killer cell mediated cytotoxicit...,61,0,0.34,1.00000,1,1,0,BP
GO:0042269,regulation of natural killer cell mediat...,50,0,0.28,1.00000,1,1,0,BP
GO:0042278,purine nucleoside metabolic process,64,0,0.36,1.00000,1,1,0,BP
GO:0042304,regulation of fatty acid biosynthetic pr...,41,0,0.23,1.00000,1,1,0,BP
GO:0042310,vasoconstriction,101,0,0.57,1.00000,1,1,0,BP
GO:0042398,cellular modified amino acid biosyntheti...,42,0,0.24,1.00000,1,1,0,BP
GO:0042403,thyroid hormone metabolic process,25,0,0.14,1.00000,1,1,0,BP
GO:0042430,indole-containing compound metabolic pro...,25,0,0.14,1.00000,1,1,0,BP
GO:0042446,hormone biosynthetic process,75,0,0.42,1.00000,1,1,0,BP
GO:0042451,purine nucleoside biosynthetic process,20,0,0.11,1.00000,1,1,0,BP
GO:0042455,ribonucleoside biosynthetic process,27,0,0.15,1.00000,1,1,0,BP
GO:0042461,photoreceptor cell development,62,0,0.35,1.00000,1,1,0,BP
GO:0042462,eye photoreceptor cell development,44,0,0.25,1.00000,1,1,0,BP
GO:0042474,middle ear morphogenesis,24,0,0.13,1.00000,1,1,0,BP
GO:0042475,odontogenesis of dentin-containing tooth,87,0,0.49,1.00000,1,1,0,BP
GO:0042501,serine phosphorylation of STAT protein,36,0,0.2,1.00000,1,1,0,BP
GO:0042509,regulation of tyrosine phosphorylation o...,72,0,0.4,1.00000,1,1,0,BP
GO:0042531,positive regulation of tyrosine phosphor...,56,0,0.31,1.00000,1,1,0,BP
GO:0042537,benzene-containing compound metabolic pr...,22,0,0.12,1.00000,1,1,0,BP
GO:0042538,hyperosmotic salinity response,28,0,0.16,1.00000,1,1,0,BP
GO:0042558,pteridine-containing compound metabolic ...,31,0,0.17,1.00000,1,1,0,BP
GO:0042572,retinol metabolic process,24,0,0.13,1.00000,1,1,0,BP
GO:0042573,retinoic acid metabolic process,25,0,0.14,1.00000,1,1,0,BP
GO:0042634,regulation of hair cycle,31,0,0.17,1.00000,1,1,0,BP
GO:0042698,ovulation cycle,61,0,0.34,1.00000,1,1,0,BP
GO:0042730,fibrinolysis,20,0,0.11,1.00000,1,1,0,BP
GO:0042733,embryonic digit morphogenesis,73,0,0.41,1.00000,1,1,0,BP
GO:0042737,drug catabolic process,150,0,0.84,1.00000,1,1,0,BP
GO:0042738,exogenous drug catabolic process,53,0,0.3,1.00000,1,1,0,BP
GO:0042744,hydrogen peroxide catabolic process,27,0,0.15,1.00000,1,1,0,BP
GO:0042745,circadian sleep/wake cycle,35,0,0.2,1.00000,1,1,0,BP
GO:0042749,regulation of circadian sleep/wake cycle,31,0,0.17,1.00000,1,1,0,BP
GO:0042752,regulation of circadian rhythm,124,0,0.7,1.00000,1,1,0,BP
GO:0042753,positive regulation of circadian rhythm,27,0,0.15,1.00000,1,1,0,BP
GO:0042755,eating behavior,48,0,0.27,1.00000,1,1,0,BP
GO:0042771,intrinsic apoptotic signaling pathway in...,43,0,0.24,1.00000,1,1,0,BP
GO:0042832,defense response to protozoan,34,0,0.19,1.00000,1,1,0,BP
GO:0043011,myeloid dendritic cell differentiation,20,0,0.11,1.00000,1,1,0,BP
GO:0043029,T cell homeostasis,46,0,0.26,1.00000,1,1,0,BP
GO:0043038,amino acid activation,45,0,0.25,1.00000,1,1,0,BP
GO:0043039,tRNA aminoacylation,44,0,0.25,1.00000,1,1,0,BP
GO:0043090,amino acid import,31,0,0.17,1.00000,1,1,0,BP
GO:0043124,negative regulation of I-kappaB kinase/N...,46,0,0.26,1.00000,1,1,0,BP
GO:0043153,entrainment of circadian clock by photop...,23,0,0.13,1.00000,1,1,0,BP
GO:0043171,peptide catabolic process,26,0,0.15,1.00000,1,1,0,BP
GO:0043243,positive regulation of protein complex d...,34,0,0.19,1.00000,1,1,0,BP
GO:0043267,negative regulation of potassium ion tra...,38,0,0.21,1.00000,1,1,0,BP
GO:0043276,anoikis,31,0,0.17,1.00000,1,1,0,BP
GO:0043299,leukocyte degranulation,69,0,0.39,1.00000,1,1,0,BP
GO:0043300,regulation of leukocyte degranulation,49,0,0.28,1.00000,1,1,0,BP
GO:0043302,positive regulation of leukocyte degranu...,31,0,0.17,1.00000,1,1,0,BP
GO:0043303,mast cell degranulation,48,0,0.27,1.00000,1,1,0,BP
GO:0043304,regulation of mast cell degranulation,35,0,0.2,1.00000,1,1,0,BP
GO:0043306,positive regulation of mast cell degranu...,22,0,0.12,1.00000,1,1,0,BP
GO:0043330,response to exogenous dsRNA,56,0,0.31,1.00000,1,1,0,BP
GO:0043331,response to dsRNA,63,0,0.35,1.00000,1,1,0,BP
GO:0043367,"CD4-positive, alpha-beta T cell differen...",81,0,0.45,1.00000,1,1,0,BP
GO:0043368,positive T cell selection,38,0,0.21,1.00000,1,1,0,BP
GO:0043369,"CD4-positive or CD8-positive, alpha-beta...",21,0,0.12,1.00000,1,1,0,BP
GO:0043370,"regulation of CD4-positive, alpha-beta T...",50,0,0.28,1.00000,1,1,0,BP
GO:0043371,"negative regulation of CD4-positive, alp...",23,0,0.13,1.00000,1,1,0,BP
GO:0043372,"positive regulation of CD4-positive, alp...",30,0,0.17,1.00000,1,1,0,BP
GO:0043388,positive regulation of DNA binding,63,0,0.35,1.00000,1,1,0,BP
GO:0043392,negative regulation of DNA binding,54,0,0.3,1.00000,1,1,0,BP
GO:0043403,skeletal muscle tissue regeneration,43,0,0.24,1.00000,1,1,0,BP
GO:0043407,negative regulation of MAP kinase activi...,69,0,0.39,1.00000,1,1,0,BP
GO:0043462,regulation of ATPase activity,64,0,0.36,1.00000,1,1,0,BP
GO:0043484,regulation of RNA splicing,140,0,0.79,1.00000,1,1,0,BP
GO:0043496,regulation of protein homodimerization a...,24,0,0.13,1.00000,1,1,0,BP
GO:0043516,"regulation of DNA damage response, signa...",36,0,0.2,1.00000,1,1,0,BP
GO:0043537,negative regulation of blood vessel endo...,32,0,0.18,1.00000,1,1,0,BP
GO:0043543,protein acylation,233,0,1.31,1.00000,1,1,0,BP
GO:0043550,regulation of lipid kinase activity,51,0,0.29,1.00000,1,1,0,BP
GO:0043551,regulation of phosphatidylinositol 3-kin...,41,0,0.23,1.00000,1,1,0,BP
GO:0043552,positive regulation of phosphatidylinosi...,29,0,0.16,1.00000,1,1,0,BP
GO:0043574,peroxisomal transport,20,0,0.11,1.00000,1,1,0,BP
GO:0043576,regulation of respiratory gaseous exchan...,23,0,0.13,1.00000,1,1,0,BP
GO:0043586,tongue development,21,0,0.12,1.00000,1,1,0,BP
GO:0043627,response to estrogen,73,0,0.41,1.00000,1,1,0,BP
GO:0043687,post-translational protein modification,23,0,0.13,1.00000,1,1,0,BP
GO:0043921,modulation by host of viral transcriptio...,24,0,0.13,1.00000,1,1,0,BP
GO:0043931,ossification involved in bone maturation,20,0,0.11,1.00000,1,1,0,BP
GO:0043950,positive regulation of cAMP-mediated sig...,33,0,0.19,1.00000,1,1,0,BP
GO:0043954,cellular component maintenance,59,0,0.33,1.00000,1,1,0,BP
GO:0043966,histone H3 acetylation,63,0,0.35,1.00000,1,1,0,BP
GO:0043967,histone H4 acetylation,63,0,0.35,1.00000,1,1,0,BP
GO:0043984,histone H4-K16 acetylation,21,0,0.12,1.00000,1,1,0,BP
GO:0044003,modification by symbiont of host morphol...,28,0,0.16,1.00000,1,1,0,BP
GO:0044030,regulation of DNA methylation,30,0,0.17,1.00000,1,1,0,BP
GO:0044062,regulation of excretion,31,0,0.17,1.00000,1,1,0,BP
GO:0044070,regulation of anion transport,121,0,0.68,1.00000,1,1,0,BP
GO:0044247,cellular polysaccharide catabolic proces...,22,0,0.12,1.00000,1,1,0,BP
GO:0044272,sulfur compound biosynthetic process,80,0,0.45,1.00000,1,1,0,BP
GO:0044273,sulfur compound catabolic process,21,0,0.12,1.00000,1,1,0,BP
GO:0044275,cellular carbohydrate catabolic process,36,0,0.2,1.00000,1,1,0,BP
GO:0044319,"wound healing, spreading of cells",31,0,0.17,1.00000,1,1,0,BP
GO:0044331,cell-cell adhesion mediated by cadherin,40,0,0.22,1.00000,1,1,0,BP
GO:0044344,cellular response to fibroblast growth f...,88,0,0.49,1.00000,1,1,0,BP
GO:0044346,fibroblast apoptotic process,21,0,0.12,1.00000,1,1,0,BP
GO:0044364,disruption of cells of other organism,40,0,0.22,1.00000,1,1,0,BP
GO:0044409,entry into host,59,0,0.33,1.00000,1,1,0,BP
GO:0044458,motile cilium assembly,30,0,0.17,1.00000,1,1,0,BP
GO:0044728,DNA methylation or demethylation,84,0,0.47,1.00000,1,1,0,BP
GO:0044764,multi-organism cellular process,41,0,0.23,1.00000,1,1,0,BP
GO:0044773,mitotic DNA damage checkpoint,57,0,0.32,1.00000,1,1,0,BP
GO:0044774,mitotic DNA integrity checkpoint,65,0,0.36,1.00000,1,1,0,BP
GO:0044783,G1 DNA damage checkpoint,20,0,0.11,1.00000,1,1,0,BP
GO:0044788,modulation by host of viral process,28,0,0.16,1.00000,1,1,0,BP
GO:0044818,mitotic G2/M transition checkpoint,31,0,0.17,1.00000,1,1,0,BP
GO:0044819,mitotic G1/S transition checkpoint,20,0,0.11,1.00000,1,1,0,BP
GO:0044851,hair cycle phase,22,0,0.12,1.00000,1,1,0,BP
GO:0045017,glycerolipid biosynthetic process,142,0,0.8,1.00000,1,1,0,BP
GO:0045022,early endosome to late endosome transpor...,38,0,0.21,1.00000,1,1,0,BP
GO:0045047,protein targeting to ER,32,0,0.18,1.00000,1,1,0,BP
GO:0045058,T cell selection,55,0,0.31,1.00000,1,1,0,BP
GO:0045061,thymic T cell selection,28,0,0.16,1.00000,1,1,0,BP
GO:0045063,T-helper 1 cell differentiation,22,0,0.12,1.00000,1,1,0,BP
GO:0045066,regulatory T cell differentiation,33,0,0.19,1.00000,1,1,0,BP
GO:0045071,negative regulation of viral genome repl...,57,0,0.32,1.00000,1,1,0,BP
GO:0045076,regulation of interleukin-2 biosynthetic...,20,0,0.11,1.00000,1,1,0,BP
GO:0045109,intermediate filament organization,26,0,0.15,1.00000,1,1,0,BP
GO:0045117,azole transport,26,0,0.15,1.00000,1,1,0,BP
GO:0045124,regulation of bone resorption,52,0,0.29,1.00000,1,1,0,BP
GO:0045132,meiotic chromosome segregation,98,0,0.55,1.00000,1,1,0,BP
GO:0045143,homologous chromosome segregation,62,0,0.35,1.00000,1,1,0,BP
GO:0045187,regulation of circadian sleep/wake cycle...,28,0,0.16,1.00000,1,1,0,BP
GO:0045191,regulation of isotype switching,40,0,0.22,1.00000,1,1,0,BP
GO:0045197,establishment or maintenance of epitheli...,42,0,0.24,1.00000,1,1,0,BP
GO:0045292,"mRNA cis splicing, via spliceosome",29,0,0.16,1.00000,1,1,0,BP
GO:0045332,phospholipid translocation,28,0,0.16,1.00000,1,1,0,BP
GO:0045428,regulation of nitric oxide biosynthetic ...,68,0,0.38,1.00000,1,1,0,BP
GO:0045429,positive regulation of nitric oxide bios...,47,0,0.26,1.00000,1,1,0,BP
GO:0045453,bone resorption,76,0,0.43,1.00000,1,1,0,BP
GO:0045454,cell redox homeostasis,63,0,0.35,1.00000,1,1,0,BP
GO:0045475,locomotor rhythm,21,0,0.12,1.00000,1,1,0,BP
GO:0045576,mast cell activation,69,0,0.39,1.00000,1,1,0,BP
GO:0045577,regulation of B cell differentiation,33,0,0.19,1.00000,1,1,0,BP
GO:0045581,negative regulation of T cell differenti...,48,0,0.27,1.00000,1,1,0,BP
GO:0045582,positive regulation of T cell differenti...,95,0,0.53,1.00000,1,1,0,BP
GO:0045589,regulation of regulatory T cell differen...,30,0,0.17,1.00000,1,1,0,BP
GO:0045600,positive regulation of fat cell differen...,62,0,0.35,1.00000,1,1,0,BP
GO:0045606,positive regulation of epidermal cell di...,22,0,0.12,1.00000,1,1,0,BP
GO:0045620,negative regulation of lymphocyte differ...,57,0,0.32,1.00000,1,1,0,BP
GO:0045621,positive regulation of lymphocyte differ...,109,0,0.61,1.00000,1,1,0,BP
GO:0045622,regulation of T-helper cell differentiat...,38,0,0.21,1.00000,1,1,0,BP
GO:0045623,negative regulation of T-helper cell dif...,20,0,0.11,1.00000,1,1,0,BP
GO:0045624,positive regulation of T-helper cell dif...,22,0,0.12,1.00000,1,1,0,BP
GO:0045638,negative regulation of myeloid cell diff...,97,0,0.54,1.00000,1,1,0,BP
GO:0045639,positive regulation of myeloid cell diff...,99,0,0.56,1.00000,1,1,0,BP
GO:0045646,regulation of erythrocyte differentiatio...,48,0,0.27,1.00000,1,1,0,BP
GO:0045648,positive regulation of erythrocyte diffe...,25,0,0.14,1.00000,1,1,0,BP
GO:0045649,regulation of macrophage differentiation,20,0,0.11,1.00000,1,1,0,BP
GO:0045652,regulation of megakaryocyte differentiat...,31,0,0.17,1.00000,1,1,0,BP
GO:0045661,regulation of myoblast differentiation,63,0,0.35,1.00000,1,1,0,BP
GO:0045662,negative regulation of myoblast differen...,31,0,0.17,1.00000,1,1,0,BP
GO:0045663,positive regulation of myoblast differen...,28,0,0.16,1.00000,1,1,0,BP
GO:0045671,negative regulation of osteoclast differ...,28,0,0.16,1.00000,1,1,0,BP
GO:0045672,positive regulation of osteoclast differ...,33,0,0.19,1.00000,1,1,0,BP
GO:0045683,negative regulation of epidermis develop...,22,0,0.12,1.00000,1,1,0,BP
GO:0045684,positive regulation of epidermis develop...,37,0,0.21,1.00000,1,1,0,BP
GO:0045686,negative regulation of glial cell differ...,35,0,0.2,1.00000,1,1,0,BP
GO:0045723,positive regulation of fatty acid biosyn...,24,0,0.13,1.00000,1,1,0,BP
GO:0045730,respiratory burst,27,0,0.15,1.00000,1,1,0,BP
GO:0045737,positive regulation of cyclin-dependent ...,26,0,0.15,1.00000,1,1,0,BP
GO:0045738,negative regulation of DNA repair,27,0,0.15,1.00000,1,1,0,BP
GO:0045742,positive regulation of epidermal growth ...,26,0,0.15,1.00000,1,1,0,BP
GO:0045744,negative regulation of G protein-coupled...,59,0,0.33,1.00000,1,1,0,BP
GO:0045745,positive regulation of G protein-coupled...,36,0,0.2,1.00000,1,1,0,BP
GO:0045746,negative regulation of Notch signaling p...,38,0,0.21,1.00000,1,1,0,BP
GO:0045747,positive regulation of Notch signaling p...,40,0,0.22,1.00000,1,1,0,BP
GO:0045761,regulation of adenylate cyclase activity,26,0,0.15,1.00000,1,1,0,BP
GO:0045776,negative regulation of blood pressure,60,0,0.34,1.00000,1,1,0,BP
GO:0045780,positive regulation of bone resorption,28,0,0.16,1.00000,1,1,0,BP
GO:0045806,negative regulation of endocytosis,59,0,0.33,1.00000,1,1,0,BP
GO:0045814,"negative regulation of gene expression, ...",90,0,0.51,1.00000,1,1,0,BP
GO:0045815,"positive regulation of gene expression, ...",36,0,0.2,1.00000,1,1,0,BP
GO:0045822,negative regulation of heart contraction,28,0,0.16,1.00000,1,1,0,BP
GO:0045823,positive regulation of heart contraction,43,0,0.24,1.00000,1,1,0,BP
GO:0045824,negative regulation of innate immune res...,60,0,0.34,1.00000,1,1,0,BP
GO:0045830,positive regulation of isotype switching,30,0,0.17,1.00000,1,1,0,BP
GO:0045838,positive regulation of membrane potentia...,20,0,0.11,1.00000,1,1,0,BP
GO:0045840,positive regulation of mitotic nuclear d...,64,0,0.36,1.00000,1,1,0,BP
GO:0045851,pH reduction,40,0,0.22,1.00000,1,1,0,BP
GO:0045880,positive regulation of smoothened signal...,38,0,0.21,1.00000,1,1,0,BP
GO:0045907,positive regulation of vasoconstriction,47,0,0.26,1.00000,1,1,0,BP
GO:0045910,negative regulation of DNA recombination,48,0,0.27,1.00000,1,1,0,BP
GO:0045911,positive regulation of DNA recombination,43,0,0.24,1.00000,1,1,0,BP
GO:0045912,negative regulation of carbohydrate meta...,52,0,0.29,1.00000,1,1,0,BP
GO:0045920,negative regulation of exocytosis,31,0,0.17,1.00000,1,1,0,BP
GO:0045921,positive regulation of exocytosis,101,0,0.57,1.00000,1,1,0,BP
GO:0045922,negative regulation of fatty acid metabo...,24,0,0.13,1.00000,1,1,0,BP
GO:0045923,positive regulation of fatty acid metabo...,42,0,0.24,1.00000,1,1,0,BP
GO:0045933,positive regulation of muscle contractio...,53,0,0.3,1.00000,1,1,0,BP
GO:0045940,positive regulation of steroid metabolic...,35,0,0.2,1.00000,1,1,0,BP
GO:0045948,positive regulation of translational ini...,21,0,0.12,1.00000,1,1,0,BP
GO:0045954,positive regulation of natural killer ce...,34,0,0.19,1.00000,1,1,0,BP
GO:0045956,positive regulation of calcium ion-depen...,28,0,0.16,1.00000,1,1,0,BP
GO:0045980,negative regulation of nucleotide metabo...,31,0,0.17,1.00000,1,1,0,BP
GO:0045987,positive regulation of smooth muscle con...,36,0,0.2,1.00000,1,1,0,BP
GO:0045992,negative regulation of embryonic develop...,29,0,0.16,1.00000,1,1,0,BP
GO:0046006,regulation of activated T cell prolifera...,39,0,0.22,1.00000,1,1,0,BP
GO:0046039,GTP metabolic process,29,0,0.16,1.00000,1,1,0,BP
GO:0046128,purine ribonucleoside metabolic process,59,0,0.33,1.00000,1,1,0,BP
GO:0046129,purine ribonucleoside biosynthetic proce...,20,0,0.11,1.00000,1,1,0,BP
GO:0046131,pyrimidine ribonucleoside metabolic proc...,20,0,0.11,1.00000,1,1,0,BP
GO:0046173,polyol biosynthetic process,71,0,0.4,1.00000,1,1,0,BP
GO:0046209,nitric oxide metabolic process,80,0,0.45,1.00000,1,1,0,BP
GO:0046320,regulation of fatty acid oxidation,35,0,0.2,1.00000,1,1,0,BP
GO:0046325,negative regulation of glucose import,21,0,0.12,1.00000,1,1,0,BP
GO:0046329,negative regulation of JNK cascade,38,0,0.21,1.00000,1,1,0,BP
GO:0046339,diacylglycerol metabolic process,22,0,0.12,1.00000,1,1,0,BP
GO:0046364,monosaccharide biosynthetic process,82,0,0.46,1.00000,1,1,0,BP
GO:0046365,monosaccharide catabolic process,30,0,0.17,1.00000,1,1,0,BP
GO:0046395,carboxylic acid catabolic process,215,0,1.21,1.00000,1,1,0,BP
GO:0046425,regulation of JAK-STAT cascade,166,0,0.93,1.00000,1,1,0,BP
GO:0046426,negative regulation of JAK-STAT cascade,25,0,0.14,1.00000,1,1,0,BP
GO:0046427,positive regulation of JAK-STAT cascade,103,0,0.58,1.00000,1,1,0,BP
GO:0046456,icosanoid biosynthetic process,39,0,0.22,1.00000,1,1,0,BP
GO:0046457,prostanoid biosynthetic process,25,0,0.14,1.00000,1,1,0,BP
GO:0046460,neutral lipid biosynthetic process,38,0,0.21,1.00000,1,1,0,BP
GO:0046461,neutral lipid catabolic process,35,0,0.2,1.00000,1,1,0,BP
GO:0046463,acylglycerol biosynthetic process,38,0,0.21,1.00000,1,1,0,BP
GO:0046464,acylglycerol catabolic process,35,0,0.2,1.00000,1,1,0,BP
GO:0046466,membrane lipid catabolic process,32,0,0.18,1.00000,1,1,0,BP
GO:0046467,membrane lipid biosynthetic process,115,0,0.65,1.00000,1,1,0,BP
GO:0046470,phosphatidylcholine metabolic process,37,0,0.21,1.00000,1,1,0,BP
GO:0046474,glycerophospholipid biosynthetic process,107,0,0.6,1.00000,1,1,0,BP
GO:0046475,glycerophospholipid catabolic process,23,0,0.13,1.00000,1,1,0,BP
GO:0046488,phosphatidylinositol metabolic process,133,0,0.75,1.00000,1,1,0,BP
GO:0046503,glycerolipid catabolic process,54,0,0.3,1.00000,1,1,0,BP
GO:0046513,ceramide biosynthetic process,56,0,0.31,1.00000,1,1,0,BP
GO:0046514,ceramide catabolic process,20,0,0.11,1.00000,1,1,0,BP
GO:0046530,photoreceptor cell differentiation,82,0,0.46,1.00000,1,1,0,BP
GO:0046580,negative regulation of Ras protein signa...,55,0,0.31,1.00000,1,1,0,BP
GO:0046596,regulation of viral entry into host cell,33,0,0.19,1.00000,1,1,0,BP
GO:0046597,negative regulation of viral entry into ...,22,0,0.12,1.00000,1,1,0,BP
GO:0046599,regulation of centriole replication,23,0,0.13,1.00000,1,1,0,BP
GO:0046605,regulation of centrosome cycle,62,0,0.35,1.00000,1,1,0,BP
GO:0046631,alpha-beta T cell activation,157,0,0.88,1.00000,1,1,0,BP
GO:0046632,alpha-beta T cell differentiation,111,0,0.62,1.00000,1,1,0,BP
GO:0046633,alpha-beta T cell proliferation,41,0,0.23,1.00000,1,1,0,BP
GO:0046634,regulation of alpha-beta T cell activati...,104,0,0.58,1.00000,1,1,0,BP
GO:0046635,positive regulation of alpha-beta T cell...,70,0,0.39,1.00000,1,1,0,BP
GO:0046636,negative regulation of alpha-beta T cell...,42,0,0.24,1.00000,1,1,0,BP
GO:0046637,regulation of alpha-beta T cell differen...,67,0,0.38,1.00000,1,1,0,BP
GO:0046638,positive regulation of alpha-beta T cell...,49,0,0.28,1.00000,1,1,0,BP
GO:0046639,negative regulation of alpha-beta T cell...,27,0,0.15,1.00000,1,1,0,BP
GO:0046640,regulation of alpha-beta T cell prolifer...,38,0,0.21,1.00000,1,1,0,BP
GO:0046641,positive regulation of alpha-beta T cell...,23,0,0.13,1.00000,1,1,0,BP
GO:0046653,tetrahydrofolate metabolic process,20,0,0.11,1.00000,1,1,0,BP
GO:0046685,response to arsenic-containing substance,24,0,0.13,1.00000,1,1,0,BP
GO:0046686,response to cadmium ion,35,0,0.2,1.00000,1,1,0,BP
GO:0046697,decidualization,21,0,0.12,1.00000,1,1,0,BP
GO:0046718,viral entry into host cell,55,0,0.31,1.00000,1,1,0,BP
GO:0046782,regulation of viral transcription,41,0,0.23,1.00000,1,1,0,BP
GO:0046834,lipid phosphorylation,53,0,0.3,1.00000,1,1,0,BP
GO:0046839,phospholipid dephosphorylation,36,0,0.2,1.00000,1,1,0,BP
GO:0046849,bone remodeling,105,0,0.59,1.00000,1,1,0,BP
GO:0046850,regulation of bone remodeling,62,0,0.35,1.00000,1,1,0,BP
GO:0046852,positive regulation of bone remodeling,28,0,0.16,1.00000,1,1,0,BP
GO:0046854,phosphatidylinositol phosphorylation,41,0,0.23,1.00000,1,1,0,BP
GO:0046856,phosphatidylinositol dephosphorylation,24,0,0.13,1.00000,1,1,0,BP
GO:0046885,regulation of hormone biosynthetic proce...,39,0,0.22,1.00000,1,1,0,BP
GO:0046902,regulation of mitochondrial membrane per...,55,0,0.31,1.00000,1,1,0,BP
GO:0046931,pore complex assembly,23,0,0.13,1.00000,1,1,0,BP
GO:0048010,vascular endothelial growth factor recep...,48,0,0.27,1.00000,1,1,0,BP
GO:0048015,phosphatidylinositol-mediated signaling,159,0,0.89,1.00000,1,1,0,BP
GO:0048016,inositol phosphate-mediated signaling,58,0,0.33,1.00000,1,1,0,BP
GO:0048017,inositol lipid-mediated signaling,162,0,0.91,1.00000,1,1,0,BP
GO:0048024,"regulation of mRNA splicing, via spliceo...",106,0,0.6,1.00000,1,1,0,BP
GO:0048025,"negative regulation of mRNA splicing, vi...",24,0,0.13,1.00000,1,1,0,BP
GO:0048026,"positive regulation of mRNA splicing, vi...",30,0,0.17,1.00000,1,1,0,BP
GO:0048103,somatic stem cell division,28,0,0.16,1.00000,1,1,0,BP
GO:0048148,behavioral response to cocaine,25,0,0.14,1.00000,1,1,0,BP
GO:0048172,regulation of short-term neuronal synapt...,20,0,0.11,1.00000,1,1,0,BP
GO:0048194,Golgi vesicle budding,34,0,0.19,1.00000,1,1,0,BP
GO:0048199,"vesicle targeting, to, from or within Go...",20,0,0.11,1.00000,1,1,0,BP
GO:0048240,sperm capacitation,34,0,0.19,1.00000,1,1,0,BP
GO:0048245,eosinophil chemotaxis,20,0,0.11,1.00000,1,1,0,BP
GO:0048246,macrophage chemotaxis,43,0,0.24,1.00000,1,1,0,BP
GO:0048259,regulation of receptor-mediated endocyto...,109,0,0.61,1.00000,1,1,0,BP
GO:0048260,positive regulation of receptor-mediated...,57,0,0.32,1.00000,1,1,0,BP
GO:0048261,negative regulation of receptor-mediated...,20,0,0.11,1.00000,1,1,0,BP
GO:0048265,response to pain,40,0,0.22,1.00000,1,1,0,BP
GO:0048266,behavioral response to pain,25,0,0.14,1.00000,1,1,0,BP
GO:0048278,vesicle docking,65,0,0.36,1.00000,1,1,0,BP
GO:0048305,immunoglobulin secretion,27,0,0.15,1.00000,1,1,0,BP
GO:0048332,mesoderm morphogenesis,69,0,0.39,1.00000,1,1,0,BP
GO:0048333,mesodermal cell differentiation,23,0,0.13,1.00000,1,1,0,BP
GO:0048483,autonomic nervous system development,49,0,0.28,1.00000,1,1,0,BP
GO:0048485,sympathetic nervous system development,23,0,0.13,1.00000,1,1,0,BP
GO:0048486,parasympathetic nervous system developme...,22,0,0.12,1.00000,1,1,0,BP
GO:0048490,anterograde synaptic vesicle transport,20,0,0.11,1.00000,1,1,0,BP
GO:0048512,circadian behavior,61,0,0.34,1.00000,1,1,0,BP
GO:0048515,spermatid differentiation,215,0,1.21,1.00000,1,1,0,BP
GO:0048520,positive regulation of behavior,40,0,0.22,1.00000,1,1,0,BP
GO:0048521,negative regulation of behavior,27,0,0.15,1.00000,1,1,0,BP
GO:0048525,negative regulation of viral process,97,0,0.54,1.00000,1,1,0,BP
GO:0048532,anatomical structure arrangement,23,0,0.13,1.00000,1,1,0,BP
GO:0048535,lymph node development,31,0,0.17,1.00000,1,1,0,BP
GO:0048536,spleen development,45,0,0.25,1.00000,1,1,0,BP
GO:0048546,digestive tract morphogenesis,54,0,0.3,1.00000,1,1,0,BP
GO:0048557,embryonic digestive tract morphogenesis,20,0,0.11,1.00000,1,1,0,BP
GO:0048566,embryonic digestive tract development,33,0,0.19,1.00000,1,1,0,BP
GO:0048569,post-embryonic animal organ development,21,0,0.12,1.00000,1,1,0,BP
GO:0048599,oocyte development,48,0,0.27,1.00000,1,1,0,BP
GO:0048643,positive regulation of skeletal muscle t...,30,0,0.17,1.00000,1,1,0,BP
GO:0048644,muscle organ morphogenesis,97,0,0.54,1.00000,1,1,0,BP
GO:0048645,animal organ formation,75,0,0.42,1.00000,1,1,0,BP
GO:0048665,neuron fate specification,37,0,0.21,1.00000,1,1,0,BP
GO:0048701,embryonic cranial skeleton morphogenesis,48,0,0.27,1.00000,1,1,0,BP
GO:0048710,regulation of astrocyte differentiation,36,0,0.2,1.00000,1,1,0,BP
GO:0048713,regulation of oligodendrocyte differenti...,52,0,0.29,1.00000,1,1,0,BP
GO:0048714,positive regulation of oligodendrocyte d...,30,0,0.17,1.00000,1,1,0,BP
GO:0048741,skeletal muscle fiber development,39,0,0.22,1.00000,1,1,0,BP
GO:0048745,smooth muscle tissue development,27,0,0.15,1.00000,1,1,0,BP
GO:0048747,muscle fiber development,81,0,0.45,1.00000,1,1,0,BP
GO:0048799,animal organ maturation,26,0,0.15,1.00000,1,1,0,BP
GO:0048814,regulation of dendrite morphogenesis,114,0,0.64,1.00000,1,1,0,BP
GO:0048820,hair follicle maturation,28,0,0.16,1.00000,1,1,0,BP
GO:0048821,erythrocyte development,39,0,0.22,1.00000,1,1,0,BP
GO:0048843,negative regulation of axon extension in...,27,0,0.15,1.00000,1,1,0,BP
GO:0048854,brain morphogenesis,44,0,0.25,1.00000,1,1,0,BP
GO:0048857,neural nucleus development,22,0,0.12,1.00000,1,1,0,BP
GO:0050000,chromosome localization,78,0,0.44,1.00000,1,1,0,BP
GO:0050434,positive regulation of viral transcripti...,20,0,0.11,1.00000,1,1,0,BP
GO:0050482,arachidonic acid secretion,31,0,0.17,1.00000,1,1,0,BP
GO:0050654,chondroitin sulfate proteoglycan metabol...,30,0,0.17,1.00000,1,1,0,BP
GO:0050670,regulation of lymphocyte proliferation,230,0,1.29,1.00000,1,1,0,BP
GO:0050671,positive regulation of lymphocyte prolif...,137,0,0.77,1.00000,1,1,0,BP
GO:0050672,negative regulation of lymphocyte prolif...,88,0,0.49,1.00000,1,1,0,BP
GO:0050679,positive regulation of epithelial cell p...,200,0,1.12,1.00000,1,1,0,BP
GO:0050684,regulation of mRNA processing,146,0,0.82,1.00000,1,1,0,BP
GO:0050685,positive regulation of mRNA processing,42,0,0.24,1.00000,1,1,0,BP
GO:0050686,negative regulation of mRNA processing,32,0,0.18,1.00000,1,1,0,BP
GO:0050687,negative regulation of defense response ...,24,0,0.13,1.00000,1,1,0,BP
GO:0050688,regulation of defense response to virus,80,0,0.45,1.00000,1,1,0,BP
GO:0050691,regulation of defense response to virus ...,44,0,0.25,1.00000,1,1,0,BP
GO:0050701,interleukin-1 secretion,62,0,0.35,1.00000,1,1,0,BP
GO:0050702,interleukin-1 beta secretion,53,0,0.3,1.00000,1,1,0,BP
GO:0050704,regulation of interleukin-1 secretion,54,0,0.3,1.00000,1,1,0,BP
GO:0050706,regulation of interleukin-1 beta secreti...,46,0,0.26,1.00000,1,1,0,BP
GO:0050710,negative regulation of cytokine secretio...,68,0,0.38,1.00000,1,1,0,BP
GO:0050716,positive regulation of interleukin-1 sec...,40,0,0.22,1.00000,1,1,0,BP
GO:0050718,positive regulation of interleukin-1 bet...,37,0,0.21,1.00000,1,1,0,BP
GO:0050732,negative regulation of peptidyl-tyrosine...,55,0,0.31,1.00000,1,1,0,BP
GO:0050765,negative regulation of phagocytosis,23,0,0.13,1.00000,1,1,0,BP
GO:0050775,positive regulation of dendrite morphoge...,55,0,0.31,1.00000,1,1,0,BP
GO:0050777,negative regulation of immune response,159,0,0.89,1.00000,1,1,0,BP
GO:0050795,regulation of behavior,95,0,0.53,1.00000,1,1,0,BP
GO:0050798,activated T cell proliferation,47,0,0.26,1.00000,1,1,0,BP
GO:0050802,"circadian sleep/wake cycle, sleep",29,0,0.16,1.00000,1,1,0,BP
GO:0050805,negative regulation of synaptic transmis...,81,0,0.45,1.00000,1,1,0,BP
GO:0050817,coagulation,161,0,0.9,1.00000,1,1,0,BP
GO:0050818,regulation of coagulation,82,0,0.46,1.00000,1,1,0,BP
GO:0050819,negative regulation of coagulation,51,0,0.29,1.00000,1,1,0,BP
GO:0050820,positive regulation of coagulation,29,0,0.16,1.00000,1,1,0,BP
GO:0050829,defense response to Gram-negative bacter...,94,0,0.53,1.00000,1,1,0,BP
GO:0050832,defense response to fungus,25,0,0.14,1.00000,1,1,0,BP
GO:0050848,regulation of calcium-mediated signaling,102,0,0.57,1.00000,1,1,0,BP
GO:0050849,negative regulation of calcium-mediated ...,28,0,0.16,1.00000,1,1,0,BP
GO:0050850,positive regulation of calcium-mediated ...,48,0,0.27,1.00000,1,1,0,BP
GO:0050853,B cell receptor signaling pathway,48,0,0.27,1.00000,1,1,0,BP
GO:0050854,regulation of antigen receptor-mediated ...,57,0,0.32,1.00000,1,1,0,BP
GO:0050856,regulation of T cell receptor signaling ...,41,0,0.23,1.00000,1,1,0,BP
GO:0050857,positive regulation of antigen receptor-...,22,0,0.12,1.00000,1,1,0,BP
GO:0050858,negative regulation of antigen receptor-...,26,0,0.15,1.00000,1,1,0,BP
GO:0050864,regulation of B cell activation,136,0,0.76,1.00000,1,1,0,BP
GO:0050866,negative regulation of cell activation,208,0,1.17,1.00000,1,1,0,BP
GO:0050868,negative regulation of T cell activation,123,0,0.69,1.00000,1,1,0,BP
GO:0050869,negative regulation of B cell activation,36,0,0.2,1.00000,1,1,0,BP
GO:0050871,positive regulation of B cell activation,85,0,0.48,1.00000,1,1,0,BP
GO:0050873,brown fat cell differentiation,49,0,0.28,1.00000,1,1,0,BP
GO:0050891,multicellular organismal water homeostas...,50,0,0.28,1.00000,1,1,0,BP
GO:0050892,intestinal absorption,38,0,0.21,1.00000,1,1,0,BP
GO:0050906,detection of stimulus involved in sensor...,133,0,0.75,1.00000,1,1,0,BP
GO:0050907,detection of chemical stimulus involved ...,59,0,0.33,1.00000,1,1,0,BP
GO:0050908,detection of light stimulus involved in ...,21,0,0.12,1.00000,1,1,0,BP
GO:0050909,sensory perception of taste,70,0,0.39,1.00000,1,1,0,BP
GO:0050910,detection of mechanical stimulus involve...,20,0,0.11,1.00000,1,1,0,BP
GO:0050912,detection of chemical stimulus involved ...,52,0,0.29,1.00000,1,1,0,BP
GO:0050913,sensory perception of bitter taste,51,0,0.29,1.00000,1,1,0,BP
GO:0050919,negative chemotaxis,45,0,0.25,1.00000,1,1,0,BP
GO:0050922,negative regulation of chemotaxis,55,0,0.31,1.00000,1,1,0,BP
GO:0050926,regulation of positive chemotaxis,27,0,0.15,1.00000,1,1,0,BP
GO:0050927,positive regulation of positive chemotax...,26,0,0.15,1.00000,1,1,0,BP
GO:0050951,sensory perception of temperature stimul...,26,0,0.15,1.00000,1,1,0,BP
GO:0050962,detection of light stimulus involved in ...,21,0,0.12,1.00000,1,1,0,BP
GO:0050966,detection of mechanical stimulus involve...,20,0,0.11,1.00000,1,1,0,BP
GO:0050974,detection of mechanical stimulus involve...,45,0,0.25,1.00000,1,1,0,BP
GO:0050982,detection of mechanical stimulus,60,0,0.34,1.00000,1,1,0,BP
GO:0050994,regulation of lipid catabolic process,57,0,0.32,1.00000,1,1,0,BP
GO:0050995,negative regulation of lipid catabolic p...,24,0,0.13,1.00000,1,1,0,BP
GO:0050996,positive regulation of lipid catabolic p...,27,0,0.15,1.00000,1,1,0,BP
GO:0051016,barbed-end actin filament capping,21,0,0.12,1.00000,1,1,0,BP
GO:0051023,regulation of immunoglobulin secretion,21,0,0.12,1.00000,1,1,0,BP
GO:0051058,negative regulation of small GTPase medi...,61,0,0.34,1.00000,1,1,0,BP
GO:0051101,regulation of DNA binding,130,0,0.73,1.00000,1,1,0,BP
GO:0051123,RNA polymerase II preinitiation complex ...,26,0,0.15,1.00000,1,1,0,BP
GO:0051125,regulation of actin nucleation,27,0,0.15,1.00000,1,1,0,BP
GO:0051149,positive regulation of muscle cell diffe...,89,0,0.5,1.00000,1,1,0,BP
GO:0051155,positive regulation of striated muscle c...,74,0,0.42,1.00000,1,1,0,BP
GO:0051180,vitamin transport,32,0,0.18,1.00000,1,1,0,BP
GO:0051181,cofactor transport,36,0,0.2,1.00000,1,1,0,BP
GO:0051187,cofactor catabolic process,55,0,0.31,1.00000,1,1,0,BP
GO:0051195,negative regulation of cofactor metaboli...,21,0,0.12,1.00000,1,1,0,BP
GO:0051205,protein insertion into membrane,25,0,0.14,1.00000,1,1,0,BP
GO:0051208,sequestering of calcium ion,120,0,0.67,1.00000,1,1,0,BP
GO:0051209,release of sequestered calcium ion into ...,115,0,0.65,1.00000,1,1,0,BP
GO:0051250,negative regulation of lymphocyte activa...,157,0,0.88,1.00000,1,1,0,BP
GO:0051262,protein tetramerization,184,0,1.03,1.00000,1,1,0,BP
GO:0051279,regulation of release of sequestered cal...,79,0,0.44,1.00000,1,1,0,BP
GO:0051281,positive regulation of release of seques...,41,0,0.23,1.00000,1,1,0,BP
GO:0051282,regulation of sequestering of calcium io...,119,0,0.67,1.00000,1,1,0,BP
GO:0051283,negative regulation of sequestering of c...,117,0,0.66,1.00000,1,1,0,BP
GO:0051289,protein homotetramerization,104,0,0.58,1.00000,1,1,0,BP
GO:0051290,protein heterotetramerization,54,0,0.3,1.00000,1,1,0,BP
GO:0051294,establishment of spindle orientation,36,0,0.2,1.00000,1,1,0,BP
GO:0051298,centrosome duplication,69,0,0.39,1.00000,1,1,0,BP
GO:0051303,establishment of chromosome localization,77,0,0.43,1.00000,1,1,0,BP
GO:0051307,meiotic chromosome separation,28,0,0.16,1.00000,1,1,0,BP
GO:0051310,metaphase plate congression,58,0,0.33,1.00000,1,1,0,BP
GO:0051339,regulation of lyase activity,40,0,0.22,1.00000,1,1,0,BP
GO:0051349,positive regulation of lyase activity,20,0,0.11,1.00000,1,1,0,BP
GO:0051354,negative regulation of oxidoreductase ac...,28,0,0.16,1.00000,1,1,0,BP
GO:0051446,positive regulation of meiotic cell cycl...,28,0,0.16,1.00000,1,1,0,BP
GO:0051447,negative regulation of meiotic cell cycl...,20,0,0.11,1.00000,1,1,0,BP
GO:0051450,myoblast proliferation,21,0,0.12,1.00000,1,1,0,BP
GO:0051452,intracellular pH reduction,35,0,0.2,1.00000,1,1,0,BP
GO:0051453,regulation of intracellular pH,69,0,0.39,1.00000,1,1,0,BP
GO:0051457,maintenance of protein location in nucle...,24,0,0.13,1.00000,1,1,0,BP
GO:0051489,regulation of filopodium assembly,47,0,0.26,1.00000,1,1,0,BP
GO:0051491,positive regulation of filopodium assemb...,31,0,0.17,1.00000,1,1,0,BP
GO:0051497,negative regulation of stress fiber asse...,26,0,0.15,1.00000,1,1,0,BP
GO:0051560,mitochondrial calcium ion homeostasis,27,0,0.15,1.00000,1,1,0,BP
GO:0051568,histone H3-K4 methylation,54,0,0.3,1.00000,1,1,0,BP
GO:0051569,regulation of histone H3-K4 methylation,30,0,0.17,1.00000,1,1,0,BP
GO:0051590,positive regulation of neurotransmitter ...,51,0,0.29,1.00000,1,1,0,BP
GO:0051604,protein maturation,300,0,1.68,1.00000,1,1,0,BP
GO:0051606,detection of stimulus,231,0,1.3,1.00000,1,1,0,BP
GO:0051647,nucleus localization,38,0,0.21,1.00000,1,1,0,BP
GO:0051673,membrane disruption in other organism,28,0,0.16,1.00000,1,1,0,BP
GO:0051701,interaction with host,118,0,0.66,1.00000,1,1,0,BP
GO:0051703,intraspecies interaction between organis...,53,0,0.3,1.00000,1,1,0,BP
GO:0051767,nitric-oxide synthase biosynthetic proce...,27,0,0.15,1.00000,1,1,0,BP
GO:0051769,regulation of nitric-oxide synthase bios...,27,0,0.15,1.00000,1,1,0,BP
GO:0051770,positive regulation of nitric-oxide synt...,21,0,0.12,1.00000,1,1,0,BP
GO:0051785,positive regulation of nuclear division,80,0,0.45,1.00000,1,1,0,BP
GO:0051788,response to misfolded protein,25,0,0.14,1.00000,1,1,0,BP
GO:0051797,regulation of hair follicle development,22,0,0.12,1.00000,1,1,0,BP
GO:0051806,entry into cell of other organism involv...,59,0,0.33,1.00000,1,1,0,BP
GO:0051817,modification of morphology or physiology...,95,0,0.53,1.00000,1,1,0,BP
GO:0051818,disruption of cells of other organism in...,21,0,0.12,1.00000,1,1,0,BP
GO:0051828,entry into other organism involved in sy...,59,0,0.33,1.00000,1,1,0,BP
GO:0051851,modification by host of symbiont morphol...,75,0,0.42,1.00000,1,1,0,BP
GO:0051875,pigment granule localization,23,0,0.13,1.00000,1,1,0,BP
GO:0051882,mitochondrial depolarization,24,0,0.13,1.00000,1,1,0,BP
GO:0051883,killing of cells in other organism invol...,21,0,0.12,1.00000,1,1,0,BP
GO:0051898,negative regulation of protein kinase B ...,44,0,0.25,1.00000,1,1,0,BP
GO:0051899,membrane depolarization,82,0,0.46,1.00000,1,1,0,BP
GO:0051900,regulation of mitochondrial depolarizati...,21,0,0.12,1.00000,1,1,0,BP
GO:0051905,establishment of pigment granule localiz...,20,0,0.11,1.00000,1,1,0,BP
GO:0051926,negative regulation of calcium ion trans...,65,0,0.36,1.00000,1,1,0,BP
GO:0051930,regulation of sensory perception of pain,54,0,0.3,1.00000,1,1,0,BP
GO:0051931,regulation of sensory perception,55,0,0.31,1.00000,1,1,0,BP
GO:0051953,negative regulation of amine transport,36,0,0.2,1.00000,1,1,0,BP
GO:0051955,regulation of amino acid transport,50,0,0.28,1.00000,1,1,0,BP
GO:0051957,positive regulation of amino acid transp...,28,0,0.16,1.00000,1,1,0,BP
GO:0051965,positive regulation of synapse assembly,77,0,0.43,1.00000,1,1,0,BP
GO:0051966,"regulation of synaptic transmission, glu...",78,0,0.44,1.00000,1,1,0,BP
GO:0051968,positive regulation of synaptic transmis...,40,0,0.22,1.00000,1,1,0,BP
GO:0051969,regulation of transmission of nerve impu...,23,0,0.13,1.00000,1,1,0,BP
GO:0051984,positive regulation of chromosome segreg...,29,0,0.16,1.00000,1,1,0,BP
GO:0052126,movement in host environment,34,0,0.19,1.00000,1,1,0,BP
GO:0052192,movement in environment of other organis...,34,0,0.19,1.00000,1,1,0,BP
GO:0052312,modulation of transcription in other org...,24,0,0.13,1.00000,1,1,0,BP
GO:0052472,modulation by host of symbiont transcrip...,24,0,0.13,1.00000,1,1,0,BP
GO:0052652,cyclic purine nucleotide metabolic proce...,24,0,0.13,1.00000,1,1,0,BP
GO:0055003,cardiac myofibril assembly,26,0,0.15,1.00000,1,1,0,BP
GO:0055008,cardiac muscle tissue morphogenesis,76,0,0.43,1.00000,1,1,0,BP
GO:0055010,ventricular cardiac muscle tissue morpho...,53,0,0.3,1.00000,1,1,0,BP
GO:0055064,chloride ion homeostasis,20,0,0.11,1.00000,1,1,0,BP
GO:0055067,monovalent inorganic cation homeostasis,150,0,0.84,1.00000,1,1,0,BP
GO:0055069,zinc ion homeostasis,27,0,0.15,1.00000,1,1,0,BP
GO:0055075,potassium ion homeostasis,31,0,0.17,1.00000,1,1,0,BP
GO:0055078,sodium ion homeostasis,54,0,0.3,1.00000,1,1,0,BP
GO:0055081,anion homeostasis,68,0,0.38,1.00000,1,1,0,BP
GO:0055083,monovalent inorganic anion homeostasis,35,0,0.2,1.00000,1,1,0,BP
GO:0055090,acylglycerol homeostasis,35,0,0.2,1.00000,1,1,0,BP
GO:0055094,response to lipoprotein particle,25,0,0.14,1.00000,1,1,0,BP
GO:0055117,regulation of cardiac muscle contraction,69,0,0.39,1.00000,1,1,0,BP
GO:0060004,reflex,25,0,0.14,1.00000,1,1,0,BP
GO:0060037,pharyngeal system development,28,0,0.16,1.00000,1,1,0,BP
GO:0060039,pericardium development,29,0,0.16,1.00000,1,1,0,BP
GO:0060042,retina morphogenesis in camera-type eye,65,0,0.36,1.00000,1,1,0,BP
GO:0060048,cardiac muscle contraction,127,0,0.71,1.00000,1,1,0,BP
GO:0060065,uterus development,26,0,0.15,1.00000,1,1,0,BP
GO:0060071,"Wnt signaling pathway, planar cell polar...",40,0,0.22,1.00000,1,1,0,BP
GO:0060074,synapse maturation,31,0,0.17,1.00000,1,1,0,BP
GO:0060080,inhibitory postsynaptic potential,23,0,0.13,1.00000,1,1,0,BP
GO:0060099,"regulation of phagocytosis, engulfment",20,0,0.11,1.00000,1,1,0,BP
GO:0060135,maternal process involved in female preg...,47,0,0.26,1.00000,1,1,0,BP
GO:0060142,regulation of syncytium formation by pla...,37,0,0.21,1.00000,1,1,0,BP
GO:0060143,positive regulation of syncytium formati...,32,0,0.18,1.00000,1,1,0,BP
GO:0060147,regulation of posttranscriptional gene s...,47,0,0.26,1.00000,1,1,0,BP
GO:0060148,positive regulation of posttranscription...,26,0,0.15,1.00000,1,1,0,BP
GO:0060216,definitive hemopoiesis,24,0,0.13,1.00000,1,1,0,BP
GO:0060218,hematopoietic stem cell differentiation,30,0,0.17,1.00000,1,1,0,BP
GO:0060219,camera-type eye photoreceptor cell diffe...,28,0,0.16,1.00000,1,1,0,BP
GO:0060252,positive regulation of glial cell prolif...,20,0,0.11,1.00000,1,1,0,BP
GO:0060259,regulation of feeding behavior,38,0,0.21,1.00000,1,1,0,BP
GO:0060260,regulation of transcription initiation f...,29,0,0.16,1.00000,1,1,0,BP
GO:0060261,positive regulation of transcription ini...,23,0,0.13,1.00000,1,1,0,BP
GO:0060285,cilium-dependent cell motility,35,0,0.2,1.00000,1,1,0,BP
GO:0060292,long-term synaptic depression,35,0,0.2,1.00000,1,1,0,BP
GO:0060294,cilium movement involved in cell motilit...,20,0,0.11,1.00000,1,1,0,BP
GO:0060306,regulation of membrane repolarization,32,0,0.18,1.00000,1,1,0,BP
GO:0060307,regulation of ventricular cardiac muscle...,20,0,0.11,1.00000,1,1,0,BP
GO:0060317,cardiac epithelial to mesenchymal transi...,30,0,0.17,1.00000,1,1,0,BP
GO:0060333,interferon-gamma-mediated signaling path...,23,0,0.13,1.00000,1,1,0,BP
GO:0060337,type I interferon signaling pathway,39,0,0.22,1.00000,1,1,0,BP
GO:0060338,regulation of type I interferon-mediated...,25,0,0.14,1.00000,1,1,0,BP
GO:0060343,trabecula formation,27,0,0.15,1.00000,1,1,0,BP
GO:0060350,endochondral bone morphogenesis,75,0,0.42,1.00000,1,1,0,BP
GO:0060351,cartilage development involved in endoch...,52,0,0.29,1.00000,1,1,0,BP
GO:0060384,innervation,29,0,0.16,1.00000,1,1,0,BP
GO:0060389,pathway-restricted SMAD protein phosphor...,66,0,0.37,1.00000,1,1,0,BP
GO:0060393,regulation of pathway-restricted SMAD pr...,63,0,0.35,1.00000,1,1,0,BP
GO:0060401,cytosolic calcium ion transport,170,0,0.95,1.00000,1,1,0,BP
GO:0060402,calcium ion transport into cytosol,157,0,0.88,1.00000,1,1,0,BP
GO:0060411,cardiac septum morphogenesis,86,0,0.48,1.00000,1,1,0,BP
GO:0060412,ventricular septum morphogenesis,51,0,0.29,1.00000,1,1,0,BP
GO:0060415,muscle tissue morphogenesis,89,0,0.5,1.00000,1,1,0,BP
GO:0060438,trachea development,22,0,0.12,1.00000,1,1,0,BP
GO:0060444,branching involved in mammary gland duct...,28,0,0.16,1.00000,1,1,0,BP
GO:0060445,branching involved in salivary gland mor...,28,0,0.16,1.00000,1,1,0,BP
GO:0060456,positive regulation of digestive system ...,20,0,0.11,1.00000,1,1,0,BP
GO:0060512,prostate gland morphogenesis,34,0,0.19,1.00000,1,1,0,BP
GO:0060536,cartilage morphogenesis,27,0,0.15,1.00000,1,1,0,BP
GO:0060571,morphogenesis of an epithelial fold,30,0,0.17,1.00000,1,1,0,BP
GO:0060575,intestinal epithelial cell differentiati...,22,0,0.12,1.00000,1,1,0,BP
GO:0060603,mammary gland duct morphogenesis,40,0,0.22,1.00000,1,1,0,BP
GO:0060612,adipose tissue development,50,0,0.28,1.00000,1,1,0,BP
GO:0060632,regulation of microtubule-based movement,31,0,0.17,1.00000,1,1,0,BP
GO:0060669,embryonic placenta morphogenesis,32,0,0.18,1.00000,1,1,0,BP
GO:0060674,placenta blood vessel development,37,0,0.21,1.00000,1,1,0,BP
GO:0060675,ureteric bud morphogenesis,71,0,0.4,1.00000,1,1,0,BP
GO:0060688,regulation of morphogenesis of a branchi...,67,0,0.38,1.00000,1,1,0,BP
GO:0060706,cell differentiation involved in embryon...,33,0,0.19,1.00000,1,1,0,BP
GO:0060711,labyrinthine layer development,59,0,0.33,1.00000,1,1,0,BP
GO:0060713,labyrinthine layer morphogenesis,27,0,0.15,1.00000,1,1,0,BP
GO:0060716,labyrinthine layer blood vessel developm...,26,0,0.15,1.00000,1,1,0,BP
GO:0060740,prostate gland epithelium morphogenesis,33,0,0.19,1.00000,1,1,0,BP
GO:0060749,mammary gland alveolus development,22,0,0.12,1.00000,1,1,0,BP
GO:0060759,regulation of response to cytokine stimu...,123,0,0.69,1.00000,1,1,0,BP
GO:0060760,positive regulation of response to cytok...,56,0,0.31,1.00000,1,1,0,BP
GO:0060761,negative regulation of response to cytok...,56,0,0.31,1.00000,1,1,0,BP
GO:0060765,regulation of androgen receptor signalin...,28,0,0.16,1.00000,1,1,0,BP
GO:0060795,cell fate commitment involved in formati...,31,0,0.17,1.00000,1,1,0,BP
GO:0060914,heart formation,31,0,0.17,1.00000,1,1,0,BP
GO:0060964,regulation of gene silencing by miRNA,44,0,0.25,1.00000,1,1,0,BP
GO:0060966,regulation of gene silencing by RNA,47,0,0.26,1.00000,1,1,0,BP
GO:0060968,regulation of gene silencing,95,0,0.53,1.00000,1,1,0,BP
GO:0060969,negative regulation of gene silencing,36,0,0.2,1.00000,1,1,0,BP
GO:0060977,coronary vasculature morphogenesis,32,0,0.18,1.00000,1,1,0,BP
GO:0061001,regulation of dendritic spine morphogene...,51,0,0.29,1.00000,1,1,0,BP
GO:0061003,positive regulation of dendritic spine m...,27,0,0.15,1.00000,1,1,0,BP
GO:0061008,hepaticobiliary system development,125,0,0.7,1.00000,1,1,0,BP
GO:0061035,regulation of cartilage development,69,0,0.39,1.00000,1,1,0,BP
GO:0061036,positive regulation of cartilage develop...,31,0,0.17,1.00000,1,1,0,BP
GO:0061037,negative regulation of cartilage develop...,30,0,0.17,1.00000,1,1,0,BP
GO:0061041,regulation of wound healing,143,0,0.8,1.00000,1,1,0,BP
GO:0061045,negative regulation of wound healing,71,0,0.4,1.00000,1,1,0,BP
GO:0061050,regulation of cell growth involved in ca...,28,0,0.16,1.00000,1,1,0,BP
GO:0061082,myeloid leukocyte cytokine production,30,0,0.17,1.00000,1,1,0,BP
GO:0061098,positive regulation of protein tyrosine ...,44,0,0.25,1.00000,1,1,0,BP
GO:0061099,negative regulation of protein tyrosine ...,27,0,0.15,1.00000,1,1,0,BP
GO:0061162,establishment of monopolar cell polarity,20,0,0.11,1.00000,1,1,0,BP
GO:0061180,mammary gland epithelium development,78,0,0.44,1.00000,1,1,0,BP
GO:0061213,positive regulation of mesonephros devel...,25,0,0.14,1.00000,1,1,0,BP
GO:0061217,regulation of mesonephros development,28,0,0.16,1.00000,1,1,0,BP
GO:0061245,establishment or maintenance of bipolar ...,50,0,0.28,1.00000,1,1,0,BP
GO:0061298,retina vasculature development in camera...,27,0,0.15,1.00000,1,1,0,BP
GO:0061311,cell surface receptor signaling pathway ...,28,0,0.16,1.00000,1,1,0,BP
GO:0061323,cell proliferation involved in heart mor...,21,0,0.12,1.00000,1,1,0,BP
GO:0061333,renal tubule morphogenesis,85,0,0.48,1.00000,1,1,0,BP
GO:0061337,cardiac conduction,58,0,0.33,1.00000,1,1,0,BP
GO:0061339,establishment or maintenance of monopola...,21,0,0.12,1.00000,1,1,0,BP
GO:0061377,mammary gland lobule development,22,0,0.12,1.00000,1,1,0,BP
GO:0061383,trabecula morphogenesis,53,0,0.3,1.00000,1,1,0,BP
GO:0061384,heart trabecula morphogenesis,36,0,0.2,1.00000,1,1,0,BP
GO:0061436,establishment of skin barrier,26,0,0.15,1.00000,1,1,0,BP
GO:0061437,renal system vasculature development,27,0,0.15,1.00000,1,1,0,BP
GO:0061440,kidney vasculature development,27,0,0.15,1.00000,1,1,0,BP
GO:0061462,protein localization to lysosome,39,0,0.22,1.00000,1,1,0,BP
GO:0061478,response to platelet aggregation inhibit...,66,0,0.37,1.00000,1,1,0,BP
GO:0061512,protein localization to cilium,58,0,0.33,1.00000,1,1,0,BP
GO:0061614,pri-miRNA transcription by RNA polymeras...,52,0,0.29,1.00000,1,1,0,BP
GO:0061982,meiosis I cell cycle process,117,0,0.66,1.00000,1,1,0,BP
GO:0062009,secondary palate development,24,0,0.13,1.00000,1,1,0,BP
GO:0065005,protein-lipid complex assembly,24,0,0.13,1.00000,1,1,0,BP
GO:0070076,histone lysine demethylation,28,0,0.16,1.00000,1,1,0,BP
GO:0070129,regulation of mitochondrial translation,27,0,0.15,1.00000,1,1,0,BP
GO:0070168,negative regulation of biomineral tissue...,26,0,0.15,1.00000,1,1,0,BP
GO:0070193,synaptonemal complex organization,25,0,0.14,1.00000,1,1,0,BP
GO:0070199,establishment of protein localization to...,24,0,0.13,1.00000,1,1,0,BP
GO:0070206,protein trimerization,62,0,0.35,1.00000,1,1,0,BP
GO:0070207,protein homotrimerization,40,0,0.22,1.00000,1,1,0,BP
GO:0070227,lymphocyte apoptotic process,98,0,0.55,1.00000,1,1,0,BP
GO:0070228,regulation of lymphocyte apoptotic proce...,76,0,0.43,1.00000,1,1,0,BP
GO:0070229,negative regulation of lymphocyte apopto...,49,0,0.28,1.00000,1,1,0,BP
GO:0070230,positive regulation of lymphocyte apopto...,21,0,0.12,1.00000,1,1,0,BP
GO:0070231,T cell apoptotic process,58,0,0.33,1.00000,1,1,0,BP
GO:0070232,regulation of T cell apoptotic process,43,0,0.24,1.00000,1,1,0,BP
GO:0070233,negative regulation of T cell apoptotic ...,26,0,0.15,1.00000,1,1,0,BP
GO:0070242,thymocyte apoptotic process,22,0,0.12,1.00000,1,1,0,BP
GO:0070265,necrotic cell death,54,0,0.3,1.00000,1,1,0,BP
GO:0070266,necroptotic process,30,0,0.17,1.00000,1,1,0,BP
GO:0070269,pyroptosis,23,0,0.13,1.00000,1,1,0,BP
GO:0070286,axonemal dynein complex assembly,32,0,0.18,1.00000,1,1,0,BP
GO:0070296,sarcoplasmic reticulum calcium ion trans...,29,0,0.16,1.00000,1,1,0,BP
GO:0070303,negative regulation of stress-activated ...,46,0,0.26,1.00000,1,1,0,BP
GO:0070328,triglyceride homeostasis,35,0,0.2,1.00000,1,1,0,BP
GO:0070498,interleukin-1-mediated signaling pathway,20,0,0.11,1.00000,1,1,0,BP
GO:0070509,calcium ion import,87,0,0.49,1.00000,1,1,0,BP
GO:0070527,platelet aggregation,45,0,0.25,1.00000,1,1,0,BP
GO:0070528,protein kinase C signaling,39,0,0.22,1.00000,1,1,0,BP
GO:0070534,protein K63-linked ubiquitination,47,0,0.26,1.00000,1,1,0,BP
GO:0070536,protein K63-linked deubiquitination,31,0,0.17,1.00000,1,1,0,BP
GO:0070613,regulation of protein processing,81,0,0.45,1.00000,1,1,0,BP
GO:0070633,transepithelial transport,21,0,0.12,1.00000,1,1,0,BP
GO:0070663,regulation of leukocyte proliferation,245,0,1.38,1.00000,1,1,0,BP
GO:0070664,negative regulation of leukocyte prolife...,93,0,0.52,1.00000,1,1,0,BP
GO:0070665,positive regulation of leukocyte prolife...,146,0,0.82,1.00000,1,1,0,BP
GO:0070734,histone H3-K27 methylation,22,0,0.12,1.00000,1,1,0,BP
GO:0070741,response to interleukin-6,32,0,0.18,1.00000,1,1,0,BP
GO:0070841,inclusion body assembly,22,0,0.12,1.00000,1,1,0,BP
GO:0070861,regulation of protein exit from endoplas...,26,0,0.15,1.00000,1,1,0,BP
GO:0070884,regulation of calcineurin-NFAT signaling...,41,0,0.23,1.00000,1,1,0,BP
GO:0070897,transcription preinitiation complex asse...,33,0,0.19,1.00000,1,1,0,BP
GO:0070918,production of small RNA involved in gene...,49,0,0.28,1.00000,1,1,0,BP
GO:0070920,regulation of production of small RNA in...,21,0,0.12,1.00000,1,1,0,BP
GO:0070972,protein localization to endoplasmic reti...,58,0,0.33,1.00000,1,1,0,BP
GO:0070977,bone maturation,22,0,0.12,1.00000,1,1,0,BP
GO:0070979,protein K11-linked ubiquitination,30,0,0.17,1.00000,1,1,0,BP
GO:0070988,demethylation,64,0,0.36,1.00000,1,1,0,BP
GO:0071108,protein K48-linked deubiquitination,28,0,0.16,1.00000,1,1,0,BP
GO:0071168,protein localization to chromatin,28,0,0.16,1.00000,1,1,0,BP
GO:0071218,cellular response to misfolded protein,23,0,0.13,1.00000,1,1,0,BP
GO:0071234,cellular response to phenylalanine,25,0,0.14,1.00000,1,1,0,BP
GO:0071276,cellular response to cadmium ion,23,0,0.13,1.00000,1,1,0,BP
GO:0071347,cellular response to interleukin-1,76,0,0.43,1.00000,1,1,0,BP
GO:0071354,cellular response to interleukin-6,30,0,0.17,1.00000,1,1,0,BP
GO:0071356,cellular response to tumor necrosis fact...,161,0,0.9,1.00000,1,1,0,BP
GO:0071357,cellular response to type I interferon,39,0,0.22,1.00000,1,1,0,BP
GO:0071359,cellular response to dsRNA,22,0,0.12,1.00000,1,1,0,BP
GO:0071361,cellular response to ethanol,27,0,0.15,1.00000,1,1,0,BP
GO:0071391,cellular response to estrogen stimulus,38,0,0.21,1.00000,1,1,0,BP
GO:0071392,cellular response to estradiol stimulus,24,0,0.13,1.00000,1,1,0,BP
GO:0071398,cellular response to fatty acid,37,0,0.21,1.00000,1,1,0,BP
GO:0071402,cellular response to lipoprotein particl...,27,0,0.15,1.00000,1,1,0,BP
GO:0071425,hematopoietic stem cell proliferation,26,0,0.15,1.00000,1,1,0,BP
GO:0071459,"protein localization to chromosome, cent...",22,0,0.12,1.00000,1,1,0,BP
GO:0071467,cellular response to pH,23,0,0.13,1.00000,1,1,0,BP
GO:0071470,cellular response to osmotic stress,51,0,0.29,1.00000,1,1,0,BP
GO:0071472,cellular response to salt stress,29,0,0.16,1.00000,1,1,0,BP
GO:0071474,cellular hyperosmotic response,27,0,0.15,1.00000,1,1,0,BP
GO:0071475,cellular hyperosmotic salinity response,23,0,0.13,1.00000,1,1,0,BP
GO:0071514,genetic imprinting,38,0,0.21,1.00000,1,1,0,BP
GO:0071526,semaphorin-plexin signaling pathway,45,0,0.25,1.00000,1,1,0,BP
GO:0071542,dopaminergic neuron differentiation,40,0,0.22,1.00000,1,1,0,BP
GO:0071548,response to dexamethasone,31,0,0.17,1.00000,1,1,0,BP
GO:0071549,cellular response to dexamethasone stimu...,28,0,0.16,1.00000,1,1,0,BP
GO:0071577,zinc ion transmembrane transport,23,0,0.13,1.00000,1,1,0,BP
GO:0071604,transforming growth factor beta producti...,36,0,0.2,1.00000,1,1,0,BP
GO:0071605,monocyte chemotactic protein-1 productio...,20,0,0.11,1.00000,1,1,0,BP
GO:0071616,acyl-CoA biosynthetic process,25,0,0.14,1.00000,1,1,0,BP
GO:0071621,granulocyte chemotaxis,124,0,0.7,1.00000,1,1,0,BP
GO:0071622,regulation of granulocyte chemotaxis,50,0,0.28,1.00000,1,1,0,BP
GO:0071624,positive regulation of granulocyte chemo...,27,0,0.15,1.00000,1,1,0,BP
GO:0071634,regulation of transforming growth factor...,34,0,0.19,1.00000,1,1,0,BP
GO:0071637,regulation of monocyte chemotactic prote...,20,0,0.11,1.00000,1,1,0,BP
GO:0071674,mononuclear cell migration,82,0,0.46,1.00000,1,1,0,BP
GO:0071675,regulation of mononuclear cell migration,50,0,0.28,1.00000,1,1,0,BP
GO:0071677,positive regulation of mononuclear cell ...,25,0,0.14,1.00000,1,1,0,BP
GO:0071684,organism emergence from protective struc...,40,0,0.22,1.00000,1,1,0,BP
GO:0071711,basement membrane organization,25,0,0.14,1.00000,1,1,0,BP
GO:0071715,icosanoid transport,53,0,0.3,1.00000,1,1,0,BP
GO:0071774,response to fibroblast growth factor,90,0,0.51,1.00000,1,1,0,BP
GO:0071800,podosome assembly,22,0,0.12,1.00000,1,1,0,BP
GO:0071825,protein-lipid complex subunit organizati...,37,0,0.21,1.00000,1,1,0,BP
GO:0071827,plasma lipoprotein particle organization,33,0,0.19,1.00000,1,1,0,BP
GO:0071887,leukocyte apoptotic process,132,0,0.74,1.00000,1,1,0,BP
GO:0071985,multivesicular body sorting pathway,32,0,0.18,1.00000,1,1,0,BP
GO:0072012,glomerulus vasculature development,26,0,0.15,1.00000,1,1,0,BP
GO:0072028,nephron morphogenesis,82,0,0.46,1.00000,1,1,0,BP
GO:0072078,nephron tubule morphogenesis,79,0,0.44,1.00000,1,1,0,BP
GO:0072079,nephron tubule formation,20,0,0.11,1.00000,1,1,0,BP
GO:0072087,renal vesicle development,20,0,0.11,1.00000,1,1,0,BP
GO:0072088,nephron epithelium morphogenesis,81,0,0.45,1.00000,1,1,0,BP
GO:0072111,cell proliferation involved in kidney de...,22,0,0.12,1.00000,1,1,0,BP
GO:0072132,mesenchyme morphogenesis,51,0,0.29,1.00000,1,1,0,BP
GO:0072163,mesonephric epithelium development,104,0,0.58,1.00000,1,1,0,BP
GO:0072164,mesonephric tubule development,104,0,0.58,1.00000,1,1,0,BP
GO:0072171,mesonephric tubule morphogenesis,72,0,0.4,1.00000,1,1,0,BP
GO:0072210,metanephric nephron development,38,0,0.21,1.00000,1,1,0,BP
GO:0072273,metanephric nephron morphogenesis,22,0,0.12,1.00000,1,1,0,BP
GO:0072329,monocarboxylic acid catabolic process,112,0,0.63,1.00000,1,1,0,BP
GO:0072332,intrinsic apoptotic signaling pathway by...,77,0,0.43,1.00000,1,1,0,BP
GO:0072337,modified amino acid transport,23,0,0.13,1.00000,1,1,0,BP
GO:0072350,tricarboxylic acid metabolic process,37,0,0.21,1.00000,1,1,0,BP
GO:0072376,protein activation cascade,64,0,0.36,1.00000,1,1,0,BP
GO:0072395,signal transduction involved in cell cyc...,29,0,0.16,1.00000,1,1,0,BP
GO:0072401,signal transduction involved in DNA inte...,29,0,0.16,1.00000,1,1,0,BP
GO:0072422,signal transduction involved in DNA dama...,29,0,0.16,1.00000,1,1,0,BP
GO:0072527,pyrimidine-containing compound metabolic...,51,0,0.29,1.00000,1,1,0,BP
GO:0072528,pyrimidine-containing compound biosynthe...,27,0,0.15,1.00000,1,1,0,BP
GO:0072538,T-helper 17 type immune response,32,0,0.18,1.00000,1,1,0,BP
GO:0072539,T-helper 17 cell differentiation,28,0,0.16,1.00000,1,1,0,BP
GO:0072574,hepatocyte proliferation,26,0,0.15,1.00000,1,1,0,BP
GO:0072575,epithelial cell proliferation involved i...,26,0,0.15,1.00000,1,1,0,BP
GO:0072576,liver morphogenesis,28,0,0.16,1.00000,1,1,0,BP
GO:0072577,endothelial cell apoptotic process,57,0,0.32,1.00000,1,1,0,BP
GO:0072599,establishment of protein localization to...,36,0,0.2,1.00000,1,1,0,BP
GO:0072606,interleukin-8 secretion,25,0,0.14,1.00000,1,1,0,BP
GO:0072643,interferon-gamma secretion,24,0,0.13,1.00000,1,1,0,BP
GO:0072662,protein localization to peroxisome,20,0,0.11,1.00000,1,1,0,BP
GO:0072663,establishment of protein localization to...,20,0,0.11,1.00000,1,1,0,BP
GO:0072665,protein localization to vacuole,61,0,0.34,1.00000,1,1,0,BP
GO:0072666,establishment of protein localization to...,46,0,0.26,1.00000,1,1,0,BP
GO:0072677,eosinophil migration,24,0,0.13,1.00000,1,1,0,BP
GO:0080053,response to phenylalanine,25,0,0.14,1.00000,1,1,0,BP
GO:0080111,DNA demethylation,21,0,0.12,1.00000,1,1,0,BP
GO:0080154,regulation of fertilization,28,0,0.16,1.00000,1,1,0,BP
GO:0080171,lytic vacuole organization,62,0,0.35,1.00000,1,1,0,BP
GO:0086001,cardiac muscle cell action potential,54,0,0.3,1.00000,1,1,0,BP
GO:0086002,cardiac muscle cell action potential inv...,43,0,0.24,1.00000,1,1,0,BP
GO:0086003,cardiac muscle cell contraction,66,0,0.37,1.00000,1,1,0,BP
GO:0086004,regulation of cardiac muscle cell contra...,40,0,0.22,1.00000,1,1,0,BP
GO:0086005,ventricular cardiac muscle cell action p...,28,0,0.16,1.00000,1,1,0,BP
GO:0086009,membrane repolarization,41,0,0.23,1.00000,1,1,0,BP
GO:0086010,membrane depolarization during action po...,31,0,0.17,1.00000,1,1,0,BP
GO:0086019,cell-cell signaling involved in cardiac ...,25,0,0.14,1.00000,1,1,0,BP
GO:0086065,cell communication involved in cardiac c...,37,0,0.21,1.00000,1,1,0,BP
GO:0086091,regulation of heart rate by cardiac cond...,33,0,0.19,1.00000,1,1,0,BP
GO:0089718,amino acid import across plasma membrane,28,0,0.16,1.00000,1,1,0,BP
GO:0090022,regulation of neutrophil chemotaxis,31,0,0.17,1.00000,1,1,0,BP
GO:0090023,positive regulation of neutrophil chemot...,25,0,0.14,1.00000,1,1,0,BP
GO:0090025,regulation of monocyte chemotaxis,26,0,0.15,1.00000,1,1,0,BP
GO:0090036,regulation of protein kinase C signaling,20,0,0.11,1.00000,1,1,0,BP
GO:0090049,regulation of cell migration involved in...,40,0,0.22,1.00000,1,1,0,BP
GO:0090050,positive regulation of cell migration in...,21,0,0.12,1.00000,1,1,0,BP
GO:0090077,foam cell differentiation,26,0,0.15,1.00000,1,1,0,BP
GO:0090100,positive regulation of transmembrane rec...,112,0,0.63,1.00000,1,1,0,BP
GO:0090101,negative regulation of transmembrane rec...,113,0,0.63,1.00000,1,1,0,BP
GO:0090114,COPII-coated vesicle budding,25,0,0.14,1.00000,1,1,0,BP
GO:0090162,establishment of epithelial cell polarit...,31,0,0.17,1.00000,1,1,0,BP
GO:0090175,regulation of establishment of planar po...,42,0,0.24,1.00000,1,1,0,BP
GO:0090184,positive regulation of kidney developmen...,45,0,0.25,1.00000,1,1,0,BP
GO:0090189,regulation of branching involved in uret...,26,0,0.15,1.00000,1,1,0,BP
GO:0090190,positive regulation of branching involve...,23,0,0.13,1.00000,1,1,0,BP
GO:0090201,negative regulation of release of cytoch...,22,0,0.12,1.00000,1,1,0,BP
GO:0090207,regulation of triglyceride metabolic pro...,45,0,0.25,1.00000,1,1,0,BP
GO:0090208,positive regulation of triglyceride meta...,26,0,0.15,1.00000,1,1,0,BP
GO:0090218,positive regulation of lipid kinase acti...,33,0,0.19,1.00000,1,1,0,BP
GO:0090279,regulation of calcium ion import,47,0,0.26,1.00000,1,1,0,BP
GO:0090280,positive regulation of calcium ion impor...,25,0,0.14,1.00000,1,1,0,BP
GO:0090288,negative regulation of cellular response...,144,0,0.81,1.00000,1,1,0,BP
GO:0090303,positive regulation of wound healing,57,0,0.32,1.00000,1,1,0,BP
GO:0090313,regulation of protein targeting to membr...,34,0,0.19,1.00000,1,1,0,BP
GO:0090314,positive regulation of protein targeting...,28,0,0.16,1.00000,1,1,0,BP
GO:0090317,negative regulation of intracellular pro...,43,0,0.24,1.00000,1,1,0,BP
GO:0090330,regulation of platelet aggregation,22,0,0.12,1.00000,1,1,0,BP
GO:0090342,regulation of cell aging,49,0,0.28,1.00000,1,1,0,BP
GO:0090344,negative regulation of cell aging,26,0,0.15,1.00000,1,1,0,BP
GO:0090382,phagosome maturation,22,0,0.12,1.00000,1,1,0,BP
GO:0090505,epiboly involved in wound healing,31,0,0.17,1.00000,1,1,0,BP
GO:0090559,regulation of membrane permeability,67,0,0.38,1.00000,1,1,0,BP
GO:0090659,walking behavior,47,0,0.26,1.00000,1,1,0,BP
GO:0097006,regulation of plasma lipoprotein particl...,62,0,0.35,1.00000,1,1,0,BP
GO:0097009,energy homeostasis,39,0,0.22,1.00000,1,1,0,BP
GO:0097028,dendritic cell differentiation,38,0,0.21,1.00000,1,1,0,BP
GO:0097035,regulation of membrane lipid distributio...,53,0,0.3,1.00000,1,1,0,BP
GO:0097062,dendritic spine maintenance,22,0,0.12,1.00000,1,1,0,BP
GO:0097106,postsynaptic density organization,36,0,0.2,1.00000,1,1,0,BP
GO:0097107,postsynaptic density assembly,22,0,0.12,1.00000,1,1,0,BP
GO:0097150,neuronal stem cell population maintenanc...,24,0,0.13,1.00000,1,1,0,BP
GO:0097186,amelogenesis,24,0,0.13,1.00000,1,1,0,BP
GO:0097192,extrinsic apoptotic signaling pathway in...,81,0,0.45,1.00000,1,1,0,BP
GO:0097194,execution phase of apoptosis,67,0,0.38,1.00000,1,1,0,BP
GO:0097205,renal filtration,23,0,0.13,1.00000,1,1,0,BP
GO:0097300,programmed necrotic cell death,41,0,0.23,1.00000,1,1,0,BP
GO:0097320,plasma membrane tubulation,20,0,0.11,1.00000,1,1,0,BP
GO:0097345,mitochondrial outer membrane permeabiliz...,29,0,0.16,1.00000,1,1,0,BP
GO:0097352,autophagosome maturation,35,0,0.2,1.00000,1,1,0,BP
GO:0097366,response to bronchodilator,34,0,0.19,1.00000,1,1,0,BP
GO:0097484,dendrite extension,43,0,0.24,1.00000,1,1,0,BP
GO:0097502,mannosylation,23,0,0.13,1.00000,1,1,0,BP
GO:0097529,myeloid leukocyte migration,208,0,1.17,1.00000,1,1,0,BP
GO:0097530,granulocyte migration,146,0,0.82,1.00000,1,1,0,BP
GO:0097553,calcium ion transmembrane import into cy...,136,0,0.76,1.00000,1,1,0,BP
GO:0097696,STAT cascade,195,0,1.09,1.00000,1,1,0,BP
GO:0097720,calcineurin-mediated signaling,53,0,0.3,1.00000,1,1,0,BP
GO:0097722,sperm motility,105,0,0.59,1.00000,1,1,0,BP
GO:0097734,extracellular exosome biogenesis,21,0,0.12,1.00000,1,1,0,BP
GO:0097756,negative regulation of blood vessel diam...,107,0,0.6,1.00000,1,1,0,BP
GO:0098534,centriole assembly,41,0,0.23,1.00000,1,1,0,BP
GO:0098581,detection of external biotic stimulus,23,0,0.13,1.00000,1,1,0,BP
GO:0098586,cellular response to virus,50,0,0.28,1.00000,1,1,0,BP
GO:0098656,anion transmembrane transport,182,0,1.02,1.00000,1,1,0,BP
GO:0098659,inorganic cation import across plasma me...,86,0,0.48,1.00000,1,1,0,BP
GO:0098661,inorganic anion transmembrane transport,59,0,0.33,1.00000,1,1,0,BP
GO:0098698,postsynaptic specialization assembly,29,0,0.16,1.00000,1,1,0,BP
GO:0098739,import across plasma membrane,119,0,0.67,1.00000,1,1,0,BP
GO:0098743,cell aggregation,20,0,0.11,1.00000,1,1,0,BP
GO:0098801,regulation of renal system process,41,0,0.23,1.00000,1,1,0,BP
GO:0098877,neurotransmitter receptor transport to p...,22,0,0.12,1.00000,1,1,0,BP
GO:0098900,regulation of action potential,58,0,0.33,1.00000,1,1,0,BP
GO:0098901,regulation of cardiac muscle cell action...,26,0,0.15,1.00000,1,1,0,BP
GO:0098927,vesicle-mediated transport between endos...,40,0,0.22,1.00000,1,1,0,BP
GO:0098969,neurotransmitter receptor transport to p...,21,0,0.12,1.00000,1,1,0,BP
GO:0099010,modification of postsynaptic structure,26,0,0.15,1.00000,1,1,0,BP
GO:0099068,postsynapse assembly,34,0,0.19,1.00000,1,1,0,BP
GO:0099084,postsynaptic specialization organization,42,0,0.24,1.00000,1,1,0,BP
GO:0099149,regulation of postsynaptic neurotransmit...,23,0,0.13,1.00000,1,1,0,BP
GO:0099170,postsynaptic modulation of chemical syna...,22,0,0.12,1.00000,1,1,0,BP
GO:0099500,vesicle fusion to plasma membrane,26,0,0.15,1.00000,1,1,0,BP
GO:0099514,synaptic vesicle cytoskeletal transport,20,0,0.11,1.00000,1,1,0,BP
GO:0099517,synaptic vesicle transport along microtu...,20,0,0.11,1.00000,1,1,0,BP
GO:0099560,synaptic membrane adhesion,31,0,0.17,1.00000,1,1,0,BP
GO:0099563,modification of synaptic structure,33,0,0.19,1.00000,1,1,0,BP
GO:0099587,inorganic ion import across plasma membr...,86,0,0.48,1.00000,1,1,0,BP
GO:0099622,cardiac muscle cell membrane repolarizat...,29,0,0.16,1.00000,1,1,0,BP
GO:0099623,regulation of cardiac muscle cell membra...,24,0,0.13,1.00000,1,1,0,BP
GO:0099625,ventricular cardiac muscle cell membrane...,22,0,0.12,1.00000,1,1,0,BP
GO:0099632,protein transport within plasma membrane,31,0,0.17,1.00000,1,1,0,BP
GO:0099633,protein localization to postsynaptic spe...,31,0,0.17,1.00000,1,1,0,BP
GO:0099637,neurotransmitter receptor transport,31,0,0.17,1.00000,1,1,0,BP
GO:0099645,neurotransmitter receptor localization t...,31,0,0.17,1.00000,1,1,0,BP
GO:0101023,vascular endothelial cell proliferation,23,0,0.13,1.00000,1,1,0,BP
GO:0106056,regulation of calcineurin-mediated signa...,41,0,0.23,1.00000,1,1,0,BP
GO:0110110,positive regulation of animal organ morp...,101,0,0.57,1.00000,1,1,0,BP
GO:0120033,negative regulation of plasma membrane b...,25,0,0.14,1.00000,1,1,0,BP
GO:0140029,exocytic process,97,0,0.54,1.00000,1,1,0,BP
GO:0140053,mitochondrial gene expression,103,0,0.58,1.00000,1,1,0,BP
GO:0140056,organelle localization by membrane tethe...,77,0,0.43,1.00000,1,1,0,BP
GO:0140112,extracellular vesicle biogenesis,23,0,0.13,1.00000,1,1,0,BP
GO:0140115,export across plasma membrane,34,0,0.19,1.00000,1,1,0,BP
GO:0140253,cell-cell fusion,69,0,0.39,1.00000,1,1,0,BP
GO:0150077,regulation of neuroinflammatory response,25,0,0.14,1.00000,1,1,0,BP
GO:1900015,regulation of cytokine production involv...,42,0,0.24,1.00000,1,1,0,BP
GO:1900017,positive regulation of cytokine producti...,21,0,0.12,1.00000,1,1,0,BP
GO:1900027,regulation of ruffle assembly,29,0,0.16,1.00000,1,1,0,BP
GO:1900046,regulation of hemostasis,79,0,0.44,1.00000,1,1,0,BP
GO:1900047,negative regulation of hemostasis,50,0,0.28,1.00000,1,1,0,BP
GO:1900048,positive regulation of hemostasis,26,0,0.15,1.00000,1,1,0,BP
GO:1900101,regulation of endoplasmic reticulum unfo...,21,0,0.12,1.00000,1,1,0,BP
GO:1900117,regulation of execution phase of apoptos...,30,0,0.17,1.00000,1,1,0,BP
GO:1900120,regulation of receptor binding,24,0,0.13,1.00000,1,1,0,BP
GO:1900181,negative regulation of protein localizat...,32,0,0.18,1.00000,1,1,0,BP
GO:1900543,negative regulation of purine nucleotide...,30,0,0.17,1.00000,1,1,0,BP
GO:1900744,regulation of p38MAPK cascade,41,0,0.23,1.00000,1,1,0,BP
GO:1900745,positive regulation of p38MAPK cascade,28,0,0.16,1.00000,1,1,0,BP
GO:1901016,regulation of potassium ion transmembran...,61,0,0.34,1.00000,1,1,0,BP
GO:1901017,negative regulation of potassium ion tra...,21,0,0.12,1.00000,1,1,0,BP
GO:1901018,positive regulation of potassium ion tra...,29,0,0.16,1.00000,1,1,0,BP
GO:1901020,negative regulation of calcium ion trans...,31,0,0.17,1.00000,1,1,0,BP
GO:1901028,regulation of mitochondrial outer membra...,20,0,0.11,1.00000,1,1,0,BP
GO:1901068,guanosine-containing compound metabolic ...,35,0,0.2,1.00000,1,1,0,BP
GO:1901071,glucosamine-containing compound metaboli...,26,0,0.15,1.00000,1,1,0,BP
GO:1901099,negative regulation of signal transducti...,33,0,0.19,1.00000,1,1,0,BP
GO:1901185,negative regulation of ERBB signaling pa...,27,0,0.15,1.00000,1,1,0,BP
GO:1901186,positive regulation of ERBB signaling pa...,28,0,0.16,1.00000,1,1,0,BP
GO:1901223,negative regulation of NIK/NF-kappaB sig...,22,0,0.12,1.00000,1,1,0,BP
GO:1901264,carbohydrate derivative transport,65,0,0.36,1.00000,1,1,0,BP
GO:1901380,negative regulation of potassium ion tra...,26,0,0.15,1.00000,1,1,0,BP
GO:1901522,positive regulation of transcription fro...,21,0,0.12,1.00000,1,1,0,BP
GO:1901532,regulation of hematopoietic progenitor c...,27,0,0.15,1.00000,1,1,0,BP
GO:1901570,fatty acid derivative biosynthetic proce...,51,0,0.29,1.00000,1,1,0,BP
GO:1901571,fatty acid derivative transport,53,0,0.3,1.00000,1,1,0,BP
GO:1901606,alpha-amino acid catabolic process,78,0,0.44,1.00000,1,1,0,BP
GO:1901607,alpha-amino acid biosynthetic process,61,0,0.34,1.00000,1,1,0,BP
GO:1901655,cellular response to ketone,135,0,0.76,1.00000,1,1,0,BP
GO:1901657,glycosyl compound metabolic process,112,0,0.63,1.00000,1,1,0,BP
GO:1901658,glycosyl compound catabolic process,25,0,0.14,1.00000,1,1,0,BP
GO:1901659,glycosyl compound biosynthetic process,31,0,0.17,1.00000,1,1,0,BP
GO:1901661,quinone metabolic process,31,0,0.17,1.00000,1,1,0,BP
GO:1901739,regulation of myoblast fusion,26,0,0.15,1.00000,1,1,0,BP
GO:1901741,positive regulation of myoblast fusion,23,0,0.13,1.00000,1,1,0,BP
GO:1901797,negative regulation of signal transducti...,32,0,0.18,1.00000,1,1,0,BP
GO:1901800,positive regulation of proteasomal prote...,105,0,0.59,1.00000,1,1,0,BP
GO:1901983,regulation of protein acetylation,74,0,0.42,1.00000,1,1,0,BP
GO:1901984,negative regulation of protein acetylati...,24,0,0.13,1.00000,1,1,0,BP
GO:1901985,positive regulation of protein acetylati...,43,0,0.24,1.00000,1,1,0,BP
GO:1901998,toxin transport,39,0,0.22,1.00000,1,1,0,BP
GO:1902041,regulation of extrinsic apoptotic signal...,47,0,0.26,1.00000,1,1,0,BP
GO:1902042,negative regulation of extrinsic apoptot...,29,0,0.16,1.00000,1,1,0,BP
GO:1902106,negative regulation of leukocyte differe...,103,0,0.58,1.00000,1,1,0,BP
GO:1902107,positive regulation of leukocyte differe...,170,0,0.95,1.00000,1,1,0,BP
GO:1902108,regulation of mitochondrial membrane per...,40,0,0.22,1.00000,1,1,0,BP
GO:1902110,positive regulation of mitochondrial mem...,32,0,0.18,1.00000,1,1,0,BP
GO:1902186,regulation of viral release from host ce...,32,0,0.18,1.00000,1,1,0,BP
GO:1902229,regulation of intrinsic apoptotic signal...,39,0,0.22,1.00000,1,1,0,BP
GO:1902230,negative regulation of intrinsic apoptot...,25,0,0.14,1.00000,1,1,0,BP
GO:1902253,regulation of intrinsic apoptotic signal...,30,0,0.17,1.00000,1,1,0,BP
GO:1902254,negative regulation of intrinsic apoptot...,20,0,0.11,1.00000,1,1,0,BP
GO:1902410,mitotic cytokinetic process,23,0,0.13,1.00000,1,1,0,BP
GO:1902473,regulation of protein localization to sy...,26,0,0.15,1.00000,1,1,0,BP
GO:1902475,L-alpha-amino acid transmembrane transpo...,39,0,0.22,1.00000,1,1,0,BP
GO:1902476,chloride transmembrane transport,39,0,0.22,1.00000,1,1,0,BP
GO:1902600,proton transmembrane transport,90,0,0.51,1.00000,1,1,0,BP
GO:1902622,regulation of neutrophil migration,41,0,0.23,1.00000,1,1,0,BP
GO:1902624,positive regulation of neutrophil migrat...,33,0,0.19,1.00000,1,1,0,BP
GO:1902668,negative regulation of axon guidance,28,0,0.16,1.00000,1,1,0,BP
GO:1902683,regulation of receptor localization to s...,24,0,0.13,1.00000,1,1,0,BP
GO:1902686,mitochondrial outer membrane permeabiliz...,34,0,0.19,1.00000,1,1,0,BP
GO:1902692,regulation of neuroblast proliferation,39,0,0.22,1.00000,1,1,0,BP
GO:1902743,regulation of lamellipodium organization,44,0,0.25,1.00000,1,1,0,BP
GO:1902745,positive regulation of lamellipodium org...,31,0,0.17,1.00000,1,1,0,BP
GO:1902750,negative regulation of cell cycle G2/M p...,52,0,0.29,1.00000,1,1,0,BP
GO:1902893,regulation of pri-miRNA transcription by...,45,0,0.25,1.00000,1,1,0,BP
GO:1902895,positive regulation of pri-miRNA transcr...,35,0,0.2,1.00000,1,1,0,BP
GO:1902914,regulation of protein polyubiquitination,23,0,0.13,1.00000,1,1,0,BP
GO:1902932,positive regulation of alcohol biosynthe...,28,0,0.16,1.00000,1,1,0,BP
GO:1903010,regulation of bone development,27,0,0.15,1.00000,1,1,0,BP
GO:1903018,regulation of glycoprotein metabolic pro...,47,0,0.26,1.00000,1,1,0,BP
GO:1903020,positive regulation of glycoprotein meta...,23,0,0.13,1.00000,1,1,0,BP
GO:1903035,negative regulation of response to wound...,89,0,0.5,1.00000,1,1,0,BP
GO:1903052,positive regulation of proteolysis invol...,118,0,0.66,1.00000,1,1,0,BP
GO:1903077,negative regulation of protein localizat...,23,0,0.13,1.00000,1,1,0,BP
GO:1903115,regulation of actin filament-based movem...,49,0,0.28,1.00000,1,1,0,BP
GO:1903131,mononuclear cell differentiation,29,0,0.16,1.00000,1,1,0,BP
GO:1903170,negative regulation of calcium ion trans...,41,0,0.23,1.00000,1,1,0,BP
GO:1903306,negative regulation of regulated secreto...,23,0,0.13,1.00000,1,1,0,BP
GO:1903307,positive regulation of regulated secreto...,63,0,0.35,1.00000,1,1,0,BP
GO:1903317,regulation of protein maturation,83,0,0.47,1.00000,1,1,0,BP
GO:1903318,negative regulation of protein maturatio...,37,0,0.21,1.00000,1,1,0,BP
GO:1903319,positive regulation of protein maturatio...,30,0,0.17,1.00000,1,1,0,BP
GO:1903428,positive regulation of reactive oxygen s...,61,0,0.34,1.00000,1,1,0,BP
GO:1903429,regulation of cell maturation,33,0,0.19,1.00000,1,1,0,BP
GO:1903432,regulation of TORC1 signaling,37,0,0.21,1.00000,1,1,0,BP
GO:1903487,regulation of lactation,29,0,0.16,1.00000,1,1,0,BP
GO:1903489,positive regulation of lactation,27,0,0.15,1.00000,1,1,0,BP
GO:1903509,liposaccharide metabolic process,82,0,0.46,1.00000,1,1,0,BP
GO:1903510,mucopolysaccharide metabolic process,58,0,0.33,1.00000,1,1,0,BP
GO:1903513,endoplasmic reticulum to cytosol transpo...,27,0,0.15,1.00000,1,1,0,BP
GO:1903514,release of sequestered calcium ion into ...,22,0,0.12,1.00000,1,1,0,BP
GO:1903523,negative regulation of blood circulation,42,0,0.24,1.00000,1,1,0,BP
GO:1903524,positive regulation of blood circulation,90,0,0.51,1.00000,1,1,0,BP
GO:1903539,protein localization to postsynaptic mem...,57,0,0.32,1.00000,1,1,0,BP
GO:1903540,establishment of protein localization to...,23,0,0.13,1.00000,1,1,0,BP
GO:1903556,negative regulation of tumor necrosis fa...,65,0,0.36,1.00000,1,1,0,BP
GO:1903573,negative regulation of response to endop...,43,0,0.24,1.00000,1,1,0,BP
GO:1903579,negative regulation of ATP metabolic pro...,29,0,0.16,1.00000,1,1,0,BP
GO:1903649,regulation of cytoplasmic transport,25,0,0.14,1.00000,1,1,0,BP
GO:1903671,negative regulation of sprouting angioge...,26,0,0.15,1.00000,1,1,0,BP
GO:1903707,negative regulation of hemopoiesis,159,0,0.89,1.00000,1,1,0,BP
GO:1903708,positive regulation of hemopoiesis,209,0,1.17,1.00000,1,1,0,BP
GO:1903725,regulation of phospholipid metabolic pro...,72,0,0.4,1.00000,1,1,0,BP
GO:1903727,positive regulation of phospholipid meta...,46,0,0.26,1.00000,1,1,0,BP
GO:1903792,negative regulation of anion transport,37,0,0.21,1.00000,1,1,0,BP
GO:1903793,positive regulation of anion transport,65,0,0.36,1.00000,1,1,0,BP
GO:1903798,regulation of production of miRNAs invol...,20,0,0.11,1.00000,1,1,0,BP
GO:1903825,organic acid transmembrane transport,105,0,0.59,1.00000,1,1,0,BP
GO:1903845,negative regulation of cellular response...,66,0,0.37,1.00000,1,1,0,BP
GO:1903846,positive regulation of cellular response...,29,0,0.16,1.00000,1,1,0,BP
GO:1903859,regulation of dendrite extension,32,0,0.18,1.00000,1,1,0,BP
GO:1903861,positive regulation of dendrite extensio...,29,0,0.16,1.00000,1,1,0,BP
GO:1903901,negative regulation of viral life cycle,82,0,0.46,1.00000,1,1,0,BP
GO:1903959,regulation of anion transmembrane transp...,36,0,0.2,1.00000,1,1,0,BP
GO:1903963,arachidonate transport,31,0,0.17,1.00000,1,1,0,BP
GO:1904031,positive regulation of cyclin-dependent ...,29,0,0.16,1.00000,1,1,0,BP
GO:1904036,negative regulation of epithelial cell a...,49,0,0.28,1.00000,1,1,0,BP
GO:1904063,negative regulation of cation transmembr...,90,0,0.51,1.00000,1,1,0,BP
GO:1904292,regulation of ERAD pathway,28,0,0.16,1.00000,1,1,0,BP
GO:1904321,response to forskolin,65,0,0.36,1.00000,1,1,0,BP
GO:1904322,cellular response to forskolin,65,0,0.36,1.00000,1,1,0,BP
GO:1904357,negative regulation of telomere maintena...,26,0,0.15,1.00000,1,1,0,BP
GO:1904376,negative regulation of protein localizat...,25,0,0.14,1.00000,1,1,0,BP
GO:1904407,positive regulation of nitric oxide meta...,48,0,0.27,1.00000,1,1,0,BP
GO:1904861,excitatory synapse assembly,29,0,0.16,1.00000,1,1,0,BP
GO:1904892,regulation of STAT cascade,171,0,0.96,1.00000,1,1,0,BP
GO:1904893,negative regulation of STAT cascade,26,0,0.15,1.00000,1,1,0,BP
GO:1904894,positive regulation of STAT cascade,107,0,0.6,1.00000,1,1,0,BP
GO:1904994,regulation of leukocyte adhesion to vasc...,20,0,0.11,1.00000,1,1,0,BP
GO:1905039,carboxylic acid transmembrane transport,105,0,0.59,1.00000,1,1,0,BP
GO:1905153,regulation of membrane invagination,21,0,0.12,1.00000,1,1,0,BP
GO:1905207,regulation of cardiocyte differentiation,61,0,0.34,1.00000,1,1,0,BP
GO:1905208,negative regulation of cardiocyte differ...,24,0,0.13,1.00000,1,1,0,BP
GO:1905209,positive regulation of cardiocyte differ...,36,0,0.2,1.00000,1,1,0,BP
GO:1905268,negative regulation of chromatin organiz...,62,0,0.35,1.00000,1,1,0,BP
GO:1905314,semi-lunar valve development,31,0,0.17,1.00000,1,1,0,BP
GO:1905330,regulation of morphogenesis of an epithe...,115,0,0.65,1.00000,1,1,0,BP
GO:1905332,positive regulation of morphogenesis of ...,40,0,0.22,1.00000,1,1,0,BP
GO:1905476,negative regulation of protein localizat...,31,0,0.17,1.00000,1,1,0,BP
GO:1905517,macrophage migration,57,0,0.32,1.00000,1,1,0,BP
GO:1905521,regulation of macrophage migration,42,0,0.24,1.00000,1,1,0,BP
GO:1905523,positive regulation of macrophage migrat...,27,0,0.15,1.00000,1,1,0,BP
GO:1905562,regulation of vascular endothelial cell ...,23,0,0.13,1.00000,1,1,0,BP
GO:1905710,positive regulation of membrane permeabi...,39,0,0.22,1.00000,1,1,0,BP
GO:1905809,negative regulation of synapse organizat...,25,0,0.14,1.00000,1,1,0,BP
GO:1905939,regulation of gonad development,25,0,0.14,1.00000,1,1,0,BP
GO:1990089,response to nerve growth factor,36,0,0.2,1.00000,1,1,0,BP
GO:1990090,cellular response to nerve growth factor...,36,0,0.2,1.00000,1,1,0,BP
GO:1990126,"retrograde transport, endosome to plasma...",29,0,0.16,1.00000,1,1,0,BP
GO:1990182,exosomal secretion,20,0,0.11,1.00000,1,1,0,BP
GO:1990266,neutrophil migration,119,0,0.67,1.00000,1,1,0,BP
GO:1990403,embryonic brain development,20,0,0.11,1.00000,1,1,0,BP
GO:1990573,potassium ion import across plasma membr...,43,0,0.24,1.00000,1,1,0,BP
GO:1990928,response to amino acid starvation,46,0,0.26,1.00000,1,1,0,BP
GO:2000050,regulation of non-canonical Wnt signalin...,26,0,0.15,1.00000,1,1,0,BP
GO:2000060,positive regulation of ubiquitin-depende...,94,0,0.53,1.00000,1,1,0,BP
GO:2000106,regulation of leukocyte apoptotic proces...,108,0,0.61,1.00000,1,1,0,BP
GO:2000107,negative regulation of leukocyte apoptot...,69,0,0.39,1.00000,1,1,0,BP
GO:2000108,positive regulation of leukocyte apoptot...,33,0,0.19,1.00000,1,1,0,BP
GO:2000136,regulation of cell proliferation involve...,20,0,0.11,1.00000,1,1,0,BP
GO:2000142,regulation of DNA-templated transcriptio...,39,0,0.22,1.00000,1,1,0,BP
GO:2000144,positive regulation of DNA-templated tra...,31,0,0.17,1.00000,1,1,0,BP
GO:2000171,negative regulation of dendrite developm...,35,0,0.2,1.00000,1,1,0,BP
GO:2000178,negative regulation of neural precursor ...,28,0,0.16,1.00000,1,1,0,BP
GO:2000191,regulation of fatty acid transport,32,0,0.18,1.00000,1,1,0,BP
GO:2000193,positive regulation of fatty acid transp...,21,0,0.12,1.00000,1,1,0,BP
GO:2000209,regulation of anoikis,21,0,0.12,1.00000,1,1,0,BP
GO:2000243,positive regulation of reproductive proc...,81,0,0.45,1.00000,1,1,0,BP
GO:2000249,regulation of actin cytoskeleton reorgan...,35,0,0.2,1.00000,1,1,0,BP
GO:2000272,negative regulation of signaling recepto...,27,0,0.15,1.00000,1,1,0,BP
GO:2000279,negative regulation of DNA biosynthetic ...,44,0,0.25,1.00000,1,1,0,BP
GO:2000311,regulation of AMPA receptor activity,28,0,0.16,1.00000,1,1,0,BP
GO:2000316,regulation of T-helper 17 type immune re...,23,0,0.13,1.00000,1,1,0,BP
GO:2000351,regulation of endothelial cell apoptotic...,54,0,0.3,1.00000,1,1,0,BP
GO:2000352,negative regulation of endothelial cell ...,31,0,0.17,1.00000,1,1,0,BP
GO:2000353,positive regulation of endothelial cell ...,22,0,0.12,1.00000,1,1,0,BP
GO:2000463,positive regulation of excitatory postsy...,38,0,0.21,1.00000,1,1,0,BP
GO:2000482,regulation of interleukin-8 secretion,21,0,0.12,1.00000,1,1,0,BP
GO:2000514,"regulation of CD4-positive, alpha-beta T...",64,0,0.36,1.00000,1,1,0,BP
GO:2000515,"negative regulation of CD4-positive, alp...",31,0,0.17,1.00000,1,1,0,BP
GO:2000516,"positive regulation of CD4-positive, alp...",36,0,0.2,1.00000,1,1,0,BP
GO:2000637,positive regulation of gene silencing by...,25,0,0.14,1.00000,1,1,0,BP
GO:2000648,positive regulation of stem cell prolife...,56,0,0.31,1.00000,1,1,0,BP
GO:2000677,regulation of transcription regulatory r...,52,0,0.29,1.00000,1,1,0,BP
GO:2000678,negative regulation of transcription reg...,20,0,0.11,1.00000,1,1,0,BP
GO:2000679,positive regulation of transcription reg...,25,0,0.14,1.00000,1,1,0,BP
GO:2000725,regulation of cardiac muscle cell differ...,48,0,0.27,1.00000,1,1,0,BP
GO:2000726,negative regulation of cardiac muscle ce...,20,0,0.11,1.00000,1,1,0,BP
GO:2000727,positive regulation of cardiac muscle ce...,27,0,0.15,1.00000,1,1,0,BP
GO:2000738,positive regulation of stem cell differe...,26,0,0.15,1.00000,1,1,0,BP
GO:2000756,regulation of peptidyl-lysine acetylatio...,63,0,0.35,1.00000,1,1,0,BP
GO:2000757,negative regulation of peptidyl-lysine a...,22,0,0.12,1.00000,1,1,0,BP
GO:2000758,positive regulation of peptidyl-lysine a...,34,0,0.19,1.00000,1,1,0,BP
GO:2000765,regulation of cytoplasmic translation,26,0,0.15,1.00000,1,1,0,BP
GO:2000772,regulation of cellular senescence,41,0,0.23,1.00000,1,1,0,BP
GO:2000780,negative regulation of double-strand bre...,26,0,0.15,1.00000,1,1,0,BP
GO:2000826,regulation of heart morphogenesis,42,0,0.24,1.00000,1,1,0,BP
GO:2001021,negative regulation of response to DNA d...,71,0,0.4,1.00000,1,1,0,BP
GO:2001026,regulation of endothelial cell chemotaxi...,22,0,0.12,1.00000,1,1,0,BP
GO:2001032,regulation of double-strand break repair...,21,0,0.12,1.00000,1,1,0,BP
GO:2001057,reactive nitrogen species metabolic proc...,84,0,0.47,1.00000,1,1,0,BP
GO:2001222,regulation of neuron migration,52,0,0.29,1.00000,1,1,0,BP
GO:2001224,positive regulation of neuron migration,21,0,0.12,1.00000,1,1,0,BP
GO:2001238,positive regulation of extrinsic apoptot...,60,0,0.34,1.00000,1,1,0,BP
GO:2001239,regulation of extrinsic apoptotic signal...,48,0,0.27,1.00000,1,1,0,BP
GO:2001240,negative regulation of extrinsic apoptot...,33,0,0.19,1.00000,1,1,0,BP
GO:2001258,negative regulation of cation channel ac...,41,0,0.23,1.00000,1,1,0,BP
GO:0005488,binding,13259,106,74.45,2.2e-11,1.8238e-8,1.8238e-8,1.42,MF
GO:0005198,structural molecule activity,610,20,3.43,1.9e-10,1.5750999999999999e-7,7.875499999999999e-8,5.83,MF
GO:0003735,structural constituent of ribosome,151,11,0.85,9.0e-10,7.461e-7,2.487e-7,12.94,MF
GO:0005515,protein binding,8941,82,50.2,2.4e-09,1.9896e-6,4.974e-7,1.63,MF
GO:0003723,RNA binding,1068,24,6,4.8e-09,3.9792e-6,7.9584e-7,4,MF
GO:0019899,enzyme binding,2351,34,13.2,1.3e-07,1.0776999999999999e-4,1.3816666666666666e-5,2.58,MF
GO:0097159,organic cyclic compound binding,5162,55,28.98,1.4e-07,1.1606000000000001e-4,1.3816666666666666e-5,1.9,MF
GO:0019843,rRNA binding,71,7,0.4,1.5e-07,1.2435e-4,1.3816666666666666e-5,17.5,MF
GO:0003676,nucleic acid binding,3105,40,17.43,1.5e-07,1.2435e-4,1.3816666666666666e-5,2.29,MF
GO:1901363,heterocyclic compound binding,5061,54,28.42,2.0e-07,1.658e-4,1.658e-5,1.9,MF
GO:0003729,mRNA binding,270,10,1.52,3.0e-06,0.002487,2.2609090909090908e-4,6.58,MF
GO:0043169,cation binding,3631,41,20.39,3.5e-06,0.0029015,2.4179166666666666e-4,2.01,MF
GO:0043167,ion binding,5533,54,31.07,3.9e-06,0.0032331,2.487e-4,1.74,MF
GO:0046872,metal ion binding,3533,40,19.84,4.6e-06,0.0038134,2.723857142857143e-4,2.02,MF
GO:0044877,protein-containing complex binding,1256,21,7.05,6.2e-06,0.0051398,3.426533333333333e-4,2.98,MF
GO:0008092,cytoskeletal protein binding,976,18,5.48,8.3e-06,0.0068807,4.3004375e-4,3.28,MF
GO:0008017,microtubule binding,242,8,1.36,6.8e-05,0.056372,0.003316,5.88,MF
GO:0015631,tubulin binding,339,9,1.9,0.00013,0.10776999999999999,0.005987222222222222,4.74,MF
GO:0005509,calcium ion binding,621,12,3.49,0.00020,0.1658,0.008726315789473684,3.44,MF
GO:0042393,histone binding,218,7,1.22,0.00023,0.19067,0.0095335,5.74,MF
GO:0031625,ubiquitin protein ligase binding,307,8,1.72,0.00034,0.28186,0.013421904761904762,4.65,MF
GO:0044389,ubiquitin-like protein ligase binding,326,8,1.83,0.00051,0.42279000000000005,0.019217727272727272,4.37,MF
GO:0019900,kinase binding,821,13,4.61,0.00071,0.5885900000000001,0.024524583333333332,2.82,MF
GO:0003779,actin binding,429,9,2.41,0.00071,0.5885900000000001,0.024524583333333332,3.73,MF
GO:0003774,motor activity,133,5,0.75,0.00093,0.77097,0.0308388,6.67,MF
GO:0003682,chromatin binding,589,10,3.31,0.00180,1,0.05739230769230769,3.02,MF
GO:0051082,unfolded protein binding,97,4,0.54,0.00219,1,0.06724111111111111,7.41,MF
GO:0017048,Rho GTPase binding,166,5,0.93,0.00247,1,0.07312964285714285,5.38,MF
GO:0051020,GTPase binding,527,9,2.96,0.00292,1,0.08347172413793102,3.04,MF
GO:0035591,signaling adaptor activity,55,3,0.31,0.00366,1,0.101138,9.68,MF
GO:0050840,extracellular matrix binding,59,3,0.33,0.00446,1,0.11926903225806453,9.09,MF
GO:0005518,collagen binding,68,3,0.38,0.00663,1,0.1717584375,7.89,MF
GO:0016773,"phosphotransferase activity, alcohol gro...",717,10,4.03,0.00717,1,0.1736536842105263,2.48,MF
GO:0035254,glutamate receptor binding,70,3,0.39,0.00719,1,0.1736536842105263,7.69,MF
GO:0048306,calcium-dependent protein binding,71,3,0.4,0.00747,1,0.1736536842105263,7.5,MF
GO:0004672,protein kinase activity,616,9,3.46,0.00796,1,0.1736536842105263,2.6,MF
GO:0050780,dopamine receptor binding,24,2,0.13,0.00796,1,0.1736536842105263,15.38,MF
GO:0070840,dynein complex binding,24,2,0.13,0.00796,1,0.1736536842105263,15.38,MF
GO:0046914,transition metal ion binding,971,12,5.45,0.00843,1,0.177406,2.2,MF
GO:0030234,enzyme regulator activity,973,12,5.46,0.00856,1,0.177406,2.2,MF
GO:0005158,insulin receptor binding,26,2,0.15,0.00930,1,0.18797093023255815,13.33,MF
GO:0008135,"translation factor activity, RNA binding",78,3,0.44,0.00967,1,0.18797093023255815,6.82,MF
GO:0002020,protease binding,148,4,0.83,0.00975,1,0.18797093023255815,4.82,MF
GO:0030554,adenyl nucleotide binding,1505,16,8.45,0.00998,1,0.18803227272727271,1.89,MF
GO:0005070,SH3/SH2 adaptor activity,28,2,0.16,0.01074,1,0.19785466666666665,12.5,MF
GO:0003777,microtubule motor activity,84,3,0.47,0.01182,1,0.21301695652173913,6.38,MF
GO:0016301,kinase activity,778,10,4.37,0.01227,1,0.21642191489361703,2.29,MF
GO:0043236,laminin binding,31,2,0.17,0.01307,1,0.22572979166666665,11.76,MF
GO:0017076,purine nucleotide binding,1843,18,10.35,0.01442,1,0.24396285714285718,1.74,MF
GO:0019904,protein domain specific binding,813,10,4.57,0.01624,1,0.2692592,2.19,MF
GO:0051087,chaperone binding,100,3,0.56,0.01881,1,0.30575470588235293,5.36,MF
GO:0032559,adenyl ribonucleotide binding,1494,15,8.39,0.02010,1,0.3204403846153846,1.79,MF
GO:0005102,signaling receptor binding,1644,16,9.23,0.02146,1,0.3356667924528302,1.73,MF
GO:0019901,protein kinase binding,740,9,4.16,0.02364,1,0.3629177777777778,2.16,MF
GO:0019212,phosphatase inhibitor activity,43,2,0.24,0.02430,1,0.3662672727272727,8.33,MF
GO:0060090,molecular adaptor activity,200,4,1.12,0.02638,1,0.3737295081967213,3.57,MF
GO:0035255,ionotropic glutamate receptor binding,45,2,0.25,0.02645,1,0.3737295081967213,8,MF
GO:0032555,purine ribonucleotide binding,1831,17,10.28,0.02689,1,0.3737295081967213,1.65,MF
GO:0016462,pyrophosphatase activity,883,10,4.96,0.02695,1,0.3737295081967213,2.02,MF
GO:0016817,"hydrolase activity, acting on acid anhyd...",886,10,4.97,0.02750,1,0.3737295081967213,2.01,MF
GO:0016818,"hydrolase activity, acting on acid anhyd...",886,10,4.97,0.02750,1,0.3737295081967213,2.01,MF
GO:0032553,ribonucleotide binding,1848,17,10.38,0.02906,1,0.38634031746031744,1.64,MF
GO:0005524,ATP binding,1429,14,8.02,0.02936,1,0.38634031746031744,1.75,MF
GO:0017016,Ras GTPase binding,417,6,2.34,0.03034,1,0.3929978125,2.56,MF
GO:0019894,kinesin binding,49,2,0.28,0.03097,1,0.39498661538461544,7.14,MF
GO:0097367,carbohydrate derivative binding,2158,19,12.12,0.03178,1,0.39917606060606065,1.57,MF
GO:0016772,"transferase activity, transferring phosp...",921,10,5.17,0.03453,1,0.4272443283582089,1.93,MF
GO:0031267,small GTPase binding,432,6,2.43,0.03514,1,0.42839794117647056,2.47,MF
GO:0035639,purine ribonucleoside triphosphate bindi...,1756,16,9.86,0.03653,1,0.43888942028985506,1.62,MF
GO:0030674,"protein binding, bridging",132,3,0.74,0.03836,1,0.4506957746478874,4.05,MF
GO:0003677,DNA binding,2059,18,11.56,0.03860,1,0.4506957746478874,1.56,MF
GO:0045182,translation regulator activity,57,2,0.32,0.04083,1,0.4611032432432433,6.25,MF
GO:0000166,nucleotide binding,2075,18,11.65,0.04116,1,0.4611032432432433,1.55,MF
GO:1901265,nucleoside phosphate binding,2075,18,11.65,0.04116,1,0.4611032432432433,1.55,MF
GO:0017111,nucleoside-triphosphatase activity,830,9,4.66,0.04417,1,0.4882257333333333,1.93,MF
GO:0008022,protein C-terminus binding,238,4,1.34,0.04533,1,0.49445486842105263,2.99,MF
GO:0004674,protein serine/threonine kinase activity,463,6,2.6,0.04655,1,0.5011681818181818,2.31,MF
GO:0008144,drug binding,1685,15,9.46,0.05017,1,0.5332170512820512,1.59,MF
GO:0008134,transcription factor binding,726,8,4.08,0.05206,1,0.546300506329114,1.96,MF
GO:0048365,Rac GTPase binding,68,2,0.38,0.05602,1,0.58050725,5.26,MF
GO:0005089,Rho guanyl-nucleotide exchange factor ac...,70,2,0.39,0.05897,1,0.6034513414634146,5.13,MF
GO:0003713,transcription coactivator activity,261,4,1.47,0.05969,1,0.6034513414634146,2.72,MF
GO:0002039,p53 binding,72,2,0.4,0.06197,1,0.611584880952381,5,MF
GO:0008094,DNA-dependent ATPase activity,72,2,0.4,0.06197,1,0.611584880952381,5,MF
GO:0140096,"catalytic activity, acting on a protein",2187,18,12.28,0.06275,1,0.6119970588235295,1.47,MF
GO:0004857,enzyme inhibitor activity,381,5,2.14,0.06379,1,0.6126490217391304,2.34,MF
GO:0019887,protein kinase regulator activity,164,3,0.92,0.06510,1,0.6126490217391304,3.26,MF
GO:0030971,receptor tyrosine kinase binding,75,2,0.42,0.06656,1,0.6126490217391304,4.76,MF
GO:0016887,ATPase activity,386,5,2.17,0.06667,1,0.6126490217391304,2.3,MF
GO:0042802,identical protein binding,1906,16,10.7,0.06731,1,0.6126490217391304,1.5,MF
GO:0005506,iron ion binding,167,3,0.94,0.06795,1,0.6126490217391304,3.19,MF
GO:0098772,molecular function regulator,1760,15,9.88,0.06799,1,0.6126490217391304,1.52,MF
GO:0042623,"ATPase activity, coupled",286,4,1.61,0.07774,1,0.692972688172043,2.48,MF
GO:0043168,anion binding,2733,21,15.35,0.08252,1,0.727756170212766,1.37,MF
GO:0003725,double-stranded RNA binding,86,2,0.48,0.08430,1,0.727965625,4.17,MF
GO:0019208,phosphatase regulator activity,86,2,0.48,0.08430,1,0.727965625,4.17,MF
GO:0001664,G protein-coupled receptor binding,296,4,1.66,0.08565,1,0.7319984536082474,2.41,MF
GO:0042277,peptide binding,298,4,1.67,0.08728,1,0.7377262626262626,2.4,MF
GO:0060589,nucleoside-triphosphatase regulator acti...,299,4,1.68,0.08810,1,0.7377262626262626,2.38,MF
GO:0003714,transcription corepressor activity,190,3,1.07,0.09164,1,0.7547963725490195,2.8,MF
GO:0005516,calmodulin binding,191,3,1.07,0.09274,1,0.7547963725490195,2.8,MF
GO:0036094,small molecule binding,2460,19,13.81,0.09287,1,0.7547963725490195,1.38,MF
GO:0008270,zinc ion binding,691,7,3.88,0.09445,1,0.7601849514563107,1.8,MF
GO:0019207,kinase regulator activity,196,3,1.1,0.09832,1,0.7779572857142857,2.73,MF
GO:0003727,single-stranded RNA binding,95,2,0.53,0.09975,1,0.7779572857142857,3.77,MF
GO:0005085,guanyl-nucleotide exchange factor activi...,198,3,1.11,0.10059,1,0.7779572857142857,2.7,MF
GO:0046983,protein dimerization activity,1422,12,7.98,0.10252,1,0.7779572857142857,1.5,MF
GO:0051015,actin filament binding,200,3,1.12,0.10288,1,0.7779572857142857,2.68,MF
GO:0004725,protein tyrosine phosphatase activity,98,2,0.55,0.10507,1,0.7779572857142857,3.64,MF
GO:0000287,magnesium ion binding,202,3,1.13,0.10519,1,0.7779572857142857,2.65,MF
GO:0017049,GTP-Rho binding,20,1,0.11,0.10655,1,0.7779572857142857,9.09,MF
GO:0043274,phospholipase binding,20,1,0.11,0.10655,1,0.7779572857142857,9.09,MF
GO:0070064,proline-rich region binding,20,1,0.11,0.10655,1,0.7779572857142857,9.09,MF
GO:0046982,protein heterodimerization activity,579,6,3.25,0.10783,1,0.7779572857142857,1.85,MF
GO:0051428,peptide hormone receptor binding,21,1,0.12,0.11157,1,0.7779572857142857,8.33,MF
GO:1990782,protein tyrosine kinase binding,103,2,0.58,0.11409,1,0.7779572857142857,3.45,MF
GO:0008047,enzyme activator activity,457,5,2.57,0.11503,1,0.7779572857142857,1.95,MF
GO:0001223,transcription coactivator binding,22,1,0.12,0.11657,1,0.7779572857142857,8.33,MF
GO:0008157,protein phosphatase 1 binding,22,1,0.12,0.11657,1,0.7779572857142857,8.33,MF
GO:0032947,protein-containing complex scaffold acti...,22,1,0.12,0.11657,1,0.7779572857142857,8.33,MF
GO:0050998,nitric-oxide synthase binding,22,1,0.12,0.11657,1,0.7779572857142857,8.33,MF
GO:0003712,transcription coregulator activity,460,5,2.58,0.11737,1,0.7779572857142857,1.94,MF
GO:0051219,phosphoprotein binding,106,2,0.6,0.11960,1,0.7779572857142857,3.33,MF
GO:0005496,steroid binding,107,2,0.6,0.12145,1,0.7779572857142857,3.33,MF
GO:0042562,hormone binding,107,2,0.6,0.12145,1,0.7779572857142857,3.33,MF
GO:0017056,structural constituent of nuclear pore,23,1,0.13,0.12153,1,0.7779572857142857,7.69,MF
GO:0030506,ankyrin binding,23,1,0.13,0.12153,1,0.7779572857142857,7.69,MF
GO:0031492,nucleosomal DNA binding,23,1,0.13,0.12153,1,0.7779572857142857,7.69,MF
GO:0019902,phosphatase binding,217,3,1.22,0.12315,1,0.7779572857142857,2.46,MF
GO:0004129,cytochrome-c oxidase activity,24,1,0.13,0.12647,1,0.7779572857142857,7.69,MF
GO:0015002,heme-copper terminal oxidase activity,24,1,0.13,0.12647,1,0.7779572857142857,7.69,MF
GO:0015026,coreceptor activity,24,1,0.13,0.12647,1,0.7779572857142857,7.69,MF
GO:0016676,"oxidoreductase activity, acting on a hem...",24,1,0.13,0.12647,1,0.7779572857142857,7.69,MF
GO:0048027,mRNA 5'-UTR binding,24,1,0.13,0.12647,1,0.7779572857142857,7.69,MF
GO:0005212,structural constituent of eye lens,25,1,0.14,0.13138,1,0.7779572857142857,7.14,MF
GO:0016675,"oxidoreductase activity, acting on a hem...",25,1,0.14,0.13138,1,0.7779572857142857,7.14,MF
GO:0016722,"oxidoreductase activity, oxidizing metal...",25,1,0.14,0.13138,1,0.7779572857142857,7.14,MF
GO:0030371,translation repressor activity,25,1,0.14,0.13138,1,0.7779572857142857,7.14,MF
GO:0030515,snoRNA binding,25,1,0.14,0.13138,1,0.7779572857142857,7.14,MF
GO:0070412,R-SMAD binding,25,1,0.14,0.13138,1,0.7779572857142857,7.14,MF
GO:0003697,single-stranded DNA binding,113,2,0.63,0.13270,1,0.7802007092198582,3.17,MF
GO:0017134,fibroblast growth factor binding,26,1,0.15,0.13627,1,0.7955480985915494,6.67,MF
GO:0003785,actin monomer binding,27,1,0.15,0.14112,1,0.81242,6.67,MF
GO:0008143,poly(A) binding,27,1,0.15,0.14112,1,0.81242,6.67,MF
GO:0001530,lipopolysaccharide binding,28,1,0.16,0.14595,1,0.8221825657894736,6.25,MF
GO:0005520,insulin-like growth factor binding,28,1,0.16,0.14595,1,0.8221825657894736,6.25,MF
GO:0008574,ATP-dependent microtubule motor activity...,28,1,0.16,0.14595,1,0.8221825657894736,6.25,MF
GO:0033218,amide binding,364,4,2.04,0.14881,1,0.8221825657894736,1.96,MF
GO:0008266,poly(U) RNA binding,29,1,0.16,0.15075,1,0.8221825657894736,6.25,MF
GO:0030291,protein serine/threonine kinase inhibito...,29,1,0.16,0.15075,1,0.8221825657894736,6.25,MF
GO:0071813,lipoprotein particle binding,29,1,0.16,0.15075,1,0.8221825657894736,6.25,MF
GO:0071814,protein-lipid complex binding,29,1,0.16,0.15075,1,0.8221825657894736,6.25,MF
GO:0005096,GTPase activator activity,241,3,1.35,0.15398,1,0.8318346451612904,2.22,MF
GO:0042287,MHC protein binding,30,1,0.17,0.15553,1,0.8318346451612904,5.88,MF
GO:0050681,androgen receptor binding,30,1,0.17,0.15553,1,0.8318346451612904,5.88,MF
GO:0001968,fibronectin binding,31,1,0.17,0.16028,1,0.851744358974359,5.88,MF
GO:0005088,Ras guanyl-nucleotide exchange factor ac...,128,2,0.72,0.16175,1,0.8532521118012423,2.78,MF
GO:0008198,ferrous iron binding,32,1,0.18,0.16500,1,0.8532521118012423,5.56,MF
GO:0016504,peptidase activator activity,32,1,0.18,0.16500,1,0.8532521118012423,5.56,MF
GO:0030507,spectrin binding,32,1,0.18,0.16500,1,0.8532521118012423,5.56,MF
GO:0047485,protein N-terminus binding,130,2,0.73,0.16571,1,0.8532521118012423,2.74,MF
GO:0004842,ubiquitin-protein transferase activity,383,4,2.15,0.16901,1,0.863024601226994,1.86,MF
GO:0035035,histone acetyltransferase binding,33,1,0.19,0.16969,1,0.863024601226994,5.26,MF
GO:0003755,peptidyl-prolyl cis-trans isomerase acti...,34,1,0.19,0.17436,1,0.8707496385542168,5.26,MF
GO:0008187,poly-pyrimidine tract binding,34,1,0.19,0.17436,1,0.8707496385542168,5.26,MF
GO:0051019,mitogen-activated protein kinase binding,34,1,0.19,0.17436,1,0.8707496385542168,5.26,MF
GO:0030695,GTPase regulator activity,259,3,1.45,0.17853,1,0.8729370000000001,2.07,MF
GO:0001965,G-protein alpha-subunit binding,35,1,0.2,0.17901,1,0.8729370000000001,5,MF
GO:0008200,ion channel inhibitor activity,35,1,0.2,0.17901,1,0.8729370000000001,5,MF
GO:0070717,poly-purine tract binding,35,1,0.2,0.17901,1,0.8729370000000001,5,MF
GO:0042162,telomeric DNA binding,36,1,0.2,0.18362,1,0.8854876744186047,5,MF
GO:0044325,ion channel binding,139,2,0.78,0.18372,1,0.8854876744186047,2.56,MF
GO:0016248,channel inhibitor activity,37,1,0.21,0.18822,1,0.8967493103448276,4.76,MF
GO:0071949,FAD binding,37,1,0.21,0.18822,1,0.8967493103448276,4.76,MF
GO:0016859,cis-trans isomerase activity,38,1,0.21,0.19278,1,0.9115702840909091,4.76,MF
GO:0019787,ubiquitin-like protein transferase activ...,405,4,2.27,0.19353,1,0.9115702840909091,1.76,MF
GO:0004864,protein phosphatase inhibitor activity,39,1,0.22,0.19732,1,0.9217734831460674,4.55,MF
GO:0019838,growth factor binding,146,2,0.82,0.19792,1,0.9217734831460674,2.44,MF
GO:0060590,ATPase regulator activity,40,1,0.22,0.20184,1,0.9295853333333333,4.55,MF
GO:0098631,cell adhesion mediator activity,40,1,0.22,0.20184,1,0.9295853333333333,4.55,MF
GO:0043531,ADP binding,41,1,0.23,0.20633,1,0.9450141988950276,4.35,MF
GO:0016853,isomerase activity,152,2,0.85,0.21019,1,0.9574039010989011,2.35,MF
GO:0043548,phosphatidylinositol 3-kinase binding,43,1,0.24,0.21523,1,0.9750036612021858,4.17,MF
GO:0004386,helicase activity,156,2,0.88,0.21842,1,0.9840770652173912,2.27,MF
GO:0001784,phosphotyrosine residue binding,45,1,0.25,0.22404,1,1,4,MF
GO:0003743,translation initiation factor activity,47,1,0.26,0.23275,1,1,3.85,MF
GO:0015485,cholesterol binding,47,1,0.26,0.23275,1,1,3.85,MF
GO:0016538,cyclin-dependent protein serine/threonin...,47,1,0.26,0.23275,1,1,3.85,MF
GO:0070888,E-box binding,47,1,0.26,0.23275,1,1,3.85,MF
GO:0015459,potassium channel regulator activity,48,1,0.27,0.23707,1,1,3.7,MF
GO:0001228,DNA-binding transcription activator acti...,443,4,2.49,0.23823,1,1,1.61,MF
GO:1990939,ATP-dependent microtubule motor activity,49,1,0.28,0.24136,1,1,3.57,MF
GO:0008289,lipid binding,748,6,4.2,0.24404,1,1,1.43,MF
GO:0019903,protein phosphatase binding,170,2,0.95,0.24740,1,1,2.11,MF
GO:0140030,modification-dependent protein binding,171,2,0.96,0.24948,1,1,2.08,MF
GO:0001221,transcription cofactor binding,51,1,0.29,0.24988,1,1,3.45,MF
GO:0017046,peptide hormone binding,52,1,0.29,0.25410,1,1,3.45,MF
GO:0004721,phosphoprotein phosphatase activity,175,2,0.98,0.25779,1,1,2.04,MF
GO:0004860,protein kinase inhibitor activity,53,1,0.3,0.25830,1,1,3.33,MF
GO:0030276,clathrin binding,53,1,0.3,0.25830,1,1,3.33,MF
GO:0031491,nucleosome binding,53,1,0.3,0.25830,1,1,3.33,MF
GO:0032934,sterol binding,53,1,0.3,0.25830,1,1,3.33,MF
GO:1990841,promoter-specific chromatin binding,53,1,0.3,0.25830,1,1,3.33,MF
GO:0003824,catalytic activity,5780,36,32.45,0.26123,1,1,1.11,MF
GO:0051018,protein kinase A binding,54,1,0.3,0.26247,1,1,3.33,MF
GO:0003707,steroid hormone receptor activity,55,1,0.31,0.26663,1,1,3.23,MF
GO:0051427,hormone receptor binding,183,2,1.03,0.27443,1,1,1.94,MF
GO:0045309,protein phosphorylated amino acid bindin...,57,1,0.32,0.27486,1,1,3.12,MF
GO:0019210,kinase inhibitor activity,58,1,0.33,0.27894,1,1,3.03,MF
GO:0004714,transmembrane receptor protein tyrosine ...,59,1,0.33,0.28300,1,1,3.03,MF
GO:0005507,copper ion binding,60,1,0.34,0.28704,1,1,2.94,MF
GO:0016491,oxidoreductase activity,796,6,4.47,0.28980,1,1,1.34,MF
GO:0001540,amyloid-beta binding,61,1,0.34,0.29106,1,1,2.94,MF
GO:0000049,tRNA binding,63,1,0.35,0.29902,1,1,2.86,MF
GO:0005200,structural constituent of cytoskeleton,63,1,0.35,0.29902,1,1,2.86,MF
GO:0051287,NAD binding,63,1,0.35,0.29902,1,1,2.86,MF
GO:0043022,ribosome binding,66,1,0.37,0.31080,1,1,2.7,MF
GO:0016705,"oxidoreductase activity, acting on paire...",203,2,1.14,0.31591,1,1,1.75,MF
GO:0009055,electron transfer activity,72,1,0.4,0.33377,1,1,2.5,MF
GO:0019888,protein phosphatase regulator activity,73,1,0.41,0.33752,1,1,2.44,MF
GO:0043130,ubiquitin binding,74,1,0.42,0.34125,1,1,2.38,MF
GO:0017022,myosin binding,75,1,0.42,0.34496,1,1,2.38,MF
GO:0019199,transmembrane receptor protein kinase ac...,76,1,0.43,0.34866,1,1,2.33,MF
GO:0140110,transcription regulator activity,1354,9,7.6,0.35007,1,1,1.18,MF
GO:0030295,protein kinase activator activity,79,1,0.44,0.35961,1,1,2.27,MF
GO:0005546,"phosphatidylinositol-4,5-bisphosphate bi...",80,1,0.45,0.36322,1,1,2.22,MF
GO:0016651,"oxidoreductase activity, acting on NAD(P...",84,1,0.47,0.37745,1,1,2.13,MF
GO:0038024,cargo receptor activity,84,1,0.47,0.37745,1,1,2.13,MF
GO:0016209,antioxidant activity,85,1,0.48,0.38096,1,1,2.08,MF
GO:0019209,kinase activator activity,85,1,0.48,0.38096,1,1,2.08,MF
GO:0043178,alcohol binding,85,1,0.48,0.38096,1,1,2.08,MF
GO:0050660,flavin adenine dinucleotide binding,85,1,0.48,0.38096,1,1,2.08,MF
GO:0061630,ubiquitin protein ligase activity,235,2,1.32,0.38103,1,1,1.52,MF
GO:0008013,beta-catenin binding,86,1,0.48,0.38445,1,1,2.08,MF
GO:0046332,SMAD binding,86,1,0.48,0.38445,1,1,2.08,MF
GO:0035064,methylated histone binding,88,1,0.49,0.39138,1,1,2.04,MF
GO:0140034,methylation-dependent protein binding,88,1,0.49,0.39138,1,1,2.04,MF
GO:0001227,DNA-binding transcription repressor acti...,241,2,1.35,0.39297,1,1,1.48,MF
GO:0035258,steroid hormone receptor binding,89,1,0.5,0.39481,1,1,2,MF
GO:0061659,ubiquitin-like protein ligase activity,244,2,1.37,0.39890,1,1,1.46,MF
GO:0050839,cell adhesion molecule binding,245,2,1.38,0.40087,1,1,1.45,MF
GO:0016740,transferase activity,2276,14,12.78,0.40109,1,1,1.1,MF
GO:0033613,activating transcription factor binding,92,1,0.52,0.40499,1,1,1.92,MF
GO:0051117,ATPase binding,94,1,0.53,0.41168,1,1,1.89,MF
GO:0003730,mRNA 3'-UTR binding,95,1,0.53,0.41500,1,1,1.89,MF
GO:0032182,ubiquitin-like protein binding,95,1,0.53,0.41500,1,1,1.89,MF
GO:0004197,cysteine-type endopeptidase activity,96,1,0.54,0.41830,1,1,1.85,MF
GO:0031490,chromatin DNA binding,96,1,0.54,0.41830,1,1,1.85,MF
GO:0005543,phospholipid binding,422,3,2.37,0.42356,1,1,1.27,MF
GO:0000980,RNA polymerase II distal enhancer sequen...,100,1,0.56,0.43132,1,1,1.79,MF
GO:0000981,DNA-binding transcription factor activit...,767,5,4.31,0.43211,1,1,1.16,MF
GO:0004222,metalloendopeptidase activity,101,1,0.57,0.43452,1,1,1.75,MF
GO:0016791,phosphatase activity,266,2,1.49,0.44155,1,1,1.34,MF
GO:0042803,protein homodimerization activity,950,6,5.33,0.44396,1,1,1.13,MF
GO:0030246,carbohydrate binding,269,2,1.51,0.44724,1,1,1.32,MF
GO:0019783,ubiquitin-like protein-specific protease...,109,1,0.61,0.45955,1,1,1.64,MF
GO:0043565,sequence-specific DNA binding,1145,7,6.43,0.46437,1,1,1.09,MF
GO:1902936,phosphatidylinositol bisphosphate bindin...,111,1,0.62,0.46564,1,1,1.61,MF
GO:0099106,ion channel regulator activity,117,1,0.66,0.48349,1,1,1.52,MF
GO:0004867,serine-type endopeptidase inhibitor acti...,118,1,0.66,0.48640,1,1,1.52,MF
GO:0030165,PDZ domain binding,118,1,0.66,0.48640,1,1,1.52,MF
GO:0044212,transcription regulatory region DNA bind...,995,6,5.59,0.48862,1,1,1.07,MF
GO:0001067,regulatory region nucleic acid binding,999,6,5.61,0.49254,1,1,1.07,MF
GO:0003700,DNA-binding transcription factor activit...,999,6,5.61,0.49254,1,1,1.07,MF
GO:0015078,proton transmembrane transporter activit...,121,1,0.68,0.49506,1,1,1.47,MF
GO:0003924,GTPase activity,303,2,1.7,0.50937,1,1,1.18,MF
GO:0001158,enhancer sequence-specific DNA binding,127,1,0.71,0.51193,1,1,1.41,MF
GO:0005178,integrin binding,128,1,0.72,0.51469,1,1,1.39,MF
GO:0004713,protein tyrosine kinase activity,129,1,0.72,0.51743,1,1,1.39,MF
GO:0017124,SH3 domain binding,131,1,0.74,0.52287,1,1,1.35,MF
GO:0035326,enhancer binding,138,1,0.77,0.54142,1,1,1.3,MF
GO:0031072,heat shock protein binding,140,1,0.79,0.54659,1,1,1.27,MF
GO:0005201,extracellular matrix structural constitu...,141,1,0.79,0.54916,1,1,1.27,MF
GO:0016247,channel regulator activity,146,1,0.82,0.56176,1,1,1.22,MF
GO:0070851,growth factor receptor binding,148,1,0.83,0.56670,1,1,1.2,MF
GO:0016787,hydrolase activity,2534,14,14.23,0.56829,1,1,0.98,MF
GO:0043021,ribonucleoprotein complex binding,152,1,0.85,0.57642,1,1,1.18,MF
GO:0035257,nuclear hormone receptor binding,154,1,0.86,0.58120,1,1,1.16,MF
GO:0008201,heparin binding,156,1,0.88,0.58592,1,1,1.14,MF
GO:0042578,phosphoric ester hydrolase activity,359,2,2.02,0.60138,1,1,0.99,MF
GO:0005525,GTP binding,360,2,2.02,0.60290,1,1,0.99,MF
GO:1901981,phosphatidylinositol phosphate binding,166,1,0.93,0.60877,1,1,1.08,MF
GO:0032550,purine ribonucleoside binding,367,2,2.06,0.61343,1,1,0.97,MF
GO:0017137,Rab GTPase binding,170,1,0.95,0.61755,1,1,1.05,MF
GO:0001883,purine nucleoside binding,372,2,2.09,0.62082,1,1,0.96,MF
GO:0032549,ribonucleoside binding,372,2,2.09,0.62082,1,1,0.96,MF
GO:0008234,cysteine-type peptidase activity,172,1,0.97,0.62187,1,1,1.03,MF
GO:0001085,RNA polymerase II transcription factor b...,173,1,0.97,0.62401,1,1,1.03,MF
GO:0000978,RNA polymerase II proximal promoter sequ...,573,3,3.22,0.62794,1,1,0.93,MF
GO:0008237,metallopeptidase activity,177,1,0.99,0.63245,1,1,1.01,MF
GO:0001882,nucleoside binding,383,2,2.15,0.63669,1,1,0.93,MF
GO:0019001,guanyl nucleotide binding,384,2,2.16,0.63811,1,1,0.93,MF
GO:0032561,guanyl ribonucleotide binding,384,2,2.16,0.63811,1,1,0.93,MF
GO:0000987,proximal promoter sequence-specific DNA ...,585,3,3.28,0.64193,1,1,0.91,MF
GO:0140097,"catalytic activity, acting on DNA",191,1,1.07,0.66055,1,1,0.93,MF
GO:0004866,endopeptidase inhibitor activity,197,1,1.11,0.67193,1,1,0.9,MF
GO:0061135,endopeptidase regulator activity,204,1,1.15,0.68473,1,1,0.87,MF
GO:0030414,peptidase inhibitor activity,208,1,1.17,0.69182,1,1,0.85,MF
GO:0005539,glycosaminoglycan binding,210,1,1.18,0.69531,1,1,0.85,MF
GO:0000977,RNA polymerase II regulatory region sequ...,837,4,4.7,0.69651,1,1,0.85,MF
GO:0001012,RNA polymerase II regulatory region DNA ...,845,4,4.74,0.70364,1,1,0.84,MF
GO:0004175,endopeptidase activity,440,2,2.47,0.71075,1,1,0.81,MF
GO:0000976,transcription regulatory region sequence...,882,4,4.95,0.73505,1,1,0.81,MF
GO:0061134,peptidase regulator activity,239,1,1.34,0.74167,1,1,0.75,MF
GO:0035091,phosphatidylinositol binding,251,1,1.41,0.75875,1,1,0.71,MF
GO:1901681,sulfur compound binding,253,1,1.42,0.76148,1,1,0.7,MF
GO:1990837,sequence-specific double-stranded DNA bi...,925,4,5.19,0.76837,1,1,0.77,MF
GO:0030545,receptor regulator activity,527,2,2.96,0.79933,1,1,0.68,MF
GO:0050662,coenzyme binding,295,1,1.66,0.81231,1,1,0.6,MF
GO:0003690,double-stranded DNA binding,1014,4,5.69,0.82698,1,1,0.7,MF
GO:0070011,"peptidase activity, acting on L-amino ac...",613,2,3.44,0.86258,1,1,0.58,MF
GO:0015077,monovalent inorganic cation transmembran...,363,1,2.04,0.87280,1,1,0.49,MF
GO:0008233,peptidase activity,640,2,3.59,0.87835,1,1,0.56,MF
GO:0016788,"hydrolase activity, acting on ester bond...",741,2,4.16,0.92373,1,1,0.48,MF
GO:0048018,receptor ligand activity,492,1,2.76,0.93941,1,1,0.36,MF
GO:0048037,cofactor binding,542,1,3.04,0.95460,1,1,0.33,MF
GO:0022890,inorganic cation transmembrane transport...,575,1,3.23,0.96250,1,1,0.31,MF
GO:0008324,cation transmembrane transporter activit...,627,1,3.52,0.97226,1,1,0.28,MF
GO:0004930,G protein-coupled receptor activity,750,1,4.21,0.98645,1,1,0.24,MF
GO:0015318,inorganic molecular entity transmembrane...,796,1,4.47,0.98964,1,1,0.22,MF
GO:0015075,ion transmembrane transporter activity,855,1,4.8,0.99267,1,1,0.21,MF
GO:0060089,molecular transducer activity,2344,6,13.16,0.99317,1,1,0.46,MF
GO:0022857,transmembrane transporter activity,1013,1,5.69,0.99711,1,1,0.18,MF
GO:0038023,signaling receptor activity,2295,5,12.89,0.99729,1,1,0.39,MF
GO:0005215,transporter activity,1099,1,6.17,0.99827,1,1,0.16,MF
GO:0004888,transmembrane signaling receptor activit...,2107,2,11.83,0.99995,1,1,0.17,MF
GO:0003674,molecular_function,20837,117,117,1.00000,1,1,1,MF
GO:0000030,mannosyltransferase activity,26,0,0.15,1.00000,1,1,0,MF
GO:0000062,fatty-acyl-CoA binding,26,0,0.15,1.00000,1,1,0,MF
GO:0000149,SNARE binding,118,0,0.66,1.00000,1,1,0,MF
GO:0000175,3'-5'-exoribonuclease activity,29,0,0.16,1.00000,1,1,0,MF
GO:0000217,DNA secondary structure binding,25,0,0.14,1.00000,1,1,0,MF
GO:0000979,RNA polymerase II core promoter sequence...,38,0,0.21,1.00000,1,1,0,MF
GO:0000993,RNA polymerase II complex binding,38,0,0.21,1.00000,1,1,0,MF
GO:0001046,core promoter sequence-specific DNA bind...,49,0,0.28,1.00000,1,1,0,MF
GO:0001047,core promoter binding,62,0,0.35,1.00000,1,1,0,MF
GO:0001091,RNA polymerase II basal transcription fa...,22,0,0.12,1.00000,1,1,0,MF
GO:0001098,basal transcription machinery binding,58,0,0.33,1.00000,1,1,0,MF
GO:0001099,basal RNA polymerase II transcription ma...,58,0,0.33,1.00000,1,1,0,MF
GO:0001102,RNA polymerase II activating transcripti...,55,0,0.31,1.00000,1,1,0,MF
GO:0001103,RNA polymerase II repressing transcripti...,35,0,0.2,1.00000,1,1,0,MF
GO:0001222,transcription corepressor binding,20,0,0.11,1.00000,1,1,0,MF
GO:0001614,purinergic nucleotide receptor activity,20,0,0.11,1.00000,1,1,0,MF
GO:0001618,virus receptor activity,20,0,0.11,1.00000,1,1,0,MF
GO:0001637,G protein-coupled chemoattractant recept...,25,0,0.14,1.00000,1,1,0,MF
GO:0001653,peptide receptor activity,149,0,0.84,1.00000,1,1,0,MF
GO:0001671,ATPase activator activity,26,0,0.15,1.00000,1,1,0,MF
GO:0001786,phosphatidylserine binding,63,0,0.35,1.00000,1,1,0,MF
GO:0001848,complement binding,22,0,0.12,1.00000,1,1,0,MF
GO:0001871,pattern binding,21,0,0.12,1.00000,1,1,0,MF
GO:0003678,DNA helicase activity,61,0,0.34,1.00000,1,1,0,MF
GO:0003684,damaged DNA binding,56,0,0.31,1.00000,1,1,0,MF
GO:0003688,DNA replication origin binding,23,0,0.13,1.00000,1,1,0,MF
GO:0003724,RNA helicase activity,65,0,0.36,1.00000,1,1,0,MF
GO:0003823,antigen binding,57,0,0.32,1.00000,1,1,0,MF
GO:0003887,DNA-directed DNA polymerase activity,27,0,0.15,1.00000,1,1,0,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activi...,37,0,0.21,1.00000,1,1,0,MF
GO:0003950,NAD+ ADP-ribosyltransferase activity,23,0,0.13,1.00000,1,1,0,MF
GO:0003954,NADH dehydrogenase activity,29,0,0.16,1.00000,1,1,0,MF
GO:0004003,ATP-dependent DNA helicase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0004033,aldo-keto reductase (NADP) activity,28,0,0.16,1.00000,1,1,0,MF
GO:0004112,cyclic-nucleotide phosphodiesterase acti...,31,0,0.17,1.00000,1,1,0,MF
GO:0004114,"3',5'-cyclic-nucleotide phosphodiesteras...",30,0,0.17,1.00000,1,1,0,MF
GO:0004177,aminopeptidase activity,44,0,0.25,1.00000,1,1,0,MF
GO:0004180,carboxypeptidase activity,42,0,0.24,1.00000,1,1,0,MF
GO:0004181,metallocarboxypeptidase activity,25,0,0.14,1.00000,1,1,0,MF
GO:0004190,aspartic-type endopeptidase activity,29,0,0.16,1.00000,1,1,0,MF
GO:0004252,serine-type endopeptidase activity,181,0,1.02,1.00000,1,1,0,MF
GO:0004298,threonine-type endopeptidase activity,21,0,0.12,1.00000,1,1,0,MF
GO:0004364,glutathione transferase activity,34,0,0.19,1.00000,1,1,0,MF
GO:0004402,histone acetyltransferase activity,65,0,0.36,1.00000,1,1,0,MF
GO:0004407,histone deacetylase activity,28,0,0.16,1.00000,1,1,0,MF
GO:0004497,monooxygenase activity,141,0,0.79,1.00000,1,1,0,MF
GO:0004518,nuclease activity,200,0,1.12,1.00000,1,1,0,MF
GO:0004519,endonuclease activity,129,0,0.72,1.00000,1,1,0,MF
GO:0004520,endodeoxyribonuclease activity,40,0,0.22,1.00000,1,1,0,MF
GO:0004521,endoribonuclease activity,65,0,0.36,1.00000,1,1,0,MF
GO:0004527,exonuclease activity,75,0,0.42,1.00000,1,1,0,MF
GO:0004529,exodeoxyribonuclease activity,25,0,0.14,1.00000,1,1,0,MF
GO:0004532,exoribonuclease activity,32,0,0.18,1.00000,1,1,0,MF
GO:0004536,deoxyribonuclease activity,59,0,0.33,1.00000,1,1,0,MF
GO:0004540,ribonuclease activity,116,0,0.65,1.00000,1,1,0,MF
GO:0004553,"hydrolase activity, hydrolyzing O-glycos...",100,0,0.56,1.00000,1,1,0,MF
GO:0004601,peroxidase activity,52,0,0.29,1.00000,1,1,0,MF
GO:0004602,glutathione peroxidase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0004620,phospholipase activity,89,0,0.5,1.00000,1,1,0,MF
GO:0004623,phospholipase A2 activity,31,0,0.17,1.00000,1,1,0,MF
GO:0004683,calmodulin-dependent protein kinase acti...,27,0,0.15,1.00000,1,1,0,MF
GO:0004693,cyclin-dependent protein serine/threonin...,30,0,0.17,1.00000,1,1,0,MF
GO:0004709,MAP kinase kinase kinase activity,26,0,0.15,1.00000,1,1,0,MF
GO:0004712,protein serine/threonine/tyrosine kinase...,39,0,0.22,1.00000,1,1,0,MF
GO:0004715,non-membrane spanning protein tyrosine k...,45,0,0.25,1.00000,1,1,0,MF
GO:0004722,protein serine/threonine phosphatase act...,70,0,0.39,1.00000,1,1,0,MF
GO:0004745,retinol dehydrogenase activity,21,0,0.12,1.00000,1,1,0,MF
GO:0004806,triglyceride lipase activity,27,0,0.15,1.00000,1,1,0,MF
GO:0004812,aminoacyl-tRNA ligase activity,41,0,0.23,1.00000,1,1,0,MF
GO:0004843,thiol-dependent ubiquitin-specific prote...,90,0,0.51,1.00000,1,1,0,MF
GO:0004869,cysteine-type endopeptidase inhibitor ac...,68,0,0.38,1.00000,1,1,0,MF
GO:0004879,nuclear receptor activity,40,0,0.22,1.00000,1,1,0,MF
GO:0004896,cytokine receptor activity,98,0,0.55,1.00000,1,1,0,MF
GO:0004950,chemokine receptor activity,25,0,0.14,1.00000,1,1,0,MF
GO:0004984,olfactory receptor activity,1110,0,6.23,1.00000,1,1,0,MF
GO:0004993,G protein-coupled serotonin receptor act...,39,0,0.22,1.00000,1,1,0,MF
GO:0005044,scavenger receptor activity,45,0,0.25,1.00000,1,1,0,MF
GO:0005048,signal sequence binding,39,0,0.22,1.00000,1,1,0,MF
GO:0005080,protein kinase C binding,62,0,0.35,1.00000,1,1,0,MF
GO:0005104,fibroblast growth factor receptor bindin...,26,0,0.15,1.00000,1,1,0,MF
GO:0005109,frizzled binding,43,0,0.24,1.00000,1,1,0,MF
GO:0005112,Notch binding,25,0,0.14,1.00000,1,1,0,MF
GO:0005125,cytokine activity,217,0,1.22,1.00000,1,1,0,MF
GO:0005126,cytokine receptor binding,330,0,1.85,1.00000,1,1,0,MF
GO:0005132,type I interferon receptor binding,24,0,0.13,1.00000,1,1,0,MF
GO:0005148,prolactin receptor binding,27,0,0.15,1.00000,1,1,0,MF
GO:0005154,epidermal growth factor receptor binding,36,0,0.2,1.00000,1,1,0,MF
GO:0005160,transforming growth factor beta receptor...,54,0,0.3,1.00000,1,1,0,MF
GO:0005164,tumor necrosis factor receptor binding,34,0,0.19,1.00000,1,1,0,MF
GO:0005179,hormone activity,129,0,0.72,1.00000,1,1,0,MF
GO:0005184,neuropeptide hormone activity,25,0,0.14,1.00000,1,1,0,MF
GO:0005216,ion channel activity,407,0,2.29,1.00000,1,1,0,MF
GO:0005217,intracellular ligand-gated ion channel a...,32,0,0.18,1.00000,1,1,0,MF
GO:0005227,calcium activated cation channel activit...,29,0,0.16,1.00000,1,1,0,MF
GO:0005230,extracellular ligand-gated ion channel a...,71,0,0.4,1.00000,1,1,0,MF
GO:0005231,excitatory extracellular ligand-gated io...,36,0,0.2,1.00000,1,1,0,MF
GO:0005242,inward rectifier potassium channel activ...,20,0,0.11,1.00000,1,1,0,MF
GO:0005244,voltage-gated ion channel activity,195,0,1.09,1.00000,1,1,0,MF
GO:0005245,voltage-gated calcium channel activity,52,0,0.29,1.00000,1,1,0,MF
GO:0005246,calcium channel regulator activity,48,0,0.27,1.00000,1,1,0,MF
GO:0005248,voltage-gated sodium channel activity,21,0,0.12,1.00000,1,1,0,MF
GO:0005249,voltage-gated potassium channel activity,86,0,0.48,1.00000,1,1,0,MF
GO:0005251,delayed rectifier potassium channel acti...,30,0,0.17,1.00000,1,1,0,MF
GO:0005253,anion channel activity,80,0,0.45,1.00000,1,1,0,MF
GO:0005254,chloride channel activity,69,0,0.39,1.00000,1,1,0,MF
GO:0005261,cation channel activity,317,0,1.78,1.00000,1,1,0,MF
GO:0005262,calcium channel activity,123,0,0.69,1.00000,1,1,0,MF
GO:0005267,potassium channel activity,123,0,0.69,1.00000,1,1,0,MF
GO:0005272,sodium channel activity,40,0,0.22,1.00000,1,1,0,MF
GO:0005310,dicarboxylic acid transmembrane transpor...,36,0,0.2,1.00000,1,1,0,MF
GO:0005319,lipid transporter activity,136,0,0.76,1.00000,1,1,0,MF
GO:0005326,neurotransmitter transporter activity,50,0,0.28,1.00000,1,1,0,MF
GO:0005328,neurotransmitter:sodium symporter activi...,26,0,0.15,1.00000,1,1,0,MF
GO:0005342,organic acid transmembrane transporter a...,150,0,0.84,1.00000,1,1,0,MF
GO:0005343,organic acid:sodium symporter activity,25,0,0.14,1.00000,1,1,0,MF
GO:0005355,glucose transmembrane transporter activi...,23,0,0.13,1.00000,1,1,0,MF
GO:0005385,zinc ion transmembrane transporter activ...,22,0,0.12,1.00000,1,1,0,MF
GO:0005402,carbohydrate:cation symporter activity,20,0,0.11,1.00000,1,1,0,MF
GO:0005484,SNAP receptor activity,33,0,0.19,1.00000,1,1,0,MF
GO:0005501,retinoid binding,32,0,0.18,1.00000,1,1,0,MF
GO:0005504,fatty acid binding,45,0,0.25,1.00000,1,1,0,MF
GO:0005537,mannose binding,26,0,0.15,1.00000,1,1,0,MF
GO:0005540,hyaluronic acid binding,21,0,0.12,1.00000,1,1,0,MF
GO:0005544,calcium-dependent phospholipid binding,54,0,0.3,1.00000,1,1,0,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate...",41,0,0.23,1.00000,1,1,0,MF
GO:0005548,phospholipid transporter activity,52,0,0.29,1.00000,1,1,0,MF
GO:0005549,odorant binding,578,0,3.25,1.00000,1,1,0,MF
GO:0005550,pheromone binding,216,0,1.21,1.00000,1,1,0,MF
GO:0008009,chemokine activity,43,0,0.24,1.00000,1,1,0,MF
GO:0008026,ATP-dependent helicase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0008028,monocarboxylic acid transmembrane transp...,52,0,0.29,1.00000,1,1,0,MF
GO:0008066,glutamate receptor activity,27,0,0.15,1.00000,1,1,0,MF
GO:0008080,N-acetyltransferase activity,94,0,0.53,1.00000,1,1,0,MF
GO:0008081,phosphoric diester hydrolase activity,90,0,0.51,1.00000,1,1,0,MF
GO:0008083,growth factor activity,147,0,0.83,1.00000,1,1,0,MF
GO:0008106,alcohol dehydrogenase (NADP+) activity,25,0,0.14,1.00000,1,1,0,MF
GO:0008137,NADH dehydrogenase (ubiquinone) activity,26,0,0.15,1.00000,1,1,0,MF
GO:0008138,protein tyrosine/serine/threonine phosph...,40,0,0.22,1.00000,1,1,0,MF
GO:0008146,sulfotransferase activity,56,0,0.31,1.00000,1,1,0,MF
GO:0008168,methyltransferase activity,201,0,1.13,1.00000,1,1,0,MF
GO:0008170,N-methyltransferase activity,88,0,0.49,1.00000,1,1,0,MF
GO:0008171,O-methyltransferase activity,25,0,0.14,1.00000,1,1,0,MF
GO:0008173,RNA methyltransferase activity,63,0,0.35,1.00000,1,1,0,MF
GO:0008175,tRNA methyltransferase activity,32,0,0.18,1.00000,1,1,0,MF
GO:0008188,neuropeptide receptor activity,45,0,0.25,1.00000,1,1,0,MF
GO:0008194,UDP-glycosyltransferase activity,151,0,0.85,1.00000,1,1,0,MF
GO:0008227,G protein-coupled amine receptor activit...,72,0,0.4,1.00000,1,1,0,MF
GO:0008235,metalloexopeptidase activity,53,0,0.3,1.00000,1,1,0,MF
GO:0008236,serine-type peptidase activity,203,0,1.14,1.00000,1,1,0,MF
GO:0008238,exopeptidase activity,101,0,0.57,1.00000,1,1,0,MF
GO:0008276,protein methyltransferase activity,86,0,0.48,1.00000,1,1,0,MF
GO:0008307,structural constituent of muscle,25,0,0.14,1.00000,1,1,0,MF
GO:0008327,methyl-CpG binding,21,0,0.12,1.00000,1,1,0,MF
GO:0008373,sialyltransferase activity,21,0,0.12,1.00000,1,1,0,MF
GO:0008374,O-acyltransferase activity,43,0,0.24,1.00000,1,1,0,MF
GO:0008375,acetylglucosaminyltransferase activity,56,0,0.31,1.00000,1,1,0,MF
GO:0008376,acetylgalactosaminyltransferase activity,44,0,0.25,1.00000,1,1,0,MF
GO:0008378,galactosyltransferase activity,36,0,0.2,1.00000,1,1,0,MF
GO:0008391,arachidonic acid monooxygenase activity,38,0,0.21,1.00000,1,1,0,MF
GO:0008392,arachidonic acid epoxygenase activity,34,0,0.19,1.00000,1,1,0,MF
GO:0008395,steroid hydroxylase activity,73,0,0.41,1.00000,1,1,0,MF
GO:0008408,3'-5' exonuclease activity,50,0,0.28,1.00000,1,1,0,MF
GO:0008483,transaminase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0008509,anion transmembrane transporter activity,313,0,1.76,1.00000,1,1,0,MF
GO:0008514,organic anion transmembrane transporter ...,210,0,1.18,1.00000,1,1,0,MF
GO:0008519,ammonium transmembrane transporter activ...,32,0,0.18,1.00000,1,1,0,MF
GO:0008527,taste receptor activity,36,0,0.2,1.00000,1,1,0,MF
GO:0008528,G protein-coupled peptide receptor activ...,140,0,0.79,1.00000,1,1,0,MF
GO:0008536,Ran GTPase binding,38,0,0.21,1.00000,1,1,0,MF
GO:0008553,"proton-exporting ATPase activity, phosph...",20,0,0.11,1.00000,1,1,0,MF
GO:0008569,ATP-dependent microtubule motor activity...,21,0,0.12,1.00000,1,1,0,MF
GO:0008757,S-adenosylmethionine-dependent methyltra...,148,0,0.83,1.00000,1,1,0,MF
GO:0009975,cyclase activity,25,0,0.14,1.00000,1,1,0,MF
GO:0010485,H4 histone acetyltransferase activity,23,0,0.13,1.00000,1,1,0,MF
GO:0015020,glucuronosyltransferase activity,33,0,0.19,1.00000,1,1,0,MF
GO:0015036,disulfide oxidoreductase activity,42,0,0.24,1.00000,1,1,0,MF
GO:0015079,potassium ion transmembrane transporter ...,159,0,0.89,1.00000,1,1,0,MF
GO:0015081,sodium ion transmembrane transporter act...,143,0,0.8,1.00000,1,1,0,MF
GO:0015085,calcium ion transmembrane transporter ac...,140,0,0.79,1.00000,1,1,0,MF
GO:0015101,organic cation transmembrane transporter...,23,0,0.13,1.00000,1,1,0,MF
GO:0015103,inorganic anion transmembrane transporte...,132,0,0.74,1.00000,1,1,0,MF
GO:0015106,bicarbonate transmembrane transporter ac...,20,0,0.11,1.00000,1,1,0,MF
GO:0015108,chloride transmembrane transporter activ...,96,0,0.54,1.00000,1,1,0,MF
GO:0015125,bile acid transmembrane transporter acti...,20,0,0.11,1.00000,1,1,0,MF
GO:0015144,carbohydrate transmembrane transporter a...,38,0,0.21,1.00000,1,1,0,MF
GO:0015145,monosaccharide transmembrane transporter...,25,0,0.14,1.00000,1,1,0,MF
GO:0015149,hexose transmembrane transporter activit...,23,0,0.13,1.00000,1,1,0,MF
GO:0015171,amino acid transmembrane transporter act...,75,0,0.42,1.00000,1,1,0,MF
GO:0015175,neutral amino acid transmembrane transpo...,32,0,0.18,1.00000,1,1,0,MF
GO:0015179,L-amino acid transmembrane transporter a...,57,0,0.32,1.00000,1,1,0,MF
GO:0015238,drug transmembrane transporter activity,89,0,0.5,1.00000,1,1,0,MF
GO:0015248,sterol transporter activity,31,0,0.17,1.00000,1,1,0,MF
GO:0015267,channel activity,444,0,2.49,1.00000,1,1,0,MF
GO:0015276,ligand-gated ion channel activity,133,0,0.75,1.00000,1,1,0,MF
GO:0015278,calcium-release channel activity,20,0,0.11,1.00000,1,1,0,MF
GO:0015291,secondary active transmembrane transport...,235,0,1.32,1.00000,1,1,0,MF
GO:0015293,symporter activity,145,0,0.81,1.00000,1,1,0,MF
GO:0015294,solute:cation symporter activity,99,0,0.56,1.00000,1,1,0,MF
GO:0015295,solute:proton symporter activity,22,0,0.12,1.00000,1,1,0,MF
GO:0015297,antiporter activity,78,0,0.44,1.00000,1,1,0,MF
GO:0015298,solute:cation antiporter activity,29,0,0.16,1.00000,1,1,0,MF
GO:0015301,anion:anion antiporter activity,29,0,0.16,1.00000,1,1,0,MF
GO:0015370,solute:sodium symporter activity,70,0,0.39,1.00000,1,1,0,MF
GO:0015399,primary active transmembrane transporter...,119,0,0.67,1.00000,1,1,0,MF
GO:0015405,P-P-bond-hydrolysis-driven transmembrane...,118,0,0.66,1.00000,1,1,0,MF
GO:0015464,acetylcholine receptor activity,22,0,0.12,1.00000,1,1,0,MF
GO:0015491,cation:cation antiporter activity,24,0,0.13,1.00000,1,1,0,MF
GO:0015605,organophosphate ester transmembrane tran...,27,0,0.15,1.00000,1,1,0,MF
GO:0015662,"ATPase activity, coupled to transmembran...",39,0,0.22,1.00000,1,1,0,MF
GO:0015932,nucleobase-containing compound transmemb...,44,0,0.25,1.00000,1,1,0,MF
GO:0016229,steroid dehydrogenase activity,45,0,0.25,1.00000,1,1,0,MF
GO:0016278,lysine N-methyltransferase activity,56,0,0.31,1.00000,1,1,0,MF
GO:0016279,protein-lysine N-methyltransferase activ...,56,0,0.31,1.00000,1,1,0,MF
GO:0016289,CoA hydrolase activity,27,0,0.15,1.00000,1,1,0,MF
GO:0016298,lipase activity,122,0,0.69,1.00000,1,1,0,MF
GO:0016405,CoA-ligase activity,23,0,0.13,1.00000,1,1,0,MF
GO:0016407,acetyltransferase activity,117,0,0.66,1.00000,1,1,0,MF
GO:0016408,C-acyltransferase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0016409,palmitoyltransferase activity,39,0,0.22,1.00000,1,1,0,MF
GO:0016410,N-acyltransferase activity,115,0,0.65,1.00000,1,1,0,MF
GO:0016417,S-acyltransferase activity,33,0,0.19,1.00000,1,1,0,MF
GO:0016493,C-C chemokine receptor activity,24,0,0.13,1.00000,1,1,0,MF
GO:0016502,nucleotide receptor activity,20,0,0.11,1.00000,1,1,0,MF
GO:0016503,pheromone receptor activity,99,0,0.56,1.00000,1,1,0,MF
GO:0016597,amino acid binding,72,0,0.4,1.00000,1,1,0,MF
GO:0016614,"oxidoreductase activity, acting on CH-OH...",143,0,0.8,1.00000,1,1,0,MF
GO:0016616,"oxidoreductase activity, acting on the C...",134,0,0.75,1.00000,1,1,0,MF
GO:0016620,"oxidoreductase activity, acting on the a...",42,0,0.24,1.00000,1,1,0,MF
GO:0016627,"oxidoreductase activity, acting on the C...",56,0,0.31,1.00000,1,1,0,MF
GO:0016628,"oxidoreductase activity, acting on the C...",24,0,0.13,1.00000,1,1,0,MF
GO:0016638,"oxidoreductase activity, acting on the C...",24,0,0.13,1.00000,1,1,0,MF
GO:0016641,"oxidoreductase activity, acting on the C...",21,0,0.12,1.00000,1,1,0,MF
GO:0016645,"oxidoreductase activity, acting on the C...",28,0,0.16,1.00000,1,1,0,MF
GO:0016655,"oxidoreductase activity, acting on NAD(P...",37,0,0.21,1.00000,1,1,0,MF
GO:0016667,"oxidoreductase activity, acting on a sul...",57,0,0.32,1.00000,1,1,0,MF
GO:0016684,"oxidoreductase activity, acting on perox...",56,0,0.31,1.00000,1,1,0,MF
GO:0016701,"oxidoreductase activity, acting on singl...",31,0,0.17,1.00000,1,1,0,MF
GO:0016702,"oxidoreductase activity, acting on singl...",30,0,0.17,1.00000,1,1,0,MF
GO:0016706,"oxidoreductase activity, acting on paire...",45,0,0.25,1.00000,1,1,0,MF
GO:0016709,"oxidoreductase activity, acting on paire...",45,0,0.25,1.00000,1,1,0,MF
GO:0016712,"oxidoreductase activity, acting on paire...",61,0,0.34,1.00000,1,1,0,MF
GO:0016725,"oxidoreductase activity, acting on CH or...",23,0,0.13,1.00000,1,1,0,MF
GO:0016741,"transferase activity, transferring one-c...",213,0,1.2,1.00000,1,1,0,MF
GO:0016746,"transferase activity, transferring acyl ...",270,0,1.52,1.00000,1,1,0,MF
GO:0016747,"transferase activity, transferring acyl ...",236,0,1.33,1.00000,1,1,0,MF
GO:0016757,"transferase activity, transferring glyco...",278,0,1.56,1.00000,1,1,0,MF
GO:0016758,"transferase activity, transferring hexos...",209,0,1.17,1.00000,1,1,0,MF
GO:0016763,"transferase activity, transferring pento...",50,0,0.28,1.00000,1,1,0,MF
GO:0016765,"transferase activity, transferring alkyl...",64,0,0.36,1.00000,1,1,0,MF
GO:0016769,"transferase activity, transferring nitro...",25,0,0.14,1.00000,1,1,0,MF
GO:0016776,"phosphotransferase activity, phosphate g...",34,0,0.19,1.00000,1,1,0,MF
GO:0016779,nucleotidyltransferase activity,123,0,0.69,1.00000,1,1,0,MF
GO:0016782,"transferase activity, transferring sulfu...",74,0,0.42,1.00000,1,1,0,MF
GO:0016790,thiolester hydrolase activity,46,0,0.26,1.00000,1,1,0,MF
GO:0016796,"exonuclease activity, active with either...",52,0,0.29,1.00000,1,1,0,MF
GO:0016798,"hydrolase activity, acting on glycosyl b...",125,0,0.7,1.00000,1,1,0,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycos...",22,0,0.12,1.00000,1,1,0,MF
GO:0016810,"hydrolase activity, acting on carbon-nit...",133,0,0.75,1.00000,1,1,0,MF
GO:0016811,"hydrolase activity, acting on carbon-nit...",82,0,0.46,1.00000,1,1,0,MF
GO:0016814,"hydrolase activity, acting on carbon-nit...",29,0,0.16,1.00000,1,1,0,MF
GO:0016829,lyase activity,185,0,1.04,1.00000,1,1,0,MF
GO:0016830,carbon-carbon lyase activity,51,0,0.29,1.00000,1,1,0,MF
GO:0016831,carboxy-lyase activity,34,0,0.19,1.00000,1,1,0,MF
GO:0016835,carbon-oxygen lyase activity,67,0,0.38,1.00000,1,1,0,MF
GO:0016836,hydro-lyase activity,55,0,0.31,1.00000,1,1,0,MF
GO:0016849,phosphorus-oxygen lyase activity,25,0,0.14,1.00000,1,1,0,MF
GO:0016860,intramolecular oxidoreductase activity,46,0,0.26,1.00000,1,1,0,MF
GO:0016866,intramolecular transferase activity,27,0,0.15,1.00000,1,1,0,MF
GO:0016874,ligase activity,147,0,0.83,1.00000,1,1,0,MF
GO:0016875,"ligase activity, forming carbon-oxygen b...",41,0,0.23,1.00000,1,1,0,MF
GO:0016877,"ligase activity, forming carbon-sulfur b...",37,0,0.21,1.00000,1,1,0,MF
GO:0016878,acid-thiol ligase activity,26,0,0.15,1.00000,1,1,0,MF
GO:0016879,"ligase activity, forming carbon-nitrogen...",47,0,0.26,1.00000,1,1,0,MF
GO:0016891,"endoribonuclease activity, producing 5'-...",28,0,0.16,1.00000,1,1,0,MF
GO:0016893,"endonuclease activity, active with eithe...",40,0,0.22,1.00000,1,1,0,MF
GO:0016895,"exodeoxyribonuclease activity, producing...",23,0,0.13,1.00000,1,1,0,MF
GO:0016896,"exoribonuclease activity, producing 5'-p...",31,0,0.17,1.00000,1,1,0,MF
GO:0016903,"oxidoreductase activity, acting on the a...",52,0,0.29,1.00000,1,1,0,MF
GO:0016917,GABA receptor activity,22,0,0.12,1.00000,1,1,0,MF
GO:0016922,nuclear receptor binding,26,0,0.15,1.00000,1,1,0,MF
GO:0017025,TBP-class protein binding,23,0,0.13,1.00000,1,1,0,MF
GO:0017069,snRNA binding,39,0,0.22,1.00000,1,1,0,MF
GO:0017075,syntaxin-1 binding,27,0,0.15,1.00000,1,1,0,MF
GO:0017080,sodium channel regulator activity,33,0,0.19,1.00000,1,1,0,MF
GO:0017091,AU-rich element binding,31,0,0.17,1.00000,1,1,0,MF
GO:0017112,Rab guanyl-nucleotide exchange factor ac...,38,0,0.21,1.00000,1,1,0,MF
GO:0017116,single-stranded DNA-dependent ATP-depend...,20,0,0.11,1.00000,1,1,0,MF
GO:0017127,cholesterol transporter activity,20,0,0.11,1.00000,1,1,0,MF
GO:0017147,Wnt-protein binding,38,0,0.21,1.00000,1,1,0,MF
GO:0017171,serine hydrolase activity,208,0,1.17,1.00000,1,1,0,MF
GO:0018024,histone-lysine N-methyltransferase activ...,44,0,0.25,1.00000,1,1,0,MF
GO:0019003,GDP binding,77,0,0.43,1.00000,1,1,0,MF
GO:0019200,carbohydrate kinase activity,21,0,0.12,1.00000,1,1,0,MF
GO:0019205,nucleobase-containing compound kinase ac...,38,0,0.21,1.00000,1,1,0,MF
GO:0019213,deacetylase activity,42,0,0.24,1.00000,1,1,0,MF
GO:0019239,deaminase activity,27,0,0.15,1.00000,1,1,0,MF
GO:0019706,protein-cysteine S-palmitoyltransferase ...,29,0,0.16,1.00000,1,1,0,MF
GO:0019707,protein-cysteine S-acyltransferase activ...,29,0,0.16,1.00000,1,1,0,MF
GO:0019789,SUMO transferase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0019825,oxygen binding,23,0,0.13,1.00000,1,1,0,MF
GO:0019829,cation-transporting ATPase activity,61,0,0.34,1.00000,1,1,0,MF
GO:0019840,isoprenoid binding,38,0,0.21,1.00000,1,1,0,MF
GO:0019842,vitamin binding,135,0,0.76,1.00000,1,1,0,MF
GO:0019865,immunoglobulin binding,22,0,0.12,1.00000,1,1,0,MF
GO:0019905,syntaxin binding,79,0,0.44,1.00000,1,1,0,MF
GO:0019955,cytokine binding,131,0,0.74,1.00000,1,1,0,MF
GO:0019956,chemokine binding,33,0,0.19,1.00000,1,1,0,MF
GO:0019957,C-C chemokine binding,25,0,0.14,1.00000,1,1,0,MF
GO:0020037,heme binding,155,0,0.87,1.00000,1,1,0,MF
GO:0022803,passive transmembrane transporter activi...,444,0,2.49,1.00000,1,1,0,MF
GO:0022804,active transmembrane transporter activit...,355,0,1.99,1.00000,1,1,0,MF
GO:0022824,transmitter-gated ion channel activity,58,0,0.33,1.00000,1,1,0,MF
GO:0022829,wide pore channel activity,22,0,0.12,1.00000,1,1,0,MF
GO:0022832,voltage-gated channel activity,195,0,1.09,1.00000,1,1,0,MF
GO:0022834,ligand-gated channel activity,136,0,0.76,1.00000,1,1,0,MF
GO:0022835,transmitter-gated channel activity,58,0,0.33,1.00000,1,1,0,MF
GO:0022836,gated channel activity,335,0,1.88,1.00000,1,1,0,MF
GO:0022838,substrate-specific channel activity,420,0,2.36,1.00000,1,1,0,MF
GO:0022839,ion gated channel activity,323,0,1.81,1.00000,1,1,0,MF
GO:0022843,voltage-gated cation channel activity,146,0,0.82,1.00000,1,1,0,MF
GO:0022853,active ion transmembrane transporter act...,61,0,0.34,1.00000,1,1,0,MF
GO:0030020,extracellular matrix structural constitu...,39,0,0.22,1.00000,1,1,0,MF
GO:0030145,manganese ion binding,59,0,0.33,1.00000,1,1,0,MF
GO:0030170,pyridoxal phosphate binding,53,0,0.3,1.00000,1,1,0,MF
GO:0030215,semaphorin receptor binding,22,0,0.12,1.00000,1,1,0,MF
GO:0030247,polysaccharide binding,21,0,0.12,1.00000,1,1,0,MF
GO:0030331,estrogen receptor binding,50,0,0.28,1.00000,1,1,0,MF
GO:0030332,cyclin binding,32,0,0.18,1.00000,1,1,0,MF
GO:0030374,nuclear receptor transcription coactivat...,64,0,0.36,1.00000,1,1,0,MF
GO:0030544,Hsp70 protein binding,49,0,0.28,1.00000,1,1,0,MF
GO:0030547,receptor inhibitor activity,26,0,0.15,1.00000,1,1,0,MF
GO:0030551,cyclic nucleotide binding,36,0,0.2,1.00000,1,1,0,MF
GO:0030552,cAMP binding,22,0,0.12,1.00000,1,1,0,MF
GO:0030594,neurotransmitter receptor activity,117,0,0.66,1.00000,1,1,0,MF
GO:0030742,GTP-dependent protein binding,25,0,0.14,1.00000,1,1,0,MF
GO:0031210,phosphatidylcholine binding,25,0,0.14,1.00000,1,1,0,MF
GO:0031369,translation initiation factor binding,40,0,0.22,1.00000,1,1,0,MF
GO:0031406,carboxylic acid binding,211,0,1.18,1.00000,1,1,0,MF
GO:0031420,alkali metal ion binding,22,0,0.12,1.00000,1,1,0,MF
GO:0031435,mitogen-activated protein kinase kinase ...,27,0,0.15,1.00000,1,1,0,MF
GO:0031489,myosin V binding,21,0,0.12,1.00000,1,1,0,MF
GO:0031593,polyubiquitin modification-dependent pro...,55,0,0.31,1.00000,1,1,0,MF
GO:0031624,ubiquitin conjugating enzyme binding,34,0,0.19,1.00000,1,1,0,MF
GO:0031681,G-protein beta-subunit binding,23,0,0.13,1.00000,1,1,0,MF
GO:0031683,G-protein beta/gamma-subunit complex bin...,24,0,0.13,1.00000,1,1,0,MF
GO:0031690,adrenergic receptor binding,21,0,0.12,1.00000,1,1,0,MF
GO:0032266,phosphatidylinositol-3-phosphate binding,41,0,0.23,1.00000,1,1,0,MF
GO:0032451,demethylase activity,42,0,0.24,1.00000,1,1,0,MF
GO:0032452,histone demethylase activity,27,0,0.15,1.00000,1,1,0,MF
GO:0032794,GTPase activating protein binding,20,0,0.11,1.00000,1,1,0,MF
GO:0032813,tumor necrosis factor receptor superfami...,46,0,0.26,1.00000,1,1,0,MF
GO:0033038,bitter taste receptor activity,29,0,0.16,1.00000,1,1,0,MF
GO:0033293,monocarboxylic acid binding,69,0,0.39,1.00000,1,1,0,MF
GO:0033558,protein deacetylase activity,29,0,0.16,1.00000,1,1,0,MF
GO:0033612,receptor serine/threonine kinase binding,28,0,0.16,1.00000,1,1,0,MF
GO:0033764,"steroid dehydrogenase activity, acting o...",37,0,0.21,1.00000,1,1,0,MF
GO:0034061,DNA polymerase activity,33,0,0.19,1.00000,1,1,0,MF
GO:0034062,5'-3' RNA polymerase activity,39,0,0.22,1.00000,1,1,0,MF
GO:0034212,peptide N-acetyltransferase activity,76,0,0.43,1.00000,1,1,0,MF
GO:0034237,protein kinase A regulatory subunit bind...,22,0,0.12,1.00000,1,1,0,MF
GO:0034593,phosphatidylinositol bisphosphate phosph...,21,0,0.12,1.00000,1,1,0,MF
GO:0035014,phosphatidylinositol 3-kinase regulator ...,20,0,0.11,1.00000,1,1,0,MF
GO:0035198,miRNA binding,29,0,0.16,1.00000,1,1,0,MF
GO:0035250,UDP-galactosyltransferase activity,25,0,0.14,1.00000,1,1,0,MF
GO:0035259,glucocorticoid receptor binding,21,0,0.12,1.00000,1,1,0,MF
GO:0035586,purinergic receptor activity,25,0,0.14,1.00000,1,1,0,MF
GO:0035925,mRNA 3'-UTR AU-rich region binding,29,0,0.16,1.00000,1,1,0,MF
GO:0036002,pre-mRNA binding,35,0,0.2,1.00000,1,1,0,MF
GO:0036442,proton-exporting ATPase activity,31,0,0.17,1.00000,1,1,0,MF
GO:0036459,thiol-dependent ubiquitinyl hydrolase ac...,99,0,0.56,1.00000,1,1,0,MF
GO:0042054,histone methyltransferase activity,57,0,0.32,1.00000,1,1,0,MF
GO:0042056,chemoattractant activity,40,0,0.22,1.00000,1,1,0,MF
GO:0042165,neurotransmitter binding,61,0,0.34,1.00000,1,1,0,MF
GO:0042169,SH2 domain binding,39,0,0.22,1.00000,1,1,0,MF
GO:0042379,chemokine receptor binding,66,0,0.37,1.00000,1,1,0,MF
GO:0042605,peptide antigen binding,35,0,0.2,1.00000,1,1,0,MF
GO:0042625,ATPase coupled ion transmembrane transpo...,61,0,0.34,1.00000,1,1,0,MF
GO:0042626,"ATPase activity, coupled to transmembran...",113,0,0.63,1.00000,1,1,0,MF
GO:0042805,actinin binding,48,0,0.27,1.00000,1,1,0,MF
GO:0042826,histone deacetylase binding,122,0,0.69,1.00000,1,1,0,MF
GO:0042887,amide transmembrane transporter activity,43,0,0.24,1.00000,1,1,0,MF
GO:0042923,neuropeptide binding,25,0,0.14,1.00000,1,1,0,MF
GO:0042974,retinoic acid receptor binding,33,0,0.19,1.00000,1,1,0,MF
GO:0042975,peroxisome proliferator activated recept...,21,0,0.12,1.00000,1,1,0,MF
GO:0043014,alpha-tubulin binding,38,0,0.21,1.00000,1,1,0,MF
GO:0043015,gamma-tubulin binding,29,0,0.16,1.00000,1,1,0,MF
GO:0043027,cysteine-type endopeptidase inhibitor ac...,28,0,0.16,1.00000,1,1,0,MF
GO:0043028,cysteine-type endopeptidase regulator ac...,39,0,0.22,1.00000,1,1,0,MF
GO:0043138,3'-5' DNA helicase activity,21,0,0.12,1.00000,1,1,0,MF
GO:0043142,single-stranded DNA-dependent ATPase act...,20,0,0.11,1.00000,1,1,0,MF
GO:0043175,RNA polymerase core enzyme binding,43,0,0.24,1.00000,1,1,0,MF
GO:0043177,organic acid binding,224,0,1.26,1.00000,1,1,0,MF
GO:0043325,"phosphatidylinositol-3,4-bisphosphate bi...",28,0,0.16,1.00000,1,1,0,MF
GO:0043394,proteoglycan binding,37,0,0.21,1.00000,1,1,0,MF
GO:0043425,bHLH transcription factor binding,32,0,0.18,1.00000,1,1,0,MF
GO:0043492,"ATPase activity, coupled to movement of ...",114,0,0.64,1.00000,1,1,0,MF
GO:0043539,protein serine/threonine kinase activato...,29,0,0.16,1.00000,1,1,0,MF
GO:0043621,protein self-association,65,0,0.36,1.00000,1,1,0,MF
GO:0044183,protein binding involved in protein fold...,22,0,0.12,1.00000,1,1,0,MF
GO:0044390,ubiquitin-like protein conjugating enzym...,39,0,0.22,1.00000,1,1,0,MF
GO:0044769,"ATPase activity, coupled to transmembran...",34,0,0.19,1.00000,1,1,0,MF
GO:0045296,cadherin binding,70,0,0.39,1.00000,1,1,0,MF
GO:0045499,chemorepellent activity,28,0,0.16,1.00000,1,1,0,MF
GO:0045503,dynein light chain binding,30,0,0.17,1.00000,1,1,0,MF
GO:0045505,dynein intermediate chain binding,33,0,0.19,1.00000,1,1,0,MF
GO:0046625,sphingolipid binding,26,0,0.15,1.00000,1,1,0,MF
GO:0046873,metal ion transmembrane transporter acti...,433,0,2.43,1.00000,1,1,0,MF
GO:0046875,ephrin receptor binding,31,0,0.17,1.00000,1,1,0,MF
GO:0046906,tetrapyrrole binding,164,0,0.92,1.00000,1,1,0,MF
GO:0046915,transition metal ion transmembrane trans...,37,0,0.21,1.00000,1,1,0,MF
GO:0046943,carboxylic acid transmembrane transporte...,150,0,0.84,1.00000,1,1,0,MF
GO:0046961,"proton-transporting ATPase activity, rot...",21,0,0.12,1.00000,1,1,0,MF
GO:0046965,retinoid X receptor binding,23,0,0.13,1.00000,1,1,0,MF
GO:0046966,thyroid hormone receptor binding,26,0,0.15,1.00000,1,1,0,MF
GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activ...",20,0,0.11,1.00000,1,1,0,MF
GO:0047617,acyl-CoA hydrolase activity,25,0,0.14,1.00000,1,1,0,MF
GO:0048020,CCR chemokine receptor binding,46,0,0.26,1.00000,1,1,0,MF
GO:0048029,monosaccharide binding,85,0,0.48,1.00000,1,1,0,MF
GO:0048156,tau protein binding,21,0,0.12,1.00000,1,1,0,MF
GO:0048487,beta-tubulin binding,43,0,0.24,1.00000,1,1,0,MF
GO:0050136,NADH dehydrogenase (quinone) activity,26,0,0.15,1.00000,1,1,0,MF
GO:0050321,tau-protein kinase activity,20,0,0.11,1.00000,1,1,0,MF
GO:0050431,transforming growth factor beta binding,21,0,0.12,1.00000,1,1,0,MF
GO:0050661,NADP binding,48,0,0.27,1.00000,1,1,0,MF
GO:0050699,WW domain binding,31,0,0.17,1.00000,1,1,0,MF
GO:0050750,low-density lipoprotein particle recepto...,26,0,0.15,1.00000,1,1,0,MF
GO:0050997,quaternary ammonium group binding,25,0,0.14,1.00000,1,1,0,MF
GO:0051059,NF-kappaB binding,32,0,0.18,1.00000,1,1,0,MF
GO:0051119,sugar transmembrane transporter activity,26,0,0.15,1.00000,1,1,0,MF
GO:0051213,dioxygenase activity,94,0,0.53,1.00000,1,1,0,MF
GO:0051371,muscle alpha-actinin binding,21,0,0.12,1.00000,1,1,0,MF
GO:0051393,alpha-actinin binding,37,0,0.21,1.00000,1,1,0,MF
GO:0051536,iron-sulfur cluster binding,63,0,0.35,1.00000,1,1,0,MF
GO:0051537,"2 iron, 2 sulfur cluster binding",25,0,0.14,1.00000,1,1,0,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",39,0,0.22,1.00000,1,1,0,MF
GO:0051540,metal cluster binding,63,0,0.35,1.00000,1,1,0,MF
GO:0051721,protein phosphatase 2A binding,38,0,0.21,1.00000,1,1,0,MF
GO:0051787,misfolded protein binding,24,0,0.13,1.00000,1,1,0,MF
GO:0051861,glycolipid binding,21,0,0.12,1.00000,1,1,0,MF
GO:0051879,Hsp90 protein binding,46,0,0.26,1.00000,1,1,0,MF
GO:0051959,dynein light intermediate chain binding,33,0,0.19,1.00000,1,1,0,MF
GO:0052689,carboxylic ester hydrolase activity,143,0,0.8,1.00000,1,1,0,MF
GO:0052745,inositol phosphate phosphatase activity,20,0,0.11,1.00000,1,1,0,MF
GO:0052866,phosphatidylinositol phosphate phosphata...,25,0,0.14,1.00000,1,1,0,MF
GO:0061631,ubiquitin conjugating enzyme activity,39,0,0.22,1.00000,1,1,0,MF
GO:0061650,ubiquitin-like protein conjugating enzym...,41,0,0.23,1.00000,1,1,0,MF
GO:0061733,peptide-lysine-N-acetyltransferase activ...,67,0,0.38,1.00000,1,1,0,MF
GO:0061980,regulatory RNA binding,36,0,0.2,1.00000,1,1,0,MF
GO:0070001,aspartic-type peptidase activity,30,0,0.17,1.00000,1,1,0,MF
GO:0070003,threonine-type peptidase activity,21,0,0.12,1.00000,1,1,0,MF
GO:0070035,purine NTP-dependent helicase activity,22,0,0.12,1.00000,1,1,0,MF
GO:0070063,RNA polymerase binding,58,0,0.33,1.00000,1,1,0,MF
GO:0070273,phosphatidylinositol-4-phosphate binding,36,0,0.2,1.00000,1,1,0,MF
GO:0070279,vitamin B6 binding,54,0,0.3,1.00000,1,1,0,MF
GO:0070300,phosphatidic acid binding,20,0,0.11,1.00000,1,1,0,MF
GO:0070325,lipoprotein particle receptor binding,30,0,0.17,1.00000,1,1,0,MF
GO:0070330,aromatase activity,35,0,0.2,1.00000,1,1,0,MF
GO:0070405,ammonium ion binding,80,0,0.45,1.00000,1,1,0,MF
GO:0070491,repressing transcription factor binding,71,0,0.4,1.00000,1,1,0,MF
GO:0070530,K63-linked polyubiquitin modification-de...,22,0,0.12,1.00000,1,1,0,MF
GO:0070566,adenylyltransferase activity,30,0,0.17,1.00000,1,1,0,MF
GO:0070696,transmembrane receptor protein serine/th...,20,0,0.11,1.00000,1,1,0,MF
GO:0071837,HMG box domain binding,25,0,0.14,1.00000,1,1,0,MF
GO:0071855,neuropeptide receptor binding,32,0,0.18,1.00000,1,1,0,MF
GO:0071889,14-3-3 protein binding,29,0,0.16,1.00000,1,1,0,MF
GO:0072341,modified amino acid binding,104,0,0.58,1.00000,1,1,0,MF
GO:0072509,divalent inorganic cation transmembrane ...,27,0,0.15,1.00000,1,1,0,MF
GO:0080025,"phosphatidylinositol-3,5-bisphosphate bi...",27,0,0.15,1.00000,1,1,0,MF
GO:0090079,"translation regulator activity, nucleic ...",23,0,0.13,1.00000,1,1,0,MF
GO:0090482,vitamin transmembrane transporter activi...,22,0,0.12,1.00000,1,1,0,MF
GO:0097110,scaffold protein binding,76,0,0.43,1.00000,1,1,0,MF
GO:0097472,cyclin-dependent protein kinase activity,31,0,0.17,1.00000,1,1,0,MF
GO:0097718,disordered domain specific binding,35,0,0.2,1.00000,1,1,0,MF
GO:0097747,RNA polymerase activity,39,0,0.22,1.00000,1,1,0,MF
GO:0098531,"transcription factor activity, direct li...",40,0,0.22,1.00000,1,1,0,MF
GO:0098632,cell-cell adhesion mediator activity,31,0,0.17,1.00000,1,1,0,MF
GO:0098918,structural constituent of synapse,30,0,0.17,1.00000,1,1,0,MF
GO:0098960,postsynaptic neurotransmitter receptor a...,57,0,0.32,1.00000,1,1,0,MF
GO:0099094,ligand-gated cation channel activity,99,0,0.56,1.00000,1,1,0,MF
GO:0099095,ligand-gated anion channel activity,21,0,0.12,1.00000,1,1,0,MF
GO:0099516,ion antiporter activity,54,0,0.3,1.00000,1,1,0,MF
GO:0099528,G protein-coupled neurotransmitter recep...,45,0,0.25,1.00000,1,1,0,MF
GO:0099529,neurotransmitter receptor activity invol...,55,0,0.31,1.00000,1,1,0,MF
GO:0099589,serotonin receptor activity,39,0,0.22,1.00000,1,1,0,MF
GO:0099604,ligand-gated calcium channel activity,26,0,0.15,1.00000,1,1,0,MF
GO:0101005,ubiquitinyl hydrolase activity,101,0,0.57,1.00000,1,1,0,MF
GO:0104005,hijacked molecular function,20,0,0.11,1.00000,1,1,0,MF
GO:0120013,intermembrane lipid transfer activity,29,0,0.16,1.00000,1,1,0,MF
GO:0120015,intermembrane sterol transfer activity,21,0,0.12,1.00000,1,1,0,MF
GO:0120020,intermembrane cholesterol transfer activ...,20,0,0.11,1.00000,1,1,0,MF
GO:0140098,"catalytic activity, acting on RNA",362,0,2.03,1.00000,1,1,0,MF
GO:0140101,"catalytic activity, acting on a tRNA",113,0,0.63,1.00000,1,1,0,MF
GO:0140103,"catalytic activity, acting on a glycopro...",22,0,0.12,1.00000,1,1,0,MF
GO:0140104,molecular carrier activity,50,0,0.28,1.00000,1,1,0,MF
GO:0140142,nucleocytoplasmic carrier activity,29,0,0.16,1.00000,1,1,0,MF
GO:1901338,catecholamine binding,21,0,0.12,1.00000,1,1,0,MF
GO:1901505,carbohydrate derivative transmembrane tr...,46,0,0.26,1.00000,1,1,0,MF
GO:1901567,fatty acid derivative binding,35,0,0.2,1.00000,1,1,0,MF
GO:1901618,organic hydroxy compound transmembrane t...,43,0,0.24,1.00000,1,1,0,MF
GO:1901682,sulfur compound transmembrane transporte...,31,0,0.17,1.00000,1,1,0,MF
GO:1904315,transmitter-gated ion channel activity i...,52,0,0.29,1.00000,1,1,0,MF
GO:1904680,peptide transmembrane transporter activi...,27,0,0.15,1.00000,1,1,0,MF
GO:0043229,intracellular organelle,11997,107,66.65,5.8e-16,3.654e-13,3.654e-13,1.61,CC
GO:0043226,organelle,12314,107,68.41,6.4e-15,4.032e-12,2.016e-12,1.56,CC
GO:0043231,intracellular membrane-bounded organelle,10334,97,57.41,5.7e-14,3.5909999999999995e-11,1.134e-11,1.69,CC
GO:0044424,intracellular part,13717,111,76.21,7.3e-14,4.599e-11,1.134e-11,1.46,CC
GO:0005622,intracellular,13747,111,76.38,9.0e-14,5.6699999999999995e-11,1.134e-11,1.45,CC
GO:0005737,cytoplasm,10993,99,61.08,3.2e-13,2.016e-10,3.36e-11,1.62,CC
GO:0043227,membrane-bounded organelle,11062,99,61.46,5.2e-13,3.276e-10,4.68e-11,1.61,CC
GO:0005634,nucleus,6846,76,38.04,8.2e-13,5.166000000000001e-10,6.457500000000001e-11,2,CC
GO:0044444,cytoplasmic part,8386,84,46.59,3.3e-12,2.079e-9,2.31e-10,1.8,CC
GO:0022626,cytosolic ribosome,109,11,0.61,2.4e-11,1.512e-8,1.5120000000000002e-9,18.03,CC
GO:0043232,intracellular non-membrane-bounded organ...,4141,53,23.01,3.1e-10,1.953e-7,1.7754545454545454e-8,2.3,CC
GO:0043228,non-membrane-bounded organelle,4161,53,23.12,3.7e-10,2.3310000000000002e-7,1.9425e-8,2.29,CC
GO:0044446,intracellular organelle part,7228,73,40.16,6.4e-10,4.0319999999999996e-7,3.101538461538461e-8,1.82,CC
GO:0044422,organelle part,7595,75,42.2,8.0e-10,5.040000000000001e-7,3.6e-8,1.78,CC
GO:0032991,protein-containing complex,5422,60,30.12,3.4e-09,2.142e-6,1.4279999999999998e-7,1.99,CC
GO:0005840,ribosome,227,12,1.26,5.3e-09,3.339e-6,2.086875e-7,9.52,CC
GO:0097458,neuron part,1982,33,11.01,5.7e-09,3.591e-6,2.1123529411764706e-7,3,CC
GO:0044391,ribosomal subunit,192,11,1.07,1.0e-08,6.3e-6,3.3157894736842106e-7,10.28,CC
GO:0044464,cell part,16127,113,89.6,1.0e-08,6.3e-6,3.3157894736842106e-7,1.26,CC
GO:0005623,cell,16132,113,89.63,1.1e-08,6.93e-6,3.465e-7,1.26,CC
GO:1990904,ribonucleoprotein complex,967,22,5.37,1.6e-08,1.008e-5,4.800000000000001e-7,4.1,CC
GO:0045202,synapse,1417,26,7.87,5.2e-08,3.2760000000000005e-5,1.489090909090909e-6,3.3,CC
GO:0005829,cytosol,3292,42,18.29,6.6e-08,4.158e-5,1.8078260869565215e-6,2.3,CC
GO:0022627,cytosolic small ribosomal subunit,44,6,0.24,1.5e-07,9.449999999999999e-5,3.9375e-6,25,CC
GO:0030426,growth cone,206,10,1.14,2.3e-07,1.449e-4,5.796e-6,8.77,CC
GO:0044445,cytosolic part,265,11,1.47,2.7e-07,1.7010000000000001e-4,6.542307692307692e-6,7.48,CC
GO:0030427,site of polarized growth,211,10,1.17,2.9e-07,1.827e-4,6.766666666666666e-6,8.55,CC
GO:0030424,axon,717,17,3.98,4.6e-07,2.898e-4,1.035e-5,4.27,CC
GO:0015629,actin cytoskeleton,494,14,2.74,6.5e-07,4.0950000000000003e-4,1.407e-5,5.11,CC
GO:0044428,nuclear part,3985,45,22.14,6.7e-07,4.221e-4,1.407e-5,2.03,CC
GO:0043005,neuron projection,1523,25,8.46,8.0e-07,5.04e-4,1.6258064516129034e-5,2.96,CC
GO:0032432,actin filament bundle,96,7,0.53,1.1e-06,6.93e-4,2.165625e-5,13.21,CC
GO:0033267,axon part,454,13,2.52,1.5e-06,9.45e-4,2.8636363636363637e-5,5.16,CC
GO:0031672,A band,40,5,0.22,2.7e-06,0.001701,5.002941176470589e-5,22.73,CC
GO:0005856,cytoskeleton,2118,29,11.77,3.6e-06,0.002268,6.48e-5,2.46,CC
GO:0015935,small ribosomal subunit,76,6,0.42,4.1e-06,0.002583,7.175e-5,14.29,CC
GO:0044295,axonal growth cone,45,5,0.25,5.0e-06,0.0031500000000000005,8.513513513513514e-5,20,CC
GO:0150034,distal axon,374,11,2.08,7.8e-06,0.004914,1.293157894736842e-4,5.29,CC
GO:0001725,stress fiber,87,6,0.48,9.1e-06,0.005732999999999999,1.4136585365853659e-4,12.5,CC
GO:0097517,contractile actin filament bundle,87,6,0.48,9.1e-06,0.005732999999999999,1.4136585365853659e-4,12.5,CC
GO:0012505,endomembrane system,3805,41,21.14,9.2e-06,0.005796,1.4136585365853659e-4,1.94,CC
GO:0044297,cell body,811,16,4.51,1.1e-05,0.0069299999999999995,1.65e-4,3.55,CC
GO:0014069,postsynaptic density,397,11,2.21,1.4e-05,0.00882,2.0045454545454547e-4,4.98,CC
GO:0120025,plasma membrane bounded cell projection,2273,29,12.63,1.4e-05,0.00882,2.0045454545454547e-4,2.3,CC
GO:0032279,asymmetric synapse,400,11,2.22,1.5e-05,0.00945,2.1e-4,4.95,CC
GO:0042641,actomyosin,98,6,0.54,1.8e-05,0.011340000000000001,2.4127659574468084e-4,11.11,CC
GO:0001726,ruffle,147,7,0.82,1.8e-05,0.011340000000000001,2.4127659574468084e-4,8.54,CC
GO:0022625,cytosolic large ribosomal subunit,61,5,0.34,2.3e-05,0.01449,3.01875e-4,14.71,CC
GO:0098984,neuron to neuron synapse,425,11,2.36,2.5e-05,0.01575,3.2142857142857147e-4,4.66,CC
GO:0042995,cell projection,2473,30,13.74,2.6e-05,0.01638,3.276e-4,2.18,CC
GO:0043209,myelin sheath,219,8,1.22,3.1e-05,0.019530000000000002,3.829411764705883e-4,6.56,CC
GO:0099572,postsynaptic specialization,436,11,2.42,3.2e-05,0.020159999999999997,3.8769230769230764e-4,4.55,CC
GO:0044430,cytoskeletal part,1561,22,8.67,4.4e-05,0.027719999999999998,5.230188679245283e-4,2.54,CC
GO:0044463,cell projection part,1567,22,8.71,4.7e-05,0.029609999999999997,5.383636363636363e-4,2.53,CC
GO:0120038,plasma membrane bounded cell projection ...,1567,22,8.71,4.7e-05,0.029609999999999997,5.383636363636363e-4,2.53,CC
GO:0043025,neuronal cell body,722,14,4.01,4.9e-05,0.030869999999999998,5.5125e-4,3.49,CC
GO:0005938,cell cortex,316,9,1.76,6.9e-05,0.043469999999999995,7.626315789473684e-4,5.11,CC
GO:0048471,perinuclear region of cytoplasm,656,13,3.64,7.4e-05,0.046619999999999995,8.037931034482759e-4,3.57,CC
GO:0099568,cytoplasmic region,481,11,2.67,7.8e-05,0.049139999999999996,8.328813559322034e-4,4.12,CC
GO:0070013,intracellular organelle lumen,3883,39,21.57,8.6e-05,0.05418,8.738709677419355e-4,1.81,CC
GO:0031974,membrane-enclosed lumen,3884,39,21.58,8.6e-05,0.05418,8.738709677419355e-4,1.81,CC
GO:0043233,organelle lumen,3884,39,21.58,8.6e-05,0.05418,8.738709677419355e-4,1.81,CC
GO:0099512,supramolecular fiber,899,15,4.99,0.00014,0.08819999999999999,0.0013999999999999998,3.01,CC
GO:0099081,supramolecular polymer,905,15,5.03,0.00015,0.09449999999999999,0.0014538461538461537,2.98,CC
GO:0099080,supramolecular complex,906,15,5.03,0.00015,0.09449999999999999,0.0014538461538461537,2.98,CC
GO:0005791,rough endoplasmic reticulum,92,5,0.51,0.00016,0.10080000000000001,0.0015272727272727274,9.8,CC
GO:0030425,dendrite,728,13,4.04,0.00021,0.1323,0.0019746268656716417,3.22,CC
GO:0097447,dendritic tree,731,13,4.06,0.00022,0.1386,0.002038235294117647,3.2,CC
GO:0031430,M band,22,3,0.12,0.00024,0.1512,0.00216,25,CC
GO:0098794,postsynapse,740,13,4.11,0.00024,0.1512,0.00216,3.16,CC
GO:0036477,somatodendritic compartment,1056,16,5.87,0.00025,0.1575,0.0022183098591549294,2.73,CC
GO:0031981,nuclear lumen,3506,35,19.48,0.00026,0.16379999999999997,0.0022749999999999997,1.8,CC
GO:0031967,organelle envelope,1063,16,5.91,0.00027,0.1701,0.0022986486486486486,2.71,CC
GO:0031975,envelope,1064,16,5.91,0.00027,0.1701,0.0022986486486486486,2.71,CC
GO:0031252,cell leading edge,387,9,2.15,0.00032,0.20160000000000003,0.0026880000000000003,4.19,CC
GO:0030027,lamellipodium,168,6,0.93,0.00036,0.2268,0.0029842105263157893,6.45,CC
GO:0044456,synapse part,1098,16,6.1,0.00038,0.2394,0.003109090909090909,2.62,CC
GO:0005905,clathrin-coated pit,64,4,0.36,0.00044,0.2772,0.003553846153846154,11.11,CC
GO:0034399,nuclear periphery,115,5,0.64,0.00046,0.2898,0.003668354430379747,7.81,CC
GO:0005783,endoplasmic reticulum,1715,21,9.53,0.00047,0.2961,0.0037012499999999997,2.2,CC
GO:0015934,large ribosomal subunit,122,5,0.68,0.00060,0.37799999999999995,0.004666666666666666,7.35,CC
GO:0032587,ruffle membrane,71,4,0.39,0.00066,0.4158,0.005070731707317073,10.26,CC
GO:0036464,cytoplasmic ribonucleoprotein granule,203,6,1.13,0.00096,0.6048,0.007286746987951807,5.31,CC
GO:0008180,COP9 signalosome,36,3,0.2,0.00104,0.6551999999999999,0.0078,15,CC
GO:0044448,cell cortex part,212,6,1.18,0.00120,0.7559999999999999,0.008894117647058823,5.08,CC
GO:0035770,ribonucleoprotein granule,214,6,1.19,0.00126,0.7938000000000001,0.009230232558139534,5.04,CC
GO:0099513,polymeric cytoskeletal fiber,679,11,3.77,0.00143,0.9009,0.010355172413793103,2.92,CC
GO:0005875,microtubule associated complex,150,5,0.83,0.00152,0.9576,0.010881818181818182,6.02,CC
GO:0016363,nuclear matrix,90,4,0.5,0.00160,1,0.01127,8,CC
GO:0031256,leading edge membrane,152,5,0.84,0.00161,1,0.01127,5.95,CC
GO:0005635,nuclear envelope,414,8,2.3,0.00221,1,0.015300000000000001,3.48,CC
GO:0030864,cortical actin cytoskeleton,101,4,0.56,0.00244,1,0.01670869565217391,7.14,CC
GO:0031410,cytoplasmic vesicle,1830,20,10.17,0.00258,1,0.017477419354838708,1.97,CC
GO:0097708,intracellular vesicle,1835,20,10.19,0.00266,1,0.017827659574468083,1.96,CC
GO:0005874,microtubule,429,8,2.38,0.00275,1,0.01823684210526316,3.36,CC
GO:0030135,coated vesicle,181,5,1.01,0.00343,1,0.022509374999999998,4.95,CC
GO:0005871,kinesin complex,57,3,0.32,0.00393,1,0.025524742268041238,9.38,CC
GO:0030017,sarcomere,192,5,1.07,0.00440,1,0.02828571428571429,4.67,CC
GO:0000775,"chromosome, centromeric region",195,5,1.08,0.00470,1,0.02990909090909091,4.63,CC
GO:0015630,microtubule cytoskeleton,1156,14,6.42,0.00491,1,0.030933000000000002,2.18,CC
GO:0045277,respiratory chain complex IV,20,2,0.11,0.00545,1,0.0339950495049505,18.18,CC
GO:0010494,cytoplasmic stress granule,65,3,0.36,0.00569,1,0.035144117647058826,8.33,CC
GO:0031982,vesicle,1969,20,10.94,0.00587,1,0.03580096153846154,1.83,CC
GO:0044449,contractile fiber part,206,5,1.14,0.00591,1,0.03580096153846154,4.39,CC
GO:0030863,cortical cytoskeleton,134,4,0.74,0.00668,1,0.040080000000000005,5.41,CC
GO:0030016,myofibril,215,5,1.19,0.00705,1,0.041900943396226416,4.2,CC
GO:0035371,microtubule plus-end,23,2,0.13,0.00718,1,0.04211666666666666,15.38,CC
GO:0000776,kinetochore,137,4,0.76,0.00722,1,0.04211666666666666,5.26,CC
GO:0005844,polysome,75,3,0.42,0.00844,1,0.04878165137614679,7.14,CC
GO:0005689,U12-type spliceosomal complex,26,2,0.14,0.00912,1,0.05176216216216216,14.29,CC
GO:0043292,contractile fiber,229,5,1.27,0.00912,1,0.05176216216216216,3.94,CC
GO:0032839,dendrite cytoplasm,27,2,0.15,0.00981,1,0.055181249999999994,13.33,CC
GO:0097386,glial cell projection,28,2,0.16,0.01053,1,0.05824736842105263,12.5,CC
GO:0005925,focal adhesion,153,4,0.85,0.01054,1,0.05824736842105263,4.71,CC
GO:0005924,cell-substrate adherens junction,159,4,0.88,0.01201,1,0.06579391304347826,4.55,CC
GO:0044304,main axon,86,3,0.48,0.01225,1,0.06653017241379311,6.25,CC
GO:0042788,polysomal ribosome,31,2,0.17,0.01281,1,0.06839237288135594,11.76,CC
GO:1990752,microtubule end,31,2,0.17,0.01281,1,0.06839237288135594,11.76,CC
GO:0070069,cytochrome complex,32,2,0.18,0.01362,1,0.07210588235294117,11.11,CC
GO:0031970,organelle envelope lumen,90,3,0.5,0.01384,1,0.07221570247933884,6,CC
GO:0030055,cell-substrate junction,166,4,0.92,0.01387,1,0.07221570247933884,4.35,CC
GO:0005654,nucleoplasm,2607,23,14.48,0.01615,1,0.08297560975609755,1.59,CC
GO:0005730,nucleolus,821,10,4.56,0.01620,1,0.08297560975609755,2.19,CC
GO:0005790,smooth endoplasmic reticulum,36,2,0.2,0.01705,1,0.08662500000000001,10,CC
GO:0030139,endocytic vesicle,179,4,0.99,0.01781,1,0.08976239999999999,4.04,CC
GO:0098590,plasma membrane region,1226,13,6.81,0.01868,1,0.0934,1.91,CC
GO:0005694,chromosome,1111,12,6.17,0.02072,1,0.10278425196850394,1.94,CC
GO:0044427,chromosomal part,991,11,5.51,0.02211,1,0.10882265625000001,2,CC
GO:0120111,neuron projection cytoplasm,42,2,0.23,0.02280,1,0.11134883720930233,8.7,CC
GO:0005681,spliceosomal complex,194,4,1.08,0.02314,1,0.11213999999999999,3.7,CC
GO:0043197,dendritic spine,197,4,1.09,0.02431,1,0.11691068702290076,3.67,CC
GO:0098978,glutamatergic synapse,514,7,2.86,0.02475,1,0.118125,2.45,CC
GO:0044309,neuron spine,202,4,1.12,0.02634,1,0.12454253731343283,3.57,CC
GO:0005912,adherens junction,301,5,1.67,0.02649,1,0.12454253731343283,2.99,CC
GO:0031253,cell projection membrane,305,5,1.69,0.02783,1,0.12987333333333334,2.96,CC
GO:0005789,endoplasmic reticulum membrane,529,7,2.94,0.02834,1,0.1312808823529412,2.38,CC
GO:0098687,chromosomal region,308,5,1.71,0.02886,1,0.1327138686131387,2.92,CC
GO:0005740,mitochondrial envelope,663,8,3.68,0.03170,1,0.14381223021582734,2.17,CC
GO:0070161,anchoring junction,316,5,1.76,0.03173,1,0.14381223021582734,2.84,CC
GO:0098827,endoplasmic reticulum subcompartment,543,7,3.02,0.03200,1,0.14400000000000002,2.32,CC
GO:0005884,actin filament,125,3,0.69,0.03258,1,0.1455702127659574,4.35,CC
GO:0042175,nuclear outer membrane-endoplasmic retic...,554,7,3.08,0.03509,1,0.15568098591549295,2.27,CC
GO:0030018,Z disc,133,3,0.74,0.03808,1,0.16776503496503498,4.05,CC
GO:0005743,mitochondrial inner membrane,446,6,2.48,0.03838,1,0.1679125,2.42,CC
GO:0012506,vesicle membrane,336,5,1.87,0.03966,1,0.17231586206896554,2.67,CC
GO:0005739,mitochondrion,1809,16,10.05,0.04248,1,0.1833041095890411,1.59,CC
GO:0031965,nuclear membrane,237,4,1.32,0.04335,1,0.18578571428571428,3.03,CC
GO:0016459,myosin complex,60,2,0.33,0.04396,1,0.18712702702702702,6.06,CC
GO:0005768,endosome,840,9,4.67,0.04456,1,0.18837,1.93,CC
GO:0099503,secretory vesicle,585,7,3.25,0.04485,1,0.18837,2.15,CC
GO:0030176,integral component of endoplasmic reticu...,143,3,0.79,0.04558,1,0.19016052631578945,3.8,CC
GO:0000785,chromatin,588,7,3.27,0.04588,1,0.19016052631578945,2.14,CC
GO:0031674,I band,145,3,0.81,0.04716,1,0.19418823529411763,3.7,CC
GO:0031227,intrinsic component of endoplasmic retic...,151,3,0.84,0.05206,1,0.21297272727272729,3.57,CC
GO:0030054,cell junction,1144,11,6.36,0.05350,1,0.2174516129032258,1.73,CC
GO:0043198,dendritic shaft,68,2,0.38,0.05499,1,0.222075,5.26,CC
GO:0019866,organelle inner membrane,489,6,2.72,0.05543,1,0.22242611464968157,2.21,CC
GO:0032589,neuron projection membrane,69,2,0.38,0.05643,1,0.22500569620253164,5.26,CC
GO:0031966,mitochondrial membrane,619,7,3.44,0.05741,1,0.2274735849056604,2.03,CC
GO:0005769,early endosome,266,4,1.48,0.06120,1,0.240975,2.7,CC
GO:0030141,secretory granule,385,5,2.14,0.06380,1,0.24965217391304345,2.34,CC
GO:0044432,endoplasmic reticulum part,641,7,3.56,0.06659,1,0.2584932515337423,1.97,CC
GO:0016529,sarcoplasmic reticulum,76,2,0.42,0.06688,1,0.2584932515337423,4.76,CC
GO:0005758,mitochondrial intermembrane space,77,2,0.43,0.06842,1,0.2628329268292683,4.65,CC
GO:0005881,cytoplasmic microtubule,78,2,0.43,0.06997,1,0.26463772455089823,4.65,CC
GO:0070603,SWI/SNF superfamily-type complex,78,2,0.43,0.06997,1,0.26463772455089823,4.65,CC
GO:0043235,receptor complex,396,5,2.2,0.07015,1,0.26463772455089823,2.27,CC
GO:0032838,plasma membrane bounded cell projection ...,174,3,0.97,0.07302,1,0.273825,3.09,CC
GO:0000790,nuclear chromatin,406,5,2.26,0.07621,1,0.284096449704142,2.21,CC
GO:0098803,respiratory chain complex,83,2,0.46,0.07791,1,0.288725294117647,4.35,CC
GO:0016528,sarcoplasm,85,2,0.47,0.08116,1,0.29901052631578945,4.26,CC
GO:0005794,Golgi apparatus,1398,12,7.77,0.08807,1,0.32258197674418604,1.54,CC
GO:0070469,respiratory chain,91,2,0.51,0.09115,1,0.3319335260115607,3.92,CC
GO:0030659,cytoplasmic vesicle membrane,309,4,1.72,0.09375,1,0.3394396551724138,2.33,CC
GO:0030175,filopodium,93,2,0.52,0.09456,1,0.34041600000000005,3.85,CC
GO:0048786,presynaptic active zone,94,2,0.52,0.09628,1,0.3446386363636364,3.85,CC
GO:1904949,ATPase complex,96,2,0.53,0.09974,1,0.3550067796610169,3.77,CC
GO:0044429,mitochondrial part,851,8,4.73,0.10167,1,0.3598432584269663,1.69,CC
GO:0030136,clathrin-coated vesicle,99,2,0.55,0.10500,1,0.36515769230769235,3.64,CC
GO:0031091,platelet alpha granule,20,1,0.11,0.10549,1,0.36515769230769235,9.09,CC
GO:0044232,organelle membrane contact site,20,1,0.11,0.10549,1,0.36515769230769235,9.09,CC
GO:0090723,growth cone part,20,1,0.11,0.10549,1,0.36515769230769235,9.09,CC
GO:0031090,organelle membrane,1753,14,9.74,0.10728,1,0.36932459016393443,1.44,CC
GO:1902911,protein kinase complex,102,2,0.57,0.11033,1,0.3761610810810811,3.51,CC
GO:0030673,axolemma,21,1,0.12,0.11046,1,0.3761610810810811,8.33,CC
GO:0098858,actin-based cell projection,211,3,1.17,0.11318,1,0.38335161290322584,2.56,CC
GO:0031307,integral component of mitochondrial oute...,22,1,0.12,0.11541,1,0.3857333333333334,8.33,CC
GO:0043194,axon initial segment,22,1,0.12,0.11541,1,0.3857333333333334,8.33,CC
GO:0016020,membrane,9366,59,52.04,0.11572,1,0.3857333333333334,1.13,CC
GO:0044441,ciliary part,464,5,2.58,0.11672,1,0.3870189473684211,1.94,CC
GO:0031306,intrinsic component of mitochondrial out...,23,1,0.13,0.12033,1,0.3927870466321244,7.69,CC
GO:0097470,ribbon synapse,23,1,0.13,0.12033,1,0.3927870466321244,7.69,CC
GO:0099243,extrinsic component of synaptic membrane,23,1,0.13,0.12033,1,0.3927870466321244,7.69,CC
GO:0005604,basement membrane,108,2,0.6,0.12120,1,0.39358762886597937,3.33,CC
GO:0044455,mitochondrial membrane part,219,3,1.22,0.12279,1,0.3967061538461538,2.46,CC
GO:0072686,mitotic spindle,110,2,0.61,0.12488,1,0.4004497461928934,3.28,CC
GO:0005721,pericentric heterochromatin,24,1,0.13,0.12522,1,0.4004497461928934,7.69,CC
GO:0042588,zymogen granule,25,1,0.14,0.13009,1,0.4139227272727273,7.14,CC
GO:0005911,cell-cell junction,484,5,2.69,0.13268,1,0.4187172413793104,1.86,CC
GO:0005913,cell-cell adherens junction,115,2,0.64,0.13420,1,0.4187172413793104,3.12,CC
GO:0005868,cytoplasmic dynein complex,26,1,0.14,0.13492,1,0.4187172413793104,7.14,CC
GO:0097038,perinuclear endoplasmic reticulum,26,1,0.14,0.13492,1,0.4187172413793104,7.14,CC
GO:0099059,integral component of presynaptic active...,26,1,0.14,0.13492,1,0.4187172413793104,7.14,CC
GO:0031984,organelle subcompartment,913,8,5.07,0.13591,1,0.4197220588235294,1.58,CC
GO:0030137,COPI-coated vesicle,28,1,0.16,0.14452,1,0.44197864077669907,6.25,CC
GO:0031045,dense core granule,28,1,0.16,0.14452,1,0.44197864077669907,6.25,CC
GO:0005923,bicellular tight junction,122,2,0.68,0.14749,1,0.4488826086956522,2.94,CC
GO:0000780,"condensed nuclear chromosome, centromeri...",29,1,0.16,0.14928,1,0.4499827751196172,6.25,CC
GO:0016342,catenin complex,29,1,0.16,0.14928,1,0.4499827751196172,6.25,CC
GO:0045121,membrane raft,370,4,2.06,0.15102,1,0.45305999999999996,1.94,CC
GO:0098857,membrane microdomain,371,4,2.06,0.15205,1,0.4539881516587677,1.94,CC
GO:0097431,mitotic spindle pole,30,1,0.17,0.15401,1,0.4576712264150944,5.88,CC
GO:0045334,clathrin-coated endocytic vesicle,31,1,0.17,0.15872,1,0.4672598130841122,5.88,CC
GO:0098945,intrinsic component of presynaptic activ...,31,1,0.17,0.15872,1,0.4672598130841122,5.88,CC
GO:0097060,synaptic membrane,516,5,2.87,0.16012,1,0.4680290322580645,1.74,CC
GO:0070160,tight junction,129,2,0.72,0.16104,1,0.4680290322580645,2.78,CC
GO:0061695,"transferase complex, transferring phosph...",249,3,1.38,0.16121,1,0.4680290322580645,2.17,CC
GO:0009986,cell surface,955,8,5.31,0.16207,1,0.46836743119266055,1.51,CC
GO:0098589,membrane region,383,4,2.13,0.16466,1,0.47238545454545455,1.88,CC
GO:0001650,fibrillar center,131,2,0.73,0.16496,1,0.47238545454545455,2.74,CC
GO:0098805,whole membrane,1114,9,6.19,0.16696,1,0.4759493212669683,1.45,CC
GO:0005798,Golgi-associated vesicle,135,2,0.75,0.17283,1,0.4904635135135135,2.67,CC
GO:0005903,brush border,137,2,0.76,0.17680,1,0.49862812500000003,2.63,CC
GO:0051233,spindle midzone,35,1,0.19,0.17729,1,0.49862812500000003,5.26,CC
GO:0031463,Cul3-RING ubiquitin ligase complex,37,1,0.21,0.18642,1,0.5183207048458149,4.76,CC
GO:0031941,filamentous actin,37,1,0.21,0.18642,1,0.5183207048458149,4.76,CC
GO:0043296,apical junction complex,142,2,0.79,0.18676,1,0.5183207048458149,2.53,CC
GO:0005777,peroxisome,146,2,0.81,0.19479,1,0.535885152838428,2.47,CC
GO:0042579,microbody,146,2,0.81,0.19479,1,0.535885152838428,2.47,CC
GO:0005819,spindle,280,3,1.56,0.20416,1,0.5592208695652174,1.92,CC
GO:0098793,presynapse,564,5,3.13,0.20515,1,0.5595,1.6,CC
GO:0097730,non-motile cilium,152,2,0.84,0.20691,1,0.5618676724137932,2.38,CC
GO:0045177,apical part of cell,422,4,2.34,0.20802,1,0.5621807692307693,1.71,CC
GO:0032154,cleavage furrow,42,1,0.23,0.20881,1,0.5621807692307693,4.35,CC
GO:0005667,transcription factor complex,426,4,2.37,0.21265,1,0.5667873417721518,1.69,CC
GO:0000307,cyclin-dependent protein kinase holoenzy...,43,1,0.24,0.21322,1,0.5667873417721518,4.17,CC
GO:0005720,nuclear heterochromatin,43,1,0.24,0.21322,1,0.5667873417721518,4.17,CC
GO:0048787,presynaptic active zone membrane,46,1,0.26,0.22628,1,0.5989764705882353,3.85,CC
GO:0009898,cytoplasmic side of plasma membrane,165,2,0.92,0.23342,1,0.6152912133891213,2.17,CC
GO:0032590,dendrite membrane,48,1,0.27,0.23488,1,0.6155439834024896,3.7,CC
GO:0045111,intermediate filament cytoskeleton,166,2,0.92,0.23547,1,0.6155439834024896,2.17,CC
GO:0005741,mitochondrial outer membrane,171,2,0.95,0.24573,1,0.6397103305785125,2.11,CC
GO:0000779,"condensed chromosome, centromeric region",51,1,0.28,0.24759,1,0.6419,3.57,CC
GO:0030134,COPII-coated ER to Golgi transport vesic...,53,1,0.29,0.25594,1,0.6581314285714286,3.45,CC
GO:0032155,cell division site part,53,1,0.29,0.25594,1,0.6581314285714286,3.45,CC
GO:0019898,extrinsic component of membrane,320,3,1.78,0.26283,1,0.6711786290322581,1.69,CC
GO:0044454,nuclear chromosome part,621,5,3.45,0.26333,1,0.6711786290322581,1.45,CC
GO:0099738,cell cortex region,55,1,0.31,0.26421,1,0.6711786290322581,3.23,CC
GO:0016607,nuclear speck,323,3,1.79,0.26732,1,0.6762672,1.68,CC
GO:0098562,cytoplasmic side of membrane,182,2,1.01,0.26836,1,0.6762672,1.98,CC
GO:0044452,nucleolar part,184,2,1.02,0.27248,1,0.6803015625000001,1.96,CC
GO:0005929,cilium,632,5,3.51,0.27500,1,0.6803015625000001,1.42,CC
GO:0016328,lateral plasma membrane,58,1,0.32,0.27644,1,0.6803015625000001,3.12,CC
GO:0030120,vesicle coat,58,1,0.32,0.27644,1,0.6803015625000001,3.12,CC
GO:0030286,dynein complex,58,1,0.32,0.27644,1,0.6803015625000001,3.12,CC
GO:0032153,cell division site,58,1,0.32,0.27644,1,0.6803015625000001,3.12,CC
GO:0019897,extrinsic component of plasma membrane,187,2,1.04,0.27865,1,0.6830719844357978,1.92,CC
GO:0097525,spliceosomal snRNP complex,59,1,0.33,0.28047,1,0.6848686046511627,3.03,CC
GO:0019867,outer membrane,189,2,1.05,0.28277,1,0.6851734615384616,1.9,CC
GO:0031968,organelle outer membrane,189,2,1.05,0.28277,1,0.6851734615384616,1.9,CC
GO:0005788,endoplasmic reticulum lumen,60,1,0.33,0.28448,1,0.6866758620689655,3.03,CC
GO:0044438,microbody part,61,1,0.34,0.28846,1,0.6903511363636363,2.94,CC
GO:0044439,peroxisomal part,61,1,0.34,0.28846,1,0.6903511363636363,2.94,CC
GO:0071944,cell periphery,5388,33,29.93,0.28929,1,0.6903511363636363,1.1,CC
GO:0098862,cluster of actin-based cell projections,194,2,1.08,0.29304,1,0.6966611320754718,1.85,CC
GO:0098796,membrane protein complex,1134,8,6.3,0.29518,1,0.6980911439114391,1.27,CC
GO:0014704,intercalated disc,63,1,0.35,0.29637,1,0.6980911439114391,2.86,CC
GO:0000793,condensed chromosome,197,2,1.09,0.29920,1,0.6980911439114391,1.83,CC
GO:0000228,nuclear chromosome,655,5,3.64,0.29973,1,0.6980911439114391,1.37,CC
GO:0030532,small nuclear ribonucleoprotein complex,64,1,0.36,0.30029,1,0.6980911439114391,2.78,CC
GO:0030660,Golgi-associated vesicle membrane,64,1,0.36,0.30029,1,0.6980911439114391,2.78,CC
GO:0042734,presynaptic membrane,200,2,1.11,0.30535,1,0.7072444852941178,1.8,CC
GO:0016604,nuclear body,670,5,3.72,0.31606,1,0.7293692307692308,1.34,CC
GO:0005793,endoplasmic reticulum-Golgi intermediate...,69,1,0.38,0.31957,1,0.7323120000000001,2.63,CC
GO:0044306,neuron projection terminus,207,2,1.15,0.31966,1,0.7323120000000001,1.74,CC
GO:0062023,collagen-containing extracellular matrix,360,3,2,0.32333,1,0.7380358695652174,1.5,CC
GO:0005643,nuclear pore,72,1,0.4,0.33089,1,0.747555319148936,2.5,CC
GO:0032592,integral component of mitochondrial memb...,72,1,0.4,0.33089,1,0.747555319148936,2.5,CC
GO:0044459,plasma membrane part,2879,18,16,0.33271,1,0.747555319148936,1.12,CC
GO:0000932,P-body,73,1,0.41,0.33462,1,0.747555319148936,2.44,CC
GO:0005776,autophagosome,73,1,0.41,0.33462,1,0.747555319148936,2.44,CC
GO:0016605,PML body,73,1,0.41,0.33462,1,0.747555319148936,2.44,CC
GO:0044433,cytoplasmic vesicle part,527,4,2.93,0.33635,1,0.7487650176678444,1.37,CC
GO:0098573,intrinsic component of mitochondrial mem...,74,1,0.41,0.33833,1,0.7505207746478874,2.44,CC
GO:0120114,Sm-like protein family complex,75,1,0.42,0.34202,1,0.7560442105263159,2.38,CC
GO:0016234,inclusion body,76,1,0.42,0.34568,1,0.7614629370629371,2.38,CC
GO:0005773,vacuole,536,4,2.98,0.34772,1,0.7632878048780488,1.34,CC
GO:0016591,"RNA polymerase II, holoenzyme",77,1,0.43,0.34933,1,0.764159375,2.33,CC
GO:0008076,voltage-gated potassium channel complex,78,1,0.43,0.35296,1,0.7666863481228668,2.33,CC
GO:0030684,preribosome,78,1,0.43,0.35296,1,0.7666863481228668,2.33,CC
GO:0000784,"nuclear chromosome, telomeric region",79,1,0.44,0.35657,1,0.7666863481228668,2.27,CC
GO:0005746,mitochondrial respiratory chain,79,1,0.44,0.35657,1,0.7666863481228668,2.27,CC
GO:0030662,coated vesicle membrane,79,1,0.44,0.35657,1,0.7666863481228668,2.27,CC
GO:0008021,synaptic vesicle,227,2,1.26,0.36011,1,0.7691552542372881,1.59,CC
GO:0001750,photoreceptor outer segment,80,1,0.44,0.36016,1,0.7691552542372881,2.27,CC
GO:0071013,catalytic step 2 spliceosome,83,1,0.46,0.37080,1,0.7865454545454545,2.17,CC
GO:1902554,serine/threonine protein kinase complex,83,1,0.46,0.37080,1,0.7865454545454545,2.17,CC
GO:0030667,secretory granule membrane,84,1,0.47,0.37431,1,0.7886799331103678,2.13,CC
GO:0044291,cell-cell contact zone,84,1,0.47,0.37431,1,0.7886799331103678,2.13,CC
GO:0005886,plasma membrane,5243,31,29.13,0.37852,1,0.794892,1.06,CC
GO:0005684,U2-type spliceosomal complex,89,1,0.49,0.39157,1,0.8168513245033113,2.04,CC
GO:0034705,potassium channel complex,89,1,0.49,0.39157,1,0.8168513245033113,2.04,CC
GO:0097223,sperm part,244,2,1.36,0.39380,1,0.8187920792079207,1.47,CC
GO:0070062,extracellular exosome,91,1,0.51,0.39834,1,0.8255072368421053,1.96,CC
GO:0070382,exocytic vesicle,247,2,1.37,0.39966,1,0.8255272131147542,1.46,CC
GO:0005902,microvillus,92,1,0.51,0.40170,1,0.8270294117647058,1.96,CC
GO:0045335,phagocytic vesicle,93,1,0.52,0.40503,1,0.8311690553745928,1.92,CC
GO:0005901,caveola,94,1,0.52,0.40835,1,0.8352613636363636,1.92,CC
GO:0000792,heterochromatin,95,1,0.53,0.41166,1,0.8393067961165049,1.89,CC
GO:0031594,neuromuscular junction,98,1,0.54,0.42145,1,0.8537411575562701,1.85,CC
GO:0098839,postsynaptic density membrane,98,1,0.54,0.42145,1,0.8537411575562701,1.85,CC
GO:1903561,extracellular vesicle,99,1,0.55,0.42468,1,0.85578,1.82,CC
GO:0030117,membrane coat,100,1,0.56,0.42789,1,0.85578,1.79,CC
GO:0048475,coated membrane,100,1,0.56,0.42789,1,0.85578,1.79,CC
GO:0055029,nuclear DNA-directed RNA polymerase comp...,100,1,0.56,0.42789,1,0.85578,1.79,CC
GO:0000428,DNA-directed RNA polymerase complex,101,1,0.56,0.43108,1,0.8594316455696203,1.79,CC
GO:0030880,RNA polymerase complex,104,1,0.58,0.44056,1,0.8755608832807571,1.72,CC
GO:0005764,lysosome,440,3,2.44,0.44339,1,0.8784141509433963,1.23,CC
GO:0000323,lytic vacuole,441,3,2.45,0.44485,1,0.8785438871473356,1.22,CC
GO:0098552,side of membrane,615,4,3.42,0.44688,1,0.879795,1.17,CC
GO:0030672,synaptic vesicle membrane,112,1,0.62,0.46507,1,0.9099195652173913,1.61,CC
GO:0099501,exocytic vesicle membrane,112,1,0.62,0.46507,1,0.9099195652173913,1.61,CC
GO:0000781,"chromosome, telomeric region",114,1,0.63,0.47103,1,0.9130735384615385,1.59,CC
GO:0043230,extracellular organelle,114,1,0.63,0.47103,1,0.9130735384615385,1.59,CC
GO:0097733,photoreceptor cell cilium,114,1,0.63,0.47103,1,0.9130735384615385,1.59,CC
GO:0097731,9+0 non-motile cilium,116,1,0.64,0.47692,1,0.9160353658536585,1.56,CC
GO:0098685,Schaffer collateral - CA1 synapse,116,1,0.64,0.47692,1,0.9160353658536585,1.56,CC
GO:0099056,integral component of presynaptic membra...,116,1,0.64,0.47692,1,0.9160353658536585,1.56,CC
GO:1902494,catalytic complex,1365,8,7.58,0.49060,1,0.93807,1.06,CC
GO:0036126,sperm flagellum,121,1,0.67,0.49137,1,0.93807,1.49,CC
GO:0031012,extracellular matrix,477,3,2.65,0.49633,1,0.943178313253012,1.13,CC
GO:0044853,plasma membrane raft,123,1,0.68,0.49704,1,0.943178313253012,1.47,CC
GO:0044451,nucleoplasm part,1017,6,5.65,0.49961,1,0.9446227544910181,1.06,CC
GO:0044425,membrane part,7301,41,40.56,0.50080,1,0.9446227544910181,1.01,CC
GO:0005882,intermediate filament,125,1,0.69,0.50264,1,0.9452632835820896,1.45,CC
GO:0097729,9+2 motile cilium,128,1,0.71,0.51093,1,0.9551510385756676,1.41,CC
GO:0098889,intrinsic component of presynaptic membr...,128,1,0.71,0.51093,1,0.9551510385756676,1.41,CC
GO:0001669,acrosomal vesicle,129,1,0.72,0.51367,1,0.9568217647058823,1.39,CC
GO:0005930,axoneme,130,1,0.72,0.51638,1,0.9568217647058823,1.39,CC
GO:0098800,inner mitochondrial membrane protein com...,130,1,0.72,0.51638,1,0.9568217647058823,1.39,CC
GO:0097014,ciliary plasm,131,1,0.73,0.51909,1,0.9590225806451613,1.37,CC
GO:0005815,microtubule organizing center,680,4,3.78,0.52501,1,0.9671236842105263,1.06,CC
GO:0000922,spindle pole,134,1,0.74,0.52711,1,0.9681612244897959,1.35,CC
GO:0099634,postsynaptic specialization membrane,137,1,0.76,0.53500,1,0.979796511627907,1.32,CC
GO:0030133,transport vesicle,324,2,1.8,0.53966,1,0.983564739884393,1.11,CC
GO:0043204,perikaryon,139,1,0.77,0.54018,1,0.983564739884393,1.3,CC
GO:0005813,centrosome,517,3,2.87,0.55066,1,0.9980716332378222,1.05,CC
GO:0000794,condensed nuclear chromosome,144,1,0.8,0.55290,1,0.9980716332378222,1.25,CC
GO:0030658,transport vesicle membrane,144,1,0.8,0.55290,1,0.9980716332378222,1.25,CC
GO:0055037,recycling endosome,145,1,0.81,0.55540,1,0.99972,1.23,CC
GO:0098797,plasma membrane protein complex,545,3,3.03,0.58661,1,1,0.99,CC
GO:0031461,cullin-RING ubiquitin ligase complex,160,1,0.89,0.59129,1,1,1.12,CC
GO:0090575,RNA polymerase II transcription factor c...,166,1,0.92,0.60483,1,1,1.09,CC
GO:0042383,sarcolemma,167,1,0.93,0.60704,1,1,1.08,CC
GO:0099055,integral component of postsynaptic membr...,171,1,0.95,0.61577,1,1,1.05,CC
GO:0045211,postsynaptic membrane,376,2,2.09,0.62082,1,1,0.96,CC
GO:1990234,transferase complex,770,4,4.28,0.62375,1,1,0.93,CC
GO:0098936,intrinsic component of postsynaptic memb...,180,1,1,0.63471,1,1,1,CC
GO:0098802,plasma membrane receptor complex,182,1,1.01,0.63879,1,1,0.99,CC
GO:0043679,axon terminus,185,1,1.03,0.64483,1,1,0.97,CC
GO:0031514,motile cilium,204,1,1.13,0.68081,1,1,0.88,CC
GO:0044798,nuclear transcription factor complex,207,1,1.15,0.68616,1,1,0.87,CC
GO:0005615,extracellular space,1621,8,9.01,0.68672,1,1,0.89,CC
GO:0009897,external side of plasma membrane,434,2,2.41,0.69796,1,1,0.83,CC
GO:0098588,bounding membrane of organelle,1060,5,5.89,0.70722,1,1,0.85,CC
GO:0044421,extracellular region part,1855,9,10.31,0.71231,1,1,0.87,CC
GO:0034703,cation channel complex,224,1,1.24,0.71479,1,1,0.81,CC
GO:0031301,integral component of organelle membrane,228,1,1.27,0.72114,1,1,0.79,CC
GO:0099699,integral component of synaptic membrane,228,1,1.27,0.72114,1,1,0.79,CC
GO:0016323,basolateral plasma membrane,236,1,1.31,0.73343,1,1,0.76,CC
GO:0000139,Golgi membrane,242,1,1.34,0.74229,1,1,0.75,CC
GO:0099240,intrinsic component of synaptic membrane,246,1,1.37,0.74803,1,1,0.73,CC
GO:0031300,intrinsic component of organelle membran...,256,1,1.42,0.76185,1,1,0.7,CC
GO:0005759,mitochondrial matrix,266,1,1.48,0.77491,1,1,0.68,CC
GO:0098798,mitochondrial protein complex,266,1,1.48,0.77491,1,1,0.68,CC
GO:0005576,extracellular region,2399,11,13.33,0.79182,1,1,0.83,CC
GO:0000151,ubiquitin ligase complex,282,1,1.57,0.79434,1,1,0.64,CC
GO:0034702,ion channel complex,299,1,1.66,0.81317,1,1,0.6,CC
GO:1902495,transmembrane transporter complex,314,1,1.74,0.82836,1,1,0.57,CC
GO:0016324,apical plasma membrane,320,1,1.78,0.83408,1,1,0.56,CC
GO:1990351,transporter complex,325,1,1.81,0.83871,1,1,0.55,CC
GO:0005887,integral component of plasma membrane,1526,6,8.48,0.85910,1,1,0.71,CC
GO:0031226,intrinsic component of plasma membrane,1604,6,8.91,0.88893,1,1,0.67,CC
GO:0016021,integral component of membrane,5896,27,32.76,0.90311,1,1,0.82,CC
GO:0098791,Golgi subcompartment,444,1,2.47,0.91789,1,1,0.4,CC
GO:0031224,intrinsic component of membrane,6068,27,33.71,0.93205,1,1,0.8,CC
GO:0044431,Golgi apparatus part,497,1,2.76,0.93929,1,1,0.36,CC
GO:0005575,cellular_component,21419,119,119,1.00000,1,1,1,CC
GO:0000118,histone deacetylase complex,59,0,0.33,1.00000,1,1,0,CC
GO:0000123,histone acetyltransferase complex,83,0,0.46,1.00000,1,1,0,CC
GO:0000152,nuclear ubiquitin ligase complex,41,0,0.23,1.00000,1,1,0,CC
GO:0000159,protein phosphatase type 2A complex,20,0,0.11,1.00000,1,1,0,CC
GO:0000178,exosome (RNase complex),23,0,0.13,1.00000,1,1,0,CC
GO:0000242,pericentriolar material,21,0,0.12,1.00000,1,1,0,CC
GO:0000313,organellar ribosome,93,0,0.52,1.00000,1,1,0,CC
GO:0000314,organellar small ribosomal subunit,31,0,0.17,1.00000,1,1,0,CC
GO:0000315,organellar large ribosomal subunit,60,0,0.33,1.00000,1,1,0,CC
GO:0000407,phagophore assembly site,31,0,0.17,1.00000,1,1,0,CC
GO:0000421,autophagosome membrane,23,0,0.13,1.00000,1,1,0,CC
GO:0000502,proteasome complex,66,0,0.37,1.00000,1,1,0,CC
GO:0000777,condensed chromosome kinetochore,35,0,0.19,1.00000,1,1,0,CC
GO:0000786,nucleosome,88,0,0.49,1.00000,1,1,0,CC
GO:0000788,nuclear nucleosome,38,0,0.21,1.00000,1,1,0,CC
GO:0000791,euchromatin,45,0,0.25,1.00000,1,1,0,CC
GO:0000795,synaptonemal complex,81,0,0.45,1.00000,1,1,0,CC
GO:0000803,sex chromosome,41,0,0.23,1.00000,1,1,0,CC
GO:0000930,gamma-tubulin complex,20,0,0.11,1.00000,1,1,0,CC
GO:0001533,cornified envelope,56,0,0.31,1.00000,1,1,0,CC
GO:0001673,male germ cell nucleus,23,0,0.13,1.00000,1,1,0,CC
GO:0001741,XY body,22,0,0.12,1.00000,1,1,0,CC
GO:0001772,immunological synapse,38,0,0.21,1.00000,1,1,0,CC
GO:0001891,phagocytic cup,22,0,0.12,1.00000,1,1,0,CC
GO:0001917,photoreceptor inner segment,58,0,0.32,1.00000,1,1,0,CC
GO:0002080,acrosomal membrane,23,0,0.13,1.00000,1,1,0,CC
GO:0002102,podosome,27,0,0.15,1.00000,1,1,0,CC
GO:0005581,collagen trimer,83,0,0.46,1.00000,1,1,0,CC
GO:0005637,nuclear inner membrane,42,0,0.23,1.00000,1,1,0,CC
GO:0005657,replication fork,72,0,0.4,1.00000,1,1,0,CC
GO:0005669,transcription factor TFIID complex,38,0,0.21,1.00000,1,1,0,CC
GO:0005680,anaphase-promoting complex,20,0,0.11,1.00000,1,1,0,CC
GO:0005686,U2 snRNP,20,0,0.11,1.00000,1,1,0,CC
GO:0005719,nuclear euchromatin,35,0,0.19,1.00000,1,1,0,CC
GO:0005732,small nucleolar ribonucleoprotein comple...,26,0,0.14,1.00000,1,1,0,CC
GO:0005747,mitochondrial respiratory chain complex ...,50,0,0.28,1.00000,1,1,0,CC
GO:0005753,mitochondrial proton-transporting ATP sy...,20,0,0.11,1.00000,1,1,0,CC
GO:0005761,mitochondrial ribosome,93,0,0.52,1.00000,1,1,0,CC
GO:0005762,mitochondrial large ribosomal subunit,60,0,0.33,1.00000,1,1,0,CC
GO:0005763,mitochondrial small ribosomal subunit,31,0,0.17,1.00000,1,1,0,CC
GO:0005765,lysosomal membrane,110,0,0.61,1.00000,1,1,0,CC
GO:0005770,late endosome,203,0,1.13,1.00000,1,1,0,CC
GO:0005771,multivesicular body,42,0,0.23,1.00000,1,1,0,CC
GO:0005774,vacuolar membrane,169,0,0.94,1.00000,1,1,0,CC
GO:0005778,peroxisomal membrane,45,0,0.25,1.00000,1,1,0,CC
GO:0005795,Golgi stack,86,0,0.48,1.00000,1,1,0,CC
GO:0005797,Golgi medial cisterna,23,0,0.13,1.00000,1,1,0,CC
GO:0005801,cis-Golgi network,49,0,0.27,1.00000,1,1,0,CC
GO:0005802,trans-Golgi network,225,0,1.25,1.00000,1,1,0,CC
GO:0005811,lipid droplet,83,0,0.46,1.00000,1,1,0,CC
GO:0005814,centriole,115,0,0.64,1.00000,1,1,0,CC
GO:0005834,heterotrimeric G-protein complex,33,0,0.18,1.00000,1,1,0,CC
GO:0005838,proteasome regulatory particle,23,0,0.13,1.00000,1,1,0,CC
GO:0005849,mRNA cleavage factor complex,20,0,0.11,1.00000,1,1,0,CC
GO:0005858,axonemal dynein complex,24,0,0.13,1.00000,1,1,0,CC
GO:0005865,striated muscle thin filament,30,0,0.17,1.00000,1,1,0,CC
GO:0005876,spindle microtubule,57,0,0.32,1.00000,1,1,0,CC
GO:0005891,voltage-gated calcium channel complex,45,0,0.25,1.00000,1,1,0,CC
GO:0005921,gap junction,33,0,0.18,1.00000,1,1,0,CC
GO:0005922,connexin complex,20,0,0.11,1.00000,1,1,0,CC
GO:0005942,phosphatidylinositol 3-kinase complex,30,0,0.17,1.00000,1,1,0,CC
GO:0008023,transcription elongation factor complex,53,0,0.29,1.00000,1,1,0,CC
GO:0008287,protein serine/threonine phosphatase com...,46,0,0.26,1.00000,1,1,0,CC
GO:0008305,integrin complex,32,0,0.18,1.00000,1,1,0,CC
GO:0008328,ionotropic glutamate receptor complex,57,0,0.32,1.00000,1,1,0,CC
GO:0009295,nucleoid,47,0,0.26,1.00000,1,1,0,CC
GO:0009925,basal plasma membrane,43,0,0.24,1.00000,1,1,0,CC
GO:0010008,endosome membrane,210,0,1.17,1.00000,1,1,0,CC
GO:0012507,ER to Golgi transport vesicle membrane,21,0,0.12,1.00000,1,1,0,CC
GO:0015030,Cajal body,35,0,0.19,1.00000,1,1,0,CC
GO:0016010,dystrophin-associated glycoprotein compl...,20,0,0.11,1.00000,1,1,0,CC
GO:0016235,aggresome,40,0,0.22,1.00000,1,1,0,CC
GO:0016327,apicolateral plasma membrane,22,0,0.12,1.00000,1,1,0,CC
GO:0016442,RISC complex,123,0,0.68,1.00000,1,1,0,CC
GO:0016469,proton-transporting two-sector ATPase co...,49,0,0.27,1.00000,1,1,0,CC
GO:0016592,mediator complex,36,0,0.2,1.00000,1,1,0,CC
GO:0017053,transcriptional repressor complex,83,0,0.46,1.00000,1,1,0,CC
GO:0018995,host,24,0,0.13,1.00000,1,1,0,CC
GO:0019005,SCF ubiquitin ligase complex,68,0,0.38,1.00000,1,1,0,CC
GO:0022624,proteasome accessory complex,25,0,0.14,1.00000,1,1,0,CC
GO:0030057,desmosome,25,0,0.14,1.00000,1,1,0,CC
GO:0030118,clathrin coat,49,0,0.27,1.00000,1,1,0,CC
GO:0030119,AP-type membrane coat adaptor complex,48,0,0.27,1.00000,1,1,0,CC
GO:0030125,clathrin vesicle coat,29,0,0.16,1.00000,1,1,0,CC
GO:0030131,clathrin adaptor complex,30,0,0.17,1.00000,1,1,0,CC
GO:0030132,clathrin coat of coated pit,22,0,0.12,1.00000,1,1,0,CC
GO:0030140,trans-Golgi network transport vesicle,29,0,0.16,1.00000,1,1,0,CC
GO:0030173,integral component of Golgi membrane,53,0,0.29,1.00000,1,1,0,CC
GO:0030285,integral component of synaptic vesicle m...,45,0,0.25,1.00000,1,1,0,CC
GO:0030315,T-tubule,74,0,0.41,1.00000,1,1,0,CC
GO:0030496,midbody,144,0,0.8,1.00000,1,1,0,CC
GO:0030665,clathrin-coated vesicle membrane,37,0,0.21,1.00000,1,1,0,CC
GO:0030666,endocytic vesicle membrane,32,0,0.18,1.00000,1,1,0,CC
GO:0030686,90S preribosome,30,0,0.17,1.00000,1,1,0,CC
GO:0030687,"preribosome, large subunit precursor",25,0,0.14,1.00000,1,1,0,CC
GO:0030894,replisome,25,0,0.14,1.00000,1,1,0,CC
GO:0030904,retromer complex,20,0,0.11,1.00000,1,1,0,CC
GO:0030964,NADH dehydrogenase complex,50,0,0.28,1.00000,1,1,0,CC
GO:0030990,intraciliary transport particle,29,0,0.16,1.00000,1,1,0,CC
GO:0030992,intraciliary transport particle B,21,0,0.12,1.00000,1,1,0,CC
GO:0031082,BLOC complex,20,0,0.11,1.00000,1,1,0,CC
GO:0031201,SNARE complex,49,0,0.27,1.00000,1,1,0,CC
GO:0031225,anchored component of membrane,192,0,1.07,1.00000,1,1,0,CC
GO:0031228,intrinsic component of Golgi membrane,55,0,0.31,1.00000,1,1,0,CC
GO:0031231,intrinsic component of peroxisomal membr...,20,0,0.11,1.00000,1,1,0,CC
GO:0031233,intrinsic component of external side of ...,25,0,0.14,1.00000,1,1,0,CC
GO:0031234,extrinsic component of cytoplasmic side ...,98,0,0.54,1.00000,1,1,0,CC
GO:0031248,protein acetyltransferase complex,93,0,0.52,1.00000,1,1,0,CC
GO:0031304,intrinsic component of mitochondrial inn...,44,0,0.24,1.00000,1,1,0,CC
GO:0031305,integral component of mitochondrial inne...,43,0,0.24,1.00000,1,1,0,CC
GO:0031312,extrinsic component of organelle membran...,56,0,0.31,1.00000,1,1,0,CC
GO:0031332,RNAi effector complex,123,0,0.68,1.00000,1,1,0,CC
GO:0031362,anchored component of external side of p...,22,0,0.12,1.00000,1,1,0,CC
GO:0031519,PcG protein complex,47,0,0.26,1.00000,1,1,0,CC
GO:0031526,brush border membrane,77,0,0.43,1.00000,1,1,0,CC
GO:0031616,spindle pole centrosome,20,0,0.11,1.00000,1,1,0,CC
GO:0031901,early endosome membrane,51,0,0.28,1.00000,1,1,0,CC
GO:0031902,late endosome membrane,54,0,0.3,1.00000,1,1,0,CC
GO:0031903,microbody membrane,45,0,0.25,1.00000,1,1,0,CC
GO:0031985,Golgi cisterna,62,0,0.34,1.00000,1,1,0,CC
GO:0032040,small-subunit processome,37,0,0.21,1.00000,1,1,0,CC
GO:0032281,AMPA glutamate receptor complex,32,0,0.18,1.00000,1,1,0,CC
GO:0032391,photoreceptor connecting cilium,46,0,0.26,1.00000,1,1,0,CC
GO:0032420,stereocilium,54,0,0.3,1.00000,1,1,0,CC
GO:0032421,stereocilium bundle,64,0,0.36,1.00000,1,1,0,CC
GO:0032426,stereocilium tip,20,0,0.11,1.00000,1,1,0,CC
GO:0032588,trans-Golgi network membrane,34,0,0.19,1.00000,1,1,0,CC
GO:0032806,carboxy-terminal domain protein kinase c...,21,0,0.12,1.00000,1,1,0,CC
GO:0032809,neuronal cell body membrane,36,0,0.2,1.00000,1,1,0,CC
GO:0032993,protein-DNA complex,191,0,1.06,1.00000,1,1,0,CC
GO:0032994,protein-lipid complex,36,0,0.2,1.00000,1,1,0,CC
GO:0033017,sarcoplasmic reticulum membrane,24,0,0.13,1.00000,1,1,0,CC
GO:0033176,proton-transporting V-type ATPase comple...,26,0,0.14,1.00000,1,1,0,CC
GO:0033177,proton-transporting two-sector ATPase co...,22,0,0.12,1.00000,1,1,0,CC
GO:0033643,host cell part,22,0,0.12,1.00000,1,1,0,CC
GO:0033646,host intracellular part,20,0,0.11,1.00000,1,1,0,CC
GO:0034358,plasma lipoprotein particle,34,0,0.19,1.00000,1,1,0,CC
GO:0034364,high-density lipoprotein particle,23,0,0.13,1.00000,1,1,0,CC
GO:0034451,centriolar satellite,32,0,0.18,1.00000,1,1,0,CC
GO:0034704,calcium channel complex,64,0,0.36,1.00000,1,1,0,CC
GO:0034706,sodium channel complex,24,0,0.13,1.00000,1,1,0,CC
GO:0034707,chloride channel complex,46,0,0.26,1.00000,1,1,0,CC
GO:0034708,methyltransferase complex,118,0,0.66,1.00000,1,1,0,CC
GO:0035097,histone methyltransferase complex,94,0,0.52,1.00000,1,1,0,CC
GO:0035145,exon-exon junction complex,21,0,0.12,1.00000,1,1,0,CC
GO:0035267,NuA4 histone acetyltransferase complex,21,0,0.12,1.00000,1,1,0,CC
GO:0035327,transcriptionally active chromatin,25,0,0.14,1.00000,1,1,0,CC
GO:0035861,site of double-strand break,50,0,0.28,1.00000,1,1,0,CC
GO:0035869,ciliary transition zone,73,0,0.41,1.00000,1,1,0,CC
GO:0036064,ciliary basal body,148,0,0.82,1.00000,1,1,0,CC
GO:0036379,myofilament,32,0,0.18,1.00000,1,1,0,CC
GO:0036452,ESCRT complex,24,0,0.13,1.00000,1,1,0,CC
GO:0042470,melanosome,31,0,0.17,1.00000,1,1,0,CC
GO:0042611,MHC protein complex,21,0,0.12,1.00000,1,1,0,CC
GO:0042645,mitochondrial nucleoid,47,0,0.26,1.00000,1,1,0,CC
GO:0043073,germ cell nucleus,30,0,0.17,1.00000,1,1,0,CC
GO:0043083,synaptic cleft,20,0,0.11,1.00000,1,1,0,CC
GO:0043189,H4/H2A histone acetyltransferase complex,21,0,0.12,1.00000,1,1,0,CC
GO:0043195,terminal bouton,87,0,0.48,1.00000,1,1,0,CC
GO:0043596,nuclear replication fork,41,0,0.23,1.00000,1,1,0,CC
GO:0043601,nuclear replisome,24,0,0.13,1.00000,1,1,0,CC
GO:0043656,intracellular region of host,20,0,0.11,1.00000,1,1,0,CC
GO:0043657,host cell,24,0,0.13,1.00000,1,1,0,CC
GO:0044215,other organism,30,0,0.17,1.00000,1,1,0,CC
GO:0044216,other organism cell,30,0,0.17,1.00000,1,1,0,CC
GO:0044217,other organism part,30,0,0.17,1.00000,1,1,0,CC
GO:0044292,dendrite terminus,20,0,0.11,1.00000,1,1,0,CC
GO:0044298,cell body membrane,38,0,0.21,1.00000,1,1,0,CC
GO:0044305,calyx of Held,30,0,0.17,1.00000,1,1,0,CC
GO:0044420,extracellular matrix component,52,0,0.29,1.00000,1,1,0,CC
GO:0044437,vacuolar part,180,0,1,1.00000,1,1,0,CC
GO:0044440,endosomal part,234,0,1.3,1.00000,1,1,0,CC
GO:0044447,axoneme part,40,0,0.22,1.00000,1,1,0,CC
GO:0044450,microtubule organizing center part,165,0,0.92,1.00000,1,1,0,CC
GO:0044665,MLL1/2 complex,30,0,0.17,1.00000,1,1,0,CC
GO:0044815,DNA packaging complex,96,0,0.53,1.00000,1,1,0,CC
GO:0045095,keratin filament,40,0,0.22,1.00000,1,1,0,CC
GO:0045120,pronucleus,23,0,0.13,1.00000,1,1,0,CC
GO:0045171,intercellular bridge,58,0,0.32,1.00000,1,1,0,CC
GO:0045178,basal part of cell,66,0,0.37,1.00000,1,1,0,CC
GO:0045259,proton-transporting ATP synthase complex,21,0,0.12,1.00000,1,1,0,CC
GO:0045271,respiratory chain complex I,50,0,0.28,1.00000,1,1,0,CC
GO:0046540,U4/U6 x U5 tri-snRNP complex,33,0,0.18,1.00000,1,1,0,CC
GO:0046658,anchored component of plasma membrane,73,0,0.41,1.00000,1,1,0,CC
GO:0046930,pore complex,23,0,0.13,1.00000,1,1,0,CC
GO:0048770,pigment granule,31,0,0.17,1.00000,1,1,0,CC
GO:0055038,recycling endosome membrane,45,0,0.25,1.00000,1,1,0,CC
GO:0060076,excitatory synapse,76,0,0.42,1.00000,1,1,0,CC
GO:0060077,inhibitory synapse,25,0,0.14,1.00000,1,1,0,CC
GO:0060170,ciliary membrane,53,0,0.29,1.00000,1,1,0,CC
GO:0061702,inflammasome complex,21,0,0.12,1.00000,1,1,0,CC
GO:0070461,SAGA-type complex,26,0,0.14,1.00000,1,1,0,CC
GO:0070971,endoplasmic reticulum exit site,27,0,0.15,1.00000,1,1,0,CC
GO:0071005,U2-type precatalytic spliceosome,49,0,0.27,1.00000,1,1,0,CC
GO:0071007,U2-type catalytic step 2 spliceosome,28,0,0.16,1.00000,1,1,0,CC
GO:0071011,precatalytic spliceosome,50,0,0.28,1.00000,1,1,0,CC
GO:0071339,MLL1 complex,30,0,0.17,1.00000,1,1,0,CC
GO:0071782,endoplasmic reticulum tubular network,23,0,0.13,1.00000,1,1,0,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,32,0,0.18,1.00000,1,1,0,CC
GO:0090568,nuclear transcriptional repressor comple...,29,0,0.16,1.00000,1,1,0,CC
GO:0090665,glycoprotein complex,20,0,0.11,1.00000,1,1,0,CC
GO:0090734,site of DNA damage,65,0,0.36,1.00000,1,1,0,CC
GO:0097225,sperm midpiece,28,0,0.16,1.00000,1,1,0,CC
GO:0097228,sperm principal piece,32,0,0.18,1.00000,1,1,0,CC
GO:0097346,INO80-type complex,24,0,0.13,1.00000,1,1,0,CC
GO:0097440,apical dendrite,27,0,0.15,1.00000,1,1,0,CC
GO:0097526,spliceosomal tri-snRNP complex,33,0,0.18,1.00000,1,1,0,CC
GO:0097546,ciliary base,35,0,0.19,1.00000,1,1,0,CC
GO:0098563,intrinsic component of synaptic vesicle ...,65,0,0.36,1.00000,1,1,0,CC
GO:0098636,protein complex involved in cell adhesio...,37,0,0.21,1.00000,1,1,0,CC
GO:0098686,hippocampal mossy fiber to CA3 synapse,50,0,0.28,1.00000,1,1,0,CC
GO:0098688,parallel fiber to Purkinje cell synapse,33,0,0.18,1.00000,1,1,0,CC
GO:0098831,presynaptic active zone cytoplasmic comp...,23,0,0.13,1.00000,1,1,0,CC
GO:0098852,lytic vacuole membrane,111,0,0.62,1.00000,1,1,0,CC
GO:0098878,neurotransmitter receptor complex,59,0,0.33,1.00000,1,1,0,CC
GO:0098948,intrinsic component of postsynaptic spec...,113,0,0.63,1.00000,1,1,0,CC
GO:0098982,GABA-ergic synapse,104,0,0.58,1.00000,1,1,0,CC
GO:0098993,anchored component of synaptic vesicle m...,20,0,0.11,1.00000,1,1,0,CC
GO:0099023,tethering complex,63,0,0.35,1.00000,1,1,0,CC
GO:0099060,integral component of postsynaptic speci...,107,0,0.59,1.00000,1,1,0,CC
GO:0099061,integral component of postsynaptic densi...,74,0,0.41,1.00000,1,1,0,CC
GO:0099086,synaptonemal structure,81,0,0.45,1.00000,1,1,0,CC
GO:0099091,"postsynaptic specialization, intracellul...",38,0,0.21,1.00000,1,1,0,CC
GO:0099092,"postsynaptic density, intracellular comp...",32,0,0.18,1.00000,1,1,0,CC
GO:0099146,intrinsic component of postsynaptic dens...,80,0,0.44,1.00000,1,1,0,CC
GO:0099522,region of cytosol,41,0,0.23,1.00000,1,1,0,CC
GO:0099523,presynaptic cytosol,25,0,0.14,1.00000,1,1,0,CC
GO:0099524,postsynaptic cytosol,27,0,0.15,1.00000,1,1,0,CC
GO:0101031,chaperone complex,21,0,0.12,1.00000,1,1,0,CC
GO:1902493,acetyltransferase complex,93,0,0.52,1.00000,1,1,0,CC
GO:1902555,endoribonuclease complex,31,0,0.17,1.00000,1,1,0,CC
GO:1902562,H4 histone acetyltransferase complex,43,0,0.24,1.00000,1,1,0,CC
GO:1902710,GABA receptor complex,21,0,0.12,1.00000,1,1,0,CC
GO:1903293,phosphatase complex,46,0,0.26,1.00000,1,1,0,CC
GO:1905348,endonuclease complex,32,0,0.18,1.00000,1,1,0,CC
GO:1905354,exoribonuclease complex,23,0,0.13,1.00000,1,1,0,CC
GO:1905360,GTPase complex,33,0,0.18,1.00000,1,1,0,CC
GO:1905368,peptidase complex,93,0,0.52,1.00000,1,1,0,CC
GO:1905369,endopeptidase complex,67,0,0.37,1.00000,1,1,0,CC
GO:1990204,oxidoreductase complex,109,0,0.61,1.00000,1,1,0,CC
GO:1990391,DNA repair complex,38,0,0.21,1.00000,1,1,0,CC
GO:1990777,lipoprotein particle,34,0,0.19,1.00000,1,1,0,CC
